0001385613-22-000120.txt : 20221102 0001385613-22-000120.hdr.sgml : 20221102 20221102163010 ACCESSION NUMBER: 0001385613-22-000120 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREENLIGHT CAPITAL RE, LTD. CENTRAL INDEX KEY: 0001385613 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33493 FILM NUMBER: 221354569 BUSINESS ADDRESS: STREET 1: 65 MARKET STREET, SUITE 1207, STREET 2: CAMANA BAY, P.O. BOX 31110 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 BUSINESS PHONE: 345 943 4573 MAIL ADDRESS: STREET 1: 65 MARKET STREET, SUITE 1207, STREET 2: CAMANA BAY, P.O. BOX 31110 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1205 FORMER COMPANY: FORMER CONFORMED NAME: Greenlight Capital Re, Ltd. DATE OF NAME CHANGE: 20070109 10-Q 1 glre-20220930.htm 10-Q glre-20220930
000138561312/312022Q3falsehttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Memberhttp://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006MemberP3Dhttp://fasb.org/us-gaap/2022#OtherAssetshttp://fasb.org/us-gaap/2022#OtherLiabilities00013856132022-01-012022-09-300001385613us-gaap:CommonClassAMember2022-10-28xbrli:shares0001385613us-gaap:CommonClassBMember2022-10-2800013856132022-09-30iso4217:USD00013856132021-12-31iso4217:USDxbrli:shares0001385613us-gaap:CommonClassAMember2022-09-300001385613us-gaap:CommonClassAMember2021-12-310001385613us-gaap:CommonClassBMember2021-12-310001385613us-gaap:CommonClassBMember2022-09-3000013856132022-07-012022-09-3000013856132021-07-012021-09-3000013856132021-01-012021-09-300001385613us-gaap:CommonStockMember2022-06-300001385613us-gaap:CommonStockMember2021-06-300001385613us-gaap:CommonStockMember2021-12-310001385613us-gaap:CommonStockMember2020-12-310001385613us-gaap:CommonStockMember2022-07-012022-09-300001385613us-gaap:CommonStockMember2021-07-012021-09-300001385613us-gaap:CommonStockMember2022-01-012022-09-300001385613us-gaap:CommonStockMember2021-01-012021-09-300001385613us-gaap:CommonStockMember2022-09-300001385613us-gaap:CommonStockMember2021-09-300001385613us-gaap:AdditionalPaidInCapitalMember2022-06-300001385613us-gaap:AdditionalPaidInCapitalMember2021-06-300001385613us-gaap:AdditionalPaidInCapitalMember2021-12-310001385613us-gaap:AdditionalPaidInCapitalMember2020-12-310001385613us-gaap:AccountingStandardsUpdate202006Member2021-01-012021-12-310001385613us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate202006Member2022-06-300001385613us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001385613us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001385613us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001385613us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001385613us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300001385613us-gaap:AdditionalPaidInCapitalMember2022-09-300001385613us-gaap:AdditionalPaidInCapitalMember2021-09-300001385613us-gaap:RetainedEarningsMember2022-06-300001385613us-gaap:RetainedEarningsMember2021-06-300001385613us-gaap:RetainedEarningsMember2021-12-310001385613us-gaap:RetainedEarningsMember2020-12-310001385613us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate202006Member2022-06-300001385613us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001385613us-gaap:RetainedEarningsMember2022-07-012022-09-300001385613us-gaap:RetainedEarningsMember2021-07-012021-09-300001385613us-gaap:RetainedEarningsMember2022-01-012022-09-300001385613us-gaap:RetainedEarningsMember2021-01-012021-09-300001385613us-gaap:RetainedEarningsMember2022-09-300001385613us-gaap:RetainedEarningsMember2021-09-3000013856132021-09-3000013856132020-12-310001385613glre:CedentsMember2022-09-300001385613glre:CedentsMember2021-12-310001385613us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001385613us-gaap:EmployeeStockOptionMember2021-07-012021-09-300001385613us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001385613us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001385613us-gaap:RestrictedStockMember2022-07-012022-09-300001385613us-gaap:RestrictedStockMember2021-07-012021-09-300001385613us-gaap:RestrictedStockMember2022-01-012022-09-300001385613us-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:ConvertibleDebtSecuritiesMember2022-07-012022-09-300001385613us-gaap:ConvertibleDebtSecuritiesMember2021-07-012021-09-300001385613us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-09-300001385613us-gaap:ConvertibleDebtSecuritiesMember2021-01-012021-09-300001385613srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-31xbrli:pure0001385613glre:SolasglasInvestmentsLPSILPMemberglre:GreenlightCapitalReLimitedPartnersMember2022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberglre:GreenlightCapitalReLimitedPartnersMember2021-12-310001385613glre:SILPGeneralPartnerMember2022-09-300001385613glre:SILPGeneralPartnerMember2021-12-310001385613glre:LimitedPartnershipAgreementMember2022-01-012022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-12-310001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-12-310001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-07-012022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-07-012021-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-01-012022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-01-012021-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-07-012022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-07-012021-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-01-012022-09-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-01-012021-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2022-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2022-01-012022-09-300001385613us-gaap:ConvertibleDebtSecuritiesMember2022-09-300001385613us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-09-300001385613us-gaap:CertificatesOfDepositMember2022-09-300001385613us-gaap:CertificatesOfDepositMember2022-01-012022-09-300001385613us-gaap:OtherInvestmentsMember2022-09-300001385613us-gaap:OtherInvestmentsMember2022-01-012022-09-300001385613glre:PrivateAndUnlistedEquitySecuritiesMember2021-12-310001385613glre:PrivateAndUnlistedEquitySecuritiesMember2021-01-012021-12-310001385613glre:DerivativeFinancialInstrumentsMember2021-12-310001385613glre:DerivativeFinancialInstrumentsMember2021-01-012021-12-310001385613us-gaap:OtherInvestmentsMember2021-12-310001385613us-gaap:OtherInvestmentsMember2021-01-012021-12-310001385613us-gaap:FairValueMeasurementsNonrecurringMember2022-09-300001385613us-gaap:FairValueMeasurementsNonrecurringMember2021-09-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMemberus-gaap:FairValueMeasurementsNonrecurringMember2022-09-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMemberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310001385613glre:MeasurementPeriodOneMember2022-09-300001385613glre:MeasurementPeriodTwoMember2022-09-300001385613glre:MeasurementPeriodThreeMember2022-09-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2022-09-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2021-12-310001385613glre:RussianUkrainianConflictMember2022-09-300001385613glre:HurricaneIanMember2022-09-300001385613us-gaap:HealthInsuranceProductLineMember2021-12-310001385613us-gaap:HealthInsuranceProductLineMember2020-12-310001385613us-gaap:HealthInsuranceProductLineMember2022-01-012022-09-300001385613us-gaap:HealthInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:HealthInsuranceProductLineMember2022-09-300001385613us-gaap:HealthInsuranceProductLineMember2021-09-300001385613glre:UnratedMemberus-gaap:CededCreditRiskUnsecuredMember2022-09-300001385613glre:UnratedMemberus-gaap:CededCreditRiskUnsecuredMember2021-12-310001385613glre:UnratedMemberus-gaap:CededCreditRiskSecuredMember2022-09-300001385613glre:UnratedMemberus-gaap:CededCreditRiskSecuredMember2021-12-310001385613srt:AMBestAMinusRatingMember2022-09-300001385613srt:AMBestAMinusRatingMember2021-12-310001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2018-08-070001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2022-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2021-12-310001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2022-07-012022-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2022-01-012022-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2021-07-012021-09-300001385613us-gaap:SeniorNotesMemberglre:SeniorUnsecuredConvertibleNotesMember2021-01-012021-09-300001385613us-gaap:ConvertibleDebtMember2022-09-300001385613us-gaap:SubsequentEventMember2022-10-012022-11-020001385613us-gaap:CommonClassAMember2020-10-290001385613us-gaap:CommonClassAMember2020-10-2800013856132020-10-290001385613us-gaap:CommonClassAMember2022-01-012022-09-300001385613us-gaap:CommonClassAMember2020-12-310001385613us-gaap:CommonClassBMember2020-12-310001385613us-gaap:CommonClassBMember2022-01-012022-09-300001385613us-gaap:CommonClassAMember2021-01-012021-09-300001385613us-gaap:CommonClassBMember2021-01-012021-09-300001385613us-gaap:CommonClassAMember2021-09-300001385613us-gaap:CommonClassBMember2021-09-300001385613us-gaap:CommonClassAMemberglre:NonEmployeeDirectorMemberus-gaap:RestrictedStockMember2022-01-012022-09-300001385613us-gaap:CommonClassAMemberglre:NonEmployeeDirectorMemberus-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:CommonClassAMemberus-gaap:RestrictedStockMember2022-01-012022-09-300001385613us-gaap:CommonClassAMemberus-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:RestrictedStockMember2022-01-012022-09-300001385613srt:MinimumMemberus-gaap:RestrictedStockMember2022-01-012022-09-300001385613srt:MaximumMemberus-gaap:RestrictedStockMember2022-01-012022-09-300001385613srt:ChiefExecutiveOfficerMemberus-gaap:RestrictedStockMember2022-01-012022-09-300001385613glre:PerformanceRestrictedStockMembersrt:ChiefExecutiveOfficerMember2022-09-300001385613srt:ChiefExecutiveOfficerMember2022-09-300001385613srt:ChiefExecutiveOfficerMember2021-09-300001385613us-gaap:RestrictedStockMember2021-01-012021-09-300001385613us-gaap:RestrictedStockMember2022-09-300001385613us-gaap:RestrictedStockMember2021-12-310001385613us-gaap:RestrictedStockMember2021-01-012021-12-310001385613glre:PerformanceRestrictedStockMember2021-12-310001385613glre:ServiceRestrictedStockMember2021-12-310001385613glre:PerformanceRestrictedStockMember2022-01-012022-09-300001385613glre:ServiceRestrictedStockMember2022-01-012022-09-300001385613glre:PerformanceRestrictedStockMember2022-09-300001385613glre:ServiceRestrictedStockMember2022-09-300001385613us-gaap:CommonClassAMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001385613glre:PerformanceRestrictedStockUnitsMember2022-01-012022-09-300001385613glre:PerformanceRestrictedStockUnitsMembersrt:MinimumMember2022-01-012022-09-300001385613glre:PerformanceRestrictedStockUnitsMembersrt:MaximumMember2022-01-012022-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2022-09-300001385613us-gaap:RestrictedStockUnitsRSUMember2021-12-310001385613us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001385613glre:PerformanceRestrictedStockUnitsMember2021-12-310001385613glre:ServiceRestrictedStockUnitsMember2021-12-310001385613glre:ServiceRestrictedStockUnitsMember2022-01-012022-09-300001385613glre:PerformanceRestrictedStockUnitsMember2022-09-300001385613glre:ServiceRestrictedStockUnitsMember2022-09-300001385613us-gaap:CommonClassAMemberus-gaap:EmployeeStockOptionMembersrt:ChiefExecutiveOfficerMember2021-01-012021-09-300001385613us-gaap:CommonClassAMemberus-gaap:EmployeeStockOptionMembersrt:ChiefExecutiveOfficerMember2022-01-012022-09-300001385613us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001385613us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001385613us-gaap:EmployeeStockOptionMember2022-09-300001385613us-gaap:EmployeeStockOptionMember2021-12-310001385613us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001385613us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001385613us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-09-300001385613us-gaap:OtherAssetsMember2022-09-300001385613us-gaap:OtherAssetsMember2021-12-310001385613srt:BoardOfDirectorsChairmanMemberglre:LimitedPartnershipAgreementMember2018-09-012018-09-010001385613srt:BoardOfDirectorsChairmanMemberglre:LimitedPartnershipAgreementMember2022-01-012022-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:InvestmentAdvisoryAgreementMember2018-09-012018-09-010001385613srt:AffiliatedEntityMemberglre:GreenBricksPartnersIncGRBKMember2022-09-300001385613glre:GreenBricksPartnersIncGRBKMemberglre:SolasglasInvestmentsLPSILPMembersrt:AffiliatedEntityMember2022-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:ServiceAgreementMember2022-01-012022-09-300001385613srt:BoardOfDirectorsChairmanMemberglre:CollateralAssetsInvestementManagementAgreementMember2019-01-012019-01-01glre:facility0001385613glre:CitibankEuropePlcMemberus-gaap:FinancialStandbyLetterOfCreditMember2022-09-300001385613glre:CitibankEuropePlcMemberus-gaap:FinancialStandbyLetterOfCreditMember2022-01-012022-09-300001385613us-gaap:LetterOfCreditMember2022-09-300001385613us-gaap:LetterOfCreditMember2021-12-31glre:segment0001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2022-07-012022-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2022-01-012022-09-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2021-01-012021-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2022-07-012022-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2021-07-012021-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2022-01-012022-09-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2021-01-012021-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2022-07-012022-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2022-01-012022-09-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:PropertyInsuranceProductLineMember2022-07-012022-09-300001385613us-gaap:PropertyInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:PropertyInsuranceProductLineMember2022-01-012022-09-300001385613us-gaap:PropertyInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:GeneralLiabilityMember2022-07-012022-09-300001385613us-gaap:GeneralLiabilityMember2021-07-012021-09-300001385613us-gaap:GeneralLiabilityMember2022-01-012022-09-300001385613us-gaap:GeneralLiabilityMember2021-01-012021-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2022-07-012022-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2021-07-012021-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2022-01-012022-09-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2021-01-012021-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2022-07-012022-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2021-07-012021-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2022-01-012022-09-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2021-01-012021-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2022-07-012022-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2021-07-012021-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2022-01-012022-09-300001385613glre:WorkersCompensationInsuranceProductLineMember2021-01-012021-09-300001385613glre:MultilineMember2022-07-012022-09-300001385613glre:MultilineMember2021-07-012021-09-300001385613glre:MultilineMember2022-01-012022-09-300001385613glre:MultilineMember2021-01-012021-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2022-07-012022-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2021-07-012021-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2022-01-012022-09-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2021-01-012021-09-300001385613us-gaap:HealthInsuranceProductLineMember2022-07-012022-09-300001385613us-gaap:HealthInsuranceProductLineMember2021-07-012021-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2022-07-012022-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2021-07-012021-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2022-01-012022-09-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2021-01-012021-09-300001385613glre:MarineCasualtyInsuranceMember2022-07-012022-09-300001385613glre:MarineCasualtyInsuranceMember2021-07-012021-09-300001385613glre:MarineCasualtyInsuranceMember2022-01-012022-09-300001385613glre:MarineCasualtyInsuranceMember2021-01-012021-09-300001385613us-gaap:OtherInsuranceProductLineMember2022-07-012022-09-300001385613us-gaap:OtherInsuranceProductLineMember2021-07-012021-09-300001385613us-gaap:OtherInsuranceProductLineMember2022-01-012022-09-300001385613us-gaap:OtherInsuranceProductLineMember2021-01-012021-09-300001385613glre:TotalSpecialtyDomain2022-07-012022-09-300001385613glre:TotalSpecialtyDomain2021-07-012021-09-300001385613glre:TotalSpecialtyDomain2022-01-012022-09-300001385613glre:TotalSpecialtyDomain2021-01-012021-09-300001385613srt:NorthAmericaMember2022-07-012022-09-300001385613srt:NorthAmericaMember2021-07-012021-09-300001385613srt:NorthAmericaMember2022-01-012022-09-300001385613srt:NorthAmericaMember2021-01-012021-09-300001385613glre:WorldwideMember2022-07-012022-09-300001385613glre:WorldwideMember2021-07-012021-09-300001385613glre:WorldwideMember2022-01-012022-09-300001385613glre:WorldwideMember2021-01-012021-09-300001385613srt:EuropeMember2022-07-012022-09-300001385613srt:EuropeMember2021-07-012021-09-300001385613srt:EuropeMember2022-01-012022-09-300001385613srt:EuropeMember2021-01-012021-09-300001385613srt:AsiaMember2022-07-012022-09-300001385613srt:AsiaMember2021-07-012021-09-300001385613srt:AsiaMember2022-01-012022-09-300001385613srt:AsiaMember2021-01-012021-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________
FORM 10-Q 
__________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022

or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from     to
Commission file number 001-33493
____________________________________________________________________________________
GREENLIGHT CAPITAL RE, LTD.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________
Cayman IslandsN/A
(State or other jurisdiction of incorporation or organization)(I.R.S. employer identification no.)
65 Market Street
Suite 1207, Jasmine Court
P.O. Box 31110
Camana Bay
Grand Cayman
Cayman IslandsKY1-1205
(Address of principal executive offices)(Zip code)

(345) 943-4573
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report) 

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Ordinary SharesGLRENasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): 
Large accelerated filer ☐         Accelerated filer ☒          Non-accelerated filer ☐          Smaller reporting company ☐          Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) 
Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class A Ordinary Shares, $0.10 par value28,569,346
Class B Ordinary Shares, $0.10 par value6,254,715
(Class)Outstanding at October 28, 2022


GREENLIGHT CAPITAL RE, LTD.
 
TABLE OF CONTENTS
 
  Page
 Condensed Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 (unaudited)
 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021 (unaudited)
 Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and nine months ended September 30, 2022 and 2021 (unaudited)
 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (unaudited)
 Notes to the Condensed Consolidated Financial Statements (unaudited)


 
2
PART I — FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS 
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED) 
September 30, 2022 and December 31, 2021
(expressed in thousands of U.S. dollars, except per share and share amounts)
 September 30, 2022December 31, 2021
Assets  
Investments  
Investment in related party investment fund$195,199 $183,591 
Other investments65,081 47,384 
Total investments260,280 230,975 
Cash and cash equivalents32,278 76,307 
Restricted cash and cash equivalents648,897 634,794 
Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89)
473,564 405,365 
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47)
10,604 11,100 
Deferred acquisition costs 78,836 63,026 
Unearned premiums ceded13,659 42 
Other assets6,425 5,885 
Total assets$1,524,543 $1,427,494 
Liabilities and equity 
Liabilities 
Loss and loss adjustment expense reserves$540,827 $524,010 
Unearned premium reserves298,173 227,584 
Reinsurance balances payable108,772 91,224 
Funds withheld11,446 3,792 
Other liabilities4,927 7,164 
Convertible senior notes payable93,446 98,057 
Total liabilities1,057,591 951,831 
Shareholders' equity 
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)
— — 
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 28,569,346 (2021: 27,589,731): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2021: 6,254,715))
3,482 3,384 
Additional paid-in capital477,021 481,784 
Retained earnings (deficit)(13,551)(9,505)
Total shareholders' equity466,952 475,663 
Total liabilities and equity$1,524,543 $1,427,494 
 





  The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements.
3
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED) 
For the three and nine months ended September 30, 2022 and 2021
(expressed in thousands of U.S. dollars, except per share and share amounts)
Three months ended September 30Nine months ended September 30
 2022202120222021
Revenues 
Gross premiums written$155,146 $128,735 $435,812 $440,249 
Gross premiums ceded(8,801)(60)(21,973)(6)
Net premiums written146,345 128,675 413,839 440,243 
Change in net unearned premium reserves(24,397)6,849 (55,747)(36,844)
Net premiums earned121,948 135,524 358,092 403,399 
Income (loss) from investment in related party investment fund (net of related party expenses - Note 3) 8,521 (6,214)24,474 (4,196)
Net investment income (loss)3,038 10,303 11,978 28,999 
Other income (expense), net(6,784)(342)(13,374)(1,076)
Total revenues126,723 139,271 381,170 427,126 
Expenses
Net loss and loss adjustment expenses incurred94,559 110,400 252,789 295,078 
Acquisition costs36,821 35,048 106,101 106,060 
General and administrative expenses7,389 6,060 22,727 21,340 
Deposit interest expense6,148 38 6,373 2,957 
Interest expense1,091 1,578 3,411 4,684 
Total expenses146,008 153,124 391,401 430,119 
Income (loss) before income tax(19,285)(13,853)(10,231)(2,993)
Income tax (expense) benefit816 — 823 (3,733)
Net income (loss)$(18,469)$(13,853)$(9,408)$(6,726)
Earnings (loss) per share (Class A and Class B)
Basic$(0.56)$(0.42)$(0.28)$(0.20)
Diluted$(0.56)$(0.42)$(0.28)$(0.20)
Weighted average number of ordinary shares used in the determination of earnings and loss per share
Basic33,127,384 32,929,097 33,119,814 33,507,060 
Diluted33,127,384 32,929,097 33,119,814 33,507,060 
 










 
The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements.  
4
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(UNAUDITED)
 For the nine months ended September 30, 2022 and 2021
(expressed in thousands of U.S. dollars)

Three months ended September 30Nine months ended September 30
2022202120222021
Ordinary share capital
Balance - beginning of period$3,472 $3,417 $3,384 $3,452 
Issue of Class A ordinary shares, net of forfeitures11 3 99 41 
Repurchase of Class A ordinary shares(1)(36)(1)(109)
Balance - end of period3,482 3,384 3,482 3,384 
Additional paid-in capital
Balance - beginning of period475,903 483,365 481,784 488,488 
Cumulative effect of adoption of accounting guidance for convertible debt at January 1, 2022— — (7,896)— 
Repurchase of Class A ordinary shares(34)(3,216)(34)(9,891)
Share-based compensation expense1,152 790 3,167 2,342 
Balance - end of period477,021 480,939 477,021 480,939 
Retained earnings (deficit)
Balance - beginning of period4,918 (19,956)(9,505)(27,083)
Cumulative effect of adoption of accounting guidance for convertible debt at January 1, 2022— — 5,362 — 
Net income (loss)(18,469)(13,853)(9,408)(6,726)
Balance - end of period(13,551)(33,809)(13,551)(33,809)
Total shareholders' equity$466,952 $450,514 $466,952 $450,514 






















The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 

5
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the nine months ended September 30, 2022 and 2021
(expressed in thousands of U.S. dollars) 
Nine months ended September 30
 20222021
Cash provided by (used in) operating activities 
Net income (loss)$(9,408)$(6,726)
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
Loss (income) from investments in related party investment fund(24,474)4,196 
Net realized gain on repurchase of convertible senior notes payable(149)— 
Net change in unrealized gains and losses on investments and notes receivable(9,237)(14,860)
Net realized (gains) losses on investments and notes receivable— (14,210)
Foreign exchange (gains) losses10,364 14 
Share-based compensation expense3,266 2,383 
Amortization and interest expense, net of change in accruals(612)684 
Depreciation expense— 16 
Net change in
Reinsurance balances receivable(97,651)(50,185)
Loss and loss adjustment expenses recoverable496 3,769 
Deferred acquisition costs(15,810)(9,620)
Unearned premiums ceded(13,617)(26)
Other assets, excluding depreciation(540)(3,760)
Loss and loss adjustment expense reserves36,394 46,600 
Unearned premium reserves70,589 36,837 
Reinsurance balances payable17,548 (14,722)
Funds withheld7,654 612 
Other liabilities(2,237)219 
Net cash provided by (used in) operating activities(27,424)(18,779)
Investing activities
Proceeds from redemptions from related party investment fund77,993 51,904 
Contributions to related party investment fund(65,127)(69,604)
Purchases of investments(8,627)(4,761)
Proceeds from sales of investments— 20,755 
Change in notes receivable— 6,101 
Net cash provided by (used in) investing activities4,239 4,395 
Financing activities
Repurchases of convertible senior notes payable(6,384)— 
Repurchase of Class A ordinary shares(35)(10,000)
Net cash provided by (used in) financing activities(6,419)(10,000)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash(322)— 
Net increase (decrease) in cash, cash equivalents and restricted cash(29,926)(24,384)
Cash, cash equivalents and restricted cash at beginning of the period 711,101 754,306 
Cash, cash equivalents and restricted cash at end of the period $681,175 $729,922 
Supplementary information 
Interest paid in cash$4,023 $4,000 
Income tax paid in cash— 3,700 

The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 
6
GREENLIGHT CAPITAL RE, LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
September 30, 2022
  
1. ORGANIZATION AND BASIS OF PRESENTATION
 
Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”) and is subject to regulation by the Cayman Islands Monetary Authority. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  In 2020, GLRE established Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) as a wholly-owned subsidiary to increase the Company’s presence in the London market. In 2022, Greenlight Innovation Syndicate 3456 (“Syndicate 3456”) commenced underwriting under the Lloyd’s syndicate-in-a-box model, with Greenlight Re as the sole capital provider. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission on March 8, 2022. The condensed consolidated financial statements include the accounts of GLRE and its wholly-owned subsidiaries, Greenlight Re, GRIL, Verdant, and Greenlight Re UK. The condensed consolidated financial statements also include the accounts of Syndicate 3456. All significant intercompany transactions and balances have been eliminated on consolidation.

Certain amounts in the prior periods presented have been reclassified to conform to the current period financial statements presentation. These reclassifications do not affect previously reported net income or retained earnings.

In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented.

Significant estimates used to prepare the Company’s condensed consolidated financial statements, including those associated with premiums and the estimations of loss and loss adjustment expense reserves, may be subject to significant adjustments in future periods.

2. SIGNIFICANT ACCOUNTING POLICIES
 
There have been no material changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2021.

Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s
7
condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, premiums written, earned, and receivable, variability underlying risk transfer assessments, allowances for credit losses, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.

Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
 
Cash and cash equivalents consist of cash and short-term, highly liquid investments and certificates of deposit with original maturity dates of three months or less. Certificates of deposit with original maturities greater than three months are included under the caption "Other investments" on the condensed consolidated balance sheets.

The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2022December 31, 2021
 ($ in thousands)
Cash and cash equivalents$32,278 $76,307 
Restricted cash and cash equivalents648,897 634,794 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$681,175 $711,101 

Funds Held by Cedents

The caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes financial assets held by cedents. At September 30, 2022, funds held by cedents were $303.1 million (December 31, 2021: $246.9 million). Such amounts include premiums withheld by Lloyd’s syndicates and funds contributed by the Company to Lloyd's as security for members’ underwriting activities. The syndicates invest a portion of the premiums withheld in fixed maturity securities and investment funds. The Company records its share of income (or expense) from these assets in its condensed consolidated statements of operations under the caption “Other income (expense).”
 
Reinsurance Assets

The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets.

The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. Credit ratings of the counterparties are forward-looking and consider various economic scenarios. The Company's evaluation of the required allowance for reinsurance balances receivable and loss and loss adjustment expenses recoverable considers the current economic environment as well as potential macroeconomic developments.

For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.

At September 30, 2022, the Company has recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million (December 31, 2021: $0.1 million).
8

Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the captions “Other income (expense)” and “Deposit interest expense,” respectively. The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2022, deposit assets and deposit liabilities were $3.2 million and $13.7 million, respectively (December 31, 2021: $3.5 million and $18.6 million, respectively). For the three and nine months ended September 30, 2022, and 2021, the interest income and expense on deposit accounted contracts were as follows:
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Deposit interest income$— $— $— $— 
Deposit interest expense$(6,148)$(38)$(6,373)$(2,957)
Deposit interest income/(expense), net$(6,148)$(38)$(6,373)$(2,957)


Foreign Exchange

The reporting and functional currency of the Company and all its significant subsidiaries is the U.S. dollar. The Company records foreign currency transactions at the exchange rates in effect on the transaction date. Monetary assets and liabilities in foreign currencies at the balance sheet date are converted at the exchange rate in effect at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are carried at their historical exchange rates. The Company includes any foreign exchange gains and losses under the caption “Other income (expense), net” in the Company’s condensed consolidated statements of operations. 

For the three and nine months ended September 30, 2022, $5.0 million and $10.4 million, respectively, (three and nine months ended September 30, 2021: $0.6 million and $1.4 million, respectively), of foreign exchange loss was included in the Company’s net income (loss) in the condensed consolidated statements of operations. 

Derivative instruments

The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.
9

Other Assets

The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, taxes recoverable, and deferred tax assets.

Other Liabilities

The caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities.

Earnings (Loss) Per Share
 
The Company has issued unvested restricted stock awards, some of which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid. These awards are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of ordinary shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect, if any, of the following:

•Restricted Stock Units (“RSUs”) issued that convert to ordinary shares upon vesting;
•Unvested restricted share awards which are not considered “participating securities”;
•Additional potential ordinary shares issuable when in-the-money stock options are exercised, determined using the treasury stock method;
•For periods prior to January 1, 2022, those ordinary shares with the potential to be issued in connection with convertible notes and other such convertible instruments, determined using the treasury stock method; and
•Effective January 1, 2022, the dilutive effect of the convertible notes is calculated using the if-converted method. Under the if-converted method, the convertible notes are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted net income per common share calculation. Interest expense related to the convertible notes incurred in the period is added back to the numerator for purposes of the if-converted calculation.
For the three and nine months ended September 30, 2022, the effect of the assumed conversion of the convertible notes was anti-dilutive and was not included in the computation of diluted earnings per share.

Diluted earnings (or loss) per share contemplates a conversion to ordinary shares of all convertible instruments only if they are dilutive. In the event of a net loss, all RSUs, stock options, shares potentially issuable in connection with convertible notes, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.

10
The following table reconciles net income (loss) and weighted average shares used in computing basic and diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021 (expressed in thousands of U.S. dollars, except per share and share amounts):
 Three months ended September 30Nine months ended September 30
 2022202120222021
Numerator for earnings per share
Net income (loss) - basic$(18,469)$(13,853)$(9,408)$(6,726)
Add: interest on convertible notes— — — — 
Net income (loss) - diluted$(18,469)$(13,853)$(9,408)$(6,726)
Denominator for earnings per share
Weighted average shares outstanding - basic33,127,384 32,929,097 33,119,814 33,507,060 
Effect of dilutive employee and director share-based awards— — — — 
Shares potentially issuable in connection with convertible notes — — — — 
Weighted average shares outstanding - diluted33,127,384 32,929,097 33,119,814 33,507,060 
Anti-dilutive stock options outstanding690,337 735,627 690,337 735,627 
Participating securities excluded from calculation of loss per share 848,841 946,556 848,841 946,556 
Shares potentially issuable in connection with convertible notes excluded from calculation of diluted loss per share5,686,747 — 5,773,889 — 
Earnings (loss) per Class A and Class B Ordinary share:
Basic$(0.56)$(0.42)$(0.28)$(0.20)
Diluted$(0.56)$(0.42)$(0.28)$(0.20)


Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Act, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes a tax on profits, income, gains, or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2021: 21%). Verdant’s tax years 2018 and beyond remain open and may be subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. 

11
Recent Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” (“ASU 2022-03”). ASU 2022-03 clarifies the guidance for measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 is effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company does not expect ASU 2022-03 to have a material impact on its financial position, results of operations, or cash flows.

Recently Issued Accounting Standards Adopted

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; instead, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring the application of the if-converted method when calculating diluted earnings per share. Under the if-converted method, the shares potentially issuable in connection with convertible debt are assumed to be converted at the beginning of the period. The resulting ordinary shares are included in the denominator of the diluted earnings per share calculation for the period presented.

The Company adopted ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. The adoption of ASU 2020-06 resulted in a decrease in the Company’s opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes (see Note 7). The adoption of ASU 2020-06 did not have a material impact on the Company’s net income, cash flows, or any other balances.


3. INVESTMENT IN RELATED PARTY INVESTMENT FUND

The Company has entered into the Second Amended and Restated Exempted Limited Partnership Agreement (the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, and GRIL, (together, the “GLRE Limited Partners”). SILP has entered into a SILP investment advisory agreement (“IAA”) with DME Advisors. LP (“DME Advisors”) pursuant to which DME Advisors is the investment manager for SILP. DME II and DME Advisors are related to the Company, and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors (the “Chairman”).

The SILP LPA includes the following proviso: “The Investment Portfolio of each Partner will not exceed the product of (a) such Partner’s surplus (Greenlight Re Surplus or GRIL Surplus, as the case may be) multiplied by (b) the Investment Cap (50%), and the General Partner will designate any portion of a Partner’s Investment Portfolio as Designated Securities to effectuate such limit.”

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•DME II holds an interest in excess of 10% of SILP’s net assets, which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.

12
Consequently, the Company has concluded that DME II’s interests, not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company presents its investment in SILP in its condensed consolidated balance sheets in the caption “Investment in related party investment fund.”

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. At September 30, 2022, the net asset value of the GLRE Limited Partners’ investment in SILP was $195.2 million (December 31, 2021: $183.6 million), representing 75.3% (December 31, 2021: 78.2%) of SILP’s total net assets. DME II held the remaining 24.7% (December 31, 2021: 21.8%) of SILP’s total net assets. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. At September 30, 2022, the majority of SILP’s long investments were composed of cash and publicly traded equity securities, which could be readily liquidated to meet the GLRE Limited Partners’ redemption requests.

The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, 2022, was $8.5 million and $24.5 million, respectively (three and nine months ended September 30, 2021: $(6.2) million and $(4.2) million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of SILP are presented below.


13
Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2022December 31, 2021
($ in thousands)
Assets
Investments, at fair value$258,386 $297,937 
Derivative contracts, at fair value15,727 2,542 
Due from brokers149,071 84,775 
Interest and dividends receivable64 28 
Total assets423,248 385,282 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(153,892)(132,360)
Derivative contracts, at fair value(9,739)(7,253)
Capital withdrawals payable— (10,000)
Due to brokers(10)— 
Interest and dividends payable(295)(580)
Other liabilities(201)(358)
Total liabilities(164,137)(150,551)
Net Assets$259,111 $234,731 
GLRE Limited Partners’ share of Net Assets$195,199 $183,591 


14
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$305 $146 $928 $509 
Interest income693 51 1,028 770 
Total Investment income998 197 1,956 1,279 
Expenses
Management fee(901)(883)(2,686)(2,632)
Interest(464)(205)(1,199)(874)
Dividends(356)(306)(938)(852)
Professional fees and other(262)(227)(756)(786)
Total expenses(1,983)(1,621)(5,579)(5,144)
Net investment income (loss)(985)(1,424)(3,623)(3,865)
Realized and change in unrealized gains (losses)
Net realized gain (loss) 7,221 (1,411)58,196 (14,809)
Net change in unrealized appreciation (depreciation) 6,464 (5,437)(17,027)12,143 
Net gain (loss) on investment transactions13,685 (6,848)41,169 (2,666)
Net income (loss)$12,700 $(8,272)$37,546 $(6,531)
GLRE Limited Partners’ share of net income (loss) (1)
$8,521 $(6,214)$24,474 $(4,196)

(1) Net income (loss) is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Management fees$901 $883 $2,686 $2,632 
Performance allocation947 $(224)2,719 — 
Total$1,848 $659 $5,405 $2,632 

See Note 11 for further details on related party management fees and performance allocation.

4. FINANCIAL INSTRUMENTS 
 
Investments
  
Other Investments

The Company’s “Other investments” are composed of the following:

•Private investments, unlisted equities, and convertible debt instruments, which consist primarily of Innovations-related investments supporting technology innovators in the (re)insurance market; and
15
•Certificates of deposit with original maturities greater than three months.

At September 30, 2022, the Company included the following securities in the caption “Other investments”:
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $22,037 $42,412 $(3,368)$61,081 
Convertible debt securities1,000 — — 1,000 
Certificates of deposit3,000 — — 3,000 
Total other investments$26,037 $42,412 $(3,368)$65,081 

At December 31, 2021, the Company included the following securities in the caption “Other investments”: 
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$17,411 $31,438 $(1,800)$47,049 
Derivative financial instruments (not designated as hedging instruments)— 335 — 335 
Total other investments$17,411 $31,773 $(1,800)$47,384 

Private investments and unlisted equity securities without readily determinable fair values

The Company measures its private investments and unlisted equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from identical or similar investments of the same issuers (the “measurement alternative”), with such changes recognized in the caption “Net investment income (loss)” in the condensed consolidated statements of operations. The Company considers the need for impairment on a by-investment basis, based on certain indicators. Under the measurement alternative, the Company makes two types of valuation adjustments:

•When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an “asset measured at fair value on a nonrecurring basis.”
•If the Company determines that the investment is impaired and the fair value is less than its carrying value, it writes down the investment to its fair value. Once the Company records such an adjustment, the investment is considered an “asset measured at fair value on a nonrecurring basis.”

The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2022, and 2021, and the related adjustments recorded during the periods then ended.
Nine months ended September 30
20222021
($ in thousands)
Carrying value (1)
$61,081 $42,349 
Upward carrying value changes (2)
$11,260 $13,355 
Downward carrying value changes and impairment (3)
$(1,676)$(500)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(2) The cumulative upward carrying value changes from inception to September 30, 2022, totaled $42.8 million.
(3) The cumulative downward carrying value changes and impairments from inception to September 30, 2022, totaled $3.7 million.

16
Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on the extent to which the inputs are observable in the market. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

•Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
•Level 3: Unobservable inputs supported by little or no market activity and significant to the fair value of the assets and liabilities. The term “unobservable inputs” includes certain pricing models, discounted cash flow methodologies, and similar techniques.

Assets measured at fair value on a nonrecurring basis

At September 30, 2022, and December 31, 2021, the Company held $53.0 million and $40.5 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. The Company classifies these assets as Level 3 within the fair value hierarchy. The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2022, for the private and unlisted equities measured at fair value on a nonrecurring basis:

Less than 6 months6 to 12 monthsOver 1 yearTotal
($ in thousands)
Fair values measured on a nonrecurring basis$24,451 $17,080 $11,423 $52,954 

At September 30, 2022, and December 31, 2021, the Company held $8.1 million and $6.5 million, respectively, of private investments and unlisted equities measured at cost.

Assets measured at fair value on a recurring basis

In accordance with ASC 320, “Investments - Debt Securities,” the Company has classified the convertible debt securities as “trading” measured at estimated fair value with unrealized gains and losses reported in net income. The Company classifies these securities as Level 3 within the fair value hierarchy and estimates their fair values primarily based on inputs such as third-party quotes, issuers’ book value, market multiples, and other inputs. Valuation of these securities is subjective as the markets’ illiquidity may increase the likelihood that the estimated fair value of an investment is not reflective of the price at which an actual transaction could occur.

The carrying value of certificates of deposit with original maturities of one year or less approximates their fair values. The Company classifies these assets as Level 2 within the fair value hierarchy.

At September 30, 2022, and December 31, 2021, the Company did not carry any other investments at fair value with an assigned Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at fair value using the net asset value practical expedient. It is therefore not classified within the fair value hierarchy. (See Note 3 for further details on the related party investment fund.)

During the three and nine months ended September 30, 2022 and 2021, there were no transfers between Level 2 and Level 3 of the fair value hierarchy.

Financial Instruments Disclosed, But Not Carried, at Fair Value

The caption “Convertible senior notes payable” represents financial instruments that the Company carries at amortized cost. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).

17
5. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

At September 30, 2022, the Company’s loss and loss adjustment expense reserves included estimated amounts for several catastrophe events. For significant catastrophe events, including, but not limited to, hurricanes, tornados, typhoons, floods, earthquakes, wildfires, and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when received. To establish IBNR loss estimates, the Company makes use of, among other things, the following information:

•estimates communicated by ceding companies;
•information received from clients, brokers, and loss adjusters;
•an understanding of the underlying business written and its exposures to catastrophe event-related losses;
•industry data;
•catastrophe scenario modeling software; and
•management’s judgment.

At September 30, 2022, the Company’s loss and loss adjustment expense reserves included $13.6 million from the Russian-Ukrainian conflict and $19.5 million from Hurricane Ian. Additional information the Company considered in estimating its loss reserves included the following:

•a review of in-force treaties that may provide coverage and incur losses;
•catastrophe and scenario modeling analyses and results shared by cedents;
•preliminary loss estimates received from clients, brokers, and loss adjusters;
•reviews of industry insured loss estimates and market share analyses; and
•management’s judgment.

The Company’s Russian-Ukrainian conflict loss estimates include actuarial assumptions, including:

•the areas within the affected regions that have incurred losses;
•the scope of coverage provided by the underlying policies;
•the interpretation of contract terms;
•the determination of loss-triggering events;
•regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry; and
•the ability of the cedents and insured to mitigate some or all of their losses.

Due to the uncertainty associated with the foregoing assumptions, the Company’s loss estimates are subject to significant variability, and actual losses may ultimately differ materially from the Company's current estimates. The Company will evaluate its assumptions as new information becomes available and may adjust its loss estimates in future periods. Such adjustments may be material to the Company's results of operations and financial condition.

Additionally, if the Russian-Ukrainian conflict is prolonged, the Company may incur additional losses in subsequent periods.

The Company made no significant changes in the actuarial methodology or reserving process related to its loss and loss adjustment expense reserves for the nine months ended September 30, 2022.

At September 30, 2022 and December 31, 2021, loss and loss adjustment expense reserves were composed of the following:
September 30, 2022December 31, 2021
 ($ in thousands)
Case reserves$186,945 $190,220 
IBNR353,882 333,790 
Total$540,827 $524,010 
18

A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated for the nine months ended September 30, 2022 and 2021 is as follows: 
Consolidated20222021
 ($ in thousands)
Gross balance at January 1$524,010 $494,179 
Less: Losses recoverable(11,100)(16,851)
Net balance at January 1512,910 477,328 
Incurred losses related to:  
Current year251,231 296,333 
Prior years1,558 (1,255)
Total incurred252,789 295,078 
Paid losses related to:  
Current year(54,866)(96,442)
Prior years(160,094)(146,545)
Total paid(214,960)(242,987)
Foreign currency revaluation(20,516)(1,722)
Net balance at September 30530,223 527,697 
Add: Losses recoverable10,604 13,082 
Gross balance at September 30$540,827 $540,779 
    
For the nine months ended September 30, 2022, the estimate of net losses incurred relating to prior accident years increased by $1.6 million, primarily due to the following:
•adverse development on motor and health business driven by the inflationary increase in claims costs;
•adverse development on a multi-line quota share program resulting from newly reported losses received from the cedent;
•newly reported claims received relating to excess of loss marine and energy contracts; and
•claims deterioration on a cyber contract.

The adverse developments were partially offset by favorable developments relating to prior accident years primarily due to the following:
•favorable experience on mortgage business;
•loss reserves released relating to catastrophe events and COVID-19 based on updated claims reporting received from cedents; and
•loss reserves released on an excess of loss workers’ compensation contract.

For the nine months ended September 30, 2021, the estimate of net losses incurred relating to prior accident years decreased by $1.3 million due primarily to favorable development on catastrophe events, a mortgage contract associated with the COVID-19 pandemic, and certain health contracts. The decrease in prior accident years was partially offset by adverse loss development on certain workers’ compensation and multi-line casualty contracts written between 2014 and 2018.



19
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2022 and 2021 are as follows:
Health20222021
 ($ in thousands)
Gross balance at January 1$9,938 $17,485 
Less: Losses recoverable— — 
Net balance at January 19,938 17,485 
Incurred losses related to: 
Current year6,567 31,189 
Prior years3,552 (1,898)
Total incurred10,119 29,291 
Paid losses related to: 
Current year(3,051)(20,224)
Prior years(11,146)(13,824)
Total paid(14,197)(34,048)
Foreign currency revaluation— — 
Net balance at September 305,860 12,728 
Add: Losses recoverable— — 
Gross balance at September 30$5,860 $12,728 


6. RETROCESSION
 
From time to time, the Company purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, reduce its net liability on individual risks, obtain additional underwriting capacity and balance its underwriting portfolio. The Company records loss and loss adjustment expenses recoverable from retrocessionaires as assets.

For the three and nine months ended September 30, 2022, the Company’s earned ceded premiums were $4.4 million and $8.4 million, respectively (insignificant for the three and nine months ended September 30, 2021). For the three and nine months ended September 30, 2022, loss and loss adjustment expenses recovered and changes in losses recoverable were $2.5 million and $2.5 million, respectively. The recoveries recognized by the Company for the three and nine months ended September 30, 2021, were nil and $0.1 million, respectively.

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2022, the Company’s loss reserves recoverable consisted of (i) $7.9 million (December 31, 2021: $8.4 million) recoverable from unrated retrocessionaires, of which $6.9 million (December 31, 2021: $8.2 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $2.7 million (December 31, 2021: $2.8 million) recoverable from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2022, the Company had recorded an allowance for expected credit losses of $47 thousand (December 31, 2021: $47 thousand).

7. SENIOR CONVERTIBLE NOTES

On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0%, payable semiannually on February 1 and August 1 of each year beginning February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity. At September 30, 2022, the Company’s share price was lower than the conversion price of $17.19 per share.
20
If a holder redeems the Notes, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. Prior to January 1, 2022, the Company bifurcated the Notes into liability and equity components. Effective January 1, 2022, upon adoption of ASU 2020-06, the Company no longer bifurcates the Notes and presents the entire balance as a single liability on the Company’s condensed consolidated balance sheets (see Note 2 for recently issued accounting standards adopted).
The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%. The Company incurred issuance costs in connection with the issuance of the Notes. At September 30, 2022, the unamortized portion of these costs was $0.6 million (December 31, 2021: $1.0 million), which the Company expects to amortize through the maturity date.

During the three and nine months ended September 30, 2022 the Company repurchased and canceled $6.6 million of the Notes. The carrying value of the Notes at September 30, 2022, including accrued interest of $0.6 million, was $93.4 million (December 31, 2021: $98.1 million). At September 30, 2022, the Company estimated the fair value of the Notes to be $90.2 million (December 31, 2021: $97.5 million) (see Note 4 Financial Instruments).
For the three and nine months ended September 30, 2022, the Company recognized interest expenses of $1.1 million and $3.4 million, respectively (three and nine months ended September 30, 2021: $1.6 million and $4.7 million, respectively).

The Company was in compliance with all covenants relating to the Notes at September 30, 2022, and December 31, 2021. At September 30, 2022, the Company had a remaining obligation for interest and principal payments of nil and $97.2 million during 2022 and 2023, respectively.

Subsequent to September 30, 2022, the Company repurchased and canceled $13.8 million of the Notes.

8. SHARE CAPITAL

The Company’s share capital is made up of ordinary share capital and additional paid-in capital. Ordinary share capital represents the issued and outstanding Class A and Class B ordinary shares at their par values of $0.10 per share. Additional paid-in capital includes the premium paid per share by the subscribing shareholders for Class A and Class B ordinary shares, as well as the earned portion of the grant-date fair value of share-based awards.

On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million. At September 30, 2022, 2,011,426 (December 31, 2021: 3,128,276) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the stock incentive plan. 

The Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. The Board of Directors has approved a share repurchase plan, which expires on June 30, 2023, authorizing the Company to repurchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares. The repurchase plan may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice.

The Company repurchased 4,933 Class A ordinary shares during the nine months ended September 30, 2022. All Class A ordinary shares repurchased are canceled immediately upon repurchase.

21
The following table is a summary of ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20222021
Class AClass BClass AClass B
Balance – beginning of period27,589,731 6,254,715 28,260,075 6,254,715 
Issue of ordinary shares, net of forfeitures984,548 — 409,200 — 
Repurchase of ordinary shares(4,933)— (1,079,544)— 
Balance – end of period28,569,346 6,254,715 27,589,731 6,254,715 

Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares, which have a par value of $0.10 each. It also includes the earned portion of the grant-date fair value of share-based awards that have not yet vested.

9. SHARE-BASED COMPENSATION
 
The Company has a stock incentive plan for directors, employees, and consultants administered by the Compensation Committee of the Board of Directors.
 
Employee and Director Restricted Shares

The restricted shares issued to certain employees contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters.

For the nine months ended September 30, 2022, the Company issued to non-employee directors an aggregate of 107,763 (2021: 74,769) restricted Class A ordinary shares as part of their remuneration for services to the Company. These restricted shares contain similar restrictions to those issued to employees. They will vest on the earlier of (i) the first anniversary of the date of the share issuance and (ii) the Company’s next annual general meeting, subject to the grantee’s continued service with the Company. During the vesting period, non-employee directors holding these restricted shares retain voting rights and are entitled to any dividends declared by the Company.

For the nine months ended September 30, 2022, the Company issued 849,872 (2021: 334,312) Class A ordinary shares to employees pursuant to the Company’s stock incentive plan. The restricted shares granted to employees in 2022 include (i) restricted shares with both performance and service-based vesting conditions (“Performance RSs”) and (ii) restricted shares with only service-based vesting conditions (“Service RSs”). The Service RSs vest evenly each year on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSs will cliff vest at the end of a three-year performance period within a range of 25% and 100% of the awarded Performance RSs, with a target of 50%. During the vesting period, the holder of the Service RSs and Performance RSs retains voting rights but is entitled to any dividends declared by the Company only upon vesting.

Prior to fiscal year 2022, the restricted shares granted to employees cliff vested three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retained voting rights and are entitled to any dividends declared by the Company.

Prior to fiscal year 2021, the Company issued Class A ordinary shares to the Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan (“CEO RSs”). These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of the CEO’s employment, and transferability. The CEO RSs cliff vest five years after the date of issuance, subject to the performance condition being met and the CEO’s continued service with the Company. At September 30, 2022, there were 193,149 non-vested CEO RSs with a weighted average grant date fair value of $10.10 per share. As the performance conditions associated with these restricted shares have not been met, the Company recognized no compensation cost relating to the unvested shares for the nine months ended September 30, 2022, and 2021.

The Company recognizes compensation expense associated with Performance RSs and Service RSs based on the fair value of the Company's Class A ordinary shares measured at the grant date. For Service RSs, the Company recognizes this expense on a straight-line basis over the requisite service period. For Performance RSs, the Company recognizes the associated compensation expense based on achieving established performance criteria during the performance period.

22

 
For the nine months ended September 30, 2022, grantees forfeited 8,476 (2021: 20,592) restricted shares. For the nine months ended September 30, 2022, the Company reversed $26 thousand of stock compensation expense (2021: $0.1 million) in relation to the forfeited restricted shares.

The Company recorded $2.6 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2022 (2021: $1.8 million). At September 30, 2022, there was $4.4 million (December 31, 2021: $2.7 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO RSs), which the Company expects to recognize over a weighted-average period of 1.6 years (December 31, 2021: 1.8 years). For the nine months ended September 30, 2022, the total fair value of restricted shares vested was $2.0 million (2021: $1.6 million).

The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2022:

Performance Restricted SharesService Restricted Shares
 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value		Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2021193,149 $10.10 753,407 $8.68 
Granted601,213 6.82 356,422 7.02 
Vested— — (197,002)10.06 
Forfeited— — (8,476)7.67 
Balance at September 30, 2022794,362 $7.62 904,351 $7.73 


Employee Restricted Stock Units

The Company issues RSUs to certain employees as part of the stock incentive plan. Such RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan.

The RSUs granted to employees in 2022 include (i) RSUs with both performance and service-based vesting conditions (“Performance RSUs”) and (ii) RSUs with only service-based vesting conditions (“Service RSUs”). The Service RSUs vest evenly each year on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of a three-year performance period within a range of 25% and 100% of the awarded Performance RSUs, with a target of 50%.

The Company recognizes compensation expense associated with Performance RSUs and Service RSUs based on the fair value of the Company's Class A ordinary shares measured at the grant date. For Service RSUs, the Company recognizes this expense on a straight-line basis over the requisite service period. For Performance RSUs, the Company recognizes the associated compensation expense based on achieving established performance criteria during the performance period.

Prior to 2022, the RSUs issued to employees cliff vested three years after the date of issuance, subject to the grantee’s continued service with the Company. For the nine months ended September 30, 2022, the Company issued 159,215 (2021: 58,123) RSUs to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2022, and 2021, no RSUs were forfeited.

The Company recorded $0.5 million of share-based compensation expense relating to RSUs for the nine months ended September 30, 2022 (2021: $0.3 million). At September 30, 2022, the total compensation cost related to non-vested RSUs not yet recognized was $0.7 million (December 31, 2021: $0.5 million), which the Company expects to recognize over a weighted-average period of 1.6 years (December 31, 2021: 1.8 years).

23
Employee RSU activity during the nine months ended September 30, 2022, was as follows:
Performance Restricted Stock UnitsService Restricted Stock Units
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value		Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 2021— $— 154,134 $8.59 
Granted105,008 6.82 54,207 6.82 
Vested— — (35,389)10.84 
Balance at September 30, 2022105,008 $6.82 172,952 $7.58 


Employee and Director Stock Options

For the nine months ended September 30, 2022, and 2021, no Class A ordinary share purchase options were granted or exercised by directors or employees, and 45,290 Class A ordinary share purchase options expired. When the Company grants stock options, it reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

The Board of Directors does not currently anticipate that the Company will declare any dividends during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed relating to stock options for the nine months ended September 30, 2022, was $0.2 million (2021: $0.3 million). At September 30, 2022, the total compensation cost related to non-vested options not yet recognized was $0.1 million (December 31, 2021: $0.3 million), which will be recognized over a weighted-average period of 0.8 years (December 31, 2021: 1.2 years) assuming the grantee completes the service period for vesting of the options.

Employee and director stock option activity during the nine months ended September 30, 2022 was as follows: 

Number of
 options outstanding		Weighted
 average
 exercise
 price		Weighted
 average
 grant date
 fair value		Intrinsic value
($ in millions)		Weighted average remaining contractual term
Balance at December 31, 2021735,627 $22.35 $10.23 $— 4.7 years
Granted— — — — — 
Exercised— — — — — 
Forfeited— — — — — 
Expired(45,290)23.80 11.04 — — 
Balance at September 30, 2022690,337 $22.25 $10.18 $— 4.2 years

Stock Compensation Expense

For the nine months ended September 30, 2022, and 2021, the combined stock compensation expenses (net of forfeitures) included in the caption “General and administrative expenses” in the Company’s condensed consolidated statements of operations were $3.3 million and $2.4 million, respectively.



10. TAXATION

At September 30, 2022, the Company recorded a gross deferred tax asset of $3.7 million (December 31, 2021: $3.2 million) and a deferred tax asset valuation allowance of $3.2 million (December 31, 2021: $2.7 million). The net deferred tax asset is included in the caption “Other assets” in the Company’s condensed consolidated balance sheets. The Company has determined that it is more likely than not that it will fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. The Company based this determination on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit.
24

The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2022 and 2021:
Three months ended September 30Nine months ended September 30
 2022202120222021
 ($ in thousands)($ in thousands)
Current tax (expense) benefit$(234)$323 $(655)$(3,240)
Tax recovered1,050 — 1,478 — 
Deferred tax (expense) benefit170 — 428 — 
Decrease (increase) in deferred tax valuation allowance(170)(323)(428)(493)
Income tax (expense) benefit $816 $— $823 $(3,733)


11. RELATED PARTY TRANSACTIONS 
 
Investment Advisory Agreement
 
DME, DME II, and DME Advisors are each an affiliate of the Chairman and therefore are related parties to the Company.

The Company has entered into the SILP LPA (as described in Note 3 of the condensed consolidated financial statements). DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL includes the amount of investment losses to be recouped, including any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry-forward provision in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss until all losses are recouped, and an additional amount equal to 150% of the loss is earned.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio”, as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors, which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023, subject to an automatic extension for successive three-year terms.

For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2022, and 2021, refer to Note 3 of the condensed consolidated financial statements.
 
Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II, and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II, and DME Advisors for reasonable costs and expenses of investigating and defending such claims, provided such claims were not caused due to gross negligence, breach of contract, or misrepresentation by DME, DME II, or DME Advisors. The Company incurred no indemnification amounts during the periods presented.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2022, SILP, along with certain affiliates of DME Advisors, collectively owned 38% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in SILP. At September 30, 2022, SILP held 2.7 million shares of GRBK.

25
Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.


12. COMMITMENTS AND CONTINGENCIES 
 
Letters of Credit and Trusts
 
At September 30, 2022, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2023
120 days before the termination date

At September 30, 2022, an aggregate amount of $180.2 million (December 31, 2021: $136.8 million) in letters of credit was issued under the credit facility. At September 30, 2022, the Company had pledged total cash and cash equivalents with a fair value in the aggregate of $180.9 million (December 31, 2021: $137.6 million) as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the credit facility covenants at September 30, 2022 and December 31, 2021.

The Company has also established regulatory trust arrangements for certain cedents. At September 30, 2022, collateral of $468.0 million (December 31, 2021: $497.1 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets.

Lease Obligations

The Company has determined that its lease agreements for office space qualify as operating lease arrangements. At the commencement date, the Company determined the lease term by assuming the exercise of those renewal options deemed to be reasonably certain. The exercise of lease renewal options is at the Company's sole discretion, and these options do not contain any material residual value guarantees or material restrictive covenants. The Company’s weighted-average remaining operating lease term is approximately 4.0 years at September 30, 2022.

As the lease contracts generally do not provide an implicit discount rate, the Company used the weighted-average discount rate of 6%, representing its incremental borrowing rate based on information available at the commencement date, to determine the present value of lease payments. The incremental borrowing rate is based on a borrowing with a term similar to that of the associated lease. The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing.

26
At September 30, 2022, the right-of-use assets and lease liabilities relating to the operating leases were $2.0 million and $2.1 million, respectively. The operating expense for the three and nine months ended September 30, 2022, was $0.2 million and $0.5 million, respectively (three and nine months ended September 30, 2021: $0.1 million and $0.2 million, respectively).

At September 30, 2022, the commitment for operating lease liabilities for future annual periods was as follows:

Year ending December 31,($ in thousands)
2022$149 
2023611 
2024627 
2025644 
2026345 
Thereafter— 
Total lease payments2,376 
Less Imputed Interest(280)
Present value of lease liabilities$2,096 

Litigation

From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.




27
13. SEGMENT REPORTING
 
The Company has one operating segment, Property & Casualty Reinsurance.

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2022202120222021
  ($ in thousands)($ in thousands)
Property
Commercial$2,146 1.4 %$3,398 2.6 %$8,648 2.0 %$9,700 2.2 %
Motor206 0.1 6,103 4.8 768 0.2 24,537 5.6 
Personal17,669 11.4 3,631 2.8 49,425 11.3 10,318 2.3 
Total Property20,021 12.9 13,132 10.2 58,841 13.5 44,555 10.1 
Casualty
General Liability13,798 8.9 7,376 5.7 40,523 9.3 10,749 2.4 
Motor Liability565 0.4 19,823 15.4 4,061 0.9 96,795 22.0 
Professional Liability242 0.2 154 0.1 496 0.1 302 0.1 
Workers' Compensation7,216 4.6 17,117 13.3 25,504 5.9 55,237 12.5 
Multi-line 69,419 44.7 40,162 31.2 177,647 40.8 137,857 31.3 
Total Casualty91,240 58.8 84,632 65.7 248,231 57.0 300,940 68.4 
Other
Accident & Health5,879 3.8 4,175 3.3 10,377 2.4 26,427 6.0 
Financial20,065 12.9 17,920 13.9 56,481 12.9 40,134 9.1 
Marine4,675 3.0 2,462 1.9 18,425 4.2 8,412 1.9 
Other Specialty13,266 8.6 6,414 5.0 43,457 10.0 19,781 4.5 
Total Other43,885 28.3 30,971 24.1 128,740 29.5 94,754 21.5 
$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %
Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2022202120222021
 ($ in thousands)($ in thousands)
U.S. and Caribbean$72,105 46.5 %$67,087 52.1 %$224,324 51.5 %$258,849 58.8 %
Worldwide (1)
79,512 51.3 59,616 46.3 196,197 45.0 174,470 39.6 
Europe (2)
(1,797)(1.2)1,483 1.2 2,962 0.7 2,787 0.6 
Asia
5,326 3.4 549 0.4 12,329 2.8 4,143 1.0 
$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 
(2) The negative balance represents the reversal of premiums due to premium adjustments, termination of contracts, or premium returned upon novation or commutation of contracts.
28
Item 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
References to “we,” “us,” “our,” “our company,”  or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and its wholly-owned subsidiaries, Greenlight Reinsurance, Ltd, (“Greenlight Re”), Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”), and Verdant Holding Company, Ltd. (“Verdant”), as well as Greenlight Innovation Syndicate 3456 (“Syndicate 3456”), unless the context dictates otherwise. References to our “Ordinary Shares” refer collectively to our Class A Ordinary Shares and Class B Ordinary Shares.
 
The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear in our annual report on Form 10-K for the fiscal year ended December 31, 2021.

The following is a discussion and analysis of our results of operations for the nine months ended September 30, 2022 and 2021 and financial condition at September 30, 2022 and December 31, 2021.
  
Special Note About Forward-Looking Statements
 
Certain statements in Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which may cause actual results to differ materially from the forward-looking statements. We have included a detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements in the section entitled “Part II. Item 1A. Risk Factors” included in our Form 10-Q for the three months ended March 31, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on May 3, 2022, and in the section entitled “Part I, Item 1A. Risk Factors” contained in our Form 10-K for the fiscal year ended December 31, 2021, as filed with the SEC on March 8, 2022. Such risks and uncertainties include, but are not limited to:

•A downgrade or withdrawal of either of our A.M. Best ratings would materially and adversely affect our ability to implement our business strategy successfully;
•Our results of operations will likely fluctuate from period to period and may not be indicative of our long-term prospects;
•Our results of operations and financial condition could be adversely affected by the ongoing conflict between Russia and Ukraine and related disruptions in the global economy;
•The impact of COVID-19 and related risks could materially and adversely affect our results of operations, financial position, and liquidity;
•SILP may be concentrated in a few large positions, which could result in investment volatility;
•The performance of our Innovations investments could result in financial losses and reduce our capital;
•If our losses and loss adjustment expenses greatly exceed our loss reserves, our financial condition may be materially and adversely affected;
•Inflation may adversely impact our results of operations or financial condition;
•The effect of emerging claim and coverage issues on our business is uncertain;
•The property and casualty reinsurance market may be affected by cyclical trends; and
•The loss of key executives could adversely impact our ability to implement our business strategy.

We undertake no obligation to publicly update or revise any forward-looking statements, whether due to new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only to the dates they were made.
 
We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding reinsurance or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.

29
General
 
We are a global specialty property and casualty reinsurer headquartered in the Cayman Islands, with a reinsurance and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management solutions to the insurance, reinsurance, and other risk marketplaces. We focus on delivering risk solutions to clients and brokers who value our expertise, analytics, and customer service offerings.
 
We aim to complement our underwriting activities with a non-traditional investment approach designed to achieve higher rates of return over the long term than reinsurance companies that exclusively employ more traditional investment strategies. Our investment portfolio is managed according to a value-oriented philosophy, in which our investment advisor takes long positions in perceived undervalued securities and short positions in perceived overvalued securities.

Through Greenlight Re Innovations, we support technology innovators in the (re)insurance market by providing investment capital, risk capacity, and access to a broad insurance network.

Because we seek to capitalize on favorable market conditions and opportunities, period-to-period comparisons of our underwriting results may not be meaningful. Also, our historical investment results are not necessarily indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.

The Company’s subsidiaries hold an A.M. Best Financial Strength Rating of A- (Excellent) with a stable outlook.

Critical Accounting Policies and Estimates
 
Our condensed consolidated financial statements contain certain amounts that are inherently subjective and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part II. Item 1A. Risk Factors” included in our Form 10-Q for the three months ended March 31, 2022, as filed with the SEC on May 3, 2022, and in “Part I. Item IA. — Risk Factors” included in our Form 10-K for the fiscal year ended December 31, 2021, as filed with the SEC on March 8, 2022, cause actual events or results to differ materially from our underlying assumptions or estimates. In that case, there could be a material adverse effect on our results of operations, financial condition, or liquidity. “Part II. Item 7. — Management’s Discussion and Analysis of Financial Condition and Results on Operations” included in our annual report on Form 10-K for the fiscal year ended December 31, 2021, describes our critical accounting policies and estimates. The most significant estimates relate to premium revenues and risk transfer, loss and loss adjustment expense reserves, investment impairments, allowances for credit losses, and share-based compensation.

Recently issued and adopted accounting standards and their impact on the Company, if any, are presented under “Recent Accounting Pronouncements” in Note 2 to the condensed consolidated financial statements.

Segments
 
We have one operating segment, Property & Casualty reinsurance, and we analyze our business based on the following categories:
 ●Property
●Casualty
●Other

Property business covers automobile physical damage, personal lines, and commercial lines exposures. Property business includes both catastrophe and non-catastrophe coverage. We expect catastrophe business to make up a small proportion of our property business.

Casualty business covers general liability, motor liability, professional liability, and workers’ compensation exposures. The Company’s multi-line business relates predominantly to casualty reinsurance, and as such, the Company includes all multi-line business within the casualty category. Casualty business generally has losses reported and paid over a longer period than property business. We categorize Lloyd’s syndicate contracts, which incorporate incidental catastrophe exposure, as multi-line (and therefore casualty) business.

30
Other business covers accident and health, financial lines (including transactional liability, mortgage insurance, surety, and trade credit), marine, energy, as well as other specialty business such as aviation, crop, cyber, political, and terrorism exposures.

Outlook and Trends

We operate in a business where we expect volatility in our underwriting results. Hurricane Ian, which struck the southeast U.S. in September, 2022, is likely to prove one of the costliest natural disasters ever in terms of insured losses. This storm, along with the Russian-Ukraine conflict and several smaller events, have combined to make the first nine months of 2022 another challenging period for companies that participate in the global reinsurance market. We were not immune from these events; our combined ratio for the nine months ended September 30, 2022, was 104.8%.

Further, the ongoing Russian-Ukrainian conflict has resulted in the U.S., United Kingdom, European Union, and other countries imposing financial and economic sanctions, which have caused disruption in the global economy and have increased economic and geopolitical uncertainty. If this conflict is prolonged, we and other reinsurers may incur additional losses in future periods.

The continuing widespread inflation is a significant concern to the industry, as it can add uncertainty to the cost of claims, particularly for classes of business with long payout tails. As a result, it creates pricing challenges for new business and valuation challenges in claims reserves. We are addressing these concerns in multiple ways:

•Our underwriting strategy focuses on relatively short-tailed business, which is inherently less exposed to high inflation than long-tailed lines. We estimate the payout duration of our existing reserves at approximately two years.
•We incorporate inflation assumptions in all our pricing, and reassess these assumptions frequently.
•We are minimizing our exposure to classes that are experiencing severe supply-chain-driven inflation.

We expect that the rising interest rate environment will have a mixed impact on our financial results. While we have some exposure to interest rate risk from fixed income securities held by the Lloyd’s syndicates in which we participate, we expect that the higher interest rates will improve the yield on our restricted cash and cash equivalents.

The combination of the recent loss events, continued inflation and rising interest rates have led to a significant reduction in the amount of reinsurance capital available for deployment. As we approach the January 1 renewal season, we see market conditions that we consider more favorable than any we have experienced in more than a decade.

Additionally, we continue to be encouraged by our Innovations unit, whose central objective is to enhance our underwriting return and risk profile by establishing a range of strategic partnerships. Our Innovations-related premiums accounted for approximately 12% of our net premiums written in the first nine months of 2022. We see the potential for significant growth from Innovations-derived underwriting opportunities going forward.


Key Financial Measures and Non-GAAP Measures

Management uses certain key financial measures, some of which are not prescribed under U.S. GAAP rules and standards (“non-GAAP financial measures”), to evaluate our financial performance, financial position, and the change in shareholder value. Generally, a non-GAAP financial measure, as defined in SEC Regulation G, is a numerical measure of a company’s historical or future financial performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented under U.S. GAAP. We believe that these measures, which may be calculated or defined differently by other companies, provide consistent and comparable metrics of our business performance to help shareholders understand performance trends and facilitate a more thorough understanding of the Company’s business. Non-GAAP financial measures should not be viewed as substitutes for those determined under U.S. GAAP.

The key non-GAAP financial measures used in this report are:
•Basic book value per share and fully diluted book value per share; and
•Net underwriting income (loss)

These non-GAAP measures are described below.

31
Basic Book Value Per Share and Fully Diluted Book Value Per Share

We believe that long-term growth in fully diluted book value per share is the most relevant measure of our financial performance because it provides management and investors a yardstick to monitor the shareholder value generated. Fully diluted book value per share may also help our investors, shareholders, and other interested parties form a basis of comparison with other companies within the property and casualty reinsurance industry. Basic book value per share and fully diluted book value per share should not be viewed as substitutes for the comparable U.S. GAAP measures.

We calculate basic book value per share as (a) ending shareholders' equity, divided by (b) aggregate of Class A and Class B Ordinary shares issued and outstanding, including all unvested service-based restricted shares, and the earned portion of performance-based restricted shares granted after December 31, 2021. We exclude shares potentially issuable in connection with convertible notes if the conversion price exceeds the share price.

Fully diluted book value per share represents basic book value per share combined with any dilutive impact of in-the-money stock options, unvested service-based RSUs, and the earned portion of unvested performance-based RSUs granted. Fully diluted book value per share also includes the dilutive effect, if any, of ordinary shares expected to be issued upon settlement of the convertible notes.

Our primary financial goal is to increase fully diluted book value per share over the long term. We use fully diluted book value per share as a financial measure in our annual incentive compensation.

The following table presents a reconciliation of the non-GAAP financial measures basic and fully diluted book value per share to the most comparable U.S. GAAP measure:
September 30, 2022June 30, 2022March 31, 2022December 31, 2021September 30, 2021
   ($ in thousands, except per share and share amounts)
Numerator for basic and fully diluted book value per share: 
Total equity (U.S. GAAP) (numerator for basic and fully diluted book value per share)$466,952 $484,293 $468,407 $475,663 $450,514 
Denominator for basic and fully diluted book value per share: (1)
Ordinary shares issued and outstanding as presented in the Company’s condensed consolidated balance sheets 34,824,06134,721,23134,721,23133,844,44633,844,446
Less: Unearned performance-based restricted shares granted after December 31, 2021(539,161)(560,927)(581,593)——
Denominator for basic book value per share34,284,90034,160,30434,139,63833,844,44633,844,446
Add: In-the-money stock options, service-based RSUs granted, and earned performance-based RSUs granted183,790179,988176,379154,134154,134
Denominator for fully diluted book value per share 34,468,69034,340,29234,316,01733,998,58033,998,580
Basic book value per share$13.62 $14.18 $13.72 $14.05 $13.31 
Increase (decrease) in basic book value per share ($)$(0.56)$0.46 $(0.33)$0.58 $(0.35)
Increase (decrease) in basic book value per share (%)(3.9)%3.4 %(2.3)%4.3 %(2.6)%
Fully diluted book value per share$13.55 $14.10 $13.65 $13.99 $13.25 
Increase (decrease) in fully diluted book value per share ($)$(0.55)$0.45 $(0.34)$0.57 $(0.35)
Increase (decrease) in fully diluted book value per share (%)(3.9)%3.3 %(2.4)%4.2 %(2.6)%

32
(1) For periods prior to January 1, 2022, all unvested restricted shares are included in the “basic” and “fully diluted” denominators. Restricted shares with performance-based vesting conditions granted after December 31, 2021, are included in the “basic” and “fully diluted” denominators to the extent that the Company has recognized the corresponding share-based compensation expense. At September 30, 2022, the aggregate number of unearned restricted shares with performance conditions not included in the “basic” and “fully diluted” denominators was 732,310 (June 30, 2022: 754,076, March 31, 2022: 774,742, December 31, 2021: 193,149, September 30, 2021: 193,149).


Net Underwriting Income (Loss)

One way that we evaluate the Company’s underwriting performance is by measuring net underwriting income (loss). We do not use premiums written as a measure of performance. Net underwriting income (loss) is a performance measure used by management to evaluate the fundamentals underlying the Company’s underwriting operations. We believe that the use of net underwriting income (loss) enables investors and other users of the Company’s financial information to analyze our performance in a manner similar to how management analyzes performance. Management also believes that this measure follows industry practice and allows the users of financial information to compare the Company’s performance with that of our industry peer group.

Net underwriting income (loss) is considered a non-GAAP financial measure because it excludes items used to calculate net income before taxes under U.S. GAAP. We calculate net underwriting income (loss) as net premiums earned, plus other income relating to reinsurance and deposit-accounted contracts, less deposit interest expense, less net loss and loss adjustment expenses, acquisition costs, and underwriting expenses. The measure excludes, on a recurring basis: (1) investment income (loss); (2) other income (expense) not related to underwriting, including foreign exchange gains or losses, Lloyd’s interest income or expense and adjustments to the allowance for expected credit losses; (3) corporate general and administrative expenses; and (4) interest expense. We exclude total investment income or loss, foreign exchange gains or losses, Lloyd’s interest income or expense and expected credit losses as we believe these items are influenced by market conditions and other factors not related to underwriting decisions. We exclude corporate and interest expenses because these costs are generally fixed and not incremental to or directly related to our underwriting operations. We believe all of these amounts are largely independent of our underwriting process, and including them could hinder the analysis of trends in our underwriting operations. Net underwriting income (loss) should not be viewed as a substitute for U.S. GAAP net income before income taxes.

The reconciliations of net underwriting income (loss) to income (loss) before income taxes (the most directly comparable U.S. GAAP financial measure) on a consolidated basis are shown below:
Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Income (loss) before income tax$(19,285)$(13,853)$(10,231)$(2,993)
Add (subtract):
Total investment (income) loss(11,559)(4,089)(36,452)(24,803)
Other non-underwriting (income) expense6,784 342 13,374 1,076 
Corporate expenses4,104 3,444 12,693 12,030 
Interest expense1,091 1,578 3,411 4,684 
Net underwriting income (loss)$(18,865)$(12,578)$(17,205)$(10,006)


33
Results of Operations

The table below summarizes our operating results for the three and nine months ended September 30, 2022, and 2021:
Three months ended September 30Nine months ended September 30
2022202120222021
(in thousands, except percentages)
Underwriting revenue
Gross premiums written$155,146 $128,735 $435,812 $440,249 
Gross premiums ceded(8,801)(60)(21,973)(6)
Net premiums written146,345 128,675 413,839 440,243 
Change in net unearned premium reserves(24,397)6,849 (55,747)(36,844)
Net premiums earned$121,948 $135,524 $358,092 $403,399 
Underwriting related expenses
Net loss and loss adjustment expenses incurred
Current year$92,443 $111,052 $251,231 $296,333 
Prior year *2,116 (652)1,558 (1,255)
Net loss and loss adjustment expenses incurred94,559 110,400 252,789 295,078 
Acquisition costs36,821 35,048 106,101 106,060 
Underwriting expenses3,285 2,616 10,034 9,310 
Deposit accounting and other reinsurance expense (income)6,148 38 6,373 2,957 
Net underwriting income (loss)$(18,865)$(12,578)$(17,205)$(10,006)
Income (loss) from investment in related party investment fund$8,521 $(6,214)$24,474 $(4,196)
Net investment income (loss)3,038 10,303 11,978 28,999 
Total investment income (loss)$11,559 $4,089 $36,452 $24,803 
Net underwriting and investment income (loss)$(7,306)$(8,489)$19,247 $14,797 
Corporate expenses$4,104 $3,444 $12,693 $12,030 
Other (income) expense, net6,784 342 13,374 1,076 
Interest expense1,091 1,578 3,411 4,684 
Income tax expense (benefit)(816)— (823)3,733 
Net income (loss)$(18,469)$(13,853)$(9,408)$(6,726)
Earnings (loss) per share (Class A and Class B)
Basic$(0.56)$(0.42)$(0.28)$(0.20)
Diluted$(0.56)$(0.42)$(0.28)$(0.20)
Underwriting ratios
Loss ratio - current year75.8 %81.9 %70.2 %73.5 %
Loss ratio - prior year1.7 %(0.4)%0.4 %(0.4)%
Loss ratio77.5 %81.5 %70.6 %73.1 %
Acquisition cost ratio30.2 %25.9 %29.6 %26.3 %
Composite ratio107.7 %107.4 %100.2 %99.4 %
Underwriting expense ratio7.7 %1.9 %4.6 %3.0 %
Combined ratio115.4 %109.3 %104.8 %102.4 %

34
* The net financial impacts associated with changes in the estimate of losses incurred in prior years, which incorporate earned reinstatement premiums assumed and ceded, and adjustments to assumed and ceded acquisition costs, were a loss of $2.9 million and a gain of $0.2 million for the three months ended September 30, 2022, and 2021, respectively, and losses of $9.0 million and $3.2 million for the nine months ended September 30, 2022, and 2021, respectively.


Three months ended September 30, 2022, and 2021

For the three months ended September 30, 2022, the fully diluted book value per share decreased by $0.55 per share, or 3.9%, to $13.55 per share from $14.10 per share at June 30, 2022. For the three months ended September 30, 2022, basic book value per share decreased by $0.56 per share, or 3.9%, to $13.62 per share from $14.18 per share at June 30, 2022.

For the three months ended September 30, 2022, our net loss was $18.5 million, compared to a net loss of $13.9 million reported for the equivalent 2021 period.

The developments that most significantly affected our financial performance during the three months ended September 30, 2022, compared to the equivalent 2021 period, are summarized below:

•Underwriting: The underwriting loss for the three months ended September 30, 2022, was $18.9 million. This underwriting loss included $19.5 million of losses estimated from Hurricane Ian and $3.2 million from Typhoons Nanmadol and Hinnamnor. By comparison, the equivalent period in 2021 reported an underwriting loss of $12.6 million, which included $25.9 million of catastrophe losses from Hurricane Ida, the European floods and hailstorms, and South African riots. The underwriting loss for the three months ended September 30, 2022, also included $6.1 million of expense relating to deposit-accounted contracts.

Our combined ratio was 115.4% for the three months ended September 30, 2022, compared to 109.3% during the equivalent 2021 period. The catastrophe losses and the expense relating to deposit-accounted contracts contributed 23.6 percentage points to the combined ratio for the three months ended September 30, 2022.

•Investments: Our total investment income for the three months ended September 30, 2022, was $11.6 million, compared to total investment income of $4.1 million reported for the same period in 2021. Our investment in SILP reported a gain of $8.5 million during the three months ended September 30, 2022, compared to a loss of $6.2 million during the equivalent period in 2021. Other investment income totaled $3.0 million and $10.3 million during the three months ended September 30, 2022, and 2021, respectively.
•Other income (expense): For the three months ended September 30, 2022, we incurred $6.8 million of other non-underwriting expenses, primarily as a result of foreign exchange losses. The weakening of the pound sterling against the U.S. dollar drove the foreign exchange loss. In addition, the other income (expense) included our share of Lloyd’s syndicates’ investment losses on the Funds at Lloyd’s business, which is generally conducted on a funds withheld basis. The syndicates invest a portion of these funds in fixed-maturity securities and investment funds, which were negatively impacted by rising interest rates and market volatility. We record our share of these mark-to-market adjustments when the syndicates report them to us, generally one quarter in arrears.

Nine months ended September 30, 2022, and 2021

For the nine months ended September 30, 2022, fully diluted book value per share decreased by $0.44, or 3.1%, to $13.55 per share from $13.99 per share at December 31, 2021. For the nine months ended September 30, 2022, basic book value per share decreased by $0.43, or 3.1%, to $13.62 per share from $14.05 per share at December 31, 2021. The decrease in fully diluted book value per share during the nine months ended September 30, 2022, included $0.07, or 0.5%, adverse impact relating to the adoption of ASU 2020-06 (see Note 2 of the accompanying condensed consolidated financial statements for recently issued accounting standards adopted).

For the nine months ended September 30, 2022, our net loss was $9.4 million, compared to a net loss of $6.7 million reported for the equivalent 2021 period.

The developments that most significantly affected our financial performance during the nine months ended September 30, 2022, compared to the equivalent 2021 period, are summarized below:
35

•Underwriting: The underwriting loss for the nine months ended September 30, 2022, was $17.2 million, driven primarily by $13.6 million of losses related to the Russian-Ukrainian conflict and $25.5 million of losses related to Hurricane Ian, Typhoon Nanmadol, and wildfires in Tennessee. By comparison, the underwriting loss for the equivalent period in 2021 was $10.0 million, driven by losses from Hurricane Ida, the winter storm Uri, the European floods and hailstorms, and South African riots.

Our combined ratio was 104.8% for the nine months ended September 30, 2022, compared to 102.4% for the same period in 2021. The Russian-Ukrainian conflict and natural catastrophe losses contributed 10.9 percentage points to the combined ratio for the nine months ended September 30, 2022.

•Investments: Our total investment income for the nine months ended September 30, 2022, was $36.5 million, compared to $24.8 million earned during the equivalent 2021 period. For the nine months ended September 30, 2022, our investment in SILP reported a gain of $24.5 million, compared to a loss of $4.2 million during the equivalent period in 2021. Other investment income totaled $12.0 million and $29.0 million during the nine months ended September 30, 2022, and 2021, respectively.
•Other income (expense): For the nine months ended September 30, 2022, other expense of $13.4 million was driven primarily by the mark-to-market adjustments and foreign exchange losses for the reasons explained above for the three months ended September 30, 2022.

Underwriting results

We analyze our business based on three categories: “property,” “casualty,” and “other.”

Gross Premiums Written
 
Details of gross premiums written are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Property$20,021 12.9 %$13,132 10.2 %$58,841 13.5 %$44,555 10.1 %
Casualty91,240 58.8 84,632 65.7 248,231 57.0 300,940 68.4 
Other43,885 28.3 30,971 24.1 128,740 29.5 94,754 21.5 
Total$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %

As a result of our underwriting philosophy, the total premiums we write and the mix of premiums between property, casualty, and other business, may vary significantly from period to period depending on the market opportunities we identify.

For the three months ended September 30, 2022, our gross premiums written increased by $26.4 million, or 20.5%, compared to the equivalent 2021 period. The primary drivers for this change are the following:

36
Gross Premiums Written
Three months ended September 30, 2022
Increase (decrease)
($ in millions)		% changeExplanation
Property$6.952.5%The increase in property gross premiums written during the three months ended September 30, 2022, over the comparable 2021 period was due primarily to personal lines business, driven by the growth of our Innovations partners.

Our decision to reduce or terminate our participation in certain motor business partially offset this increase.
Casualty$6.67.8%The increase in casualty gross premiums written during the three months ended September 30, 2022, over the comparable 2021 period was due primarily to new contracts bound during 2022 relating to general liability and multi-line business. The growth in Lloyd’s syndicate business was also a significant driver of the increase in casualty gross premiums written.
 
Our decision to reduce or terminate our participation in certain motor business partially offset this increase.
  
Other$12.941.7%The increase in “other” gross premiums written during the three months ended September 30, 2022, over the comparable 2021 period was related primarily to marine, energy, and financial lines. New business drove most of the increase in marine and energy premiums. The growth in financial lines was driven primarily by an increase in transactional liability business.

For the nine months ended September 30, 2022, our gross premiums written decreased by $4.4 million, or 1.0%, compared to the equivalent 2021 period. The primary drivers of this change are the following:
37
Gross Premiums Written
Nine months ended September 30, 2022
Increase (decrease)
($ in millions)		% changeExplanation
Property$14.332.1%The increase in property gross premiums written during the nine months ended September 30, 2022, over the comparable 2021 period was due primarily to personal lines business, as discussed above.

Our decision to reduce or terminate our participation in certain motor business partially offset this increase.
Casualty$(52.7)(17.5)%The decrease in casualty premiums written during the nine months ended September 30, 2022, over the comparable 2021 period was due primarily to motor and workers’ compensation contracts on which we elected to reduce or not renew our participation.

Growth in general liability and multi-line premiums, driven by new and renewed Lloyd’s and Innovations-related business, partially offset the decrease in casualty premiums.
Other$34.035.9%
The increase in “other” premiums written during the nine months ended September 30, 2022, over the comparable 2021 period was due primarily to the following:

•increased financial lines business, including transactional liability contracts;
•new marine and energy contracts bound during 2022; and
•new contracts bound during 2022 relating to other specialty classes.

The increase was partially offset by a decrease in Health premiums, due primarily to changing certain exposures from a proportional basis to excess of loss.

Premiums Ceded
 
For the three and nine months ended September 30, 2022, premiums ceded were $8.8 million and $22.0 million, respectively, compared to insignificant premiums ceded for the three and nine months ended September 30, 2021. In 2022, we entered into new retrocession agreements to reduce our exposure to marine, energy, and property losses.

Net Premiums Written

Details of net premiums written are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Property$15,486 10.6 %$13,132 10.2 %$48,517 11.7 %$44,594 10.1 %
Casualty88,002 60.1 84,632 65.8 242,369 58.6 300,971 68.4 
Other42,857 29.3 30,911 24.0 122,953 29.7 94,678 21.5 
Total$146,345 100.0 %$128,675 100.0 %$413,839 100.0 %$440,243 100.0 %

For the three and nine months ended September 30, 2022, net premiums written increased by $17.7 million, or 13.7%, and decreased by $26.4 million, or 6.0%, respectively, compared to the three and nine months ended September 30, 2021. The movement in net premiums written resulted from the changes in gross premiums written and ceded during the periods.
38

Net Premiums Earned
 
Details of net premiums earned are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Property$10,951 9.0 %$14,744 10.9 %$37,577 10.5 %$43,660 10.8 %
Casualty76,511 62.7 87,960 64.9 225,322 62.9 260,741 64.6 
Other34,486 28.3 32,820 24.2 95,193 26.6 98,998 24.5 
Total$121,948 100.0 %$135,524 100.0 %$358,092 100.0 %$403,399 100.0 %

Net premiums earned are primarily a function of the amount and timing of net premiums written during the current and prior periods.

Loss and Loss Adjustment Expenses Incurred, Net
 
Details of net losses incurred are provided in the following table:

 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Property$13,157 13.9 %$15,031 13.6 %$28,641 11.3 %$33,677 11.4 %
Casualty60,901 64.4 70,151 63.5 159,918 63.3 199,636 67.7 
Other20,501 21.7 25,218 22.8 64,230 25.4 61,765 20.9 
Total$94,559 100.0 %$110,400 100.0 %$252,789 100.0 %$295,078 100.0 %

The below table summarizes the loss ratios for the nine months ended September 30, 2022, and 2021:
 Three months ended September 30Nine months ended September 30
 20222021Increase / (decrease) in loss ratio points20222021Increase / (decrease) in loss ratio points
Property120.1 %101.9 %18.2 76.2 %77.1 %(0.9)
Casualty79.6 79.8 (0.2)71.0 76.6 (5.6)
Other59.4 76.8 (17.4)67.5 62.4 5.1 
Total77.5 %81.5 %(4.0)70.6 %73.1 %(2.5)

39
The changes in net losses incurred for the three months ended September 30, 2022, as compared to the equivalent 2021 period, were attributable to the following:
Net Losses Incurred
Three months ended September 30, 2022
Increase (decrease)
($ in millions)		Increase / (decrease) in loss ratio pointsExplanation
Property$(1.9)18.2
The decrease in property losses incurred during the three months ended September 30, 2022, compared to the same period in 2021, was due primarily to a reduction in motor business related to contracts on which we elected to reduce or non-renew our participation. Higher personal lines business and losses from Hurricane Ian and Typhoons Nanmadol and Hinnamnor partially offset the decrease.

The property loss ratio increased 18.2 percentage points during the three months ended September 30, 2022, over the equivalent 2021 period, due primarily to losses from Hurricane Ian and Typhoons Nanmadol and Hinnamnor.

Casualty$(9.3)(0.2)
The decrease in losses incurred during the three months ended September 30, 2022, over the comparable 2021 period was due primarily to reductions in motor and workers’ compensation exposures. Partially offsetting the decrease were losses driven by the following:

•Hurricane Ian;
•new and renewed multi-line contracts; and
•adverse prior-year development

The casualty loss ratio decreased 0.2 percentage points during the three months ended September 30, 2022, over the equivalent 2021 period, due primarily to changes in our business mix. Our underlying casualty loss ratios have improved as we significantly reduced our motor and workers’ compensation exposures and increased our multi-line business. However, losses from Hurricane Ian on certain multi-line contracts mostly offset the improvement in the casualty loss ratio.

Other$(4.7)(17.4)
The decrease in “other” losses incurred during the three months ended September 30, 2022, over the comparable 2021 period was due primarily to the following:

•our decision to reduce or terminate our participation in certain health and crop contracts; and
•losses incurred during the comparable 2021 period from South African riots and Hurricane Ida.
  
Increased losses on marine and energy contracts and our growing transactional liability business partially offset this overall decrease.

The “other” loss ratio decreased 17.4 percentage points during the three months ended September 30, 2022, over the equivalent 2021 period, due primarily to the reasons described above.

40

The changes in net losses incurred and loss ratios during the nine months ended September 30, 2022, were attributable to the following:
Net Losses Incurred
Nine months ended September 30, 2022
Increase (decrease)
($ in millions)		Increase / (decrease) in loss ratio pointsExplanation
Property$(5.0)(0.9)
Our decision to reduce or terminate our participation in certain motor business was the primary driver of the decrease in property losses incurred during the nine months ended September 30, 2022, compared to the same period in 2021. The decrease was partially offset by losses relating to the following:

•our growing personal lines portfolio; and
•catastrophes that occurred during 2022, including Hurricane Ian, Typhoons Nanmadol and Hinnamnor, and Tennessee wildfires.

The property loss ratio decreased 0.9 percentage points during the nine months ended September 30, 2022 over the equivalent 2021 period. This decrease was due primarily to the reduction in our motor business. Catastrophe losses partially offset the decrease.

Casualty$(39.7)(5.6)
Our decision to reduce or terminate our participation in certain motor business was the primary driver of the decrease in casualty losses incurred during the nine months ended September 30, 2022, compared to the same period in 2021.

The decrease was partially offset by higher incurred losses in our Lloyd’s syndicate business relating to the following:

•Hurricane Ian; and
•general liability and multi-line contracts.

Additionally, the prior period incurred losses included losses from winter storm Uri.

The casualty loss ratio decreased 5.6 percentage points during the nine months ended September 30, 2022, over the equivalent 2021 period, due primarily to changes in our business mix. We increased our general liability and multi-line business, which generally incorporates lower loss ratios than the motor and workers’ compensation business it replaced. Adverse loss development on certain motor, workers’ compensation, and multi-line contracts partially offset the loss ratio decreases.

Other$2.55.1
The increase in “other” losses incurred during the nine months ended September 30, 2022, compared to the same period in 2021, was due primarily to losses relating to the Russian-Ukrainian conflict. Our growing book of transactional liability and marine and energy business also contributed to the increase.

The increase was partially offset by the following:
•lower losses incurred on health contracts on which we elected to reduce or not renew our participation;
•the release of loss reserves on certain mortgage contracts; and
•crop losses incurred in the equivalent 2021 period.

The “other” loss ratio increased 5.1 percentage points during the nine months ended September 30, 2022, over the equivalent 2021 period, due primarily to the reasons described above.


Russian-Ukrainian Conflict

41
Our loss and loss adjustment expenses from the Russian-Ukrainian conflict relate primarily to marine, energy, political violence, and terrorism (“MEPVT”) policies and whole account contracts, all of which are included in our Specialty book of business. We have purchased excess of loss reinsurance to reduce our net exposure relating to MEPVT exposures. As of September 30, 2022, we have not recorded any reinsurance recoveries, as the estimated losses had not impacted the excess layers. However, we may generate recoveries under the retroceded contracts if we recognize significant further MEPVT losses from the Russian-Ukrainian conflict.

See Note 5 of the accompanying condensed consolidated financial statements for additional discussion of our reserving techniques and prior period development of net claims and claim expenses.

Acquisition Costs, Net
 
Details of acquisition costs are provided in the following table: 
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Property$2,081 5.7 %$3,178 9.1 %$8,474 8.0 %$9,260 8.7 %
Casualty24,200 65.7 22,942 65.5 64,511 60.8 67,499 63.6 
Other10,540 28.6 8,928 25.5 33,116 31.2 29,301 27.6 
Total$36,821 100.0 %$35,048 100.0 %$106,101 100.0 %$106,060 100.0 %

The acquisition cost ratios for the nine months ended September 30, 2022 and 2021, were as follows:
 Three months ended September 30Nine months ended September 30
 20222021Increase / (decrease)20222021Increase / (decrease)
Property19.0 %21.6 %(2.6)%22.6 %21.2 %1.4 %
Casualty31.6 26.1 5.5 28.6 25.9 2.7 
Other30.6 27.2 3.4 34.8 29.6 5.2 
Total30.2 %25.9 %4.3 %29.6 %26.3 %3.3 %
42


The changes in the acquisition cost ratios for the three months ended September 30, 2022, compared to the equivalent period in 2021, were attributable to the following:
Change in Acquisition Cost Ratios
Three months ended September 30, 2022
 Increase / (decrease) in acquisition cost ratio pointsExplanation
Property(2.6)The decrease in the property acquisition cost ratio during the three months ended September 30, 2022, over the comparable 2021 period, was due primarily to a change in our business mix. During the 2022 period, a higher proportion of the property business we wrote related to excess of loss contracts, which incorporate lower commissions than the quota share contracts that comprised a larger proportion of the business we wrote during the third quarter of 2021.
Casualty5.5
The increase in the casualty acquisition cost ratio during the three months ended September 30, 2022, over the comparable 2021 period, was due primarily to changes in our business mix. Our motor and workers’ compensation premium, which decreased in 2022, generally incorporates lower ceding commission ratios than our general liability and multi-line business, which grew compared to the equivalent 2021 period.

Other3.4
The increase in the “other” acquisition cost ratio during the three months ended September 30, 2022, over the comparable 2021 period was due primarily to the following:

•growth in transactional liability business, which carries higher ceding commission ratios than other specialty business; and
•new specialty quota share contracts bound in 2022, which incorporate relatively high acquisition costs.



The changes in the acquisition cost ratios during the nine months ended September 30, 2022, compared to the equivalent period in 2021, were attributable to the following:
Change in Acquisition Cost Ratios
Nine months ended September 30, 2022
 Increase / (decrease) in acquisition cost ratio pointsExplanation
Property1.4The year-to-date increase was driven by the higher ceding commissions on the growing personal property quota share contracts relative to the shrinking motor business.
Casualty2.7
The year-to-date increase was driven by the same trends as those discussed above in reference to the third quarter.

Other5.2
The year-to-date increase was driven by the same trends as those discussed above in reference to the third quarter. A decrease in health business, which generally carries relatively low ceding commissions, was an additional driver of the increase.

43

Ratio Analysis
 
The following table provides our underwriting ratios by line of business: 


Three months ended September 30Three months ended September 30
20222021
PropertyCasualtyOtherTotalPropertyCasualtyOtherTotal
Loss ratio120.1 %79.6 %59.4 %77.5 %101.9 %79.8 %76.8 %81.5 %
Acquisition cost ratio19.0 31.6 30.6 30.2 21.6 26.1 27.2 25.9 
Composite ratio139.1 %111.2 %90.0 %107.7 %123.5 %105.9 %104.0 %107.4 %
Underwriting expense ratio7.7 1.9 
Combined ratio115.4 %109.3 %

Nine months ended September 30Nine months ended September 30
20222021
PropertyCasualtyOtherTotalPropertyCasualtyOtherTotal
Loss ratio76.2 %71.0 %67.5 %70.6 %77.1 %76.6 %62.4 %73.1 %
Acquisition cost ratio22.6 28.6 34.8 29.6 21.2 25.9 29.6 26.3 
Composite ratio98.8 %99.6 %102.3 %100.2 %98.3 %102.5 %92.0 %99.4 %
Underwriting expense ratio4.6 3.0 
Combined ratio104.8 %102.4 %

The higher underwriting expense ratio for the three months ended September 30, 2022, compared to the same period in 2021, was due to the following:

•interest expense on deposit-accounted contracts based on revised expectations of ultimate cash flows;
•lower net earned premiums compared to the same period in 2021;
•expenses related to forming and managing Syndicate 3456; and
•share-based compensation expenses.

The underwriting expense ratio for the three and nine months ended September 30, 2022, included 5.0 and 1.7 percentage points, respectively, (2021: nil and 0.7 percentage points, respectively) relating to expense on deposit-accounted contracts based on revised expectations of ultimate cash flows. Excluding deposit-accounted contracts, the higher underwriting expense ratio for the nine months ended September 30, 2022, compared to the same period in 2021, was due to the same reasons provided above for the three-month period.

General and Administrative Expenses

Details of general and administrative expenses are provided in the following table: 
Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)($ in thousands)
Underwriting expenses$3,285 $2,616 $10,034 $9,310 
Corporate expenses4,104 3,444 12,693 12,030 
General and administrative expenses$7,389 $6,060 $22,727 $21,340 
For the three months ended September 30, 2022, general and administrative expenses increased by $1.3 million, or 21.9%, compared to the equivalent 2021 period. The increase was due primarily to higher expenses relating to (i) Syndicate
44
3456-related expenses, (ii) share-based compensation, and (iii) information technology costs, compared to the same period in 2021.

For the nine months ended September 30, 2022, general and administrative expenses increased by $1.4 million, or 6.5%, compared to the equivalent 2021 period. The increase was due primarily to higher expenses relating to (i) share-based compensation, (ii) Syndicate 3456-related expenses, (iii) information technology costs, and (iv) legal and other professional fees. Lower D&O insurance and personnel costs partially offset the increase.

For the nine months ended September 30, 2022, and 2021, general and administrative expenses included $3.3 million and $2.4 million, respectively, of costs related to share-based compensation granted to employees and directors.

Total Investment Income (Loss)
 
Total investment income (loss) incorporates (i) changes in the net asset value of our investment in SILP managed by DME Advisors, (ii) interest income earned on the restricted cash and cash equivalents pledged as collateral to our clients, and (iii) gains (or losses) and interest on our portfolio of strategic and Innovations investments, notes receivable and investments accounted for under the equity method. We expect our total investment income, including any change in the net asset value of our investment in SILP, to fluctuate from period to period.

A summary of our total investment income (loss) is as follows:
Three months ended September 30Nine months ended September 30
 2022202120222021
 ($ in thousands)
Realized gains (losses)$— $— $— $14,210 
Change in unrealized gains and losses54 9,637 9,237 14,860 
Investment-related foreign exchange gains (losses)243 (15)(167)(14)
Interest and dividend income, net of withholding taxes3,220 691 4,228 175 
Interest, dividend, and other expenses(479)(10)(1,320)(232)
Net investment-related income (loss)$3,038 $10,303 $11,978 $28,999 
Income (loss) from investments in related party investment fund$8,521 $(6,214)$24,474 $(4,196)
Total investment income (loss)$11,559 $4,089 $36,452 $24,803 

The caption “Income (loss) from investment in related party investment fund” in the above table is net of management fees paid by SILP to DME Advisors and performance compensation, if any, allocated from the Company’s investment in SILP to DME II. No performance compensation is allocated in periods of loss reported by SILP. For detailed breakdowns of management fees and performance compensation for the three and nine months ended September 30, 2022, and 2021, please refer to Note 3 of the condensed consolidated financial statements.

For the three months ended September 30, 2022, the Investment Portfolio managed by DME Advisors reported a gain of 3.6%, compared to a loss of 2.7% for the three months ended September 30, 2021. SILP’s long portfolio gained 6.0%, while the short portfolio and macro positions lost 0.1% and 1.4%, respectively, during the three months ended September 30, 2022. For the three months ended September 30, 2022, the significant contributors to SILP’s investment return were long positions in Atlas Air Worldwide and Green Brick Partners (GRBK) and a short position in a basket of housing-sensitive stocks to hedge the GRBK exposure. The largest detractors were gold and two short positions.

For the three months ended September 30, 2022, there were no notable increases or decreases in our Innovations-related investments, compared to $9.6 million net unrealized gains recorded for the three months ended September 30, 2021.

For the nine months ended September 30, 2022, the Investment Portfolio managed by DME Advisors reported a gain of 10.5%, compared to a loss of 2.2% for the nine months ended September 30, 2021. The long portfolio lost 10.5%, while the short portfolio and macro positions gained 21.1% and 2.6%, respectively, during the nine months ended September 30, 2022. For the nine months ended September 30, 2022, the most significant contributors to SILP’s investment return were short positions in the S&P 500 index and a basket of stocks perceived to be overvalued, and a long position in CONSOL Energy. For
45
the nine months ended September 30, 2022, the most significant detractors were long positions in Brighthouse Financial, GRBK, and gold.

During the nine months ended September 30, 2022, some of our Innovations-related investees completed new financing rounds. The associated carry-value increases contributed to a net unrealized gain of $9.2 million. The unrealized gains are net of a $2.2 million valuation allowance on certain Innovations-related investments recorded during the nine months ended September 30, 2022.

The increase in interest income for the three and nine months ended September 30, 2022, was primarily related to our restricted cash and cash equivalents, which benefited from rising U.S. interest rates.

For the three months ended September 30, 2022, and 2021, the gross investment return (loss) on our investments managed by DME Advisors (excluding the investment advisor performance allocation) was composed of the following:
Three months ended September 30Nine months ended September 30
2022202120222021
Long portfolio gains (losses)6.0 %(3.5)%(10.5)%12.3 %
Short portfolio gains (losses)(0.1)1.1 21.1 (7.9)
Macro gains (losses)(1.4)— 2.6 (5.2)
Other income and expenses 1
(0.5)(0.4)(1.5)(1.4)
Gross investment return4.0 %(2.8)%11.7 %(2.2)%
Net investment return 1
3.6 %(2.7)%10.5 %(2.2)%

1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts.

Effective January 1, 2021, the Investment Portfolio is calculated based on 50% of GLRE Surplus, or the Company’s shareholders’ equity, as reported in the Company’s then most recent quarterly U.S. GAAP financial statements, adjusted monthly for our share of the net profits and net losses reported by SILP during any intervening period. Prior to January 1, 2021, the Investment Portfolio was calculated based on several factors, including our share of SILP’s net asset value and our posted collateral and net reserves.

Each month, we post on our website (www.greenlightre.com) the returns from our investment in SILP.
       
Income Taxes
 
We are not obligated to pay taxes in the Cayman Islands on either income or capital gains. The Governor-In-Cabinet has granted us an exemption from any income taxes that may be imposed in the Cayman Islands for the 20 years expiring February 1, 2025.

GRIL is incorporated in Ireland and is subject to the Irish corporation tax. We expect GRIL to be taxed at 12.5% on its taxable trading income and 25% on its non-trading income, if any.

Verdant is incorporated in Delaware and is subject to taxes under the U.S. federal rates and regulations prescribed by the Internal Revenue Service. We expect Verdant’s future taxable income to be taxed at 21%.

At September 30, 2022, we have included a gross deferred tax asset of $3.7 million (December 31, 2021: $3.2 million) in the caption “Other assets” in the Company’s condensed consolidated balance sheets. At September 30, 2022, a valuation allowance of $3.2 million (December 31, 2021: $2.7 million) partially offset this gross deferred tax asset. We have concluded that it is more likely than not that the Company will fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. We have based this conclusion on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit. We have not taken any other tax positions that we believe are subject to uncertainty or reasonably likely to have a material impact on the Company.
             

46
Financial Condition
 
Total investments
 
The total investments reported in the condensed consolidated balance sheets at September 30, 2022, was $260.3 million, compared to $231.0 million at December 31, 2021, an increase of $29.3 million, or 12.7%. The increase was primarily related to gains on SILP and Innovations-related investments and purchase of certificates of deposit. The increase was partially offset by net redemptions from SILP.

At September 30, 2022, 91.5% of SILP’s portfolio was valued based on quoted prices in actively traded markets (Level 1), 6.0% was composed of instruments valued based on observable inputs other than quoted prices (Level 2), and 0.0% was composed of instruments valued based on non-observable inputs (Level 3). At September 30, 2022, 2.5% of SILP’s portfolio consisted of private equity funds valued using the funds’ net asset values as a practical expedient.

At September 30, 2022, 87% of our Innovations-related portfolio was carried at fair value on a nonrecurring basis, measured as of the investees’ most recent completed financing round, and 13% was carried at original cost.

Other than our investment in SILP (see Notes 3 of the accompanying condensed consolidated financial statements), we have not participated in transactions that created relationships with unconsolidated entities or financial partnerships, including VIEs, established to facilitate off-balance sheet arrangements. 

Cash and cash equivalents; Restricted cash and cash equivalents

The unrestricted cash and cash equivalents decreased by $44.0 million, or 57.7%, from $76.3 million at December 31, 2021, to $32.3 million at September 30, 2022, primarily due to cash used for operations, including the repurchase of senior convertible debt, purchase of Innovations-related investments and collateral posted to our ceding insurers.

We use our restricted cash and cash equivalents for funding trusts and letters of credit issued to our ceding insurers. Our restricted cash increased by $14.1 million, or 2.2%, from $634.8 million at December 31, 2021, to $648.9 million at September 30, 2022, primarily due to collateral required by our ceding insurers.

Reinsurance balances receivable

During the nine months ended September 30, 2022, reinsurance balances receivable increased by $68.2 million, or 16.8%, to $473.6 million from $405.4 million at December 31, 2021. This increase was related primarily to funds withheld by cedents. At September 30, 2022, funds held by cedents were $303.1 million, compared to $246.9 million at December 31, 2021. The remaining increases related to premiums receivable on new contracts bound during nine months ended September 30, 2022.

Loss and Loss Adjustment Expense Reserves; Loss and Loss Adjustment Expenses Recoverable
 
Reserves for loss and loss adjustment expenses were composed of the following: 
 September 30, 2022December 31, 2021
 Case
Reserves		IBNRTotalCase
Reserves		IBNRTotal
 ($ in thousands)
Property$32,716 $84,009 $116,725 $21,357 $49,486 $70,843 
Casualty117,847 148,746 266,593 151,734 219,949 371,683 
Other36,382 121,127 157,509 17,129 64,355 81,484 
Total$186,945 $353,882 $540,827 $190,220 $333,790 $524,010 
 
During the nine months ended September 30, 2022, the total gross loss and loss adjustment expense reserves increased by $16.8 million, or 3.2%, to $540.8 million from $524.0 million at December 31, 2021. See Note 5 of the accompanying condensed consolidated financial statements for a summary of changes in outstanding loss and loss adjustment expense reserves and a description of prior period loss developments.

47
During the nine months ended September 30, 2022, the total loss and loss adjustment expenses recoverable decreased by $0.5 million, or 4.5%, to $10.6 million from $11.1 million at December 31, 2021. See Note 6 of the accompanying condensed consolidated financial statements for a description of the credit risk associated with our retrocessionaires.

For most of the contracts we write, defined limits of liability limit our risk exposure. Once each contract’s limit of liability has been reached, we have no further exposure to additional losses from that contract. However, certain contracts, particularly quota share contracts covering first-dollar exposure, may not contain aggregate limits.

Our property and Lloyd’s business, and to a lesser extent our casualty and other business, incorporate contracts that contain natural peril loss exposure. We currently monitor our catastrophe loss exposure in terms of our PML (probable maximum loss).

We anticipate that our PMLs will vary from period to period depending upon the modeled simulated losses and the composition of our in-force book of business.

We monitor our natural peril PMLs on a worldwide basis, with a particular focus on our peak peril regions. When these perils consist of a large geographic area, we split them into sub-regions, where the underlying geographic components can also be considered individual peril zones.

For our natural catastrophe PMLs, we utilize the output of catastrophe models at the 1-in-250 year return period. The 1-in-250 year return period PML means that we believe there is a 0.4% probability that in any given year, an occurrence of a natural catastrophe will lead to losses exceeding the stated estimate.

It is important to note that PMLs are best estimates based on the modeled data available for each underlying risk. As a result, we cannot provide assurance that any actual event will align with the modeled event or that actual losses from events similar to the modeled events will not vary materially from the modeled event PML.

Our PML estimates incorporate all significant exposure from our reinsurance operations, including coverage for property, marine and energy, motor, and catastrophe workers’ compensation.

48
At October 1, 2022, our estimated largest PML (net of retrocession and reinstatement premiums) at a 1-in-250 year return period for a single event and in aggregate was $88.7 million and $95.9 million, respectively, both relating to the peril of North Atlantic Hurricane.

The below table contains the expected modeled loss for each of our peak peril regions and sub-regions, for both a single event loss and aggregate loss measures at the 1-in-250 year return period.

October 1, 2022
Net 1-in-250 Year Return Period
PerilSingle Event LossAggregate Loss
($ in thousands)
North Atlantic Hurricane$88,673 $95,876 
Southeast Hurricane66,247 71,541 
Gulf of Mexico Hurricane59,936 64,145 
Northeast Hurricane62,020 63,404 
North America Earthquake60,793 65,126 
California Earthquake53,957 56,977 
Other N.A. Earthquake34,533 36,329 
Japan Earthquake37,771 40,751 
Japan Windstorm37,406 40,713 
Europe Windstorm30,041 36,550 

Total shareholders’ equity
 
Total equity reported on the condensed consolidated balance sheet decreased by $8.7 million to $467.0 million at September 30, 2022, compared to $475.7 million at December 31, 2021. The decrease in shareholders’ equity during the nine months ended September 30, 2022, was primarily due to the net loss of $9.4 million reported for the period, partially offset by the adoption of ASU 2020-06 (see Note 2 of the accompanying condensed consolidated financial statements). For details of other movements in shareholders’ equity, please see the “Condensed Consolidated Statements of Shareholders’ Equity.”

Liquidity and Capital Resources
 
General

Greenlight Capital Re is a holding company with no operations of its own. As a holding company, Greenlight Capital Re has minimal continuing cash needs, most of which are related to the payment of corporate and general administrative expenses and interest expenses. We conduct all our underwriting operations through our wholly-owned reinsurance subsidiaries, Greenlight Re and GRIL, which underwrite property and casualty reinsurance. There are restrictions on Greenlight Re’s and GRIL’s ability to pay dividends, described in more detail below. It is our current policy to retain earnings to support the growth of our business. We currently do not expect to pay dividends on our ordinary shares.

At September 30, 2022, Greenlight Re and GRIL were each rated “A- (Excellent)” with a stable outlook by A.M. Best. The ratings reflect A.M. Best’s opinion of our reinsurance subsidiaries’ financial strength, operating performance, and ability to meet obligations. They are not evaluations directed toward the protection of investors or a recommendation to buy, sell or hold our Class A ordinary shares.

49
Sources and Uses of Funds
 
Our sources of funds consist primarily of premium receipts (net of brokerage and ceding commissions), investment income, and other income. We use cash from our operations to pay losses and loss adjustment expenses, profit commissions, interest, and general and administrative expenses. At September 30, 2022, all of our investable assets, excluding strategic and Innovations investments and funds required for business operations and capital risk management, are invested by DME Advisors in SILP, subject to our investment guidelines. We can redeem funds from SILP at any time for operational purposes by providing three days’ notice to the general partner. At September 30, 2022, the majority of SILP’s long investments were composed of cash and cash equivalents and publicly traded equity securities, which can be readily liquidated to meet our redemption requests. We record all investment income (loss), including any changes in the net asset value of SILP, and any unrealized gains and losses, in our condensed consolidated statements of operations for each reporting period.    
   
For the nine months ended September 30, 2022 and 2021, the net cash used in operating activities was $27.4 million and $18.8 million, respectively. The net cash used in operating activities was used primarily for our underwriting activities and for payment of corporate and general administrative expenses for the nine months ended September 30, 2022 and 2021. Generally, if the premiums collected exceed claim payments within a given period, we generate cash from our underwriting activities. Our underwriting activities represented a net use of cash for the nine months ended September 30, 2022 and 2021, as the losses we paid exceeded the premiums we collected. On our Lloyd’s syndicate contracts we do not receive any premiums until the year of account is settled, net of losses, at the end of three years. Our Lloyd’s syndicate business has been growing in recent years, contributing to the net use of cash for underwriting activities. The cash used in, and generated from, underwriting activities may vary significantly from period to period depending on the mix of business, the nature of underwriting opportunities available and volume of claims submitted to us by our cedents.

For the nine months ended September 30, 2022, our investing activities provided $12.9 million of cash from redemptions from SILP (net of contributions) and used $8.6 million for new Innovations and other investments. By comparison, for the same period in 2021 our investing activities provided net cash of $4.4 million.

For the nine months ended September 30, 2022, we used $6.4 million to repurchase our convertible senior notes. During the same period in 2021, we used $10.0 million to repurchase our Class A ordinary shares.
  
At September 30, 2022, we believe we have sufficient liquidity to meet our foreseeable financial requirements. We do not expect the recent global events, including Hurricane Ian, the Russian-Ukrainian conflict, and the COVID-19 pandemic, to materially impact our operational liquidity needs. These needs will be met by cash, funds generated from underwriting activities, and investment income, including withdrawals from SILP if necessary. At September 30, 2022, we expect to fund our operations for the next twelve months from operating and investing cash flow. 

We are evaluating various alternatives in relation to the convertible senior notes that mature in August 2023. In addition, we may explore various financing options, including debt refinancing and other capital raising alternatives, to fund our business strategy, improve our capital structure, increase surplus, pay claims or make acquisitions. We can provide no assurances regarding the terms of such transactions or that any such transactions will occur. If we are unable to refinance the convertible senior notes, we will be required to fund settlement at maturity using cash on hand, or withdrawals from SILP, which may significantly and negatively affect our ability to implement our business strategy.
 
Although GLRE is not subject to any significant legal prohibitions on the payment of dividends, Greenlight Re and GRIL are each subject to regulatory minimum capital requirements and regulatory constraints that affect their ability to pay dividends to us. In addition, any dividend payment would have to be approved by the relevant regulatory authorities prior to payment. At September 30, 2022, Greenlight Re and GRIL exceeded their regulatory minimum capital requirements. 

Letters of Credit and Trust Arrangements
 
At September 30, 2022, neither Greenlight Re nor GRIL was licensed or admitted as a reinsurer in any jurisdiction other than the Cayman Islands and the European Economic Area, respectively. Many jurisdictions do not permit domestic insurance companies to take credit on their statutory financial statements for loss recoveries or ceded unearned premiums unless appropriate measures are in place for reinsurance obtained from unlicensed or non-admitted insurers. As a result, we anticipate that all of our U.S. clients and some non-U.S. clients will require us to provide collateral through funds withheld, trust arrangements, letters of credit, or a combination thereof.

At September 30, 2022, we had one letter of credit facility available with an aggregate capacity of $275.0 million (December 31, 2021: $275.0 million). See Note 12 of the accompanying condensed consolidated financial statements for details
50
on the letter of credit facility. We provide collateral to cedents in the form of letters of credit and trust arrangements. At September 30, 2022, the aggregate amount of collateral provided to cedents under such arrangements was $648.2 million (December 31, 2021: $633.9 million). At September 30, 2022, the letters of credit and trust accounts were secured by restricted cash and cash equivalents with a total fair value of $648.9 million (December 31, 2021: $634.8 million).

The letter of credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements, and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re would be prohibited from paying dividends to its parent company. The Company was in compliance with all the covenants of this facility at September 30, 2022.

Capital
 
Our capital structure currently consists of senior convertible notes and equity issued in two classes of ordinary shares. We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. Consequently, we do not presently anticipate that we will incur any additional material indebtedness in the ordinary course of our business. However, to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions, or other general corporate purposes, we have filed a Form S-3 registration statement, which expires in July 2024. In addition, as noted above, we may explore various financing alternatives, although there can be no assurance that additional financing will be available on acceptable terms when needed or desired. We did not make any significant commitments for capital expenditures during the nine months ended September 30, 2022.

The Board of Directors had previously approved a share repurchase plan authorizing the Company to repurchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. On April 26, 2022, the Board of Directors renewed and extended the share repurchase plan until June 30, 2023. The Company is not required to repurchase any Class A ordinary shares, and the repurchase plan may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice. During the nine months ended September 30, 2022, the Company repurchased 4,933 Class A ordinary shares at an average share price of $7.04.

Under the Company’s stock incentive plan, the number of Class A ordinary shares authorized for issuance is 8.0 million shares. At September 30, 2022, 2,011,426 Class A ordinary shares were available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the stock incentive plan. 
 
Contractual Obligations and Commitments
 
Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain. At September 30, 2022, we estimate that we will pay the loss and loss adjustment expense reserves as follows: 
Less than
 1 year		1-3 years3-5 yearsMore than
 5 years		Total
   ($ in thousands)
Loss and loss adjustment expense reserves (1)
$278,526 $157,381 $49,215 $55,706 $540,827 
(1)      Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.

Greenlight Re has entered into a lease agreement for office space in the Cayman Islands commencing from July 1, 2021. The lease expires on June 30, 2026, unless Greenlight Re exercises its right to renew the lease for another five-year period. GRIL has entered into a lease agreement for office space in Dublin, Ireland commencing from October 1, 2021. This lease expires on September 30, 2031, unless GRIL exercises the break clause by providing a notice of termination at least nine months prior to September 30, 2026. The aggregate annual lease obligation ranges from $0.5 million to $0.6 million.
 
At September 30, 2022, the Company has $93.4 million of senior convertible notes payable, which mature on August 1, 2023. The Company is obligated to make semiannual interest payments of $2.0 million at an interest rate of 4.0% per annum.
51
The Company has received regulatory approval to declare dividends from Greenlight Re to meet the interest payments obligation.
 
Pursuant to the IAA between SILP and DME Advisors, DME Advisors is entitled to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio, as provided in the SILP LPA. The IAA has an initial term ending on August 31, 2023, subject to automatic extension for successive three-year terms. Pursuant to the SILP LPA, DME II is entitled to a performance allocation equal to 20% of the net profit, calculated per annum, of each limited partner’s share of the capital account managed by DME Advisors, subject to a loss carry-forward provision. DME II is not entitled to earn a performance allocation in a year in which SILP incurs a loss. The loss carry-forward provision contained in the SILP LPA allows DME II to earn reduced performance allocation of 10% of net profits in years subsequent to the year in which the capital accounts of the limited partners incur a loss, until all losses are recouped and an additional amount equal to 150% of the loss is earned. At September 30, 2022, we estimate the reduced performance allocation of 10% to continue to be applied until SILP achieves additional investment returns of 164%, at which point the performance allocation will revert to 20%. For detailed breakdowns of management fees and performance compensation for the three and nine months ended September 30, 2022 and 2021, please refer to Note 3 of the condensed consolidated financial statements.

The Company has entered into a service agreement with DME Advisors pursuant to which DME Advisors will provide investor relations services to us for compensation of $5,000 per month plus expenses. The service agreement had an initial term of one year and continues for sequential one-year periods until terminated by us or DME Advisors. Either party may terminate the service agreement for any reason with 30 days prior written notice to the other party.

Our related party transactions are presented in Note 11 to the accompanying condensed consolidated financial statements.

Effects of Inflation
 
Inflation generally affects the cost of claims and claim expenses. Long-tailed lines of business generally have greater exposure to inflation than short-tailed lines, with this differential becoming more pronounced as the severity of inflation increases. Our underwriting portfolio is predominantly short-tailed, and we actively manage our exposures to classes that experience significant inflation. Our pricing and reserving models incorporate the anticipated effects of inflation on our claim costs, and we regularly review and update our assumptions. However, we cannot predict or estimate the onset, duration, and severity of an inflationary period with precision. The actual effect of inflation may differ significantly from our assumptions.

Inflation can also affect the asset values in SILP’s investment portfolio. DME Advisors regularly monitors and re-positions SILP’s investment portfolio to deal with the impact of inflation on its underlying investments, and holds macro positions to benefit from a rising inflationary environment.


Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We believe we are principally exposed to the following types of market risk: 
•equity price risk;
•commodity price risk;
•foreign currency risk;
•interest rate risk;
•credit risk; and
•political risk.
 
52
Equity Price Risk
At September 30, 2022, our investments consisted primarily of an investment in SILP. Among SILP’s holdings are equity securities, the carrying values of which are based primarily on quoted market prices. Generally, market prices of common equity securities are subject to fluctuation, which could cause the amount to be realized upon the closing of a position to differ significantly from its current reported value. This risk is partly mitigated by the presence of both long and short equity securities as part of our investment strategy. At September 30, 2022, a 10% decline in the price of each of the underlying listed equity securities and equity-based derivative instruments would result in a $2.2 million loss to our Investment Portfolio.

Computations of the prospective effects of hypothetical equity price changes are based on numerous assumptions, including the maintenance of the current composition of SILP’s portfolio. The computations should not be relied on as indicative of future results.

Commodity Price Risk
Generally, market prices of commodities are subject to fluctuation. SILP’s investments periodically include long or short investments in commodities or derivatives directly impacted by fluctuations in the prices of commodities. At September 30, 2022, SILP’s investments incorporate unhedged exposure to changes in gold, silver, uranium and crude oil prices.
The following table summarizes the net impact that a 10% increase and decrease in commodity prices would have on the value of our Investment Portfolio at September 30, 2022. The below table excludes the indirect effect that changes in commodity prices might have on equity securities in our Investment Portfolio. 
10% increase in commodity prices10% decrease in commodity prices
CommodityChange in
fair value		Change in
fair value
  ($ in millions)
Gold$3.0 $(3.0)
Silver0.3 (0.3)
Uranium0.2 (0.2)
Crude oil— (0.1)
Total$3.5 $(3.6)

Foreign Currency Risk
Certain of our reinsurance contracts are denominated in foreign currencies, whereby premiums are receivable and losses are payable in foreign currencies. Foreign currency exchange rate risk exists to the extent that our foreign currency reinsurance balances are more than (or less than) the corresponding foreign currency cash balances and there is an increase (or decrease) in the exchange rate of that foreign currency.  

While we do not seek to precisely match our liabilities under reinsurance policies that are payable in foreign currencies with investments denominated in such currencies, we continually monitor our exposure to potential foreign currency losses and may use foreign currency cash and cash equivalents or forward foreign currency exchange contracts to mitigate against adverse foreign currency movements.

Certain cedents report to us in foreign currencies even though some or all of the underlying exposure is denominated in U.S. dollars. Our condensed consolidated statements of operations may report a foreign exchange gain or loss associated with this exposure when reported by the cedents. Additionally, we may report foreign exchange gains or losses due to the mismatch between the currency exchange rates applied to foreign-denominated (i) monetary balances and (ii) non-monetary balances under U.S. GAAP. See Note 2 of the accompanying condensed consolidated financial statements for further information regarding our accounting treatment of foreign currency transactions.

We monitor our foreign currency-denominated assets and liabilities on an “underlying exposure” basis without distinguishing between monetary and non-monetary balances.

53
At September 30, 2022, our underlying exposure to GBP denominated net reinsurance asset balance was £5.9 million. At September 30, 2022, a 10% decrease in the U.S. dollar against the GBP (all else constant) would result in an estimated $0.7 million foreign exchange gain. Alternatively, a 10% increase in the U.S dollar against the GBP would result in an estimated $0.7 million foreign exchange loss. Similarly, at September 30, 2022, our net underlying exposure to Euro-denominated reinsurance liability balances was €11.6 million. At September 30, 2022, a 10% decrease in the U.S. dollar against the Euro (all else constant) would result in an estimated $1.1 million foreign exchange loss. Alternatively, a 10% increase in the U.S dollar against the Euro would result in an estimated $1.1 million foreign exchange gain.

We may also be exposed to foreign currency risk through SILP’s underlying cash, forwards, options, and investments in securities denominated in foreign currencies. At September 30, 2022, most of SILP’s currency exposures resulting from foreign denominated securities (longs and shorts) were reduced by offsetting cash balances denominated in the corresponding foreign currencies.

At September 30, 2022, a 10% increase or decrease in the value of the U.S. dollar against foreign currencies would have no meaningful impact on the value of our Investment Portfolio. 
 
Interest Rate Risk
The primary market risk exposure for any debt instrument is interest rate risk. As interest rates rise, the fair value of a long fixed-income portfolio generally falls. Similarly, falling interest rates generally lead to increases in the fair value of fixed-income securities. Additionally, some derivative investments may be sensitive to interest rates, and their value may indirectly fluctuate with changes in interest rates. 

The caption “Reinsurance balances receivable” in our condensed consolidated balance sheets incorporates amounts held by cedents, including the Lloyd’s syndicates that we participate on. These syndicates invest a portion of the premiums withheld in fixed-income and variable-yield securities, which expose us to interest rate risk. At September 30, 2022, a 100 basis points increase or decrease in interest rates would result in an estimated $1.6 million loss or gain, respectively, which would be recorded in our condensed consolidated statements of operations under the captions “Other income (expense).”

Our restricted cash and cash equivalents earn interest at rates that generally follow the movements of the short-term U.S. Treasury rates. At September 30, 2022, a 100 basis points increase or decrease in U.S. Federal Funds Rate would result in approximately $4.8 million, increase or decrease, respectively, in our interest income on an annualized basis.
Our investment in SILP includes interest-rate sensitive securities, such as corporate and sovereign debt instruments and interest rate options. At September 30, 2022, a 100 basis points increase or decrease in interest rates would result in a $1.1 million gain or a $1.7 million loss, respectively, to our Investment Portfolio.

We, along with DME Advisors, monitor the net exposure to interest rate risk and generally do not expect changes in interest rates to have a materially adverse impact on our operations.
 
Credit Risk

Credit risk relates to the uncertainty of a counterparty’s ability to make timely payments in accordance with terms of the instrument or contract. Our maximum exposure to credit risk is the carrying value of our financial assets. We evaluate the financial condition of our business partners and clients relating to balances receivable under our reinsurance contracts, including premiums receivable, losses recoverable, and commission adjustments recoverable. We obtain collateral in the form of funds withheld, trusts, and letters of credit from our counterparties to mitigate this credit risk. We monitor our net exposure to each counterparty relative to the financial strength of our counterparties and assess the collectibility of these balances on a regular basis. See Note 2 of the accompanying condensed consolidated financial statements for further details on allowance for credit loss on reinsurance assets.

In addition, the securities, commodities, and cash in SILP’s investment portfolio are held with several prime brokers and derivative counterparties, subjecting SILP, and indirectly us, to a significant concentration of credit risk. While we have no direct control over SILP, DME Advisors regularly monitors the concentration of credit risk with each counterparty and, if appropriate, transfers cash or securities between counterparties or requests collateral to diversify and mitigate this credit risk. 

54
Political Risk

Through our assumed reinsurance contracts, we currently provide a limited amount of political risk insurance coverage. We do not expect this exposure to have a materially adverse impact on our underwriting results.

We are exposed to political risk to the extent that we underwrite business from entities located in foreign markets and to the extent that DME Advisors, on behalf of SILP and subject to our investment guidelines, trades securities listed on various U.S. and foreign exchanges and markets. The governments in any of these jurisdictions could impose restrictions, regulations, or other measures, which may have a material adverse impact on our underwriting operations and investment strategy. See “Item 1A. Risk Factors - We could face unanticipated losses from political instability which could have a material adverse effect on our financial condition and results of operations” included in our Form 10-K for the fiscal year ended December 31, 2021.

 
Item 4. CONTROLS AND PROCEDURES
 
Disclosure Controls and Procedures
 
As required by Rules 13a-15 and 15d-15 of the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports prepared in accordance with the rules and regulations of the SEC is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
 
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
 
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.  
  
Changes in Internal Control Over Financial Reporting
 
There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal controls over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.


PART II — OTHER INFORMATION
 
55
Item 1.    LEGAL PROCEEDINGS
 
From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results. 
 
Item 1A. RISK FACTORS
 
Factors that could cause our actual results to differ materially from those in this report are any of the risks described in “Part I. Item 1A. Risk Factors” included in our Form 10-K for the fiscal year ended December 31, 2021, as filed with the "Securities and Exchange Commission ("SEC") on March 8, 2022 (the “Form 10-K”) and in “Part II. Item 1A. Risk Factors” included in our Form 10-Q for the three months ended March 31, 2022, as filed with the SEC on May 3, 2022 (the “Q1 Form 10-Q”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
As of September 30, 2022, there have been no other material changes to the risk factors disclosed in “Part I. Item 1A. Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in “Part II. Item 1A. Risk Factors” included in our Q1 Form 10-Q. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 
 
Our board of directors has adopted a share repurchase plan authorizing the Company to repurchase Class A ordinary shares. From time to time, the repurchase plan has been re-approved or modified at the election of our Board of Directors. The previous plan expired on June 30, 2022. On April 26, 2022, the Board of Directors re-approved the share repurchase plan effective from July 1, 2022, until June 30, 2023, authorizing the Company to repurchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans.

The Company is not required to repurchase any Class A ordinary shares and the repurchase plan may be modified, suspended or terminated at any time without prior notice.

The table below details the share repurchases that were made under the plan during the three months ended September 30, 2022:
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares Purchased (1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(1)		Maximum Value of Shares that May Yet Be Purchased Under the Plans or Programs (1)
July 1 - 31, 20224,026 $7.00 4,026 $24,971,818 
August 1 - 31, 2022— $— — $24,971,818 
September 1 - 30, 2022907 $7.23 907 $24,965,260 
Total4,933 $7.04 4,933 $24,930,532 
(1) Class A ordinary shares.

Item 3.    DEFAULTS UPON SENIOR SECURITIES 
 
None.
 
56
Item 4.    MINE SAFETY DISCLOSURES

Not applicable
 
Item 5.    OTHER INFORMATION

None
 
Item 6.    EXHIBITS

31.1
31.2
32.1
32.2
101The following materials from the Company’s Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2022 formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Changes in Shareholders’ Equity; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 
 
57


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 GREENLIGHT CAPITAL RE, LTD.
 (Registrant)
 By:/s/ SIMON BURTON                     
 Simon Burton
Director and Chief Executive Officer
(principal executive officer)
 November 2, 2022
 By:/s/ NEIL GREENSPAN                           
 Neil Greenspan
Chief Financial Officer
(principal financial and accounting officer)
 November 2, 2022
58
 EX-31.1 2 glre-20220930exhibit311.htm EX-31.1 Document

EXHIBIT 31.1  

CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Simon Burton, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Greenlight Capital Re, Ltd.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   

Dated:November 2, 2022/s/ SIMON BURTON                     
  Simon Burton
Chief Executive Officer
(principal executive officer)
  

 EX-31.2 3 glre-20220930exhibit312.htm EX-31.2 Document

 EXHIBIT 31.2 

CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Neil Greenspan, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Greenlight Capital Re, Ltd.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   


Dated:November 2, 2022/s/ NEIL GREENSPAN  
  Neil Greenspan
  Chief Financial Officer
(principal financial officer)

 EX-32.1 4 glre-20220930exhibit321.htm EX-32.1 Document

EXHIBIT 32.1   
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the "Form 10-Q") for the period ended September 30, 2022 of Greenlight Capital Re, Ltd. (the "Issuer"). 

I, Simon Burton, the Principal Executive Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 


Dated:November 2, 2022/s/ SIMON BURTON                     
  Simon Burton
Chief Executive Officer
(principal executive officer)
 


 EX-32.2 5 glre-20220930exhibit322.htm EX-32.2 Document

EXHIBIT 32.2  
CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the period ended September 30, 2022 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’). 

I, Neil Greenspan, the Principal Financial Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.  


Dated:November 2, 2022/s/ NEIL GREENSPAN
  Neil Greenspan
Chief Financial Officer
(principal financial officer)
 


 EX-101.SCH 6 glre-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - FINANCIAL INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - RETROCESSION link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - SENIOR CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - TAXATION link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - TAXATION (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) and Weighted Average Number of Shares (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - FINANCIAL INSTRUMENTS - Other Investments (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - FINANCIAL INSTRUMENTS - Nonrecurring Fair Value Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - FINANCIAL INSTRUMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - RETROCESSION (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - SENIOR CONVERTIBLE NOTES (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - SHARE CAPITAL - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - SHARE CAPITAL - Stock by Class (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - SHARE-BASED COMPENSATION - Performance Restricted Share Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - SHARE-BASED COMPENSATION - Employee and Director Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - TAXATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - TAXATION - Components of Income Tax Expense (Benefit) (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 glre-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 glre-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 glre-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Loss and loss adjustment expenses recoverable Increase (Decrease) in Reinsurance Recoverable Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Total lease payments Lessee, Operating Lease, Liability, to be Paid Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Foreign Exchange Foreign Currency Transactions and Translations Policy [Policy Text Block] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Net loss and loss adjustment expenses incurred Policyholder Benefits and Claims Incurred, Net Facility Financial Standby Letter of Credit [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net gain (loss) on investment transactions Gain (Loss) on Investments Schedule of Liability for Unpaid Claims and Claims Adjustment Expense Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Maximum Facility Limit Line of Credit Facility, Maximum Borrowing Capacity Investor relations monthly fee Related Party Transaction, Expenses from Transactions with Related Party Income Tax Disclosure [Abstract] Fair value of debt Debt Instrument, Fair Value Disclosure Investment management fee rate - monthly (in percent) Related Party Transaction, Monthly Management Fee Percentage The monthly rate charged by investment advisor calculated as a percentage of assets under management Expenses Benefits, Losses and Expenses [Abstract] Management fee Management Fee Expense Additional paid-in capital Additional Paid in Capital Total Gross balance at January 1 Gross balance at September 30 Liability for Claims and Claims Adjustment Expense Secured Ceded Credit Risk, Secured [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Solasglas Investments, LP (SILP) Solasglas Investments, LP (SILP) [Member] Solasglas Investment LP (SILP) [Member] Exercised (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Management fees Equity Method Investment, Summarized Financial Information, Management Fee Expense Equity Method Investment, Summarized Financial Information, Management Fee Expense Weighted-average discount rate on operating leases (as a percent) Operating Lease, Weighted Average Discount Rate, Percent Debt interest rate (in percent) Debt Instrument, Interest Rate, Stated Percentage Loss and loss expenses recovered and recoverable Policyholder Benefits and Claims Incurred, Assumed and Ceded Deposit interest expense Deposit interest expense Interest Expense, Deposits Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Liability for Claims and Claims Adjustment Expense [Table] Liability for Claims and Claims Adjustment Expense [Table] Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Schedule of Other Investments Investment Holdings, Other than Securities [Table Text Block] Shares potentially issuable in connection with convertible notes and Anti-dilutive stock options outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Common stock held (in shares) Related Party Transaction, Investment Owned, Shares Related Party Transaction, Investment Owned, Shares Service Agreement Service Agreement [Member] Service Agreement [Member] Cumulative Effect, Period Of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Document Information [Line Items] Document Information [Line Items] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Year ending December 31, Lessee, Operating Lease, Liability, to be Paid [Abstract] Dividend income (net of withholding taxes) Dividend Income, Operating Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Nonrecurring Fair Value, Nonrecurring [Member] Ceded Credit Risk, Collateralization [Domain] Ceded Credit Risk, Collateralization [Domain] Ownership [Axis] Ownership [Axis] Liability for Unpaid Claims and Claims Adjustment Expense Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Cliff vesting percentage after date of issuance (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Debt and Equity Securities, FV-NI Debt and Equity Securities, FV-NI [Line Items] Investment, Name [Domain] Investment, Name [Domain] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Related Party [Domain] Related Party [Domain] Supplementary information Supplemental Cash Flow Information [Abstract] Forfeitures (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of operating segments Number of Operating Segments Unrecognized compensation costs related to non-vested restricted shares Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount 2022 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year IBNR Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount Investment management fee rate - annual (in percent) Related Party Transaction, Annual Management Fee Percentage The annual rate charged by investment advisor calculated as a percentage of assets under management Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Effect of settling the convertible debt in shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Unearned premiums ceded Prepaid Reinsurance Premiums Weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Less: Losses recoverable Loss and loss adjustment expenses recoverable Reinsurance Recoverables, Including Reinsurance Premium Paid Net investment income (loss) Net investment income (loss) Investment Income The net income earned from investments in securities and other investments including derivatives. It includes dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It also includes realized and unrealized gains and losses on all investments. Russian-Ukrainian Conflict Russian-Ukrainian Conflict [Member] Russian-Ukrainian Conflict Award Type [Axis] Award Type [Axis] New Accounting Pronouncements or Change in Accounting Principle New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Derivative contracts, at fair value Derivative Asset Expired (in shares) Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Schedule of Activity for Unvested Restricted Share Awards and Employee Restricted Stock Units Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Performance compensation full rate (in percent) Related Party Transaction, Performance Compensation Full Rate As Percentage Of Investment Income The full rate of performance compensation as a percent of investment income charged by a related party. Related Party Transaction [Domain] Related Party Transaction [Domain] Other liabilities Other liabilities Other Liabilities Lender Name [Axis] Lender Name [Axis] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Change in notes receivable Increase (Decrease) in Notes Receivables Forfeitures (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Legal Entity [Axis] Legal Entity [Axis] Certificates of deposit Certificates of Deposit [Member] Total liabilities Total liabilities Liabilities Worldwide Worldwide [Member] Worldwide Unearned premium reserves Increase (Decrease) in Unearned Premiums Weighted-average remaining lease term on operating leases Operating Lease, Weighted Average Remaining Lease Term Geographical [Axis] Geographical [Axis] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Net realized (gains) losses on investments and notes receivable Realized Gains (Losses) On Sale Of Investments And Derivatives The net realized gains (losses) on investments and derivatives sold during the period. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Loss and loss adjustment expense reserves Liability for Claims and Claims Adjustment Expense, Property-Casualty Liability Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Preferred share capital, issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted  average  exercise  price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Number of non-vested RSUs Number of non-vested restricted  shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Interest and dividends payable Interest and Dividends Payable Revenue from External Customer Revenue from External Customer [Line Items] Assets Assets, Fair Value Disclosure [Abstract] Proceeds from redemptions from related party investment fund Proceeds from Equity Method Investment, Distribution, Return of Capital Unvested weighted average grant date fair value (in dollars per share) Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Ceded Credit Risk Ceded Credit Risk [Line Items] SENIOR CONVERTIBLE NOTES Debt Disclosure [Text Block] Insurance Product Line [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Class B Common Class B [Member] Investments Investments [Abstract] Professional Liability Professional Malpractice Liability Insurance [Member] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Unsecured Ceded Credit Risk, Unsecured [Member] Realized and change in unrealized gains (losses) Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment [Abstract] Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment Other investments Other Investments Affiliated Entity Affiliated Entity [Member] FINANCIAL INSTRUMENTS Financial Instruments Disclosure [Text Block] Subsequent Event Subsequent Event [Member] Document Period End Date Document Period End Date Income Tax Examination [Table] Income Tax Examination [Table] Total other investments Other Investments [Member] Less than 6 months Measurement Period One [Member] Measurement Period One Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Accounting Standards Update 2020-06 Accounting Standards Update 2020-06 [Member] Total assets Assets Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings (loss) per share (Class A and Class B) Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Schedule of Carrying Values of Private Investments and Unlisted Equity Securities Carried under Measurement Alternative Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Service Restricted Shares Service Restricted Stock [Member] Service Restricted Stock Exercises (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Numerator for earnings per share Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Earnings (loss) per Class A and Class B Ordinary share: Earnings Per Share Attributable To Common Stockholders [Abstract] Earnings Per Share Attributable To Common Stockholders Convertible senior notes payable Convertible Notes Payable Shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Cumulative Effect, Period Of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Cedents Cedents [Member] Cedents Interest and dividends receivable Dividend and Interest Receivable Customer [Axis] Customer [Axis] Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47) Add: Losses recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Related Party Transaction Related Party Transaction [Line Items] Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Performance Restricted Shares Performance Restricted Stock [Member] Performance Restricted Stock Award Type [Domain] Award Type [Domain] Unrealized gains Equity Securities, FV-NI, Unrealized Gain Weighted average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Net realized gain on repurchase of convertible senior notes payable Gain (Loss) on Extinguishment of Debt Workers' Compensation Workers' Compensation Insurance Product Line [Member] Workers' compensation line of business of insurance coverage Investments sold short, at fair value Financial Instruments Sold, Not yet Purchased, at Fair Value Entity Registrant Name Entity Registrant Name Issue of ordinary shares, net of forfeitures (in shares) Stock Issued During Period, Shares, New Issues Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89) Reinsurance balances receivable Premiums and Other Receivables, Net Entity Address, City or Town Entity Address, City or Town Pledging Purpose [Axis] Pledging Purpose [Axis] Collateral held in trust Collateral Held In Trust Cash and securities posted as collateral by the retrocessionaire in a trust account for the benefit of the ceding reinsurer. Citibank Europe plc Citibank Europe plc [Member] Citibank Europe plc Tax recovered Tax Recovered Tax Recovered Unrated Unrated [Member] No rating assigned by any external rating agencies. Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Credit Rating Source [Domain] Credit Rating, AM Best [Domain] Ordinary share capital, par value (in dollars per share) Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Income Tax Examination Income Tax Examination [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Deferred acquisition costs Deferred Policy Acquisition Cost Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Investment, Name [Axis] Investment, Name [Axis] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Contract termination prior notice period (in days) Related Party Transactions, Contract Termination Prior Notice Period Related Party Transactions, Contract Termination Prior Notice Period Trading Symbol Trading Symbol Entity File Number Entity File Number Shares potentially issuable in connection with convertible notes Convertible debt securities Convertible Debt Securities [Member] Accrued interest Interest Payable, Current Capital withdrawals payable Capital Withdrawals Payable Capital Withdrawals Payable Derivative financial instruments (not designated as hedging instruments) Derivative Financial Instruments [Member] Derivative Financial Instruments Title of Individual [Axis] Title of Individual [Axis] Derivative instruments Derivatives, Policy [Policy Text Block] Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Number of shares issued to employees RSUs (in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period RSUs Restricted Stock Units (RSUs) [Member] Schedule of Letters of Credit Facilities Schedule of Line of Credit Facilities [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Due from brokers Due from Correspondent Brokers Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Total revenues Revenues Reinsurance Assets Reinsurance Accounting Policy [Policy Text Block] TAXATION Income Tax Disclosure [Text Block] Income (loss) from investment in related party investment fund (net of related party expenses - Note 3) Loss (income) from investments in related party investment fund Revenue from related parties GLRE limited partners’ share of net income (loss) Revenue from Related Parties Credit Facility [Domain] Credit Facility [Domain] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Interest paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activities Basic (in dollars per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Other Assets Other Assets [Member] Total fair value of restricted shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Shares authorized for issuance in relation to share purchase options granted to service provider (in shares) Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Schedule of Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Total Property Property Insurance [Member] Counterparty Name [Domain] Counterparty Name [Domain] Total shareholders' equity Beginning balance Ending balance Decrease in shareholders' equity Stockholders' Equity Attributable to Parent Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Line of Credit Facility Line of Credit Facility [Line Items] Number of credit facilities Number Of Credit Facilities Number Of Credit Facilities Ownership [Domain] Ownership [Domain] Entity Interactive Data Current Entity Interactive Data Current Ceded premiums earned Ceded Premiums Earned Net change in Increase (Decrease) in Operating Capital [Abstract] Gross premiums written (in percent) Premiums Written, Gross As Percentage Of Total Gross Premiums Written Gross written premiums by line of business as a percentage of total gross written premiums Retained earnings (deficit) Retained Earnings [Member] Segment Reporting Information Segment Reporting Information [Line Items] Other Specialty Insurance, Other [Member] Total compensation cost related to non-vested options not yet recognized Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table] Ordinary share capital Common Stock [Member] Issue of Class A ordinary shares, net of forfeitures Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Repurchase of Class A ordinary shares Payments for Repurchase of Common Stock Shares available for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Class of Stock [Axis] Class of Stock [Axis] Non Employee Director Non Employee Director [Member] Non Employee Director Taxation Income Tax, Policy [Policy Text Block] Statement [Table] Statement [Table] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Effective interest rate (in percent) Debt Instrument, Interest Rate, Effective Percentage Document Quarterly Report Document Quarterly Report Service Restricted Stock Units Service Restricted Stock Units [Member] Service Restricted Stock Units Letter of Credit Letter of Credit [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] LPA, investment cap percentage Limited Partnership Agreement, Investment Cap Percentage Limited Partnership Agreement, Investment Cap Percentage Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Related Party Transaction [Axis] Related Party Transaction [Axis] Schedule of Gross Premiums Written by Geographic Area of Risks Insured Revenue from External Customers by Geographic Areas [Table Text Block] Retained earnings (deficit) Retained Earnings (Accumulated Deficit) Equity Components [Axis] Equity Components [Axis] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Expirations (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Document Fiscal Year Focus Document Fiscal Year Focus Cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Exercised (in dollars per share) Share-based compensation arrangement by share-based payment award, Options, Exercised in period, weighted average grant date fair value Share-based compensation arrangement by share-based payment award, Options, Exercised in period, weighted average grant date fair value Unvested performance restricted shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Loss and loss adjustment expense reserves Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Total Other Total Specialty [Domain] Total of all Specialty lines insurance products types [Domain] Gross premiums written Gross premiums written Assumed Premiums Written Amortization and interest expense, net of change in accruals Amortization And Interest Expense Net Amortization And Interest Expense Net Operating lease right of use asset Operating Lease, Right-of-Use Asset Current tax (expense) benefit Current Income Tax Expense (Benefit) Repurchase of Class A ordinary shares Repurchased and cancelled shares amount Stock Repurchased During Period, Value Change in net unearned premium reserves (Increase) Decrease in Unearned Premiums, Net Downward carrying value changes and impairment Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Operating lease expense Operating Lease, Expense Document Transition Report Document Transition Report Incurred losses related to: Incurred Losses Related To [Abstract] Incurred Losses Related To [Abstract] Equity Method Investment, Nonconsolidated Investee [Axis] Equity Method Investment, Nonconsolidated Investee [Axis] Local Phone Number Local Phone Number Schedule of Activity for Employee and Director Stock Options Share-Based Payment Arrangement, Option, Activity [Table Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Collateral Assets Investment Management Agreement Collateral Assets Investement Management Agreement [Member] Collateral Assets Investement Management Agreement [Member] Carrying value Equity Securities without Readily Determinable Fair Value, Amount Document Information [Table] Document Information [Table] Denominator for earnings per share Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Ordinary share capital, outstanding (in shares) Balance – beginning of period (in shares) Balance – end of period (in shares) Common Stock, Shares, Outstanding Investment in related party investment fund Investments, at fair value Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Unrealized losses Equity Securities, FV-NI, Unrealized Loss Repurchased of ordinary shares (in shares) Stock Repurchased During Period, Shares Limited Partnership Agreement Limited Partnership Agreement [Member] Limited Partnership Agreement between SILP and its partners Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Funds withheld Funds Held under Reinsurance Agreements, Liability Total Casualty Liability and Casualty Insurance Product Line [Member] Total casualty line of business for insurance operations Income tax (expense) benefit Income tax (expense) benefit  Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Deferred tax asset valuation allowance Deferred Tax Assets, Valuation Allowance Deferred acquisition costs Increase (Decrease) in Deferred Policy Acquisition Costs Preferred share capital, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional paid-in capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Diluted (in shares) Weighted average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Derivative contracts, at fair value Derivative Liability Fair value / carrying value Equity Securities, FV-NI Insurance Loss Reserves [Abstract] Insurance Loss Reserves [Abstract] Total investments Investments Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 28,569,346 (2021: 27,589,731): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2021: 6,254,715)) Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Net change in unrealized gains and losses on investments and notes receivable Change In Unrealized Gains Losses On Investments And Derivatives The net increase (decrease) in fair value of unsold investments and derivatives not held for hedging whose gains and losses are included in net income. Senior Notes Senior Notes [Member] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Other income (expense), net Other Operating Income (Expense), Net Restricted shares issued pursuant to stock incentive plan (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Debt conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Foreign currency revaluation Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss) Net realized gain (loss) Realized Investment Gains (Losses) Convertible Debt Convertible Debt [Member] GLRE Limited Partners Greenlight Capital Re Limited Partners [Member] Greenlight Capital Re Limited Partners [Member] Purchases of investments Payments to Acquire Trading Securities Held-for-investment Preferred share capital, authorized (in shares) Preferred Stock, Shares Authorized Cash, cash equivalents and restricted cash at beginning of the period Cash, cash equivalents and restricted cash at end of the period Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Net income (loss) - basic Net Income (Loss) Available to Common Stockholders, Basic Schedule of Financial Information of Investment Equity Method Investments [Table Text Block] Ordinary share capital, issued (in shares) Common Stock, Shares, Issued Performance compensation reduced rate (in percent) Related Party Transaction, Performance Compensation Reduced Rate As Percentage of Investment Income The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision. Board of Directors Chairman Board of Directors Chairman [Member] Foreign exchange (gains) losses Foreign Currency Transaction Gain (Loss), before Tax Income Statement Location [Domain] Income Statement Location [Domain] Interest expense Interest Expense, Other Hurricane Ian Hurricane Ian [Member] Hurricane Ian Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Proceeds from sales of investments Proceeds from (Payments for) Trading Securities, Short-Term Amendment Flag Amendment Flag Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Professional fees and other Professional Fees Convertible debt, amount Debt Instrument, Face Amount Investment Type [Axis] Investment Type [Axis] Equity method investments, fair value Equity Method Investments, Fair Value Disclosure Add: interest on convertible notes Interest on Convertible Debt, Net of Tax Schedule of Gross Premiums Written by Line of Business Schedule of Segment Reporting Information, by Segment [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Other Liabilities Other Liabilities [Policy Text Block] Description of items aggregated and included under Other Liabilities on the balance sheet. Chief Executive Officer Chief Executive Officer [Member] Loss adjustment expense reserves Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments Liability for Claims and Claims Adjustment Expense Liability for Claims and Claims Adjustment Expense [Line Items] Total Investment income Interest and Dividend Income, Operating Counterparty Name [Axis] Counterparty Name [Axis] Thereafter Lessee, Operating Lease, Liability, to Be Paid, After Year Four Lessee, Operating Lease, Liability, to Be Paid, After Year Four Options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Schedule of Interest Income and Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Notice period required for termination Line Of Credit Facility, Termination Notice Period Termination notice period for LOC facilities Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Funds withheld Increase (Decrease) in Funds Held under Reinsurance Agreements Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Liabilities Liabilities [Abstract] Credit Rating Source [Axis] Credit Rating, AM Best [Axis] Anti-dilutive stock options outstanding Employee and Director Stock Options Share-Based Payment Arrangement, Option [Member] Title of Individual [Domain] Title of Individual [Domain] Forfeited (in shares) Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Balance Sheet Location [Axis] Balance Sheet Location [Axis] General Liability General Liability [Member] Ordinary share capital, authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Measurement Period [Axis] Measurement Period [Axis] Measurement Period Maximum Maximum [Member] Class A Common Class A [Member] Multi-line Multi-line [Member] Multi-line [Member] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Income tax paid in cash Income Taxes Paid, Net Weighted  average  grant date  fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Due to brokers Due to Correspondent Brokers Entity Small Business Entity Small Business Measurement Frequency [Domain] Measurement Frequency [Domain] SHARE CAPITAL Stockholders' Equity Note Disclosure [Text Block] Revenues Revenues [Abstract] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Performance RSUs Performance Restricted Stock Units Performance Restricted Stock Units [Member] Performance Restricted Stock Units Line of Credit Facility [Table] Line of Credit Facility [Table] Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Foreign currency transaction loss Foreign Currency Transaction Gain (Loss), Realized SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Net premiums earned Premiums Earned, Net Restricted shares Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Number of  options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Repurchase of ordinary shares (in shares) Repurchase of ordinary shares (in shares) Stock Repurchased and Retired During Period, Shares Title of 12(b) Security Title of 12(b) Security ORGANIZATION AND BASIS OF PRESENTATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Private investments and unlisted equities Private and unlisted equity securities [Member] Private equities and unlisted equity securities Deposit Assets and Liabilities Deposit Contracts, Policy [Policy Text Block] Ceded Credit Risk [Table] Ceded Credit Risk [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Stock Class of Stock [Line Items] Present value of lease liabilities Operating Lease, Liability SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Equity Method Investment, Nonconsolidated Investee [Domain] Equity Method Investment, Nonconsolidated Investee [Domain] Entity Address, Country Entity Address, Country Deferred tax (expense) benefit Tax Adjustments, Settlements, and Unusual Provisions Liabilities and equity Liabilities and Equity [Abstract] Commercial Property and Casualty, Commercial Insurance [Member] Grants (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Other Assets Other Assets [Policy Text Block] Description of immaterial items aggregated and included under the Other Assets line item on the balance sheet. Upward carrying value changes Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Fair value / carrying value Other Investments, Fair Value Disclosure Other Investments, Fair Value Disclosure Long-term debt, maturity, remainder of fiscal year Long-Term Debt, Maturity, Remainder of Fiscal Year Current year Current Year Claims and Claims Adjustment Expense Weighted average number of ordinary shares used in the determination of earnings and loss per share Weighted Average Number of Shares Outstanding, Diluted [Abstract] Equity Method Investment, Nonconsolidated Investee or Group of Investees Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member] Other assets, excluding depreciation Increase (Decrease) in Other Operating Assets Cost Equity Securities, FV-NI, Cost Automatic agreement extension, term (in years) Related Party Transactions, Automatic Agreement Extension, Term Related Party Transactions, Automatic Agreement Extension, Term Entity Filer Category Entity Filer Category Conversion ratio (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio Liabilities and partners’ capital Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract] Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract] Basic (in shares) Weighted average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Reinsurance balances payable Reinsurance Payable Prior years Estimate of net losses, change Prior Year Claims and Claims Adjustment Expense Stock-based compensation expense Shares Granted, Value, Share-Based Payment Arrangement, Forfeited Liabilities Liabilities, Fair Value Disclosure [Abstract] Equity method investment, ownership interest (as a percent) Equity Method Investment, Ownership Percentage Stock based compensation expense, net of forfeiture reversals Share-Based Payment Arrangement, Expense Expenses Equity Method Investments, Summarized Financial Information, Expenses [Abstract] Equity Method Investments, Summarized Financial Information, Expenses Security Exchange Name Security Exchange Name Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Acquisition costs Deferred Policy Acquisition Costs, Amortization Expense Net Assets Net Assets Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) Preferred Stock, Value, Issued Aggregate amount of letters of credit issued Letters of Credit Outstanding, Amount Participating securities excluded from calculation of loss per share  Employee and Director Restricted Shares Restricted Stock [Member] General and Administrative Expense General and Administrative Expense [Member] Unearned premiums ceded Increase (Decrease) in Prepaid Reinsurance Premiums Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Depreciation expense Depreciation, Nonproduction Loss and loss adjustment expenses recoverable, allowance Accounts Receivable, Allowance for Credit Loss Other assets Other Assets Segment Reporting [Abstract] Segment Reporting [Abstract] Assets Measured at Fair Value on a Nonrecurring Basis Fair Value Measurements, Nonrecurring [Table Text Block] Gross Premiums Written by Geographic Area of Risks Insured [Table] Revenue from External Customers by Products and Services [Table] Pledging Purpose [Domain] Pledging Purpose [Domain] Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Net premiums written Premiums Written, Net Investments [Domain] Investments [Domain] 6 to 12 months Measurement Period Two [Member] Measurement Period Two Deposit interest income/(expense), net Interest Income (Expense), Net Paid losses related to: Paid Losses Related To [Abstract] Paid Losses Related To [Abstract] Total liabilities and equity Liabilities and Equity Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Health Accident & Health Health Insurance Product Line [Member] Recognized interest expense Amortization of Debt Issuance Costs Related Party [Axis] Related Party [Axis] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Dividends Dividend Expense Dividend Expense Effect of dilutive employee and director share-based awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Investment Advisory Agreement Investment Advisory Agreement [Member] Investment Advisory Agreement [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Gross deferred tax asset Deferred Tax Assets, Gross Current Fiscal Year End Date Current Fiscal Year End Date Less Imputed Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net income (loss) - diluted Net Income (Loss) Available to Common Stockholders, Diluted Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] Diluted (in dollars per share) Earnings Per Share, Diluted Ownership percentage (in percent) Related Party Transaction, Investment Owned, Percentage Related Party Transaction, Investment Owned, Percentage Cliff vesting period after date of issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Funds Held by Cedents Funds Held by Cedents [Policy Text Block] Funds Held by Cedents Schedule of Stock by Class Schedule of Stock by Class [Table Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Performance compensation reduced rate (in percent) Related Party Transaction, Performance Compensation Reduced Rate as a Percentage of Investment Income The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision. Loss carry forward recoupment required (in percent) Related Party Transaction, Loss Carry Forward Recoupment Required As Percentage Of Aggregate Investment Loss Earned The additional amount of investment income required after a period of investment loss, in order for the performance compensation rate to return from reduced rate to full rate. Net balance at January 1 Net balance at September 30 Liability for Unpaid Claims and Claims Adjustment Expense, Net Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Investment income Equity Method Investment, Summarized Financial Information, Investment Income [Abstract] Equity Method Investment, Summarized Financial Information, Investment Income Schedule of Commitment for Operating Lease Liabilities for Future Annual Periods Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Motor Liability Motor Vehicle Liability Casualty Product Line [Member] Motor liability line of business for insurance operations RETROCESSION Reinsurance [Text Block] Total expenses Total expenses Benefits, Losses and Expenses Asset redemption notice to general partner Related Party Transaction, Asset Redemption Notice To General Partner Related Party Transaction, Asset Redemption Notice To General Partner Private Investments and Unlisted Equity Securities Private Investments and Unlisted Equity Securities [Member] Private Investments and Unlisted Equity Securities Net change in unrealized appreciation (depreciation) Unrealized Gain (Loss) on Investments Product and Service [Axis] Insurance Product Line [Axis] Product and Service [Axis] Europe (2) Europe [Member] Senior Unsecured Convertible Notes Senior Unsecured Convertible Notes [Member] Senior Unsecured Convertible Notes [Member] Class of Stock [Domain] Class of Stock [Domain] Motor Motor Vehicle Physical Damage Product Line [Member] Motor physical damage line of business for insurance operations Decrease (increase) in deferred tax valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Gross premiums ceded Ceded Premiums Written Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Interest Interest Expense Performance allocation Incentive Fee Expense Credit Facility [Axis] Credit Facility [Axis] Expired (in dollars per share) Share-based compensation arrangement by share-based payment award, Options, Expired in period, weighted average grant date fair value Share-based compensation arrangement by share-based payment award, Options, Expired in period, weighted average grant date fair value Equity [Abstract] Deposit interest income Interest Income, Deposits with Financial Institutions Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Shares authorized for the company's stock incentive plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Unamortized debt issuance expense Unamortized Debt Issuance Expense Income (loss) before income tax Income (Loss) Attributable to Parent, before Tax LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] Reinsurance balances receivable Increase (Decrease) in Premiums Receivable Reinsurance Disclosures [Abstract] Reinsurance Disclosures [Abstract] AM Best, A- Rating AM Best, A- Rating [Member] Measurement Period [Domain] Measurement Period [Domain] Measurement Period [Domain] Reinsurance balances payable Increase (Decrease) in Reinsurance Payables Asia Asia [Member] Total Total Expense Total Expense Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Deposit contracts, liabilities Deposit Contracts, Liabilities Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Marine Marine Casualty Insurance [Member] Marine Casualty Insurance [Member] Ceded Credit Risk, Collateralization [Axis] Ceded Credit Risk, Collateralization [Axis] Interest income Investment Income, Interest Measurement Frequency [Axis] Measurement Frequency [Axis] Weighted  average grant date fair value Weighted  average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Case reserves Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount Entity [Domain] Entity [Domain] Type of Adoption [Domain] Accounting Standards Update [Domain] Allowance for expected credit losses Reinsurance Recoverable, Allowance for Credit Loss City Area Code City Area Code General and administrative expenses General and Administrative Expense Assets Assets [Abstract] Personal Property and Casualty, Personal Insurance [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Green Bricks Partners Inc (GRBK) Green Bricks Partners, Inc. (GRBK) [Member] Green Bricks Partners, Inc. (GRBK) Over 1 year Measurement Period Three [Member] Measurement Period Three Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Fair values measured on a nonrecurring basis Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Deposit contracts, assets Deposit Contracts, Assets Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Long-term debt, maturity, year one Long-Term Debt, Maturity, Year One Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Contributions to related party investment fund Payments to Acquire Equity Method Investments Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Repurchases of convertible senior notes payable Repayments of Senior Debt INVESTMENT IN RELATED PARTY INVESTMENT FUND Equity Method Investments and Joint Ventures Disclosure [Text Block] U.S. and Caribbean North America [Member] Other liabilities Increase (Decrease) in Other Operating Liabilities Financial Financial Guarantee Insurance and Surety Product Line [Member] Specialized insurance coverage relating to financial risks such as surety (surety bonds) and trade credit. SILP General Partner SILP General Partner [Member] SILP General Partner Schedule of Net Income (Loss) and Weighted Average Number of Shares Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Unearned premium reserves Unearned Premiums Customer [Domain] Customer [Domain] Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible Enumeration] EX-101.PRE 10 glre-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - shares
 9 Months Ended
Sep. 30, 2022
Oct. 28, 2022
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2022  
Document Transition Report false  
Entity File Number 001-33493  
Entity Registrant Name GREENLIGHT CAPITAL RE, LTD.  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One 65 Market Street  
Entity Address, Address Line Two Suite 1207, Jasmine Court  
Entity Address, City or Town Camana Bay  
Entity Address, Country KY  
Entity Address, Postal Zip Code KY1-1205  
City Area Code 345  
Local Phone Number 943-4573  
Title of 12(b) Security Class A Ordinary Shares  
Trading Symbol GLRE  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001385613  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Class A    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   28,569,346
Class B    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   6,254,715
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Investments    
Investment in related party investment fund $ 195,199 $ 183,591
Other investments 65,081 47,384
Total investments 260,280 230,975
Cash and cash equivalents 32,278 76,307
Restricted cash and cash equivalents 648,897 634,794
Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89) 473,564 405,365
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47) 10,604 11,100
Deferred acquisition costs 78,836 63,026
Unearned premiums ceded 13,659 42
Other assets 6,425 5,885
Total assets 1,524,543 1,427,494
Liabilities    
Loss and loss adjustment expense reserves 540,827 524,010
Unearned premium reserves 298,173 227,584
Reinsurance balances payable 108,772 91,224
Funds withheld 11,446 3,792
Other liabilities 4,927 7,164
Convertible senior notes payable 93,446 98,057
Total liabilities 1,057,591 951,831
Shareholders' equity    
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) 0 0
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 28,569,346 (2021: 27,589,731): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2021: 6,254,715)) 3,482 3,384
Additional paid-in capital 477,021 481,784
Retained earnings (deficit) (13,551) (9,505)
Total shareholders' equity 466,952 475,663
Total liabilities and equity $ 1,524,543 $ 1,427,494
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Allowance for expected credit losses $ 89 $ 89
Loss and loss adjustment expenses recoverable, allowance $ 47 $ 47
Preferred share capital, par value (in dollars per share) $ 0.10 $ 0.10
Preferred share capital, authorized (in shares) 50,000,000 50,000,000
Preferred share capital, issued (in shares) 0 0
Class A    
Ordinary share capital, par value (in dollars per share) $ 0.10 $ 0.10
Ordinary share capital, authorized (in shares) 100,000,000 100,000,000
Ordinary share capital, issued (in shares) 28,569,346 27,589,731
Ordinary share capital, outstanding (in shares) 28,569,346 27,589,731
Class B    
Ordinary share capital, par value (in dollars per share) $ 0.10 $ 0.10
Ordinary share capital, authorized (in shares) 25,000,000 25,000,000
Ordinary share capital, issued (in shares) 6,254,715 6,254,715
Ordinary share capital, outstanding (in shares) 6,254,715 6,254,715
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues        
Gross premiums written $ 155,146 $ 128,735 $ 435,812 $ 440,249
Gross premiums ceded (8,801) (60) (21,973) (6)
Net premiums written 146,345 128,675 413,839 440,243
Change in net unearned premium reserves (24,397) 6,849 (55,747) (36,844)
Net premiums earned 121,948 135,524 358,092 403,399
Income (loss) from investment in related party investment fund (net of related party expenses - Note 3) 8,521 (6,214) 24,474 (4,196)
Net investment income (loss) 3,038 10,303 11,978 28,999
Other income (expense), net (6,784) (342) (13,374) (1,076)
Total revenues 126,723 139,271 381,170 427,126
Expenses        
Net loss and loss adjustment expenses incurred 94,559 110,400 252,789 295,078
Acquisition costs 36,821 35,048 106,101 106,060
General and administrative expenses 7,389 6,060 22,727 21,340
Deposit interest expense 6,148 38 6,373 2,957
Interest expense 1,091 1,578 3,411 4,684
Total expenses 146,008 153,124 391,401 430,119
Income (loss) before income tax (19,285) (13,853) (10,231) (2,993)
Income tax (expense) benefit 816 0 823 (3,733)
Net income (loss) $ (18,469) $ (13,853) $ (9,408) $ (6,726)
Earnings (loss) per share (Class A and Class B)        
Basic (in dollars per share) $ (0.56) $ (0.42) $ (0.28) $ (0.20)
Diluted (in dollars per share) $ (0.56) $ (0.42) $ (0.28) $ (0.20)
Weighted average number of ordinary shares used in the determination of earnings and loss per share        
Basic (in shares) 33,127,384 32,929,097 33,119,814 33,507,060
Diluted (in shares) 33,127,384 32,929,097 33,119,814 33,507,060
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary share capital
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings (deficit)
Retained earnings (deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2020     $ 3,452 $ 488,488   $ (27,083)  
Increase (Decrease) in Stockholders' Equity              
Issue of Class A ordinary shares, net of forfeitures     41        
Repurchase of Class A ordinary shares     (109) (9,891)      
Share-based compensation expense       2,342      
Net income (loss) $ (6,726)         (6,726)  
Ending balance at Sep. 30, 2021 450,514   3,384 480,939   (33,809)  
Beginning balance at Dec. 31, 2020     3,452 488,488   (27,083)  
Ending balance at Dec. 31, 2021 $ 475,663   3,384 481,784   (9,505)  
Ending balance (Accounting Standards Update 2020-06) at Dec. 31, 2021   $ (2,500)     $ (7,896)   $ 5,362
Increase (Decrease) in Stockholders' Equity              
Accounting Standards Update [Extensible List] | Accounting Standards Update 2020-06 Accounting Standards Update 2020-06            
Beginning balance at Jun. 30, 2021     3,417 483,365   (19,956)  
Increase (Decrease) in Stockholders' Equity              
Issue of Class A ordinary shares, net of forfeitures     3        
Repurchase of Class A ordinary shares     (36) (3,216)      
Share-based compensation expense       790      
Net income (loss) $ (13,853)         (13,853)  
Ending balance at Sep. 30, 2021 450,514   3,384 480,939   (33,809)  
Beginning balance at Dec. 31, 2021 475,663   3,384 481,784   (9,505)  
Increase (Decrease) in Stockholders' Equity              
Issue of Class A ordinary shares, net of forfeitures     99        
Repurchase of Class A ordinary shares (6,600)   (1) (34)      
Share-based compensation expense       3,167      
Net income (loss) (9,408)         (9,408)  
Ending balance at Sep. 30, 2022 466,952   3,482 477,021   (13,551)  
Beginning balance at Jun. 30, 2022     3,472 475,903   4,918  
Beginning balance (Accounting Standards Update 2020-06) at Jun. 30, 2022         $ 0   $ 0
Increase (Decrease) in Stockholders' Equity              
Issue of Class A ordinary shares, net of forfeitures     11        
Repurchase of Class A ordinary shares (6,600)   (1) (34)      
Share-based compensation expense       1,152      
Net income (loss) (18,469)         (18,469)  
Ending balance at Sep. 30, 2022 $ 466,952   $ 3,482 $ 477,021   $ (13,551)  
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash provided by (used in) operating activities    
Net income (loss) $ (9,408) $ (6,726)
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities    
Loss (income) from investments in related party investment fund (24,474) 4,196
Net realized gain on repurchase of convertible senior notes payable (149) 0
Net change in unrealized gains and losses on investments and notes receivable (9,237) (14,860)
Net realized (gains) losses on investments and notes receivable 0 (14,210)
Foreign exchange (gains) losses 10,364 14
Share-based compensation expense 3,266 2,383
Amortization and interest expense, net of change in accruals (612) 684
Depreciation expense 0 16
Net change in    
Reinsurance balances receivable (97,651) (50,185)
Loss and loss adjustment expenses recoverable 496 3,769
Deferred acquisition costs (15,810) (9,620)
Unearned premiums ceded (13,617) (26)
Other assets, excluding depreciation (540) (3,760)
Loss and loss adjustment expense reserves 36,394 46,600
Unearned premium reserves 70,589 36,837
Reinsurance balances payable 17,548 (14,722)
Funds withheld 7,654 612
Other liabilities (2,237) 219
Net cash provided by (used in) operating activities (27,424) (18,779)
Investing activities    
Proceeds from redemptions from related party investment fund 77,993 51,904
Contributions to related party investment fund (65,127) (69,604)
Purchases of investments (8,627) (4,761)
Proceeds from sales of investments 0 20,755
Change in notes receivable 0 6,101
Net cash provided by (used in) investing activities 4,239 4,395
Financing activities    
Repurchases of convertible senior notes payable (6,384) 0
Repurchase of Class A ordinary shares (35) (10,000)
Net cash provided by (used in) financing activities (6,419) (10,000)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash (322) 0
Net increase (decrease) in cash, cash equivalents and restricted cash (29,926) (24,384)
Cash, cash equivalents and restricted cash at beginning of the period 711,101 754,306
Cash, cash equivalents and restricted cash at end of the period 681,175 729,922
Supplementary information    
Interest paid in cash 4,023 4,000
Income tax paid in cash $ 0 $ 3,700
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
ORGANIZATION AND BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION ORGANIZATION AND BASIS OF PRESENTATION
 
Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”) and is subject to regulation by the Cayman Islands Monetary Authority. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  In 2020, GLRE established Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) as a wholly-owned subsidiary to increase the Company’s presence in the London market. In 2022, Greenlight Innovation Syndicate 3456 (“Syndicate 3456”) commenced underwriting under the Lloyd’s syndicate-in-a-box model, with Greenlight Re as the sole capital provider. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.

The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission on March 8, 2022. The condensed consolidated financial statements include the accounts of GLRE and its wholly-owned subsidiaries, Greenlight Re, GRIL, Verdant, and Greenlight Re UK. The condensed consolidated financial statements also include the accounts of Syndicate 3456. All significant intercompany transactions and balances have been eliminated on consolidation.

Certain amounts in the prior periods presented have been reclassified to conform to the current period financial statements presentation. These reclassifications do not affect previously reported net income or retained earnings.

In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented.

Significant estimates used to prepare the Company’s condensed consolidated financial statements, including those associated with premiums and the estimations of loss and loss adjustment expense reserves, may be subject to significant adjustments in future periods.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES
 
There have been no material changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2021.

Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s
condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, premiums written, earned, and receivable, variability underlying risk transfer assessments, allowances for credit losses, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.

Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
 
Cash and cash equivalents consist of cash and short-term, highly liquid investments and certificates of deposit with original maturity dates of three months or less. Certificates of deposit with original maturities greater than three months are included under the caption "Other investments" on the condensed consolidated balance sheets.

The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:

 September 30, 2022December 31, 2021
 ($ in thousands)
Cash and cash equivalents$32,278 $76,307 
Restricted cash and cash equivalents648,897 634,794 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$681,175 $711,101 

Funds Held by Cedents

The caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes financial assets held by cedents. At September 30, 2022, funds held by cedents were $303.1 million (December 31, 2021: $246.9 million). Such amounts include premiums withheld by Lloyd’s syndicates and funds contributed by the Company to Lloyd's as security for members’ underwriting activities. The syndicates invest a portion of the premiums withheld in fixed maturity securities and investment funds. The Company records its share of income (or expense) from these assets in its condensed consolidated statements of operations under the caption “Other income (expense).”
 
Reinsurance Assets

The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets.

The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. Credit ratings of the counterparties are forward-looking and consider various economic scenarios. The Company's evaluation of the required allowance for reinsurance balances receivable and loss and loss adjustment expenses recoverable considers the current economic environment as well as potential macroeconomic developments.

For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.

At September 30, 2022, the Company has recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million (December 31, 2021: $0.1 million).
Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the captions “Other income (expense)” and “Deposit interest expense,” respectively. The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2022, deposit assets and deposit liabilities were $3.2 million and $13.7 million, respectively (December 31, 2021: $3.5 million and $18.6 million, respectively). For the three and nine months ended September 30, 2022, and 2021, the interest income and expense on deposit accounted contracts were as follows:
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Deposit interest income$— $— $— $— 
Deposit interest expense$(6,148)$(38)$(6,373)$(2,957)
Deposit interest income/(expense), net$(6,148)$(38)$(6,373)$(2,957)


Foreign Exchange

The reporting and functional currency of the Company and all its significant subsidiaries is the U.S. dollar. The Company records foreign currency transactions at the exchange rates in effect on the transaction date. Monetary assets and liabilities in foreign currencies at the balance sheet date are converted at the exchange rate in effect at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are carried at their historical exchange rates. The Company includes any foreign exchange gains and losses under the caption “Other income (expense), net” in the Company’s condensed consolidated statements of operations. 

For the three and nine months ended September 30, 2022, $5.0 million and $10.4 million, respectively, (three and nine months ended September 30, 2021: $0.6 million and $1.4 million, respectively), of foreign exchange loss was included in the Company’s net income (loss) in the condensed consolidated statements of operations. 

Derivative instruments

The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.
Other Assets

The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, taxes recoverable, and deferred tax assets.

Other Liabilities

The caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities.

Earnings (Loss) Per Share
 
The Company has issued unvested restricted stock awards, some of which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid. These awards are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of ordinary shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect, if any, of the following:

•Restricted Stock Units (“RSUs”) issued that convert to ordinary shares upon vesting;
•Unvested restricted share awards which are not considered “participating securities”;
•Additional potential ordinary shares issuable when in-the-money stock options are exercised, determined using the treasury stock method;
•For periods prior to January 1, 2022, those ordinary shares with the potential to be issued in connection with convertible notes and other such convertible instruments, determined using the treasury stock method; and
•Effective January 1, 2022, the dilutive effect of the convertible notes is calculated using the if-converted method. Under the if-converted method, the convertible notes are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted net income per common share calculation. Interest expense related to the convertible notes incurred in the period is added back to the numerator for purposes of the if-converted calculation.
For the three and nine months ended September 30, 2022, the effect of the assumed conversion of the convertible notes was anti-dilutive and was not included in the computation of diluted earnings per share.

Diluted earnings (or loss) per share contemplates a conversion to ordinary shares of all convertible instruments only if they are dilutive. In the event of a net loss, all RSUs, stock options, shares potentially issuable in connection with convertible notes, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.
The following table reconciles net income (loss) and weighted average shares used in computing basic and diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021 (expressed in thousands of U.S. dollars, except per share and share amounts):
 Three months ended September 30Nine months ended September 30
 2022202120222021
Numerator for earnings per share
Net income (loss) - basic$(18,469)$(13,853)$(9,408)$(6,726)
Add: interest on convertible notes— — — — 
Net income (loss) - diluted$(18,469)$(13,853)$(9,408)$(6,726)
Denominator for earnings per share
Weighted average shares outstanding - basic33,127,384 32,929,097 33,119,814 33,507,060 
Effect of dilutive employee and director share-based awards— — — — 
Shares potentially issuable in connection with convertible notes — — — — 
Weighted average shares outstanding - diluted33,127,384 32,929,097 33,119,814 33,507,060 
Anti-dilutive stock options outstanding690,337 735,627 690,337 735,627 
Participating securities excluded from calculation of loss per share 848,841 946,556 848,841 946,556 
Shares potentially issuable in connection with convertible notes excluded from calculation of diluted loss per share5,686,747 — 5,773,889 — 
Earnings (loss) per Class A and Class B Ordinary share:
Basic$(0.56)$(0.42)$(0.28)$(0.20)
Diluted$(0.56)$(0.42)$(0.28)$(0.20)


Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Act, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes a tax on profits, income, gains, or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2021: 21%). Verdant’s tax years 2018 and beyond remain open and may be subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.

The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. 
Recent Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” (“ASU 2022-03”). ASU 2022-03 clarifies the guidance for measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 is effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company does not expect ASU 2022-03 to have a material impact on its financial position, results of operations, or cash flows.

Recently Issued Accounting Standards Adopted

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; instead, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring the application of the if-converted method when calculating diluted earnings per share. Under the if-converted method, the shares potentially issuable in connection with convertible debt are assumed to be converted at the beginning of the period. The resulting ordinary shares are included in the denominator of the diluted earnings per share calculation for the period presented.

The Company adopted ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. The adoption of ASU 2020-06 resulted in a decrease in the Company’s opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes (see Note 7). The adoption of ASU 2020-06 did not have a material impact on the Company’s net income, cash flows, or any other balances.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND
 9 Months Ended
Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENT IN RELATED PARTY INVESTMENT FUND INVESTMENT IN RELATED PARTY INVESTMENT FUND
The Company has entered into the Second Amended and Restated Exempted Limited Partnership Agreement (the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, and GRIL, (together, the “GLRE Limited Partners”). SILP has entered into a SILP investment advisory agreement (“IAA”) with DME Advisors. LP (“DME Advisors”) pursuant to which DME Advisors is the investment manager for SILP. DME II and DME Advisors are related to the Company, and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors (the “Chairman”).

The SILP LPA includes the following proviso: “The Investment Portfolio of each Partner will not exceed the product of (a) such Partner’s surplus (Greenlight Re Surplus or GRIL Surplus, as the case may be) multiplied by (b) the Investment Cap (50%), and the General Partner will designate any portion of a Partner’s Investment Portfolio as Designated Securities to effectuate such limit.”

The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:

•DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.

•DME II holds an interest in excess of 10% of SILP’s net assets, which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP.
Consequently, the Company has concluded that DME II’s interests, not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company presents its investment in SILP in its condensed consolidated balance sheets in the caption “Investment in related party investment fund.”

The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. At September 30, 2022, the net asset value of the GLRE Limited Partners’ investment in SILP was $195.2 million (December 31, 2021: $183.6 million), representing 75.3% (December 31, 2021: 78.2%) of SILP’s total net assets. DME II held the remaining 24.7% (December 31, 2021: 21.8%) of SILP’s total net assets. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing three business days’ notice to DME II. At September 30, 2022, the majority of SILP’s long investments were composed of cash and publicly traded equity securities, which could be readily liquidated to meet the GLRE Limited Partners’ redemption requests.

The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, 2022, was $8.5 million and $24.5 million, respectively (three and nine months ended September 30, 2021: $(6.2) million and $(4.2) million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of SILP are presented below.
Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2022December 31, 2021
($ in thousands)
Assets
Investments, at fair value$258,386 $297,937 
Derivative contracts, at fair value15,727 2,542 
Due from brokers149,071 84,775 
Interest and dividends receivable64 28 
Total assets423,248 385,282 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(153,892)(132,360)
Derivative contracts, at fair value(9,739)(7,253)
Capital withdrawals payable— (10,000)
Due to brokers(10)— 
Interest and dividends payable(295)(580)
Other liabilities(201)(358)
Total liabilities(164,137)(150,551)
Net Assets$259,111 $234,731 
GLRE Limited Partners’ share of Net Assets$195,199 $183,591 
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$305 $146 $928 $509 
Interest income693 51 1,028 770 
Total Investment income998 197 1,956 1,279 
Expenses
Management fee(901)(883)(2,686)(2,632)
Interest(464)(205)(1,199)(874)
Dividends(356)(306)(938)(852)
Professional fees and other(262)(227)(756)(786)
Total expenses(1,983)(1,621)(5,579)(5,144)
Net investment income (loss)(985)(1,424)(3,623)(3,865)
Realized and change in unrealized gains (losses)
Net realized gain (loss) 7,221 (1,411)58,196 (14,809)
Net change in unrealized appreciation (depreciation) 6,464 (5,437)(17,027)12,143 
Net gain (loss) on investment transactions13,685 (6,848)41,169 (2,666)
Net income (loss)$12,700 $(8,272)$37,546 $(6,531)
GLRE Limited Partners’ share of net income (loss) (1)
$8,521 $(6,214)$24,474 $(4,196)

(1) Net income (loss) is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Management fees$901 $883 $2,686 $2,632 
Performance allocation947 $(224)2,719 — 
Total$1,848 $659 $5,405 $2,632 

See Note 11 for further details on related party management fees and performance allocation.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS 
 
Investments
  
Other Investments

The Company’s “Other investments” are composed of the following:

•Private investments, unlisted equities, and convertible debt instruments, which consist primarily of Innovations-related investments supporting technology innovators in the (re)insurance market; and
•Certificates of deposit with original maturities greater than three months.

At September 30, 2022, the Company included the following securities in the caption “Other investments”:
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $22,037 $42,412 $(3,368)$61,081 
Convertible debt securities1,000 — — 1,000 
Certificates of deposit3,000 — — 3,000 
Total other investments$26,037 $42,412 $(3,368)$65,081 

At December 31, 2021, the Company included the following securities in the caption “Other investments”: 
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$17,411 $31,438 $(1,800)$47,049 
Derivative financial instruments (not designated as hedging instruments)— 335 — 335 
Total other investments$17,411 $31,773 $(1,800)$47,384 

Private investments and unlisted equity securities without readily determinable fair values

The Company measures its private investments and unlisted equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from identical or similar investments of the same issuers (the “measurement alternative”), with such changes recognized in the caption “Net investment income (loss)” in the condensed consolidated statements of operations. The Company considers the need for impairment on a by-investment basis, based on certain indicators. Under the measurement alternative, the Company makes two types of valuation adjustments:

•When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an “asset measured at fair value on a nonrecurring basis.”
•If the Company determines that the investment is impaired and the fair value is less than its carrying value, it writes down the investment to its fair value. Once the Company records such an adjustment, the investment is considered an “asset measured at fair value on a nonrecurring basis.”

The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2022, and 2021, and the related adjustments recorded during the periods then ended.
Nine months ended September 30
20222021
($ in thousands)
Carrying value (1)
$61,081 $42,349 
Upward carrying value changes (2)
$11,260 $13,355 
Downward carrying value changes and impairment (3)
$(1,676)$(500)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(2) The cumulative upward carrying value changes from inception to September 30, 2022, totaled $42.8 million.
(3) The cumulative downward carrying value changes and impairments from inception to September 30, 2022, totaled $3.7 million.
Fair Value Hierarchy

The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on the extent to which the inputs are observable in the market. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

•Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
•Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.
•Level 3: Unobservable inputs supported by little or no market activity and significant to the fair value of the assets and liabilities. The term “unobservable inputs” includes certain pricing models, discounted cash flow methodologies, and similar techniques.

Assets measured at fair value on a nonrecurring basis

At September 30, 2022, and December 31, 2021, the Company held $53.0 million and $40.5 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. The Company classifies these assets as Level 3 within the fair value hierarchy. The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2022, for the private and unlisted equities measured at fair value on a nonrecurring basis:

Less than 6 months6 to 12 monthsOver 1 yearTotal
($ in thousands)
Fair values measured on a nonrecurring basis$24,451 $17,080 $11,423 $52,954 

At September 30, 2022, and December 31, 2021, the Company held $8.1 million and $6.5 million, respectively, of private investments and unlisted equities measured at cost.

Assets measured at fair value on a recurring basis

In accordance with ASC 320, “Investments - Debt Securities,” the Company has classified the convertible debt securities as “trading” measured at estimated fair value with unrealized gains and losses reported in net income. The Company classifies these securities as Level 3 within the fair value hierarchy and estimates their fair values primarily based on inputs such as third-party quotes, issuers’ book value, market multiples, and other inputs. Valuation of these securities is subjective as the markets’ illiquidity may increase the likelihood that the estimated fair value of an investment is not reflective of the price at which an actual transaction could occur.

The carrying value of certificates of deposit with original maturities of one year or less approximates their fair values. The Company classifies these assets as Level 2 within the fair value hierarchy.

At September 30, 2022, and December 31, 2021, the Company did not carry any other investments at fair value with an assigned Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at fair value using the net asset value practical expedient. It is therefore not classified within the fair value hierarchy. (See Note 3 for further details on the related party investment fund.)

During the three and nine months ended September 30, 2022 and 2021, there were no transfers between Level 2 and Level 3 of the fair value hierarchy.

Financial Instruments Disclosed, But Not Carried, at Fair Value

The caption “Convertible senior notes payable” represents financial instruments that the Company carries at amortized cost. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
 9 Months Ended
Sep. 30, 2022
Insurance Loss Reserves [Abstract]  
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES
At September 30, 2022, the Company’s loss and loss adjustment expense reserves included estimated amounts for several catastrophe events. For significant catastrophe events, including, but not limited to, hurricanes, tornados, typhoons, floods, earthquakes, wildfires, and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when received. To establish IBNR loss estimates, the Company makes use of, among other things, the following information:

•estimates communicated by ceding companies;
•information received from clients, brokers, and loss adjusters;
•an understanding of the underlying business written and its exposures to catastrophe event-related losses;
•industry data;
•catastrophe scenario modeling software; and
•management’s judgment.

At September 30, 2022, the Company’s loss and loss adjustment expense reserves included $13.6 million from the Russian-Ukrainian conflict and $19.5 million from Hurricane Ian. Additional information the Company considered in estimating its loss reserves included the following:

•a review of in-force treaties that may provide coverage and incur losses;
•catastrophe and scenario modeling analyses and results shared by cedents;
•preliminary loss estimates received from clients, brokers, and loss adjusters;
•reviews of industry insured loss estimates and market share analyses; and
•management’s judgment.

The Company’s Russian-Ukrainian conflict loss estimates include actuarial assumptions, including:

•the areas within the affected regions that have incurred losses;
•the scope of coverage provided by the underlying policies;
•the interpretation of contract terms;
•the determination of loss-triggering events;
•regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry; and
•the ability of the cedents and insured to mitigate some or all of their losses.

Due to the uncertainty associated with the foregoing assumptions, the Company’s loss estimates are subject to significant variability, and actual losses may ultimately differ materially from the Company's current estimates. The Company will evaluate its assumptions as new information becomes available and may adjust its loss estimates in future periods. Such adjustments may be material to the Company's results of operations and financial condition.

Additionally, if the Russian-Ukrainian conflict is prolonged, the Company may incur additional losses in subsequent periods.

The Company made no significant changes in the actuarial methodology or reserving process related to its loss and loss adjustment expense reserves for the nine months ended September 30, 2022.

At September 30, 2022 and December 31, 2021, loss and loss adjustment expense reserves were composed of the following:
September 30, 2022December 31, 2021
 ($ in thousands)
Case reserves$186,945 $190,220 
IBNR353,882 333,790 
Total$540,827 $524,010 
A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated for the nine months ended September 30, 2022 and 2021 is as follows: 
Consolidated20222021
 ($ in thousands)
Gross balance at January 1$524,010 $494,179 
Less: Losses recoverable(11,100)(16,851)
Net balance at January 1512,910 477,328 
Incurred losses related to:  
Current year251,231 296,333 
Prior years1,558 (1,255)
Total incurred252,789 295,078 
Paid losses related to:  
Current year(54,866)(96,442)
Prior years(160,094)(146,545)
Total paid(214,960)(242,987)
Foreign currency revaluation(20,516)(1,722)
Net balance at September 30530,223 527,697 
Add: Losses recoverable10,604 13,082 
Gross balance at September 30$540,827 $540,779 
    
For the nine months ended September 30, 2022, the estimate of net losses incurred relating to prior accident years increased by $1.6 million, primarily due to the following:
•adverse development on motor and health business driven by the inflationary increase in claims costs;
•adverse development on a multi-line quota share program resulting from newly reported losses received from the cedent;
•newly reported claims received relating to excess of loss marine and energy contracts; and
•claims deterioration on a cyber contract.

The adverse developments were partially offset by favorable developments relating to prior accident years primarily due to the following:
•favorable experience on mortgage business;
•loss reserves released relating to catastrophe events and COVID-19 based on updated claims reporting received from cedents; and
•loss reserves released on an excess of loss workers’ compensation contract.

For the nine months ended September 30, 2021, the estimate of net losses incurred relating to prior accident years decreased by $1.3 million due primarily to favorable development on catastrophe events, a mortgage contract associated with the COVID-19 pandemic, and certain health contracts. The decrease in prior accident years was partially offset by adverse loss development on certain workers’ compensation and multi-line casualty contracts written between 2014 and 2018.
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2022 and 2021 are as follows:
Health20222021
 ($ in thousands)
Gross balance at January 1$9,938 $17,485 
Less: Losses recoverable— — 
Net balance at January 19,938 17,485 
Incurred losses related to: 
Current year6,567 31,189 
Prior years3,552 (1,898)
Total incurred10,119 29,291 
Paid losses related to: 
Current year(3,051)(20,224)
Prior years(11,146)(13,824)
Total paid(14,197)(34,048)
Foreign currency revaluation— — 
Net balance at September 305,860 12,728 
Add: Losses recoverable— — 
Gross balance at September 30$5,860 $12,728 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
RETROCESSION
 9 Months Ended
Sep. 30, 2022
Reinsurance Disclosures [Abstract]  
RETROCESSION RETROCESSION
 
From time to time, the Company purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, reduce its net liability on individual risks, obtain additional underwriting capacity and balance its underwriting portfolio. The Company records loss and loss adjustment expenses recoverable from retrocessionaires as assets.

For the three and nine months ended September 30, 2022, the Company’s earned ceded premiums were $4.4 million and $8.4 million, respectively (insignificant for the three and nine months ended September 30, 2021). For the three and nine months ended September 30, 2022, loss and loss adjustment expenses recovered and changes in losses recoverable were $2.5 million and $2.5 million, respectively. The recoveries recognized by the Company for the three and nine months ended September 30, 2021, were nil and $0.1 million, respectively.

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2022, the Company’s loss reserves recoverable consisted of (i) $7.9 million (December 31, 2021: $8.4 million) recoverable from unrated retrocessionaires, of which $6.9 million (December 31, 2021: $8.2 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $2.7 million (December 31, 2021: $2.8 million) recoverable from retrocessionaires rated A- or above by A.M. Best.

The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2022, the Company had recorded an allowance for expected credit losses of $47 thousand (December 31, 2021: $47 thousand).
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
SENIOR CONVERTIBLE NOTES
 9 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
SENIOR CONVERTIBLE NOTES SENIOR CONVERTIBLE NOTES
On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0%, payable semiannually on February 1 and August 1 of each year beginning February 1, 2019.

Note holders have the option, under certain conditions, to redeem the Notes prior to maturity. At September 30, 2022, the Company’s share price was lower than the conversion price of $17.19 per share.
If a holder redeems the Notes, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. Prior to January 1, 2022, the Company bifurcated the Notes into liability and equity components. Effective January 1, 2022, upon adoption of ASU 2020-06, the Company no longer bifurcates the Notes and presents the entire balance as a single liability on the Company’s condensed consolidated balance sheets (see Note 2 for recently issued accounting standards adopted).
The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%. The Company incurred issuance costs in connection with the issuance of the Notes. At September 30, 2022, the unamortized portion of these costs was $0.6 million (December 31, 2021: $1.0 million), which the Company expects to amortize through the maturity date.

During the three and nine months ended September 30, 2022 the Company repurchased and canceled $6.6 million of the Notes. The carrying value of the Notes at September 30, 2022, including accrued interest of $0.6 million, was $93.4 million (December 31, 2021: $98.1 million). At September 30, 2022, the Company estimated the fair value of the Notes to be $90.2 million (December 31, 2021: $97.5 million) (see Note 4 Financial Instruments).
For the three and nine months ended September 30, 2022, the Company recognized interest expenses of $1.1 million and $3.4 million, respectively (three and nine months ended September 30, 2021: $1.6 million and $4.7 million, respectively).

The Company was in compliance with all covenants relating to the Notes at September 30, 2022, and December 31, 2021. At September 30, 2022, the Company had a remaining obligation for interest and principal payments of nil and $97.2 million during 2022 and 2023, respectively.

Subsequent to September 30, 2022, the Company repurchased and canceled $13.8 million of the Notes.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE CAPITAL
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
SHARE CAPITAL SHARE CAPITAL
The Company’s share capital is made up of ordinary share capital and additional paid-in capital. Ordinary share capital represents the issued and outstanding Class A and Class B ordinary shares at their par values of $0.10 per share. Additional paid-in capital includes the premium paid per share by the subscribing shareholders for Class A and Class B ordinary shares, as well as the earned portion of the grant-date fair value of share-based awards.

On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million. At September 30, 2022, 2,011,426 (December 31, 2021: 3,128,276) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the stock incentive plan. 

The Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. The Board of Directors has approved a share repurchase plan, which expires on June 30, 2023, authorizing the Company to repurchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares. The repurchase plan may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice.

The Company repurchased 4,933 Class A ordinary shares during the nine months ended September 30, 2022. All Class A ordinary shares repurchased are canceled immediately upon repurchase.
The following table is a summary of ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20222021
Class AClass BClass AClass B
Balance – beginning of period27,589,731 6,254,715 28,260,075 6,254,715 
Issue of ordinary shares, net of forfeitures984,548 — 409,200 — 
Repurchase of ordinary shares(4,933)— (1,079,544)— 
Balance – end of period28,569,346 6,254,715 27,589,731 6,254,715 

Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares, which have a par value of $0.10 each. It also includes the earned portion of the grant-date fair value of share-based awards that have not yet vested.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
 
The Company has a stock incentive plan for directors, employees, and consultants administered by the Compensation Committee of the Board of Directors.
 
Employee and Director Restricted Shares

The restricted shares issued to certain employees contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters.

For the nine months ended September 30, 2022, the Company issued to non-employee directors an aggregate of 107,763 (2021: 74,769) restricted Class A ordinary shares as part of their remuneration for services to the Company. These restricted shares contain similar restrictions to those issued to employees. They will vest on the earlier of (i) the first anniversary of the date of the share issuance and (ii) the Company’s next annual general meeting, subject to the grantee’s continued service with the Company. During the vesting period, non-employee directors holding these restricted shares retain voting rights and are entitled to any dividends declared by the Company.

For the nine months ended September 30, 2022, the Company issued 849,872 (2021: 334,312) Class A ordinary shares to employees pursuant to the Company’s stock incentive plan. The restricted shares granted to employees in 2022 include (i) restricted shares with both performance and service-based vesting conditions (“Performance RSs”) and (ii) restricted shares with only service-based vesting conditions (“Service RSs”). The Service RSs vest evenly each year on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSs will cliff vest at the end of a three-year performance period within a range of 25% and 100% of the awarded Performance RSs, with a target of 50%. During the vesting period, the holder of the Service RSs and Performance RSs retains voting rights but is entitled to any dividends declared by the Company only upon vesting.

Prior to fiscal year 2022, the restricted shares granted to employees cliff vested three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retained voting rights and are entitled to any dividends declared by the Company.

Prior to fiscal year 2021, the Company issued Class A ordinary shares to the Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan (“CEO RSs”). These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of the CEO’s employment, and transferability. The CEO RSs cliff vest five years after the date of issuance, subject to the performance condition being met and the CEO’s continued service with the Company. At September 30, 2022, there were 193,149 non-vested CEO RSs with a weighted average grant date fair value of $10.10 per share. As the performance conditions associated with these restricted shares have not been met, the Company recognized no compensation cost relating to the unvested shares for the nine months ended September 30, 2022, and 2021.

The Company recognizes compensation expense associated with Performance RSs and Service RSs based on the fair value of the Company's Class A ordinary shares measured at the grant date. For Service RSs, the Company recognizes this expense on a straight-line basis over the requisite service period. For Performance RSs, the Company recognizes the associated compensation expense based on achieving established performance criteria during the performance period.
 
For the nine months ended September 30, 2022, grantees forfeited 8,476 (2021: 20,592) restricted shares. For the nine months ended September 30, 2022, the Company reversed $26 thousand of stock compensation expense (2021: $0.1 million) in relation to the forfeited restricted shares.

The Company recorded $2.6 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2022 (2021: $1.8 million). At September 30, 2022, there was $4.4 million (December 31, 2021: $2.7 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO RSs), which the Company expects to recognize over a weighted-average period of 1.6 years (December 31, 2021: 1.8 years). For the nine months ended September 30, 2022, the total fair value of restricted shares vested was $2.0 million (2021: $1.6 million).

The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2022:

Performance Restricted SharesService Restricted Shares
 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value		Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2021193,149 $10.10 753,407 $8.68 
Granted601,213 6.82 356,422 7.02 
Vested— — (197,002)10.06 
Forfeited— — (8,476)7.67 
Balance at September 30, 2022794,362 $7.62 904,351 $7.73 


Employee Restricted Stock Units

The Company issues RSUs to certain employees as part of the stock incentive plan. Such RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan.

The RSUs granted to employees in 2022 include (i) RSUs with both performance and service-based vesting conditions (“Performance RSUs”) and (ii) RSUs with only service-based vesting conditions (“Service RSUs”). The Service RSUs vest evenly each year on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of a three-year performance period within a range of 25% and 100% of the awarded Performance RSUs, with a target of 50%.

The Company recognizes compensation expense associated with Performance RSUs and Service RSUs based on the fair value of the Company's Class A ordinary shares measured at the grant date. For Service RSUs, the Company recognizes this expense on a straight-line basis over the requisite service period. For Performance RSUs, the Company recognizes the associated compensation expense based on achieving established performance criteria during the performance period.

Prior to 2022, the RSUs issued to employees cliff vested three years after the date of issuance, subject to the grantee’s continued service with the Company. For the nine months ended September 30, 2022, the Company issued 159,215 (2021: 58,123) RSUs to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2022, and 2021, no RSUs were forfeited.

The Company recorded $0.5 million of share-based compensation expense relating to RSUs for the nine months ended September 30, 2022 (2021: $0.3 million). At September 30, 2022, the total compensation cost related to non-vested RSUs not yet recognized was $0.7 million (December 31, 2021: $0.5 million), which the Company expects to recognize over a weighted-average period of 1.6 years (December 31, 2021: 1.8 years).
Employee RSU activity during the nine months ended September 30, 2022, was as follows:
Performance Restricted Stock UnitsService Restricted Stock Units
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value		Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 2021— $— 154,134 $8.59 
Granted105,008 6.82 54,207 6.82 
Vested— — (35,389)10.84 
Balance at September 30, 2022105,008 $6.82 172,952 $7.58 


Employee and Director Stock Options

For the nine months ended September 30, 2022, and 2021, no Class A ordinary share purchase options were granted or exercised by directors or employees, and 45,290 Class A ordinary share purchase options expired. When the Company grants stock options, it reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.

The Board of Directors does not currently anticipate that the Company will declare any dividends during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed relating to stock options for the nine months ended September 30, 2022, was $0.2 million (2021: $0.3 million). At September 30, 2022, the total compensation cost related to non-vested options not yet recognized was $0.1 million (December 31, 2021: $0.3 million), which will be recognized over a weighted-average period of 0.8 years (December 31, 2021: 1.2 years) assuming the grantee completes the service period for vesting of the options.

Employee and director stock option activity during the nine months ended September 30, 2022 was as follows: 

Number of
 options outstanding		Weighted
 average
 exercise
 price		Weighted
 average
 grant date
 fair value		Intrinsic value
($ in millions)		Weighted average remaining contractual term
Balance at December 31, 2021735,627 $22.35 $10.23 $— 4.7 years
Granted— — — — — 
Exercised— — — — — 
Forfeited— — — — — 
Expired(45,290)23.80 11.04 — — 
Balance at September 30, 2022690,337 $22.25 $10.18 $— 4.2 years

Stock Compensation Expense

For the nine months ended September 30, 2022, and 2021, the combined stock compensation expenses (net of forfeitures) included in the caption “General and administrative expenses” in the Company’s condensed consolidated statements of operations were $3.3 million and $2.4 million, respectively.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
TAXATION
 9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
TAXATION TAXATIONAt September 30, 2022, the Company recorded a gross deferred tax asset of $3.7 million (December 31, 2021: $3.2 million) and a deferred tax asset valuation allowance of $3.2 million (December 31, 2021: $2.7 million). The net deferred tax asset is included in the caption “Other assets” in the Company’s condensed consolidated balance sheets. The Company has determined that it is more likely than not that it will fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. The Company based this determination on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit.
The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2022 and 2021:
Three months ended September 30Nine months ended September 30
 2022202120222021
 ($ in thousands)($ in thousands)
Current tax (expense) benefit$(234)$323 $(655)$(3,240)
Tax recovered1,050 — 1,478 — 
Deferred tax (expense) benefit170 — 428 — 
Decrease (increase) in deferred tax valuation allowance(170)(323)(428)(493)
Income tax (expense) benefit $816 $— $823 $(3,733)
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS 
 
Investment Advisory Agreement
 
DME, DME II, and DME Advisors are each an affiliate of the Chairman and therefore are related parties to the Company.

The Company has entered into the SILP LPA (as described in Note 3 of the condensed consolidated financial statements). DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL includes the amount of investment losses to be recouped, including any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry-forward provision in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss until all losses are recouped, and an additional amount equal to 150% of the loss is earned.

In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio”, as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors, which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023, subject to an automatic extension for successive three-year terms.

For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2022, and 2021, refer to Note 3 of the condensed consolidated financial statements.
 
Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II, and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II, and DME Advisors for reasonable costs and expenses of investigating and defending such claims, provided such claims were not caused due to gross negligence, breach of contract, or misrepresentation by DME, DME II, or DME Advisors. The Company incurred no indemnification amounts during the periods presented.

Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2022, SILP, along with certain affiliates of DME Advisors, collectively owned 38% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in SILP. At September 30, 2022, SILP held 2.7 million shares of GRBK.
Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES 
 
Letters of Credit and Trusts
 
At September 30, 2022, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2023
120 days before the termination date

At September 30, 2022, an aggregate amount of $180.2 million (December 31, 2021: $136.8 million) in letters of credit was issued under the credit facility. At September 30, 2022, the Company had pledged total cash and cash equivalents with a fair value in the aggregate of $180.9 million (December 31, 2021: $137.6 million) as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the credit facility covenants at September 30, 2022 and December 31, 2021.

The Company has also established regulatory trust arrangements for certain cedents. At September 30, 2022, collateral of $468.0 million (December 31, 2021: $497.1 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets.

Lease Obligations

The Company has determined that its lease agreements for office space qualify as operating lease arrangements. At the commencement date, the Company determined the lease term by assuming the exercise of those renewal options deemed to be reasonably certain. The exercise of lease renewal options is at the Company's sole discretion, and these options do not contain any material residual value guarantees or material restrictive covenants. The Company’s weighted-average remaining operating lease term is approximately 4.0 years at September 30, 2022.

As the lease contracts generally do not provide an implicit discount rate, the Company used the weighted-average discount rate of 6%, representing its incremental borrowing rate based on information available at the commencement date, to determine the present value of lease payments. The incremental borrowing rate is based on a borrowing with a term similar to that of the associated lease. The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing.
At September 30, 2022, the right-of-use assets and lease liabilities relating to the operating leases were $2.0 million and $2.1 million, respectively. The operating expense for the three and nine months ended September 30, 2022, was $0.2 million and $0.5 million, respectively (three and nine months ended September 30, 2021: $0.1 million and $0.2 million, respectively).

At September 30, 2022, the commitment for operating lease liabilities for future annual periods was as follows:

Year ending December 31,($ in thousands)
2022$149 
2023611 
2024627 
2025644 
2026345 
Thereafter— 
Total lease payments2,376 
Less Imputed Interest(280)
Present value of lease liabilities$2,096 

Litigation
From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENT REPORTING
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
 
The Company has one operating segment, Property & Casualty Reinsurance.

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2022202120222021
  ($ in thousands)($ in thousands)
Property
Commercial$2,146 1.4 %$3,398 2.6 %$8,648 2.0 %$9,700 2.2 %
Motor206 0.1 6,103 4.8 768 0.2 24,537 5.6 
Personal17,669 11.4 3,631 2.8 49,425 11.3 10,318 2.3 
Total Property20,021 12.9 13,132 10.2 58,841 13.5 44,555 10.1 
Casualty
General Liability13,798 8.9 7,376 5.7 40,523 9.3 10,749 2.4 
Motor Liability565 0.4 19,823 15.4 4,061 0.9 96,795 22.0 
Professional Liability242 0.2 154 0.1 496 0.1 302 0.1 
Workers' Compensation7,216 4.6 17,117 13.3 25,504 5.9 55,237 12.5 
Multi-line 69,419 44.7 40,162 31.2 177,647 40.8 137,857 31.3 
Total Casualty91,240 58.8 84,632 65.7 248,231 57.0 300,940 68.4 
Other
Accident & Health5,879 3.8 4,175 3.3 10,377 2.4 26,427 6.0 
Financial20,065 12.9 17,920 13.9 56,481 12.9 40,134 9.1 
Marine4,675 3.0 2,462 1.9 18,425 4.2 8,412 1.9 
Other Specialty13,266 8.6 6,414 5.0 43,457 10.0 19,781 4.5 
Total Other43,885 28.3 30,971 24.1 128,740 29.5 94,754 21.5 
$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %
Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2022202120222021
 ($ in thousands)($ in thousands)
U.S. and Caribbean$72,105 46.5 %$67,087 52.1 %$224,324 51.5 %$258,849 58.8 %
Worldwide (1)
79,512 51.3 59,616 46.3 196,197 45.0 174,470 39.6 
Europe (2)
(1,797)(1.2)1,483 1.2 2,962 0.7 2,787 0.6 
Asia
5,326 3.4 549 0.4 12,329 2.8 4,143 1.0 
$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 
(2) The negative balance represents the reversal of premiums due to premium adjustments, termination of contracts, or premium returned upon novation or commutation of contracts.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates
 
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s
condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, premiums written, earned, and receivable, variability underlying risk transfer assessments, allowances for credit losses, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
 
Cash and cash equivalents consist of cash and short-term, highly liquid investments and certificates of deposit with original maturity dates of three months or less. Certificates of deposit with original maturities greater than three months are included under the caption "Other investments" on the condensed consolidated balance sheets.
The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12).
Funds Held by Cedents Funds Held by CedentsThe caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes financial assets held by cedents. At September 30, 2022, funds held by cedents were $303.1 million (December 31, 2021: $246.9 million). Such amounts include premiums withheld by Lloyd’s syndicates and funds contributed by the Company to Lloyd's as security for members’ underwriting activities. The syndicates invest a portion of the premiums withheld in fixed maturity securities and investment funds. The Company records its share of income (or expense) from these assets in its condensed consolidated statements of operations under the caption “Other income (expense).”
Reinsurance Assets
Reinsurance Assets

The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets.

The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. Credit ratings of the counterparties are forward-looking and consider various economic scenarios. The Company's evaluation of the required allowance for reinsurance balances receivable and loss and loss adjustment expenses recoverable considers the current economic environment as well as potential macroeconomic developments.

For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.
Deposit Assets and Liabilities
Deposit Assets and Liabilities
 
The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the captions “Other income (expense)” and “Deposit interest expense,” respectively. The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively.
Foreign Exchange Foreign ExchangeThe reporting and functional currency of the Company and all its significant subsidiaries is the U.S. dollar. The Company records foreign currency transactions at the exchange rates in effect on the transaction date. Monetary assets and liabilities in foreign currencies at the balance sheet date are converted at the exchange rate in effect at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are carried at their historical exchange rates. The Company includes any foreign exchange gains and losses under the caption “Other income (expense), net” in the Company’s condensed consolidated statements of operations.
Derivative instruments
Derivative instruments

The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.

The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.
Other Assets
Other Assets

The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, taxes recoverable, and deferred tax assets.
Other Liabilities Other LiabilitiesThe caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities.
Earnings (Loss) Per Share
Earnings (Loss) Per Share
 
The Company has issued unvested restricted stock awards, some of which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid. These awards are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of ordinary shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect, if any, of the following:

•Restricted Stock Units (“RSUs”) issued that convert to ordinary shares upon vesting;
•Unvested restricted share awards which are not considered “participating securities”;
•Additional potential ordinary shares issuable when in-the-money stock options are exercised, determined using the treasury stock method;
•For periods prior to January 1, 2022, those ordinary shares with the potential to be issued in connection with convertible notes and other such convertible instruments, determined using the treasury stock method; and
•Effective January 1, 2022, the dilutive effect of the convertible notes is calculated using the if-converted method. Under the if-converted method, the convertible notes are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted net income per common share calculation. Interest expense related to the convertible notes incurred in the period is added back to the numerator for purposes of the if-converted calculation.
For the three and nine months ended September 30, 2022, the effect of the assumed conversion of the convertible notes was anti-dilutive and was not included in the computation of diluted earnings per share.

Diluted earnings (or loss) per share contemplates a conversion to ordinary shares of all convertible instruments only if they are dilutive. In the event of a net loss, all RSUs, stock options, shares potentially issuable in connection with convertible notes, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.
Taxation
Taxation
 
Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Act, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes a tax on profits, income, gains, or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.
 
Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2021: 21%). Verdant’s tax years 2018 and beyond remain open and may be subject to examination by the IRS.

GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.
The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company.
Recent Accounting Pronouncements
Recent Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” (“ASU 2022-03”). ASU 2022-03 clarifies the guidance for measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 is effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company does not expect ASU 2022-03 to have a material impact on its financial position, results of operations, or cash flows.

Recently Issued Accounting Standards Adopted

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; instead, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring the application of the if-converted method when calculating diluted earnings per share. Under the if-converted method, the shares potentially issuable in connection with convertible debt are assumed to be converted at the beginning of the period. The resulting ordinary shares are included in the denominator of the diluted earnings per share calculation for the period presented.

The Company adopted ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. The adoption of ASU 2020-06 resulted in a decrease in the Company’s opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes (see Note 7). The adoption of ASU 2020-06 did not have a material impact on the Company’s net income, cash flows, or any other balances.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:
 September 30, 2022December 31, 2021
 ($ in thousands)
Cash and cash equivalents$32,278 $76,307 
Restricted cash and cash equivalents648,897 634,794 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$681,175 $711,101 
Schedule of Restrictions on Cash and Cash Equivalents The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:
 September 30, 2022December 31, 2021
 ($ in thousands)
Cash and cash equivalents$32,278 $76,307 
Restricted cash and cash equivalents648,897 634,794 
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows$681,175 $711,101 
Schedule of Interest Income and Interest Expense For the three and nine months ended September 30, 2022, and 2021, the interest income and expense on deposit accounted contracts were as follows:
 Three months ended September 30Nine months ended September 30
 2022202120222021
($ in thousands)($ in thousands)
Deposit interest income$— $— $— $— 
Deposit interest expense$(6,148)$(38)$(6,373)$(2,957)
Deposit interest income/(expense), net$(6,148)$(38)$(6,373)$(2,957)
Schedule of Net Income (Loss) and Weighted Average Number of Shares
The following table reconciles net income (loss) and weighted average shares used in computing basic and diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021 (expressed in thousands of U.S. dollars, except per share and share amounts):
 Three months ended September 30Nine months ended September 30
 2022202120222021
Numerator for earnings per share
Net income (loss) - basic$(18,469)$(13,853)$(9,408)$(6,726)
Add: interest on convertible notes— — — — 
Net income (loss) - diluted$(18,469)$(13,853)$(9,408)$(6,726)
Denominator for earnings per share
Weighted average shares outstanding - basic33,127,384 32,929,097 33,119,814 33,507,060 
Effect of dilutive employee and director share-based awards— — — — 
Shares potentially issuable in connection with convertible notes — — — — 
Weighted average shares outstanding - diluted33,127,384 32,929,097 33,119,814 33,507,060 
Anti-dilutive stock options outstanding690,337 735,627 690,337 735,627 
Participating securities excluded from calculation of loss per share 848,841 946,556 848,841 946,556 
Shares potentially issuable in connection with convertible notes excluded from calculation of diluted loss per share5,686,747 — 5,773,889 — 
Earnings (loss) per Class A and Class B Ordinary share:
Basic$(0.56)$(0.42)$(0.28)$(0.20)
Diluted$(0.56)$(0.42)$(0.28)$(0.20)
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)
 9 Months Ended
Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Financial Information of Investment The summarized financial statements of SILP are presented below.
Summarized Statement of Assets and Liabilities of Solasglas Investments, LP
September 30, 2022December 31, 2021
($ in thousands)
Assets
Investments, at fair value$258,386 $297,937 
Derivative contracts, at fair value15,727 2,542 
Due from brokers149,071 84,775 
Interest and dividends receivable64 28 
Total assets423,248 385,282 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value(153,892)(132,360)
Derivative contracts, at fair value(9,739)(7,253)
Capital withdrawals payable— (10,000)
Due to brokers(10)— 
Interest and dividends payable(295)(580)
Other liabilities(201)(358)
Total liabilities(164,137)(150,551)
Net Assets$259,111 $234,731 
GLRE Limited Partners’ share of Net Assets$195,199 $183,591 
Summarized Statement of Operations of Solasglas Investments, LP
Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Investment income
Dividend income (net of withholding taxes)$305 $146 $928 $509 
Interest income693 51 1,028 770 
Total Investment income998 197 1,956 1,279 
Expenses
Management fee(901)(883)(2,686)(2,632)
Interest(464)(205)(1,199)(874)
Dividends(356)(306)(938)(852)
Professional fees and other(262)(227)(756)(786)
Total expenses(1,983)(1,621)(5,579)(5,144)
Net investment income (loss)(985)(1,424)(3,623)(3,865)
Realized and change in unrealized gains (losses)
Net realized gain (loss) 7,221 (1,411)58,196 (14,809)
Net change in unrealized appreciation (depreciation) 6,464 (5,437)(17,027)12,143 
Net gain (loss) on investment transactions13,685 (6,848)41,169 (2,666)
Net income (loss)$12,700 $(8,272)$37,546 $(6,531)
GLRE Limited Partners’ share of net income (loss) (1)
$8,521 $(6,214)$24,474 $(4,196)

(1) Net income (loss) is net of management fees and performance allocation presented below:

Three months ended September 30Nine months ended September 30
2022202120222021
($ in thousands)
Management fees$901 $883 $2,686 $2,632 
Performance allocation947 $(224)2,719 — 
Total$1,848 $659 $5,405 $2,632 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS (Tables)
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Other Investments
At September 30, 2022, the Company included the following securities in the caption “Other investments”:
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities $22,037 $42,412 $(3,368)$61,081 
Convertible debt securities1,000 — — 1,000 
Certificates of deposit3,000 — — 3,000 
Total other investments$26,037 $42,412 $(3,368)$65,081 

At December 31, 2021, the Company included the following securities in the caption “Other investments”: 
CostUnrealized
gains		Unrealized
losses		Fair value / carrying value
 ($ in thousands)
Private investments and unlisted equities$17,411 $31,438 $(1,800)$47,049 
Derivative financial instruments (not designated as hedging instruments)— 335 — 335 
Total other investments$17,411 $31,773 $(1,800)$47,384 
Schedule of Carrying Values of Private Investments and Unlisted Equity Securities Carried under Measurement Alternative
The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2022, and 2021, and the related adjustments recorded during the periods then ended.
Nine months ended September 30
20222021
($ in thousands)
Carrying value (1)
$61,081 $42,349 
Upward carrying value changes (2)
$11,260 $13,355 
Downward carrying value changes and impairment (3)
$(1,676)$(500)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(2) The cumulative upward carrying value changes from inception to September 30, 2022, totaled $42.8 million.
(3) The cumulative downward carrying value changes and impairments from inception to September 30, 2022, totaled $3.7 million.
Assets Measured at Fair Value on a Nonrecurring Basis The Company classifies these assets as Level 3 within the fair value hierarchy. The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2022, for the private and unlisted equities measured at fair value on a nonrecurring basis:
Less than 6 months6 to 12 monthsOver 1 yearTotal
($ in thousands)
Fair values measured on a nonrecurring basis$24,451 $17,080 $11,423 $52,954 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)
 9 Months Ended
Sep. 30, 2022
Insurance Loss Reserves [Abstract]  
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense
At September 30, 2022 and December 31, 2021, loss and loss adjustment expense reserves were composed of the following:
September 30, 2022December 31, 2021
 ($ in thousands)
Case reserves$186,945 $190,220 
IBNR353,882 333,790 
Total$540,827 $524,010 
A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated for the nine months ended September 30, 2022 and 2021 is as follows: 
Consolidated20222021
 ($ in thousands)
Gross balance at January 1$524,010 $494,179 
Less: Losses recoverable(11,100)(16,851)
Net balance at January 1512,910 477,328 
Incurred losses related to:  
Current year251,231 296,333 
Prior years1,558 (1,255)
Total incurred252,789 295,078 
Paid losses related to:  
Current year(54,866)(96,442)
Prior years(160,094)(146,545)
Total paid(214,960)(242,987)
Foreign currency revaluation(20,516)(1,722)
Net balance at September 30530,223 527,697 
Add: Losses recoverable10,604 13,082 
Gross balance at September 30$540,827 $540,779 
The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2022 and 2021 are as follows:
Health20222021
 ($ in thousands)
Gross balance at January 1$9,938 $17,485 
Less: Losses recoverable— — 
Net balance at January 19,938 17,485 
Incurred losses related to: 
Current year6,567 31,189 
Prior years3,552 (1,898)
Total incurred10,119 29,291 
Paid losses related to: 
Current year(3,051)(20,224)
Prior years(11,146)(13,824)
Total paid(14,197)(34,048)
Foreign currency revaluation— — 
Net balance at September 305,860 12,728 
Add: Losses recoverable— — 
Gross balance at September 30$5,860 $12,728 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE CAPITAL (Tables)
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of Stock by Class
The following table is a summary of ordinary shares issued and outstanding:
Nine months ended September 30Nine months ended September 30
 20222021
Class AClass BClass AClass B
Balance – beginning of period27,589,731 6,254,715 28,260,075 6,254,715 
Issue of ordinary shares, net of forfeitures984,548 — 409,200 — 
Repurchase of ordinary shares(4,933)— (1,079,544)— 
Balance – end of period28,569,346 6,254,715 27,589,731 6,254,715 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity for Unvested Restricted Share Awards and Employee Restricted Stock Units
The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2022:

Performance Restricted SharesService Restricted Shares
 Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value		Number of
non-vested
restricted
 shares		Weighted
 average
grant date
fair value
Balance at December 31, 2021193,149 $10.10 753,407 $8.68 
Granted601,213 6.82 356,422 7.02 
Vested— — (197,002)10.06 
Forfeited— — (8,476)7.67 
Balance at September 30, 2022794,362 $7.62 904,351 $7.73 
Employee RSU activity during the nine months ended September 30, 2022, was as follows:
Performance Restricted Stock UnitsService Restricted Stock Units
 Number of
non-vested
RSUs		Weighted
 average
grant date
fair value		Number of
non-vested
RSUs		Weighted
 average
grant date
fair value
Balance at December 31, 2021— $— 154,134 $8.59 
Granted105,008 6.82 54,207 6.82 
Vested— — (35,389)10.84 
Balance at September 30, 2022105,008 $6.82 172,952 $7.58 
Schedule of Activity for Employee and Director Stock Options
Employee and director stock option activity during the nine months ended September 30, 2022 was as follows: 

Number of
 options outstanding		Weighted
 average
 exercise
 price		Weighted
 average
 grant date
 fair value		Intrinsic value
($ in millions)		Weighted average remaining contractual term
Balance at December 31, 2021735,627 $22.35 $10.23 $— 4.7 years
Granted— — — — — 
Exercised— — — — — 
Forfeited— — — — — 
Expired(45,290)23.80 11.04 — — 
Balance at September 30, 2022690,337 $22.25 $10.18 $— 4.2 years
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
TAXATION (Tables)
 9 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2022 and 2021:
Three months ended September 30Nine months ended September 30
 2022202120222021
 ($ in thousands)($ in thousands)
Current tax (expense) benefit$(234)$323 $(655)$(3,240)
Tax recovered1,050 — 1,478 — 
Deferred tax (expense) benefit170 — 428 — 
Decrease (increase) in deferred tax valuation allowance(170)(323)(428)(493)
Income tax (expense) benefit $816 $— $823 $(3,733)
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES (Tables)
 9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Letters of Credit Facilities
At September 30, 2022, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:
Maximum Facility LimitTermination DateNotice period required for termination
 ($ in thousands)  
Citibank Europe plc$275,000 August 20, 2023
120 days before the termination date
Schedule of Commitment for Operating Lease Liabilities for Future Annual Periods
At September 30, 2022, the commitment for operating lease liabilities for future annual periods was as follows:

Year ending December 31,($ in thousands)
2022$149 
2023611 
2024627 
2025644 
2026345 
Thereafter— 
Total lease payments2,376 
Less Imputed Interest(280)
Present value of lease liabilities$2,096 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENT REPORTING (Tables)
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of Gross Premiums Written by Line of Business Gross Premiums Written by Line of Business
  Three months ended September 30Nine months ended September 30
2022202120222021
  ($ in thousands)($ in thousands)
Property
Commercial$2,146 1.4 %$3,398 2.6 %$8,648 2.0 %$9,700 2.2 %
Motor206 0.1 6,103 4.8 768 0.2 24,537 5.6 
Personal17,669 11.4 3,631 2.8 49,425 11.3 10,318 2.3 
Total Property20,021 12.9 13,132 10.2 58,841 13.5 44,555 10.1 
Casualty
General Liability13,798 8.9 7,376 5.7 40,523 9.3 10,749 2.4 
Motor Liability565 0.4 19,823 15.4 4,061 0.9 96,795 22.0 
Professional Liability242 0.2 154 0.1 496 0.1 302 0.1 
Workers' Compensation7,216 4.6 17,117 13.3 25,504 5.9 55,237 12.5 
Multi-line 69,419 44.7 40,162 31.2 177,647 40.8 137,857 31.3 
Total Casualty91,240 58.8 84,632 65.7 248,231 57.0 300,940 68.4 
Other
Accident & Health5,879 3.8 4,175 3.3 10,377 2.4 26,427 6.0 
Financial20,065 12.9 17,920 13.9 56,481 12.9 40,134 9.1 
Marine4,675 3.0 2,462 1.9 18,425 4.2 8,412 1.9 
Other Specialty13,266 8.6 6,414 5.0 43,457 10.0 19,781 4.5 
Total Other43,885 28.3 30,971 24.1 128,740 29.5 94,754 21.5 
$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %
Schedule of Gross Premiums Written by Geographic Area of Risks Insured Gross Premiums Written by Geographic Area of Risks Insured
 Three months ended September 30Nine months ended September 30
2022202120222021
 ($ in thousands)($ in thousands)
U.S. and Caribbean$72,105 46.5 %$67,087 52.1 %$224,324 51.5 %$258,849 58.8 %
Worldwide (1)
79,512 51.3 59,616 46.3 196,197 45.0 174,470 39.6 
Europe (2)
(1,797)(1.2)1,483 1.2 2,962 0.7 2,787 0.6 
Asia
5,326 3.4 549 0.4 12,329 2.8 4,143 1.0 
$155,146 100.0 %$128,735 100.0 %$435,812 100.0 %$440,249 100.0 %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 
(2) The negative balance represents the reversal of premiums due to premium adjustments, termination of contracts, or premium returned upon novation or commutation of contracts.
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Accounting Policies [Abstract]        
Cash and cash equivalents $ 32,278 $ 76,307    
Restricted cash and cash equivalents 648,897 634,794    
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows $ 681,175 $ 711,101 $ 729,922 $ 754,306
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle          
Reinsurance balances receivable $ 473,564   $ 473,564   $ 405,365
Allowance for expected credit losses 89   89   89
Deposit contracts, assets 3,200   3,200   3,500
Deposit contracts, liabilities 13,700   13,700   18,600
Foreign currency transaction loss (5,000) $ (600) (10,400) $ (1,400)  
Convertible senior notes payable 93,446   93,446   98,057
Decrease in shareholders' equity (466,952) $ (450,514) (466,952) $ (450,514) (475,663)
Accounting Standards Update 2020-06 | Cumulative Effect, Period of Adoption, Adjustment          
New Accounting Pronouncements or Change in Accounting Principle          
Convertible senior notes payable         2,500
Decrease in shareholders' equity         2,500
Cedents          
New Accounting Pronouncements or Change in Accounting Principle          
Reinsurance balances receivable $ 303,100   $ 303,100   $ 246,900
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Accounting Policies [Abstract]        
Deposit interest income $ 0 $ 0 $ 0 $ 0
Deposit interest expense (6,148) (38) (6,373) (2,957)
Deposit interest income/(expense), net $ (6,148) $ (38) $ (6,373) $ (2,957)
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) and Weighted Average Number of Shares (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Numerator for earnings per share        
Net income (loss) - basic $ (18,469) $ (13,853) $ (9,408) $ (6,726)
Add: interest on convertible notes 0 0 0 0
Net income (loss) - diluted $ (18,469) $ (13,853) $ (9,408) $ (6,726)
Denominator for earnings per share        
Weighted average shares outstanding - basic (in shares) 33,127,384 32,929,097 33,119,814 33,507,060
Effect of dilutive employee and director share-based awards (in shares) 0 0 0 0
Effect of settling the convertible debt in shares (in shares) 0 0 0 0
Weighted average shares outstanding - diluted (in shares) 33,127,384 32,929,097 33,119,814 33,507,060
Earnings (loss) per Class A and Class B Ordinary share:        
Basic (in dollars per share) $ (0.56) $ (0.42) $ (0.28) $ (0.20)
Diluted (in dollars per share) $ (0.56) $ (0.42) $ (0.28) $ (0.20)
Anti-dilutive stock options outstanding        
Denominator for earnings per share        
Shares potentially issuable in connection with convertible notes and Anti-dilutive stock options outstanding (in shares) 690,337 735,627 690,337 735,627
Participating securities excluded from calculation of loss per share         
Denominator for earnings per share        
Shares potentially issuable in connection with convertible notes and Anti-dilutive stock options outstanding (in shares) 848,841 946,556 848,841 946,556
Shares potentially issuable in connection with convertible notes        
Denominator for earnings per share        
Shares potentially issuable in connection with convertible notes and Anti-dilutive stock options outstanding (in shares) 5,686,747 0 5,773,889 0
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]          
LPA, investment cap percentage     50.00%    
Revenue from related parties $ 8,521 $ (6,214) $ 24,474 $ (4,196)  
SILP General Partner          
Schedule of Equity Method Investments [Line Items]          
Equity method investment, ownership interest (as a percent) 24.70%   24.70%   21.80%
Limited Partnership Agreement          
Schedule of Equity Method Investments [Line Items]          
Asset redemption notice to general partner     3 days    
Solasglas Investments, LP (SILP) | GLRE Limited Partners          
Schedule of Equity Method Investments [Line Items]          
Equity method investments, fair value $ 195,200   $ 195,200   $ 183,600
Equity method investment, ownership interest (as a percent) 75.30%   75.30%   78.20%
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Assets    
Investments, at fair value $ 195,199 $ 183,591
Total assets 1,524,543 1,427,494
Liabilities    
Other liabilities (4,927) (7,164)
Total liabilities (1,057,591) (951,831)
Equity Method Investment, Nonconsolidated Investee or Group of Investees | Solasglas Investments, LP (SILP)    
Liabilities    
Net Assets 195,199 183,591
Solasglas Investments, LP (SILP) | Equity Method Investment, Nonconsolidated Investee or Group of Investees    
Assets    
Investments, at fair value 258,386 297,937
Derivative contracts, at fair value 15,727 2,542
Due from brokers 149,071 84,775
Interest and dividends receivable 64 28
Total assets 423,248 385,282
Liabilities    
Investments sold short, at fair value (153,892) (132,360)
Derivative contracts, at fair value (9,739) (7,253)
Capital withdrawals payable 0 (10,000)
Due to brokers (10) 0
Interest and dividends payable (295) (580)
Other liabilities (201) (358)
Total liabilities (164,137) (150,551)
Net Assets $ 259,111 $ 234,731
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Expenses        
Total expenses $ (146,008) $ (153,124) $ (391,401) $ (430,119)
Net investment income (loss) 3,038 10,303 11,978 28,999
Realized and change in unrealized gains (losses)        
Net income (loss) (18,469) (13,853) (9,408) (6,726)
GLRE limited partners’ share of net income (loss) 8,521 (6,214) 24,474 (4,196)
Management fees 901 883 2,686 2,632
Performance allocation 947 (224) 2,719 0
Total 1,848 659 5,405 2,632
Equity Method Investment, Nonconsolidated Investee or Group of Investees | Solasglas Investments, LP (SILP)        
Realized and change in unrealized gains (losses)        
Net income (loss) 8,521 (6,214) 24,474 (4,196)
Solasglas Investments, LP (SILP) | Equity Method Investment, Nonconsolidated Investee or Group of Investees        
Investment income        
Dividend income (net of withholding taxes) 305 146 928 509
Interest income 693 51 1,028 770
Total Investment income 998 197 1,956 1,279
Expenses        
Management fee (901) (883) (2,686) (2,632)
Interest (464) (205) (1,199) (874)
Dividends (356) (306) (938) (852)
Professional fees and other (262) (227) (756) (786)
Total expenses (1,983) (1,621) (5,579) (5,144)
Net investment income (loss) (985) (1,424) (3,623) (3,865)
Realized and change in unrealized gains (losses)        
Net realized gain (loss) 7,221 (1,411) 58,196 (14,809)
Net change in unrealized appreciation (depreciation) 6,464 (5,437) (17,027) 12,143
Net gain (loss) on investment transactions 13,685 (6,848) 41,169 (2,666)
Net income (loss) $ 12,700 $ (8,272) $ 37,546 $ (6,531)
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS - Other Investments (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Total other investments    
Debt and Equity Securities, FV-NI    
Cost $ 26,037 $ 17,411
Unrealized gains 42,412 31,773
Unrealized losses (3,368) (1,800)
Fair value / carrying value 65,081 47,384
Private investments and unlisted equities    
Debt and Equity Securities, FV-NI    
Cost 22,037 17,411
Unrealized gains 42,412 31,438
Unrealized losses (3,368) (1,800)
Fair value / carrying value 61,081 47,049
Convertible debt securities    
Debt and Equity Securities, FV-NI    
Cost 1,000  
Unrealized gains 0  
Unrealized losses 0  
Fair value / carrying value 1,000  
Certificates of deposit    
Debt and Equity Securities, FV-NI    
Cost 3,000  
Unrealized gains 0  
Unrealized losses 0  
Fair value / carrying value $ 3,000  
Derivative financial instruments (not designated as hedging instruments)    
Debt and Equity Securities, FV-NI    
Cost   0
Unrealized gains   335
Unrealized losses   0
Fair value / carrying value   $ 335
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS - Nonrecurring Fair Value Disclosures (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Sep. 30, 2021
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value    
Upward carrying value changes $ 42,800  
Downward carrying value changes and impairment (3,700)  
Fair Value, Nonrecurring    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value    
Carrying value 61,081 $ 42,349
Upward carrying value changes 11,260 13,355
Downward carrying value changes and impairment $ (1,676) $ (500)
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Other investments $ 65,081 $ 47,384
Private Investments and Unlisted Equity Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Other investments 8,100 6,500
Private Investments and Unlisted Equity Securities | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value / carrying value $ 53,000 $ 40,500
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
FINANCIAL INSTRUMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details)
$ in Thousands
Sep. 30, 2022
USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation  
Fair values measured on a nonrecurring basis $ 52,954
Less than 6 months  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation  
Fair values measured on a nonrecurring basis 24,451
6 to 12 months  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation  
Fair values measured on a nonrecurring basis 17,080
Over 1 year  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation  
Fair values measured on a nonrecurring basis $ 11,423
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Liability for Claims and Claims Adjustment Expense        
Case reserves $ 186,945   $ 190,220  
IBNR 353,882   333,790  
Total 540,827 $ 540,779 524,010 $ 494,179
Liability for Unpaid Claims and Claims Adjustment Expense        
Gross balance at January 1 524,010 494,179    
Less: Losses recoverable     (11,100) (16,851)
Net balance at January 1 512,910 477,328    
Incurred losses related to:        
Current year 251,231 296,333    
Prior years 1,558 (1,255)    
Total incurred 252,789 295,078    
Paid losses related to:        
Current year (54,866) (96,442)    
Prior years (160,094) (146,545)    
Total paid (214,960) (242,987)    
Foreign currency revaluation (20,516) (1,722)    
Net balance at September 30 530,223 527,697    
Add: Losses recoverable 10,604 13,082 11,100  
Gross balance at September 30 540,827 540,779    
Estimate of net losses, change 1,558 (1,255)    
Health        
Liability for Claims and Claims Adjustment Expense        
Total 5,860 12,728 9,938 17,485
Liability for Unpaid Claims and Claims Adjustment Expense        
Gross balance at January 1 9,938 17,485    
Less: Losses recoverable     $ 0 $ 0
Net balance at January 1 9,938 17,485    
Incurred losses related to:        
Current year 6,567 31,189    
Prior years 3,552 (1,898)    
Total incurred 10,119 29,291    
Paid losses related to:        
Current year (3,051) (20,224)    
Prior years (11,146) (13,824)    
Total paid (14,197) (34,048)    
Foreign currency revaluation 0 0    
Net balance at September 30 5,860 12,728    
Add: Losses recoverable 0 0    
Gross balance at September 30 5,860 12,728    
Estimate of net losses, change 3,552 $ (1,898)    
Russian-Ukrainian Conflict        
Liability for Claims and Claims Adjustment Expense        
Loss adjustment expense reserves 13,600      
Hurricane Ian        
Liability for Claims and Claims Adjustment Expense        
Loss adjustment expense reserves $ 19,500      
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
RETROCESSION (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Ceded Credit Risk            
Ceded premiums earned $ 4,400,000   $ 8,400,000      
Loss and loss expenses recovered and recoverable 2,500,000 $ 0 2,500,000 $ (100,000)    
Loss and loss adjustment expenses recoverable         $ 11,100,000 $ 16,851,000
Loss and loss adjustment expenses recoverable, allowance 47,000   47,000   47,000  
AM Best, A- Rating            
Ceded Credit Risk            
Loss and loss adjustment expenses recoverable 2,700,000   2,700,000   2,800,000  
Unsecured | Unrated            
Ceded Credit Risk            
Loss and loss adjustment expenses recoverable 7,900,000   7,900,000   8,400,000  
Secured | Unrated            
Ceded Credit Risk            
Loss and loss adjustment expenses recoverable $ 6,900,000   $ 6,900,000   $ 8,200,000  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
SENIOR CONVERTIBLE NOTES (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Nov. 02, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Aug. 07, 2018
Debt Instrument [Line Items]              
Repurchased and cancelled shares amount   $ 6,600   $ 6,600      
Convertible senior notes payable   $ 93,446   $ 93,446   $ 98,057  
Subsequent Event              
Debt Instrument [Line Items]              
Repurchased of ordinary shares (in shares) 13.8            
Senior Notes | Senior Unsecured Convertible Notes              
Debt Instrument [Line Items]              
Convertible debt, amount             $ 100,000
Debt interest rate (in percent)             4.00%
Debt conversion price (in dollars per share)   $ 17.19   $ 17.19      
Effective interest rate (in percent)             6.00%
Unamortized debt issuance expense   $ 600   $ 600   1,000  
Accrued interest   600   600      
Convertible senior notes payable   93,400   93,400   98,100  
Fair value of debt   90,200   90,200   $ 97,500  
Recognized interest expense   1,100 $ 1,600 3,400 $ 4,700    
Convertible Debt              
Debt Instrument [Line Items]              
Long-term debt, maturity, remainder of fiscal year   0   0      
Long-term debt, maturity, year one   $ 97,200   $ 97,200      
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE CAPITAL - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Oct. 29, 2020
Oct. 28, 2020
Class of Stock          
Stock repurchase program, authorized amount       $ 25.0  
Class A          
Class of Stock          
Common stock, par value (in dollars per share) $ 0.10   $ 0.10    
Shares authorized for issuance in relation to share purchase options granted to service provider (in shares)       3,000,000  
Shares authorized for the company's stock incentive plan (in shares)       8,000,000 5,000,000
Shares available for future issuance (in shares) 2,011,426   3,128,276    
Repurchase of ordinary shares (in shares) 4,933 1,079,544      
Class B          
Class of Stock          
Common stock, par value (in dollars per share) $ 0.10   $ 0.10    
Repurchase of ordinary shares (in shares) 0 0      
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE CAPITAL - Stock by Class (Details) - shares
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Class A    
Increase (Decrease) in Stockholders' Equity    
Balance – beginning of period (in shares) 27,589,731 28,260,075
Issue of ordinary shares, net of forfeitures (in shares) 984,548 409,200
Repurchase of ordinary shares (in shares) (4,933) (1,079,544)
Balance – end of period (in shares) 28,569,346 27,589,731
Class B    
Increase (Decrease) in Stockholders' Equity    
Balance – beginning of period (in shares) 6,254,715 6,254,715
Issue of ordinary shares, net of forfeitures (in shares) 0 0
Repurchase of ordinary shares (in shares) 0 0
Balance – end of period (in shares) 6,254,715 6,254,715
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 0    
Exercised (in shares) 0    
Expired (in shares) 45,290    
General and Administrative Expense      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock based compensation expense, net of forfeiture reversals $ 3,300 $ 2,400  
Chief Executive Officer      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted shares $ 0 $ 0  
Employee and Director Restricted Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting period after date of issuance 3 years    
Cliff vesting percentage after date of issuance (in percent) 50.00%    
Forfeited (in shares) 8,476 20,592  
Stock-based compensation expense $ 26 $ 100  
Stock based compensation expense, net of forfeiture reversals 2,600 1,800  
Unrecognized compensation costs related to non-vested restricted shares $ 4,400   $ 2,700
Weighted average period for recognition 1 year 7 months 6 days   1 year 9 months 18 days
Total fair value of restricted shares vested $ 2,000 $ 1,600  
Employee and Director Restricted Shares | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting percentage after date of issuance (in percent) 25.00%    
Employee and Director Restricted Shares | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting percentage after date of issuance (in percent) 100.00%    
Employee and Director Restricted Shares | Chief Executive Officer      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting period after date of issuance 5 years    
Employee and Director Restricted Shares | Class A      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted shares issued pursuant to stock incentive plan (in shares) 849,872 334,312  
Employee and Director Restricted Shares | Class A | Non Employee Director      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted shares issued pursuant to stock incentive plan (in shares) 107,763 74,769  
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting period after date of issuance 3 years    
Forfeited (in shares) 0    
Stock based compensation expense, net of forfeiture reversals $ 500 $ 300  
Weighted average period for recognition 1 year 7 months 6 days   1 year 9 months 18 days
Number of shares issued to employees RSUs (in shares) 159,215 58,123  
Total compensation cost related to non-vested options not yet recognized $ 700   $ 500
RSUs | Class A      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Conversion ratio (in shares) 1    
Employee and Director Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock based compensation expense, net of forfeiture reversals $ 200 $ 300  
Weighted average period for recognition 9 months 18 days   1 year 2 months 12 days
Total compensation cost related to non-vested options not yet recognized $ 100   $ 300
Employee and Director Stock Options | Class A | Chief Executive Officer      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted (in shares) 0 0  
Exercised (in shares) 0 0  
Expired (in shares) 45,290 45,290  
Performance RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting period after date of issuance 3 years    
Cliff vesting percentage after date of issuance (in percent) 50.00%    
Unvested performance restricted shares outstanding (in shares) 105,008   0
Unvested weighted average grant date fair value (in dollars per share) $ 6.82   $ 0
Number of shares issued to employees RSUs (in shares) 105,008    
Performance RSUs | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting percentage after date of issuance (in percent) 25.00%    
Performance RSUs | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cliff vesting percentage after date of issuance (in percent) 100.00%    
Performance Restricted Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested performance restricted shares outstanding (in shares) 794,362   193,149
Unvested weighted average grant date fair value (in dollars per share) $ 7.62   $ 10.10
Forfeited (in shares) 0    
Number of shares issued to employees RSUs (in shares) 601,213    
Performance Restricted Shares | Chief Executive Officer      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested performance restricted shares outstanding (in shares) 193,149    
Unvested weighted average grant date fair value (in dollars per share) $ 10.10    
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION - Restricted Stock (Details)
 9 Months Ended
Sep. 30, 2022
$ / shares
shares
Performance Restricted Shares  
Number of non-vested RSUs  
Beginning balance (in shares) | shares 193,149
Granted (in shares) | shares 601,213
Vested (in shares) | shares 0
Forfeited (in shares) | shares 0
Ending balance (in shares) | shares 794,362
Weighted  average grant date fair value  
Beginning balance (in dollars per share) | $ / shares $ 10.10
Granted (in dollars per share) | $ / shares 6.82
Vested (in dollars per share) | $ / shares 0
Forfeited (in dollars per share) | $ / shares 0
Ending balance (in dollars per share) | $ / shares $ 7.62
Service Restricted Shares  
Number of non-vested RSUs  
Beginning balance (in shares) | shares 753,407
Granted (in shares) | shares 356,422
Vested (in shares) | shares (197,002)
Forfeited (in shares) | shares (8,476)
Ending balance (in shares) | shares 904,351
Weighted  average grant date fair value  
Beginning balance (in dollars per share) | $ / shares $ 8.68
Granted (in dollars per share) | $ / shares 7.02
Vested (in dollars per share) | $ / shares 10.06
Forfeited (in dollars per share) | $ / shares 7.67
Ending balance (in dollars per share) | $ / shares $ 7.73
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION - Restricted Stock Units (Details)
 9 Months Ended
Sep. 30, 2022
$ / shares
shares
Performance Restricted Stock Units  
Number of non-vested RSUs  
Beginning balance (in shares) | shares 0
Granted (in shares) | shares 105,008
Vested (in shares) | shares 0
Ending balance (in shares) | shares 105,008
Weighted  average grant date fair value  
Beginning balance (in dollars per share) | $ / shares $ 0
Granted (in dollars per share) | $ / shares 6.82
Vested (in dollars per share) | $ / shares 0
Ending balance (in dollars per share) | $ / shares $ 6.82
Service Restricted Stock Units  
Number of non-vested RSUs  
Beginning balance (in shares) | shares 154,134
Granted (in shares) | shares 54,207
Vested (in shares) | shares (35,389)
Ending balance (in shares) | shares 172,952
Weighted  average grant date fair value  
Beginning balance (in dollars per share) | $ / shares $ 8.59
Granted (in dollars per share) | $ / shares 6.82
Vested (in dollars per share) | $ / shares 10.84
Ending balance (in dollars per share) | $ / shares $ 7.58
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION - Employee and Director Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Number of  options outstanding    
Granted (in shares) 0  
Exercised (in shares) 0  
Forfeitures (in shares) 0  
Expired (in shares) (45,290)  
Weighted  average  exercise  price    
Grants (in dollars per share) $ 0  
Exercises (in dollars per share) 0  
Forfeitures (in dollars per share) 0  
Expirations (in dollars per share) 23.80  
Weighted  average  grant date  fair value    
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Forfeited (in dollars per share) 0  
Expired (in dollars per share) $ 11.04  
Intrinsic value $ 0.0 $ 0.0
Anti-dilutive stock options outstanding    
Number of  options outstanding    
Options outstanding (in shares) 690,337 735,627
Weighted  average  exercise  price    
Balance at beginning of period (in dollars per share) $ 22.35  
Balance at end of period (in dollars per share) 22.25 $ 22.35
Weighted  average  grant date  fair value    
Balance at beginning of period (in dollars per share) 10.23  
Balance at end of period (in dollars per share) $ 10.18 $ 10.23
Weighted average remaining contractual term 4 years 2 months 12 days 4 years 8 months 12 days
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
TAXATION - Narrative (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Income Tax Examination    
Deferred tax asset valuation allowance $ 3.2 $ 2.7
Other Assets    
Income Tax Examination    
Gross deferred tax asset $ 3.7 $ 3.2
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
TAXATION - Components of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Tax Disclosure [Abstract]        
Current tax (expense) benefit $ (234) $ 323 $ (655) $ (3,240)
Tax recovered 1,050 0 1,478 0
Deferred tax (expense) benefit 170 0 428 0
Decrease (increase) in deferred tax valuation allowance (170) (323) (428) (493)
Income tax (expense) benefit  $ 816 $ 0 $ 823 $ (3,733)
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS (Details) - USD ($)
shares in Millions
 9 Months Ended
Jan. 01, 2019
Sep. 01, 2018
Sep. 30, 2022
Affiliated Entity | Green Bricks Partners Inc (GRBK) | Solasglas Investments, LP (SILP)      
Related Party Transaction      
Common stock held (in shares)     2.7
Affiliated Entity | Green Bricks Partners Inc (GRBK)      
Related Party Transaction      
Ownership percentage (in percent)     38.00%
Board of Directors Chairman | Limited Partnership Agreement      
Related Party Transaction      
Performance compensation reduced rate (in percent)   10.00%  
Performance compensation full rate (in percent)   20.00%  
Performance compensation reduced rate (in percent)     10.00%
Loss carry forward recoupment required (in percent)     150.00%
Board of Directors Chairman | Investment Advisory Agreement      
Related Party Transaction      
Investment management fee rate - monthly (in percent)   0.125%  
Investment management fee rate - annual (in percent)   1.50%  
Automatic agreement extension, term (in years)   3 years  
Board of Directors Chairman | Service Agreement      
Related Party Transaction      
Investor relations monthly fee     $ 5,000
Contract termination prior notice period (in days)     30 days
Board of Directors Chairman | Collateral Assets Investment Management Agreement      
Related Party Transaction      
Contract termination prior notice period (in days) 30 days    
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
facility
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
facility
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Line of Credit Facility          
Number of credit facilities | facility 1   1    
Aggregate amount of letters of credit issued $ 180,200   $ 180,200   $ 136,800
Collateral held in trust $ 468,000   $ 468,000   497,100
Weighted-average remaining lease term on operating leases 4 years   4 years    
Weighted-average discount rate on operating leases (as a percent) 6.00%   6.00%    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other Assets   Other Assets    
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities   Other Liabilities    
Operating lease right of use asset $ 2,000   $ 2,000    
Present value of lease liabilities 2,096   2,096    
Operating lease expense 200 $ 100 500 $ 200  
Letter of Credit          
Line of Credit Facility          
Cash and cash equivalents $ 180,900   $ 180,900   $ 137,600
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) - Citibank Europe plc - Facility
 9 Months Ended
Sep. 30, 2022
USD ($)
Line of Credit Facility  
Maximum Facility Limit $ 275,000,000
Notice period required for termination 120 days
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details)
$ in Thousands
Sep. 30, 2022
USD ($)
Year ending December 31,  
2022 $ 149
2023 611
2024 627
2025 644
2026 345
Thereafter 0
Total lease payments 2,376
Less Imputed Interest (280)
Present value of lease liabilities $ 2,096
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2021
USD ($)
Segment Reporting Information        
Number of operating segments | segment     1  
Gross premiums written $ 155,146 $ 128,735 $ 435,812 $ 440,249
Gross premiums written (in percent) 100.00% 100.00% 100.00% 100.00%
Total Property        
Segment Reporting Information        
Gross premiums written $ 20,021 $ 13,132 $ 58,841 $ 44,555
Gross premiums written (in percent) 12.90% 10.20% 13.50% 10.10%
Commercial        
Segment Reporting Information        
Gross premiums written $ 2,146 $ 3,398 $ 8,648 $ 9,700
Gross premiums written (in percent) 1.40% 2.60% 2.00% 2.20%
Motor        
Segment Reporting Information        
Gross premiums written $ 206 $ 6,103 $ 768 $ 24,537
Gross premiums written (in percent) 0.10% 4.80% 0.20% 5.60%
Personal        
Segment Reporting Information        
Gross premiums written $ 17,669 $ 3,631 $ 49,425 $ 10,318
Gross premiums written (in percent) 11.40% 2.80% 11.30% 2.30%
Total Casualty        
Segment Reporting Information        
Gross premiums written $ 91,240 $ 84,632 $ 248,231 $ 300,940
Gross premiums written (in percent) 58.80% 65.70% 57.00% 68.40%
General Liability        
Segment Reporting Information        
Gross premiums written $ 13,798 $ 7,376 $ 40,523 $ 10,749
Gross premiums written (in percent) 8.90% 5.70% 9.30% 2.40%
Motor Liability        
Segment Reporting Information        
Gross premiums written $ 565 $ 19,823 $ 4,061 $ 96,795
Gross premiums written (in percent) 0.40% 15.40% 0.90% 22.00%
Professional Liability        
Segment Reporting Information        
Gross premiums written $ 242 $ 154 $ 496 $ 302
Gross premiums written (in percent) 0.20% 0.10% 0.10% 0.10%
Workers' Compensation        
Segment Reporting Information        
Gross premiums written $ 7,216 $ 17,117 $ 25,504 $ 55,237
Gross premiums written (in percent) 4.60% 13.30% 5.90% 12.50%
Multi-line        
Segment Reporting Information        
Gross premiums written $ 69,419 $ 40,162 $ 177,647 $ 137,857
Gross premiums written (in percent) 44.70% 31.20% 40.80% 31.30%
Total Other        
Segment Reporting Information        
Gross premiums written $ 43,885 $ 30,971 $ 128,740 $ 94,754
Gross premiums written (in percent) 28.30% 24.10% 29.50% 21.50%
Accident & Health        
Segment Reporting Information        
Gross premiums written $ 5,879 $ 4,175 $ 10,377 $ 26,427
Gross premiums written (in percent) 3.80% 3.30% 2.40% 6.00%
Financial        
Segment Reporting Information        
Gross premiums written $ 20,065 $ 17,920 $ 56,481 $ 40,134
Gross premiums written (in percent) 12.90% 13.90% 12.90% 9.10%
Marine        
Segment Reporting Information        
Gross premiums written $ 4,675 $ 2,462 $ 18,425 $ 8,412
Gross premiums written (in percent) 3.00% 1.90% 4.20% 1.90%
Other Specialty        
Segment Reporting Information        
Gross premiums written $ 13,266 $ 6,414 $ 43,457 $ 19,781
Gross premiums written (in percent) 8.60% 5.00% 10.00% 4.50%
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue from External Customer        
Gross premiums written $ 155,146 $ 128,735 $ 435,812 $ 440,249
Gross premiums written (in percent) 100.00% 100.00% 100.00% 100.00%
U.S. and Caribbean        
Revenue from External Customer        
Gross premiums written $ 72,105 $ 67,087 $ 224,324 $ 258,849
Gross premiums written (in percent) 46.50% 52.10% 51.50% 58.80%
Worldwide        
Revenue from External Customer        
Gross premiums written $ 79,512 $ 59,616 $ 196,197 $ 174,470
Gross premiums written (in percent) 51.30% 46.30% 45.00% 39.60%
Europe (2)        
Revenue from External Customer        
Gross premiums written $ (1,797) $ 1,483 $ 2,962 $ 2,787
Gross premiums written (in percent) (1.20%) 1.20% 0.70% 0.60%
Asia        
Revenue from External Customer        
Gross premiums written $ 5,326 $ 549 $ 12,329 $ 4,143
Gross premiums written (in percent) 3.40% 0.40% 2.80% 1.00%
XML 68 glre-20220930_htm.xml IDEA: XBRL DOCUMENT 0001385613 2022-01-01 2022-09-30 0001385613 us-gaap:CommonClassAMember 2022-10-28 0001385613 us-gaap:CommonClassBMember 2022-10-28 0001385613 2022-09-30 0001385613 2021-12-31 0001385613 us-gaap:CommonClassAMember 2022-09-30 0001385613 us-gaap:CommonClassAMember 2021-12-31 0001385613 us-gaap:CommonClassBMember 2021-12-31 0001385613 us-gaap:CommonClassBMember 2022-09-30 0001385613 2022-07-01 2022-09-30 0001385613 2021-07-01 2021-09-30 0001385613 2021-01-01 2021-09-30 0001385613 us-gaap:CommonStockMember 2022-06-30 0001385613 us-gaap:CommonStockMember 2021-06-30 0001385613 us-gaap:CommonStockMember 2021-12-31 0001385613 us-gaap:CommonStockMember 2020-12-31 0001385613 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001385613 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001385613 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001385613 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001385613 us-gaap:CommonStockMember 2022-09-30 0001385613 us-gaap:CommonStockMember 2021-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001385613 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001385613 us-gaap:AccountingStandardsUpdate202006Member 2021-01-01 2021-12-31 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001385613 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001385613 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001385613 us-gaap:RetainedEarningsMember 2022-06-30 0001385613 us-gaap:RetainedEarningsMember 2021-06-30 0001385613 us-gaap:RetainedEarningsMember 2021-12-31 0001385613 us-gaap:RetainedEarningsMember 2020-12-31 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:RetainedEarningsMember 2022-06-30 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:RetainedEarningsMember 2021-12-31 0001385613 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001385613 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001385613 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001385613 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001385613 us-gaap:RetainedEarningsMember 2022-09-30 0001385613 us-gaap:RetainedEarningsMember 2021-09-30 0001385613 2021-09-30 0001385613 2020-12-31 0001385613 glre:CedentsMember 2022-09-30 0001385613 glre:CedentsMember 2021-12-31 0001385613 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2022-07-01 2022-09-30 0001385613 us-gaap:RestrictedStockMember 2021-07-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001385613 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001385613 us-gaap:ConvertibleDebtSecuritiesMember 2022-07-01 2022-09-30 0001385613 us-gaap:ConvertibleDebtSecuritiesMember 2021-07-01 2021-09-30 0001385613 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001385613 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-09-30 0001385613 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member 2021-12-31 0001385613 glre:GreenlightCapitalReLimitedPartnersMember glre:SolasglasInvestmentsLPSILPMember 2022-09-30 0001385613 glre:GreenlightCapitalReLimitedPartnersMember glre:SolasglasInvestmentsLPSILPMember 2021-12-31 0001385613 glre:SILPGeneralPartnerMember 2022-09-30 0001385613 glre:SILPGeneralPartnerMember 2021-12-31 0001385613 glre:LimitedPartnershipAgreementMember 2022-01-01 2022-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentsLPSILPMember 2022-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentsLPSILPMember 2021-12-31 0001385613 glre:SolasglasInvestmentsLPSILPMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-09-30 0001385613 glre:SolasglasInvestmentsLPSILPMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-12-31 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentsLPSILPMember 2022-07-01 2022-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentsLPSILPMember 2021-07-01 2021-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentsLPSILPMember 2022-01-01 2022-09-30 0001385613 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember glre:SolasglasInvestmentsLPSILPMember 2021-01-01 2021-09-30 0001385613 glre:SolasglasInvestmentsLPSILPMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-07-01 2022-09-30 0001385613 glre:SolasglasInvestmentsLPSILPMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-07-01 2021-09-30 0001385613 glre:SolasglasInvestmentsLPSILPMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2022-01-01 2022-09-30 0001385613 glre:SolasglasInvestmentsLPSILPMember us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2021-01-01 2021-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2022-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2022-01-01 2022-09-30 0001385613 us-gaap:ConvertibleDebtSecuritiesMember 2022-09-30 0001385613 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-09-30 0001385613 us-gaap:CertificatesOfDepositMember 2022-09-30 0001385613 us-gaap:CertificatesOfDepositMember 2022-01-01 2022-09-30 0001385613 us-gaap:OtherInvestmentsMember 2022-09-30 0001385613 us-gaap:OtherInvestmentsMember 2022-01-01 2022-09-30 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2021-12-31 0001385613 glre:PrivateAndUnlistedEquitySecuritiesMember 2021-01-01 2021-12-31 0001385613 glre:DerivativeFinancialInstrumentsMember 2021-12-31 0001385613 glre:DerivativeFinancialInstrumentsMember 2021-01-01 2021-12-31 0001385613 us-gaap:OtherInvestmentsMember 2021-12-31 0001385613 us-gaap:OtherInvestmentsMember 2021-01-01 2021-12-31 0001385613 us-gaap:FairValueMeasurementsNonrecurringMember 2022-09-30 0001385613 us-gaap:FairValueMeasurementsNonrecurringMember 2021-09-30 0001385613 us-gaap:FairValueMeasurementsNonrecurringMember glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember 2022-09-30 0001385613 us-gaap:FairValueMeasurementsNonrecurringMember glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember 2021-12-31 0001385613 glre:MeasurementPeriodOneMember 2022-09-30 0001385613 glre:MeasurementPeriodTwoMember 2022-09-30 0001385613 glre:MeasurementPeriodThreeMember 2022-09-30 0001385613 glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember 2022-09-30 0001385613 glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember 2021-12-31 0001385613 glre:RussianUkrainianConflictMember 2022-09-30 0001385613 glre:HurricaneIanMember 2022-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-12-31 0001385613 us-gaap:HealthInsuranceProductLineMember 2020-12-31 0001385613 us-gaap:HealthInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2022-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskUnsecuredMember 2022-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskUnsecuredMember 2021-12-31 0001385613 glre:UnratedMember us-gaap:CededCreditRiskSecuredMember 2022-09-30 0001385613 glre:UnratedMember us-gaap:CededCreditRiskSecuredMember 2021-12-31 0001385613 srt:AMBestAMinusRatingMember 2022-09-30 0001385613 srt:AMBestAMinusRatingMember 2021-12-31 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2018-08-07 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2022-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-12-31 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2022-07-01 2022-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2022-01-01 2022-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-07-01 2021-09-30 0001385613 glre:SeniorUnsecuredConvertibleNotesMember us-gaap:SeniorNotesMember 2021-01-01 2021-09-30 0001385613 us-gaap:ConvertibleDebtMember 2022-09-30 0001385613 us-gaap:SubsequentEventMember 2022-10-01 2022-11-02 0001385613 us-gaap:CommonClassAMember 2020-10-29 0001385613 us-gaap:CommonClassAMember 2020-10-28 0001385613 2020-10-29 0001385613 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001385613 us-gaap:CommonClassAMember 2020-12-31 0001385613 us-gaap:CommonClassBMember 2020-12-31 0001385613 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001385613 us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:CommonClassBMember 2021-01-01 2021-09-30 0001385613 us-gaap:CommonClassAMember 2021-09-30 0001385613 us-gaap:CommonClassBMember 2021-09-30 0001385613 glre:NonEmployeeDirectorMember us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001385613 glre:NonEmployeeDirectorMember us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001385613 us-gaap:RestrictedStockMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001385613 srt:MinimumMember us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001385613 srt:MaximumMember us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001385613 srt:ChiefExecutiveOfficerMember glre:PerformanceRestrictedStockMember 2022-09-30 0001385613 srt:ChiefExecutiveOfficerMember 2022-09-30 0001385613 srt:ChiefExecutiveOfficerMember 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockMember 2022-09-30 0001385613 us-gaap:RestrictedStockMember 2021-12-31 0001385613 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001385613 glre:PerformanceRestrictedStockMember 2021-12-31 0001385613 glre:ServiceRestrictedStockMember 2021-12-31 0001385613 glre:PerformanceRestrictedStockMember 2022-01-01 2022-09-30 0001385613 glre:ServiceRestrictedStockMember 2022-01-01 2022-09-30 0001385613 glre:PerformanceRestrictedStockMember 2022-09-30 0001385613 glre:ServiceRestrictedStockMember 2022-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001385613 glre:PerformanceRestrictedStockUnitsMember 2022-01-01 2022-09-30 0001385613 srt:MinimumMember glre:PerformanceRestrictedStockUnitsMember 2022-01-01 2022-09-30 0001385613 srt:MaximumMember glre:PerformanceRestrictedStockUnitsMember 2022-01-01 2022-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2022-09-30 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001385613 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001385613 glre:PerformanceRestrictedStockUnitsMember 2021-12-31 0001385613 glre:ServiceRestrictedStockUnitsMember 2021-12-31 0001385613 glre:ServiceRestrictedStockUnitsMember 2022-01-01 2022-09-30 0001385613 glre:PerformanceRestrictedStockUnitsMember 2022-09-30 0001385613 glre:ServiceRestrictedStockUnitsMember 2022-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2021-01-01 2021-09-30 0001385613 srt:ChiefExecutiveOfficerMember us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2022-09-30 0001385613 us-gaap:EmployeeStockOptionMember 2021-12-31 0001385613 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001385613 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001385613 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001385613 us-gaap:OtherAssetsMember 2022-09-30 0001385613 us-gaap:OtherAssetsMember 2021-12-31 0001385613 glre:LimitedPartnershipAgreementMember srt:BoardOfDirectorsChairmanMember 2018-09-01 2018-09-01 0001385613 glre:LimitedPartnershipAgreementMember srt:BoardOfDirectorsChairmanMember 2022-01-01 2022-09-30 0001385613 glre:InvestmentAdvisoryAgreementMember srt:BoardOfDirectorsChairmanMember 2018-09-01 2018-09-01 0001385613 glre:GreenBricksPartnersIncGRBKMember srt:AffiliatedEntityMember 2022-09-30 0001385613 glre:GreenBricksPartnersIncGRBKMember srt:AffiliatedEntityMember glre:SolasglasInvestmentsLPSILPMember 2022-09-30 0001385613 glre:ServiceAgreementMember srt:BoardOfDirectorsChairmanMember 2022-01-01 2022-09-30 0001385613 glre:CollateralAssetsInvestementManagementAgreementMember srt:BoardOfDirectorsChairmanMember 2019-01-01 2019-01-01 0001385613 us-gaap:FinancialStandbyLetterOfCreditMember glre:CitibankEuropePlcMember 2022-09-30 0001385613 us-gaap:FinancialStandbyLetterOfCreditMember glre:CitibankEuropePlcMember 2022-01-01 2022-09-30 0001385613 us-gaap:LetterOfCreditMember 2022-09-30 0001385613 us-gaap:LetterOfCreditMember 2021-12-31 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2022-07-01 2022-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2021-07-01 2021-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2022-01-01 2022-09-30 0001385613 glre:MotorVehiclePhysicalDamageProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 us-gaap:PropertyInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:GeneralLiabilityMember 2022-07-01 2022-09-30 0001385613 us-gaap:GeneralLiabilityMember 2021-07-01 2021-09-30 0001385613 us-gaap:GeneralLiabilityMember 2022-01-01 2022-09-30 0001385613 us-gaap:GeneralLiabilityMember 2021-01-01 2021-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2022-07-01 2022-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2021-07-01 2021-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2022-01-01 2022-09-30 0001385613 glre:MotorVehicleLiabilityCasualtyProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2022-07-01 2022-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2021-07-01 2021-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2022-01-01 2022-09-30 0001385613 us-gaap:ProfessionalMalpracticeLiabilityMember 2021-01-01 2021-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 glre:WorkersCompensationInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 glre:MultilineMember 2022-07-01 2022-09-30 0001385613 glre:MultilineMember 2021-07-01 2021-09-30 0001385613 glre:MultilineMember 2022-01-01 2022-09-30 0001385613 glre:MultilineMember 2021-01-01 2021-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 glre:LiabilityandCasualtyInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 us-gaap:HealthInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2022-07-01 2022-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2021-07-01 2021-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2022-01-01 2022-09-30 0001385613 glre:FinancialGuaranteeInsuranceandSuretyProductLineMember 2021-01-01 2021-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2022-07-01 2022-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2021-07-01 2021-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2022-01-01 2022-09-30 0001385613 glre:MarineCasualtyInsuranceMember 2021-01-01 2021-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2022-07-01 2022-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2021-07-01 2021-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2022-01-01 2022-09-30 0001385613 us-gaap:OtherInsuranceProductLineMember 2021-01-01 2021-09-30 0001385613 glre:TotalSpecialtyDomain 2022-07-01 2022-09-30 0001385613 glre:TotalSpecialtyDomain 2021-07-01 2021-09-30 0001385613 glre:TotalSpecialtyDomain 2022-01-01 2022-09-30 0001385613 glre:TotalSpecialtyDomain 2021-01-01 2021-09-30 0001385613 srt:NorthAmericaMember 2022-07-01 2022-09-30 0001385613 srt:NorthAmericaMember 2021-07-01 2021-09-30 0001385613 srt:NorthAmericaMember 2022-01-01 2022-09-30 0001385613 srt:NorthAmericaMember 2021-01-01 2021-09-30 0001385613 glre:WorldwideMember 2022-07-01 2022-09-30 0001385613 glre:WorldwideMember 2021-07-01 2021-09-30 0001385613 glre:WorldwideMember 2022-01-01 2022-09-30 0001385613 glre:WorldwideMember 2021-01-01 2021-09-30 0001385613 srt:EuropeMember 2022-07-01 2022-09-30 0001385613 srt:EuropeMember 2021-07-01 2021-09-30 0001385613 srt:EuropeMember 2022-01-01 2022-09-30 0001385613 srt:EuropeMember 2021-01-01 2021-09-30 0001385613 srt:AsiaMember 2022-07-01 2022-09-30 0001385613 srt:AsiaMember 2021-07-01 2021-09-30 0001385613 srt:AsiaMember 2022-01-01 2022-09-30 0001385613 srt:AsiaMember 2021-01-01 2021-09-30 shares iso4217:USD iso4217:USD shares pure glre:facility glre:segment 0001385613 --12-31 2022 Q3 false http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member P3D http://fasb.org/us-gaap/2022#OtherAssets http://fasb.org/us-gaap/2022#OtherLiabilities 10-Q true 2022-09-30 false 001-33493 GREENLIGHT CAPITAL RE, LTD. E9 65 Market Street Suite 1207, Jasmine Court Camana Bay KY KY1-1205 345 943-4573 Class A Ordinary Shares GLRE NASDAQ Yes Yes Accelerated Filer false false false 28569346 6254715 195199000 183591000 65081000 47384000 260280000 230975000 32278000 76307000 648897000 634794000 89000 89000 473564000 405365000 47000 47000 10604000 11100000 78836000 63026000 13659000 42000 6425000 5885000 1524543000 1427494000 540827000 524010000 298173000 227584000 108772000 91224000 11446000 3792000 4927000 7164000 93446000 98057000 1057591000 951831000 0.10 0.10 50000000 50000000 0 0 0 0 0.10 0.10 100000000 100000000 28569346 28569346 27589731 27589731 0.10 0.10 25000000 25000000 6254715 6254715 6254715 6254715 3482000 3384000 477021000 481784000 -13551000 -9505000 466952000 475663000 1524543000 1427494000 155146000 128735000 435812000 440249000 8801000 60000 21973000 6000 146345000 128675000 413839000 440243000 -24397000 6849000 -55747000 -36844000 121948000 135524000 358092000 403399000 8521000 -6214000 24474000 -4196000 3038000 10303000 11978000 28999000 -6784000 -342000 -13374000 -1076000 126723000 139271000 381170000 427126000 94559000 110400000 252789000 295078000 36821000 35048000 106101000 106060000 7389000 6060000 22727000 21340000 6148000 38000 6373000 2957000 1091000 1578000 3411000 4684000 146008000 153124000 391401000 430119000 -19285000 -13853000 -10231000 -2993000 -816000 0 -823000 3733000 -18469000 -13853000 -9408000 -6726000 -0.56 -0.56 -0.42 -0.42 -0.28 -0.28 -0.20 -0.20 -0.56 -0.56 -0.42 -0.42 -0.28 -0.28 -0.20 -0.20 33127384 32929097 33119814 33507060 33127384 32929097 33119814 33507060 3472000 3417000 3384000 3452000 11000 3000 99000 41000 1000 36000 1000 109000 3482000 3384000 3482000 3384000 475903000 483365000 481784000 488488000 0 -7896000 34000 3216000 34000 9891000 1152000 790000 3167000 2342000 477021000 480939000 477021000 480939000 4918000 -19956000 -9505000 -27083000 0 5362000 -18469000 -13853000 -9408000 -6726000 -13551000 -33809000 -13551000 -33809000 466952000 450514000 466952000 450514000 -9408000 -6726000 24474000 -4196000 149000 0 9237000 14860000 0 14210000 -10364000 -14000 3266000 2383000 612000 -684000 0 16000 97651000 50185000 -496000 -3769000 15810000 9620000 13617000 26000 540000 3760000 36394000 46600000 70589000 36837000 17548000 -14722000 -7654000 -612000 -2237000 219000 -27424000 -18779000 77993000 51904000 65127000 69604000 8627000 4761000 0 20755000 0 -6101000 4239000 4395000 6384000 0 35000 10000000 -6419000 -10000000 -322000 0 -29926000 -24384000 711101000 754306000 681175000 729922000 4023000 4000000 0 3700000 ORGANIZATION AND BASIS OF PRESENTATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greenlight Capital Re, Ltd. (“GLRE”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. GLRE’s wholly-owned subsidiary, Greenlight Reinsurance, Ltd. (“Greenlight Re”), provides global specialty property and casualty reinsurance. Greenlight Re has a Class D insurer license issued in accordance with the terms of The Insurance Act, 2010 (as amended) and underlying regulations thereto (the “Act”) and is subject to regulation by the Cayman Islands Monetary Authority. Greenlight Re commenced underwriting in April 2006. Verdant Holding Company, Ltd. (“Verdant”), a wholly-owned subsidiary of GLRE, was incorporated in 2008 in the state of Delaware. During 2010, GLRE established Greenlight Reinsurance Ireland, Designated Activity Company (“GRIL”), a wholly-owned reinsurance subsidiary based in Dublin, Ireland. GRIL is authorized as a non-life reinsurance undertaking in accordance with the provisions of the European Union (Insurance and Reinsurance) Regulations 2015. GRIL provides multi-line property and casualty reinsurance capacity to the European broker market and provides GLRE with an additional platform to serve clients located in Europe and North America.  In 2020, GLRE established Greenlight Re Marketing (UK) Limited (“Greenlight Re UK”) as a wholly-owned subsidiary to increase the Company’s presence in the London market. In 2022, Greenlight Innovation Syndicate 3456 (“Syndicate 3456”) commenced underwriting under the Lloyd’s syndicate-in-a-box model, with Greenlight Re as the sole capital provider. As used herein, the “Company” refers collectively to GLRE and its consolidated subsidiaries.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In addition, the year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the U.S. Securities and Exchange Commission on March 8, 2022. The condensed consolidated financial statements include the accounts of GLRE and its wholly-owned subsidiaries, Greenlight Re, GRIL, Verdant, and Greenlight Re UK. The condensed consolidated financial statements also include the accounts of Syndicate 3456. All significant intercompany transactions and balances have been eliminated on consolidation. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain amounts in the prior periods presented have been reclassified to conform to the current period financial statements presentation. These reclassifications do not affect previously reported net income or retained earnings.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates used to prepare the Company’s condensed consolidated financial statements, including those associated with premiums and the estimations of loss and loss adjustment expense reserves, may be subject to significant adjustments in future periods.</span></div> SIGNIFICANT ACCOUNTING POLICIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company’s significant accounting policies as described in its Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, premiums written, earned, and receivable, variability underlying risk transfer assessments, allowances for credit losses, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and short-term, highly liquid investments and certificates of deposit with original maturity dates of three months or less. Certificates of deposit with original maturities greater than three months are included under the caption "Other investments" on the condensed consolidated balance sheets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681,175 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,101 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Funds Held by Cedents</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes financial assets held by cedents. At September 30, 2022, funds held by cedents were $303.1 million (December 31, 2021: $246.9 million). Such amounts include premiums withheld by Lloyd’s syndicates and funds contributed by the Company to Lloyd's as security for members’ underwriting activities. The syndicates invest a portion of the premiums withheld in fixed maturity securities and investment funds. The Company records its share of income (or expense) from these assets in its condensed consolidated statements of operations under the caption “Other income (expense).” </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit ratings of the counterparties are forward-looking and consider various economic scenarios. The Company's evaluation of the required allowance for reinsurance balances receivable and loss and loss adjustment expenses recoverable considers the current economic environment as well as potential macroeconomic developments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the Company has recorded an allowance for expected credit loss on its Reinsurance Assets of $0.1 million (December 31, 2021: $0.1 million). </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Assets and Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the captions “Other income (expense)” and “Deposit interest expense,” respectively. The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. At September 30, 2022, deposit assets and deposit liabilities were $3.2 million and $13.7 million, respectively (December 31, 2021: $3.5 million and $18.6 million, respectively). For the three and nine months ended September 30, 2022, and 2021, the interest income and expense on deposit accounted contracts were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income/(expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,148)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,373)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reporting and functional currency of the Company and all its significant subsidiaries is the U.S. dollar. The Company records foreign currency transactions at the exchange rates in effect on the transaction date. Monetary assets and liabilities in foreign currencies at the balance sheet date are converted at the exchange rate in effect at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are carried at their historical exchange rates. The Company includes any foreign exchange gains and losses under the caption “Other income (expense), net” in the Company’s condensed consolidated statements of operations. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, $5.0 million and $10.4 million, respectively, (three and nine months ended September 30, 2021: $0.6 million and $1.4 million, respectively), of foreign exchange loss was included in the Company’s net income (loss) in the condensed consolidated statements of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative instruments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, taxes recoverable, and deferred tax assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Liabilities</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has issued unvested restricted stock awards, some of which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid. These awards are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of ordinary shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect, if any, of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Restricted Stock Units (“RSUs”) issued that convert to ordinary shares upon vesting; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Unvested restricted share awards which are not considered “participating securities”;</span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Additional potential ordinary shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">For periods prior to January 1, 2022, those ordinary shares with the potential to be issued in connection with convertible notes and other such convertible instruments, determined using the treasury stock method; and</span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Effective January 1, 2022, the dilutive effect of the convertible notes is calculated using the if-converted method. Under the if-converted method, the convertible notes are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted net income per common share calculation. Interest expense related to the convertible notes incurred in the period is added back to the numerator for purposes of the if-converted calculation. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the effect of the assumed conversion of the convertible notes was anti-dilutive and was not included in the computation of diluted earnings per share.</span></div><div style="padding-left:63pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (or loss) per share contemplates a conversion to ordinary shares of all convertible instruments only if they are dilutive. In the event of a net loss, all RSUs, stock options, shares potentially issuable in connection with convertible notes, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table reconciles net income (loss) and weighted average shares used in computing basic and diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021 (expressed in thousands of U.S. dollars, except per share and share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:51.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator for earnings per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,726)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) - diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,469)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,408)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,726)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator for earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,127,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,119,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive employee and director share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares potentially issuable in connection with convertible notes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,127,384 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,119,814 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,337 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,337 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participating securities excluded from calculation of loss per share </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848,841 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848,841 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares potentially issuable in connection with convertible notes excluded from calculation of diluted loss per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,686,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,773,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per Class A and Class B Ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Act, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes a tax on profits, income, gains, or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2021: 21%). Verdant’s tax years 2018 and beyond remain open and may be subject to examination by the IRS.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” (“ASU 2022-03”). ASU 2022-03 clarifies the guidance for measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 is effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company does not expect ASU 2022-03 to have a material impact on its financial position, results of operations, or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; instead, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring the application of the if-converted method when calculating diluted earnings per share. Under the if-converted method, the shares potentially issuable in connection with convertible debt are assumed to be converted at the beginning of the period. The resulting ordinary shares are included in the denominator of the diluted earnings per share calculation for the period presented. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. The adoption of ASU 2020-06 resulted in a decrease in the Company’s opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes (see Note 7). The adoption of ASU 2020-06 did not have a material impact on the Company’s net income, cash flows, or any other balances.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from these estimates. The significant estimates reflected in the Company’s </span></div>condensed consolidated financial statements include, but are not limited to, loss and loss adjustment expense reserves, premiums written, earned, and receivable, variability underlying risk transfer assessments, allowances for credit losses, share-based compensation, valuation allowances associated with deferred tax assets and investment impairments. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and short-term, highly liquid investments and certificates of deposit with original maturity dates of three months or less. Certificates of deposit with original maturities greater than three months are included under the caption "Other investments" on the condensed consolidated balance sheets.</span></div>The Company maintains cash and cash equivalent balances to collateralize regulatory trusts and letters of credit issued to cedents (see Note 12). The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681,175 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,101 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> The following table reconciles the cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total presented in the condensed consolidated statements of cash flows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,278 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681,175 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,101 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 32278000 76307000 648897000 634794000 681175000 711101000 Funds Held by CedentsThe caption “Reinsurance balances receivable” in the Company’s condensed consolidated balance sheets includes financial assets held by cedents. At September 30, 2022, funds held by cedents were $303.1 million (December 31, 2021: $246.9 million). Such amounts include premiums withheld by Lloyd’s syndicates and funds contributed by the Company to Lloyd's as security for members’ underwriting activities. The syndicates invest a portion of the premiums withheld in fixed maturity securities and investment funds. The Company records its share of income (or expense) from these assets in its condensed consolidated statements of operations under the caption “Other income (expense).” 303100000 246900000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reinsurance Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates an allowance for expected credit losses for its reinsurance balances receivable and loss and loss adjustment expenses recoverable by applying a Probability of Default (“PD”) / Loss Given Default (“LGD”) model. The PD / LGD approach considers the Company’s collectibility history on its reinsurance assets and representative external loss history. In calculating the probability of default, the Company also considers the estimated duration of its reinsurance assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates each counterparty’s creditworthiness based on credit ratings that independent agencies assign to the counterparty. The Company manages its credit risk in its reinsurance assets by transacting only with insurers and reinsurers that it considers financially sound. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit ratings of the counterparties are forward-looking and consider various economic scenarios. The Company's evaluation of the required allowance for reinsurance balances receivable and loss and loss adjustment expenses recoverable considers the current economic environment as well as potential macroeconomic developments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its retrocessional counterparties that are unrated, the Company may hold collateral in the form of funds withheld, trust accounts, or irrevocable letters of credit. In evaluating credit risk associated with reinsurance balances receivable, the Company considers its right to offset loss obligations against premiums receivable. The Company regularly evaluates its net credit exposure to assess the ability of cedents and retrocessionaires to honor their respective obligations.</span></div> 100000 100000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deposit Assets and Liabilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>The Company applies deposit accounting to reinsurance contracts that do not transfer sufficient insurance risk to merit reinsurance accounting. Under deposit accounting, the Company recognizes an asset or liability based on its paid or received consideration. The deposit asset or liability balance is subsequently adjusted using the interest method with the corresponding income or expense recorded in the Company’s condensed consolidated statements of operations under the captions “Other income (expense)” and “Deposit interest expense,” respectively. The Company records deposit assets and liabilities in its condensed consolidated balance sheets in the caption “Reinsurance balances receivable” and “Reinsurance balances payable,” respectively. 3200000 13700000 3500000 18600000 For the three and nine months ended September 30, 2022, and 2021, the interest income and expense on deposit accounted contracts were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit interest income/(expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,148)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,373)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,957)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0 0 0 0 6148000 38000 6373000 2957000 -6148000 -38000 -6373000 -2957000 Foreign ExchangeThe reporting and functional currency of the Company and all its significant subsidiaries is the U.S. dollar. The Company records foreign currency transactions at the exchange rates in effect on the transaction date. Monetary assets and liabilities in foreign currencies at the balance sheet date are converted at the exchange rate in effect at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are carried at their historical exchange rates. The Company includes any foreign exchange gains and losses under the caption “Other income (expense), net” in the Company’s condensed consolidated statements of operations. -5000000 -10400000 -600000 -1400000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative instruments</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes derivative financial instruments in the condensed consolidated balance sheets at their fair values. It includes any realized gains and losses and changes in unrealized gains and losses in the caption “Net investment income (loss)” in the condensed consolidated statements of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivatives do not qualify as hedges for financial reporting purposes. The Company records the associated assets and liabilities in its condensed consolidated balance sheets on a gross basis. The Company does not offset these balances against collateral pledged or received.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Other assets” in the Company’s condensed consolidated balance sheets consists primarily of prepaid expenses, fixed assets, right-of-use lease assets, other receivables, taxes recoverable, and deferred tax assets.</span></div> Other LiabilitiesThe caption “Other liabilities” in the Company’s condensed consolidated balance sheets consists primarily of accruals for legal and other professional fees, employee bonuses, taxes payable, and lease liabilities. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company has issued unvested restricted stock awards, some of which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid. These awards are considered “participating securities” for the purposes of calculating earnings (loss) per share. Basic earnings per share is calculated on the basis of the weighted average number of ordinary shares and participating securities outstanding during the period. Diluted earnings (or loss) per share includes the dilutive effect, if any, of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Restricted Stock Units (“RSUs”) issued that convert to ordinary shares upon vesting; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Unvested restricted share awards which are not considered “participating securities”;</span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Additional potential ordinary shares issuable when in-the-money stock options are exercised, determined using the treasury stock method; </span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">For periods prior to January 1, 2022, those ordinary shares with the potential to be issued in connection with convertible notes and other such convertible instruments, determined using the treasury stock method; and</span></div><div style="margin-bottom:6pt;padding-left:63pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Effective January 1, 2022, the dilutive effect of the convertible notes is calculated using the if-converted method. Under the if-converted method, the convertible notes are assumed to be converted at the beginning of the period, and the resulting common shares are included in the denominator of the diluted net income per common share calculation. Interest expense related to the convertible notes incurred in the period is added back to the numerator for purposes of the if-converted calculation. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the effect of the assumed conversion of the convertible notes was anti-dilutive and was not included in the computation of diluted earnings per share.</span></div><div style="padding-left:63pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings (or loss) per share contemplates a conversion to ordinary shares of all convertible instruments only if they are dilutive. In the event of a net loss, all RSUs, stock options, shares potentially issuable in connection with convertible notes, and participating securities are excluded from the calculation of both basic and diluted loss per share as their inclusion would be anti-dilutive.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table reconciles net income (loss) and weighted average shares used in computing basic and diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021 (expressed in thousands of U.S. dollars, except per share and share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:51.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.165%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator for earnings per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,726)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) - diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,469)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,408)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,726)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator for earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,127,384 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,119,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive employee and director share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares potentially issuable in connection with convertible notes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,127,384 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,929,097 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,119,814 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,507,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,337 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,337 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participating securities excluded from calculation of loss per share </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848,841 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848,841 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,556 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares potentially issuable in connection with convertible notes excluded from calculation of diluted loss per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,686,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,773,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per Class A and Class B Ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -18469000 -13853000 -9408000 -6726000 0 0 0 0 -18469000 -13853000 -9408000 -6726000 33127384 32929097 33119814 33507060 0 0 0 0 0 0 0 0 33127384 32929097 33119814 33507060 690337 735627 690337 735627 848841 946556 848841 946556 5686747 0 5773889 0 -0.56 -0.56 -0.42 -0.42 -0.28 -0.28 -0.20 -0.20 -0.56 -0.56 -0.42 -0.42 -0.28 -0.28 -0.20 -0.20 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current Cayman Islands law, no corporate entity, including GLRE and Greenlight Re, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company has an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Act, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes a tax on profits, income, gains, or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to GLRE, Greenlight Re nor their respective operations, or to the Class A or Class B ordinary shares or related obligations, before February 1, 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verdant is incorporated in Delaware and therefore is subject to taxes in accordance with the U.S. federal rates and regulations prescribed by the U.S. Internal Revenue Service (“IRS”). Verdant’s taxable income is generally expected to be taxed at a marginal rate of 21% (2021: 21%). Verdant’s tax years 2018 and beyond remain open and may be subject to examination by the IRS.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRIL is incorporated in Ireland and therefore is subject to the Irish corporation tax rate of 12.5% on its trading income and 25% on its non-trading income.</span></div>The Company records a valuation allowance to the extent that the Company considers it more likely than not that all or a portion of the deferred tax asset will not be realized in the future. Other than this valuation allowance, the Company has not taken any income tax positions subject to significant uncertainty that is reasonably likely to have a material impact on the Company. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” (“ASU 2022-03”). ASU 2022-03 clarifies the guidance for measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 is effective for public business entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. Early adoption is permitted. The Company does not expect ASU 2022-03 to have a material impact on its financial position, results of operations, or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Adopted</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06”). ASU 2020-06 is designed to simplify the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The amendments remove the separation models in Subtopic 470-20 for certain contracts. As a result, entities will no longer present embedded conversion features separately in equity; instead, the convertible debt instrument will be accounted for as a single liability measured at its amortized cost. ASU 2020-06 also addresses the computation of earnings per share for convertible debt instruments, requiring the application of the if-converted method when calculating diluted earnings per share. Under the if-converted method, the shares potentially issuable in connection with convertible debt are assumed to be converted at the beginning of the period. The resulting ordinary shares are included in the denominator of the diluted earnings per share calculation for the period presented. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2020-06 during the first quarter of 2022, using the “modified retrospective” transition method. The adoption of ASU 2020-06 resulted in a decrease in the Company’s opening shareholders’ equity of approximately $2.5 million, with a corresponding increase in the carrying value of the senior convertible notes (see Note 7). The adoption of ASU 2020-06 did not have a material impact on the Company’s net income, cash flows, or any other balances.</span></div> 2500000 -2500000 INVESTMENT IN RELATED PARTY INVESTMENT FUND <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into the Second Amended and Restated Exempted Limited Partnership Agreement (the “SILP LPA”) of Solasglas Investments, LP (“SILP”), with DME Advisors II, LLC (“DME II”), as General Partner, Greenlight Re, and GRIL, (together, the “GLRE Limited Partners”). SILP has entered into a SILP investment advisory agreement (“IAA”) with DME Advisors. LP (“DME Advisors”) pursuant to which DME Advisors is the investment manager for SILP. DME II and DME Advisors are related to the Company, and each is an affiliate of David Einhorn, Chairman of the Company’s Board of Directors (the “Chairman”). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SILP LPA includes the following proviso: “The Investment Portfolio of each Partner will not exceed the product of (a) such Partner’s surplus (Greenlight Re Surplus or GRIL Surplus, as the case may be) multiplied by (b) the Investment Cap (50%), and the General Partner will designate any portion of a Partner’s Investment Portfolio as Designated Securities to effectuate such limit.” </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has concluded that SILP qualifies as a variable interest entity (“VIE”) under U.S. GAAP. In assessing its interest in SILP, the Company noted the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DME II serves as SILP’s general partner and has the power of appointing the investment manager. The Company does not have the power to appoint, change or replace the investment manager or the general partner except “for cause.” Neither of the GLRE Limited Partners can participate in the investment decisions of SILP as long as SILP adheres to the investment guidelines provided within the SILP LPA. For these reasons, the GLRE Limited Partners are not considered to have substantive participating rights or kick-out rights.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DME II holds an interest in excess of 10% of SILP’s net assets, which the Company considers to represent an obligation to absorb losses and a right to receive benefits of SILP that are significant to SILP. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, the Company has concluded that DME II’s interests, not the Company’s, meet both the “power” and “benefits” criteria associated with VIE accounting guidance, and therefore DME II is SILP’s primary beneficiary. The Company presents its investment in SILP in its condensed consolidated balance sheets in the caption “Investment in related party investment fund.” </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s maximum exposure to loss relating to SILP is limited to the net asset value of the GLRE Limited Partners’ investment in SILP. At September 30, 2022, the net asset value of the GLRE Limited Partners’ investment in SILP was $195.2 million (December 31, 2021: $183.6 million), representing 75.3% (December 31, 2021: 78.2%) of SILP’s total net assets. DME II held the remaining 24.7% (December 31, 2021: 21.8%) of SILP’s total net assets. The investment in SILP is recorded at the GLRE Limited Partners’ share of the net asset value of SILP as reported by SILP’s third-party administrator. The GLRE Limited Partners can redeem their assets from SILP for operational purposes by providing <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZiZDllYTdmMzQ1ODQxNWY4NjYzODY3ZWQ2NWEwYTliL3NlYzpmYmQ5ZWE3ZjM0NTg0MTVmODY2Mzg2N2VkNjVhMGE5Yl80Ni9mcmFnOjhiNGFmMTE4MmI3NzQ1NmE4YjdiOTgyNWYwYzdjMDQ5L3RleHRyZWdpb246OGI0YWYxMTgyYjc3NDU2YThiN2I5ODI1ZjBjN2MwNDlfMjg3MA_4d2c5149-4e72-49f2-b892-e35c4db8a283">three</span> business days’ notice to DME II. At September 30, 2022, the majority of SILP’s long investments were composed of cash and publicly traded equity securities, which could be readily liquidated to meet the GLRE Limited Partners’ redemption requests. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s share of the change in the net asset value of SILP for the three and nine months ended September 30, 2022, was $8.5 million and $24.5 million, respectively (three and nine months ended September 30, 2021: $(6.2) million and $(4.2) million, respectively), and shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized financial statements of SILP are presented below. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Assets and Liabilities of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from brokers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,248 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,282 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and partners’ capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold short, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital withdrawals payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to brokers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,137)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,551)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">259,111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">195,199</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">183,591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Operations of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income (net of withholding taxes)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,983)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,579)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,144)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,865)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and change in unrealized gains (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,809)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,464 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on investment transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,685 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,666)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,531)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,521</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,214)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,196)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) is net of management fees and performance allocation presented below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.964%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance allocation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,848 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,405 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for further details on related party management fees and performance allocation.</span></div> 0.50 195200000 183600000 0.753 0.782 0.247 0.218 8500000 24500000 -6200000 -4200000 -4200000 The summarized financial statements of SILP are presented below. <div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Assets and Liabilities of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,386 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,542 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from brokers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,248 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,282 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and partners’ capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments sold short, at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative contracts, at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital withdrawals payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to brokers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and dividends payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,137)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150,551)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">259,111</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of Net Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">195,199</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">183,591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statement of Operations of Solasglas Investments, LP</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend income (net of withholding taxes)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,983)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,621)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,579)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,144)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,623)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,865)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Realized and change in unrealized gains (losses) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized gain (loss) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,411)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,809)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized appreciation (depreciation) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,464 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain (loss) on investment transactions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,685 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,666)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,272)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,531)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLRE Limited Partners’ share of net income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,521</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,214)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,474</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,196)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) is net of management fees and performance allocation presented below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.964%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance allocation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,848 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,405 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,632 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 258386000 297937000 15727000 2542000 149071000 84775000 64000 28000 423248000 385282000 153892000 132360000 9739000 7253000 0 10000000 10000 0 295000 580000 201000 358000 164137000 150551000 259111000 234731000 195199000 183591000 305000 146000 928000 509000 693000 51000 1028000 770000 998000 197000 1956000 1279000 901000 883000 2686000 2632000 464000 205000 1199000 874000 356000 306000 938000 852000 262000 227000 756000 786000 1983000 1621000 5579000 5144000 -985000 -1424000 -3623000 -3865000 7221000 -1411000 58196000 -14809000 6464000 -5437000 -17027000 12143000 13685000 -6848000 41169000 -2666000 12700000 -8272000 37546000 -6531000 8521000 -6214000 24474000 -4196000 901000 883000 2686000 2632000 947000 -224000 2719000 0 1848000 659000 5405000 2632000 FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">nvestments</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s “Other investments” are composed of the following:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:22.8pt">Private investments, unlisted equities, and convertible debt instruments, which consist primarily of Innovations-related investments supporting technology innovators in the (re)insurance market; and</span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:22.8pt">Certificates of deposit with original maturities greater than three months. </span></div><div style="padding-left:18pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2022, the Company included the following securities in the caption “Other investments”:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,037 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,081 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,037 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,368)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,081 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company included the following securities in the caption “Other investments”: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,438 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments (not designated as hedging instruments)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,411 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,773 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,384 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Private investments and unlisted equity securities without readily determinable fair values</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures its private investments and unlisted equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from identical or similar investments of the same issuers (the “measurement alternative”), with such changes recognized in the caption “Net investment income (loss)” in the condensed consolidated statements of operations. The Company considers the need for impairment on a by-investment basis, based on certain indicators. Under the measurement alternative, the Company makes two types of valuation adjustments:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:22.8pt">When the Company observes an orderly transaction of an investee’s identical or similar equity securities, the Company adjusts the carrying value based on the observable price as of the transaction date. Once the Company records such an adjustment, the investment is considered an “asset measured at fair value on a nonrecurring basis.”</span></div><div style="padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:110%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:22.8pt">If the Company determines that the investment is impaired and the fair value is less than its carrying value, it writes down the investment to its fair value. Once the Company records such an adjustment, the investment is considered an “asset measured at fair value on a nonrecurring basis.”</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2022, and 2021, and the related adjustments recorded during the periods then ended. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.580%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward carrying value changes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Downward carrying value changes and impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative upward carrying value changes from inception to September 30, 2022, totaled $42.8 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cumulative downward carrying value changes and impairments from inception to September 30, 2022, totaled $3.7 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on the extent to which the inputs are observable in the market. The categorization of financial instruments within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.859%"><tr><td style="width:1.0%"/><td style="width:2.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.318%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1: Quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2: Observable inputs other than prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated with observable market data.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">•</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3: Unobservable inputs supported by little or no market activity and significant to the fair value of the assets and liabilities. The term “unobservable inputs” includes certain pricing models, discounted cash flow methodologies, and similar techniques.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Assets measured at fair value on a nonrecurring basis</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, and December 31, 2021, the Company held $53.0 million and $40.5 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. The Company classifies these assets as Level 3 within the fair value hierarchy. The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2022, for the private and unlisted equities measured at fair value on a nonrecurring basis:</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.916%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 6 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6 to 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 1 year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair values measured on a nonrecurring basis</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,451 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,954 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, and December 31, 2021, the Company held $8.1 million and $6.5 million, respectively, of private investments and unlisted equities measured at cost.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Assets measured at fair value on a recurring basis</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In accordance with ASC 320, “Investments - Debt Securities,” the Company has classified the convertible debt securities as “trading” measured at estimated fair value with unrealized gains and losses reported in net income. The Company classifies these securities as Level 3 within the fair value hierarchy and estimates their fair values primarily based on inputs such as third-party quotes, issuers’ book value, market multiples, and other inputs. Valuation of these securities is subjective as the markets’ illiquidity may increase the likelihood that the estimated fair value of an investment is not reflective of the price at which an actual transaction could occur. </span></div><div style="padding-left:18pt;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying value of certificates of deposit with original maturities of one year or less approximates their fair values. The Company classifies these assets as Level 2 within the fair value hierarchy. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2022, and December 31, 2021, the Company did not carry any other investments at fair value with an assigned Level within the fair value hierarchy. The Company’s investment in the related party investment fund is measured at fair value using the net asset value practical expedient. It is therefore not classified within the fair value hierarchy. (See Note 3 for further details on the related party investment fund.)</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three and nine months ended September 30, 2022 and 2021, there were no transfers between Level 2 and Level 3 of the fair value hierarchy. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Disclosed, But Not Carried, at Fair Value</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The caption “Convertible senior notes payable” represents financial instruments that the Company carries at amortized cost. The fair value of the convertible senior notes payable is estimated based on the bid price observed in an inactive market for the identical instrument (Level 2 input) (see Note 7).</span></div> <div style="padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2022, the Company included the following securities in the caption “Other investments”:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.749%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.958%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,037 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,081 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,037 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,412 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,368)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,081 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company included the following securities in the caption “Other investments”: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized<br/>losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value / carrying value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private investments and unlisted equities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,411 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,438 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments (not designated as hedging instruments)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,411 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,773 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,384 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 22037000 42412000 3368000 61081000 1000000 0 0 1000000 3000000 0 0 3000000 26037000 42412000 3368000 65081000 17411000 31438000 1800000 47049000 0 335000 0 335000 17411000 31773000 1800000 47384000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at September 30, 2022, and 2021, and the related adjustments recorded during the periods then ended. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.580%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward carrying value changes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Downward carrying value changes and impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative upward carrying value changes from inception to September 30, 2022, totaled $42.8 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cumulative downward carrying value changes and impairments from inception to September 30, 2022, totaled $3.7 million.</span></div> 61081000 42349000 11260000 13355000 1676000 500000 42800000 3700000 53000000 40500000 The Company classifies these assets as Level 3 within the fair value hierarchy. The following table summarizes the periods between the most recent fair value measurement dates and September 30, 2022, for the private and unlisted equities measured at fair value on a nonrecurring basis:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.916%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than 6 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6 to 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 1 year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair values measured on a nonrecurring basis</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,451 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,954 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 24451000 17080000 11423000 52954000 8100000 6500000 LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the Company’s loss and loss adjustment expense reserves included estimated amounts for several catastrophe events. For significant catastrophe events, including, but not limited to, hurricanes, tornados, typhoons, floods, earthquakes, wildfires, and pandemics, loss reserves are generally established based on loss payments and case reserves reported by clients when received. To establish IBNR loss estimates, the Company makes use of, among other things, the following information:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">estimates communicated by ceding companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">information received from clients, brokers, and loss adjusters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">an understanding of the underlying business written and its exposures to catastrophe event-related losses; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">industry data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">catastrophe scenario modeling software; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">management’s judgment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At September 30, 2022, the Company’s loss and loss adjustment expense reserves included $13.6 million from the Russian-Ukrainian conflict and $19.5 million from Hurricane Ian. Additional information the Company considered in estimating its loss reserves included the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a review of in-force treaties that may provide coverage and incur losses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">catastrophe and scenario modeling analyses and results shared by cedents;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">preliminary loss estimates received from clients, brokers, and loss adjusters; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">reviews of industry insured loss estimates and market share analyses; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">management’s judgment.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s Russian-Ukrainian conflict loss estimates include actuarial assumptions, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the areas within the affected regions that have incurred losses;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the scope of coverage provided by the underlying policies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the interpretation of contract terms;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the determination of loss-triggering events;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">regulatory, legislative, and judicial actions that could influence contract interpretations across the insurance industry; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the ability of the cedents and insured to mitigate some or all of their losses.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the uncertainty associated with the foregoing assumptions, the Company’s loss estimates are subject to significant variability, and actual losses may ultimately differ materially from the Company's current estimates. The Company will evaluate its assumptions as new information becomes available and may adjust its loss estimates in future periods. Such adjustments may be material to the Company's results of operations and financial condition. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, if the Russian-Ukrainian conflict is prolonged, the Company may incur additional losses in subsequent periods.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company made no significant changes in the actuarial methodology or reserving process related to its loss and loss adjustment expense reserves for the nine months ended September 30, 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and December 31, 2021, loss and loss adjustment expense reserves were composed of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,945 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,220 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IBNR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,827 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,010 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated for the nine months ended September 30, 2022 and 2021 is as follows:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,010 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,910 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,328 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,789 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,078 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,960)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,987)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,516)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530,223 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,827 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,779 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2022, the estimate of net losses incurred relating to prior accident years increased by $1.6 million, primarily due to the following:</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">adverse development on motor and health business driven by the inflationary increase in claims costs; </span></div><div style="padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">adverse development on a multi-line quota share program resulting from newly reported losses received from the cedent;</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">newly reported claims received relating to excess of loss marine and energy contracts; and</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">claims deterioration on a cyber contract.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adverse developments were partially offset by favorable developments relating to prior accident years primarily due to the following:</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">favorable experience on mortgage business;</span></div><div style="padding-left:36pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">loss reserves released relating to catastrophe events and COVID-19 based on updated claims reporting received from cedents; and</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:23.5pt">loss reserves released on an excess of loss workers’ compensation contract.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021, the estimate of net losses incurred relating to prior accident years decreased by $1.3 million due primarily to favorable development on catastrophe events, a mortgage contract associated with the COVID-19 pandemic, and certain health contracts. The decrease in prior accident years was partially offset by adverse loss development on certain workers’ compensation and multi-line casualty contracts written between 2014 and 2018. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2022 and 2021 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,119 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,291 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,860 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 13600000 19500000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022 and December 31, 2021, loss and loss adjustment expense reserves were composed of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.070%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,945 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,220 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IBNR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,882 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,790 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,827 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,010 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of changes in outstanding loss and loss adjustment expense reserves for all lines of business consolidated for the nine months ended September 30, 2022 and 2021 is as follows:  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,010 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494,179 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,910 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,328 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,231 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,333 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,789 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,078 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,960)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,987)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,516)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530,223 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,697 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,827 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540,779 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the outstanding loss and loss adjustment expense reserves for health claims for the nine months ended September 30, 2022 and 2021 are as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,485 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,567 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,119 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,291 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid losses related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,048)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency revaluation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,860 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Losses recoverable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross balance at September 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,860 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,728 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 186945000 190220000 353882000 333790000 540827000 524010000 524010000 494179000 11100000 16851000 512910000 477328000 251231000 296333000 1558000 -1255000 252789000 295078000 54866000 96442000 160094000 146545000 214960000 242987000 -20516000 -1722000 530223000 527697000 10604000 13082000 540827000 540779000 1600000 -1300000 9938000 17485000 0 0 9938000 17485000 6567000 31189000 3552000 -1898000 10119000 29291000 3051000 20224000 11146000 13824000 14197000 34048000 0 0 5860000 12728000 0 0 5860000 12728000 RETROCESSION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company purchases retrocessional coverage for one or more of the following reasons: to manage its overall exposure, reduce its net liability on individual risks, obtain additional underwriting capacity and balance its underwriting portfolio. The Company records loss and loss adjustment expenses recoverable from retrocessionaires as assets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the Company’s earned ceded premiums were $4.4 million and $8.4 million, respectively (insignificant for the three and nine months ended September 30, 2021). For the three and nine months ended September 30, 2022, loss and loss adjustment expenses recovered and changes in losses recoverable were $2.5 million and $2.5 million, respectively. The recoveries recognized by the Company for the three and nine months ended September 30, 2021, were nil and $0.1 million, respectively.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. At September 30, 2022, the Company’s loss reserves recoverable consisted of (i) $7.9 million (December 31, 2021: $8.4 million) recoverable from unrated retrocessionaires, of which $6.9 million (December 31, 2021: $8.2 million) were secured by cash, letters of credit and collateral held in trust accounts for the benefit of the Company and (ii) $2.7 million (December 31, 2021: $2.8 million) recoverable from retrocessionaires rated A- or above by A.M. Best. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company regularly evaluates its net credit exposure to assess the ability of the retrocessionaires to honor their respective obligations. At September 30, 2022, the Company had recorded an allowance for expected credit losses of $47 thousand (December 31, 2021: $47 thousand).</span></div> 4400000 8400000 2500000 2500000 0 -100000 7900000 8400000 6900000 8200000 2700000 2800000 47000 47000 SENIOR CONVERTIBLE NOTES <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2018, the Company issued $100.0 million of senior unsecured convertible notes (the “Notes”), which mature on August 1, 2023. The Notes bear interest at 4.0%, payable semiannually on February 1 and August 1 of each year beginning February 1, 2019. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note holders have the option, under certain conditions, to redeem the Notes prior to maturity. At September 30, 2022, the Company’s share price was lower than the conversion price of $17.19 per share. </span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a holder redeems the Notes, the Company shall have the option to settle the conversion obligation in cash, ordinary shares of the Company, or a combination thereof pursuant to the terms of the indenture governing the Notes. Prior to January 1, 2022, the Company bifurcated the Notes into liability and equity components. Effective January 1, 2022, upon adoption of ASU 2020-06, the Company no longer bifurcates the Notes and presents the entire balance as a single liability on the Company’s condensed consolidated balance sheets (see Note 2 for recently issued accounting standards adopted). </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective borrowing rate for non-convertible debt at the time of issuance of the Notes was estimated to be 6.0%. The Company incurred issuance costs in connection with the issuance of the Notes. At September 30, 2022, the unamortized portion of these costs was $0.6 million (December 31, 2021: $1.0 million), which the Company expects to amortize through the maturity date. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2022 the Company repurchased and canceled $6.6 million of the Notes. The carrying value of the Notes at September 30, 2022, including accrued interest of $0.6 million, was $93.4 million (December 31, 2021: $98.1 million). At September 30, 2022, the Company estimated the fair value of the Notes to be $90.2 million (December 31, 2021: $97.5 million) (see Note 4 Financial Instruments).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2022, the Company recognized interest expenses of $1.1 million and $3.4 million, respectively (three and nine months ended September 30, 2021: $1.6 million and $4.7 million, respectively).</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all covenants relating to the Notes at September 30, 2022, and December 31, 2021. At September 30, 2022, the Company had a remaining obligation for interest and principal payments of nil and $97.2 million during 2022 and 2023, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to September 30, 2022, the Company repurchased and canceled $13.8 million of the Notes.</span></div> 100000000 0.040 17.19 0.060 600000 1000000 6600000 6600000 600000 93400000 98100000 90200000 97500000 1100000 3400000 1600000 4700000 0 97200000 13800000 SHARE CAPITAL<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s share capital is made up of ordinary share capital and additional paid-in capital. Ordinary share capital represents the issued and outstanding Class A and Class B ordinary shares at their par values of $0.10 per share. Additional paid-in capital includes the premium paid per share by the subscribing shareholders for Class A and Class B ordinary shares, as well as the earned portion of the grant-date fair value of share-based awards.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2020, the Company’s shareholders approved an amendment to the stock incentive plan to increase the number of Class A ordinary shares available for issuance by 3.0 million shares from 5.0 million to 8.0 million. At September 30, 2022, 2,011,426 (December 31, 2021: 3,128,276) Class A ordinary shares remained available for future issuance under the Company’s stock incentive plan. The Compensation Committee of the Board of Directors administers the stock incentive plan. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. The Board of Directors has approved a share repurchase plan, which expires on June 30, 2023, authorizing the Company to repurchase up to $25.0 million of Class A ordinary shares or securities convertible into Class A ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. The Company is not required to repurchase any of the Class A ordinary shares. The repurchase plan may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company repurchased 4,933 Class A ordinary shares during the nine months ended September 30, 2022. All Class A ordinary shares repurchased are canceled immediately upon repurchase.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of ordinary shares issued and outstanding:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:35.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,589,731 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,260,075 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issue of ordinary shares, net of forfeitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984,548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,569,346 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,589,731 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital includes the premium per share paid by the subscribing shareholders for Class A and B ordinary shares, which have a par value of $0.10 each. It also includes the earned portion of the grant-date fair value of share-based awards that have not yet vested.</span></div> 0.10 0.10 3000000 5000000 8000000 2011426 3128276 25000000 4933 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of ordinary shares issued and outstanding:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:35.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.563%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,589,731 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,260,075 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issue of ordinary shares, net of forfeitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984,548 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,933)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,079,544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,569,346 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,589,731 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,254,715 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 27589731 6254715 28260075 6254715 984548 0 409200 0 4933 0 1079544 0 28569346 6254715 27589731 6254715 0.10 0.10 SHARE-BASED COMPENSATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a stock incentive plan for directors, employees, and consultants administered by the Compensation Committee of the Board of Directors. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Restricted Shares</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restricted shares issued to certain employees contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, the Company issued to non-employee directors an aggregate of 107,763 (2021: 74,769) restricted Class A ordinary shares as part of their remuneration for services to the Company. These restricted shares contain similar restrictions to those issued to employees. They will vest on the earlier of (i) the first anniversary of the date of the share issuance and (ii) the Company’s next annual general meeting, subject to the grantee’s continued service with the Company. During the vesting period, non-employee directors holding these restricted shares retain voting rights and are entitled to any dividends declared by the Company.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, the Company issued 849,872 (2021: 334,312) Class A ordinary shares to employees pursuant to the Company’s stock incentive plan. The restricted shares granted to employees in 2022 include (i) restricted shares with both performance and service-based vesting conditions (“Performance RSs”) and (ii) restricted shares with only service-based vesting conditions (“Service RSs”). The Service RSs vest evenly each year on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSs will cliff vest at the end of a three-year performance period within a range of 25% and 100% of the awarded Performance RSs, with a target of 50%. During the vesting period, the holder of the Service RSs and Performance RSs retains voting rights but is entitled to any dividends declared by the Company only upon vesting.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to fiscal year 2022, the restricted shares granted to employees cliff vested three years after the date of issuance, subject to the grantee’s continued service with the Company. During the vesting period, the holder of the restricted shares retained voting rights and are entitled to any dividends declared by the Company.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to fiscal year 2021, the Company issued Class A ordinary shares to the Chief Executive Officer (“CEO”) pursuant to the Company’s stock incentive plan (“CEO RSs”). These shares contain performance and service conditions and certain restrictions relating to, among other things, vesting, forfeiture in the event of termination of the CEO’s employment, and transferability. The CEO RSs cliff vest five years after the date of issuance, subject to the performance condition being met and the CEO’s continued service with the Company. At September 30, 2022, there were 193,149 non-vested CEO RSs with a weighted average grant date fair value of $10.10 per share. As the performance conditions associated with these restricted shares have not been met, the Company recognized no compensation cost relating to the unvested shares for the nine months ended September 30, 2022, and 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes compensation expense associated with Performance RSs and Service RSs based on the fair value of the Company's Class A ordinary shares measured at the grant date. For Service RSs, the Company recognizes this expense on a straight-line basis over the requisite service period. For Performance RSs, the Company recognizes the associated compensation expense based on achieving established performance criteria during the performance period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, grantees forfeited 8,476 (2021: 20,592) restricted shares. For the nine months ended September 30, 2022, the Company reversed $26 thousand of stock compensation expense (2021: $0.1 million) in relation to the forfeited restricted shares. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $2.6 million of share-based compensation expense, net of forfeiture reversals, relating to restricted shares for the nine months ended September 30, 2022 (2021: $1.8 million). At September 30, 2022, there was $4.4 million (December 31, 2021: $2.7 million) of unrecognized compensation cost relating to non-vested restricted shares (excluding CEO RSs), which the Company expects to recognize over a weighted-average period of 1.6 years (December 31, 2021: 1.8 years). For the nine months ended September 30, 2022, the total fair value of restricted shares vested was $2.0 million (2021: $1.6 million).</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2022: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.121%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Restricted Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service Restricted Shares</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,407 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.68 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,422 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.02 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,362 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.62 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,351 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.73 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Restricted Stock Units</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issues RSUs to certain employees as part of the stock incentive plan. Such RSUs contain restrictions relating to vesting, forfeiture in the event of termination of employment, transferability, and other matters. On the vesting date, the Company converts each RSU into one Class A ordinary share and issues new Class A ordinary shares from the shares authorized for issuance as part of the Company’s stock incentive plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSUs granted to employees in 2022 include (i) RSUs with both performance and service-based vesting conditions (“Performance RSUs”) and (ii) RSUs with only service-based vesting conditions (“Service RSUs”). The Service RSUs vest evenly each year on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of a three-year performance period within a range of 25% and 100% of the awarded Performance RSUs, with a target of 50%. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes compensation expense associated with Performance RSUs and Service RSUs based on the fair value of the Company's Class A ordinary shares measured at the grant date. For Service RSUs, the Company recognizes this expense on a straight-line basis over the requisite service period. For Performance RSUs, the Company recognizes the associated compensation expense based on achieving established performance criteria during the performance period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2022, the RSUs issued to employees cliff vested three years after the date of issuance, subject to the grantee’s continued service with the Company. For the nine months ended September 30, 2022, the Company issued 159,215 (2021: 58,123) RSUs to employees pursuant to the Company’s stock incentive plan. For the nine months ended September 30, 2022, and 2021, no RSUs were forfeited.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $0.5 million of share-based compensation expense relating to RSUs for the nine months ended September 30, 2022 (2021: $0.3 million). At September 30, 2022, the total compensation cost related to non-vested RSUs not yet recognized was $0.7 million (December 31, 2021: $0.5 million), which the Company expects to recognize over a weighted-average period of 1.6 years (December 31, 2021: 1.8 years).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee RSU activity during the nine months ended September 30, 2022, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.743%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.033%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service Restricted Stock Units</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,952 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.58 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Stock Options</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, and 2021, no Class A ordinary share purchase options were granted or exercised by directors or employees, and 45,290 Class A ordinary share purchase options expired. When the Company grants stock options, it reduces the corresponding number from the shares authorized for issuance as part of the Company’s stock incentive plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors does not currently anticipate that the Company will declare any dividends during the expected term of the options. The Company uses graded vesting for expensing employee stock options. The total compensation cost expensed relating to stock options for the nine months ended September 30, 2022, was $0.2 million (2021: $0.3 million). At September 30, 2022, the total compensation cost related to non-vested options not yet recognized was $0.1 million (December 31, 2021: $0.3 million), which will be recognized over a weighted-average period of 0.8 years (December 31, 2021: 1.2 years) assuming the grantee completes the service period for vesting of the options.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee and director stock option activity during the nine months ended September 30, 2022 was as follows: </span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/> options outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/> exercise<br/> price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/> grant date<br/> fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic value <br/>($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining contractual term<br/></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.35 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,337 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.25 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 years</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Compensation Expense</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2022, and 2021, the combined stock compensation expenses (net of forfeitures) included in the caption “General and administrative expenses” in the Company’s condensed consolidated statements of operations were $3.3 million and $2.4 million, respectively.</span></div> 107763 74769 849872 334312 P3Y 0.25 1 0.50 P3Y P5Y 193149 10.10 0 0 8476 20592 26000 100000 2600000 1800000 4400000 2700000 P1Y7M6D P1Y9M18D 2000000 1600000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for unvested outstanding restricted share awards during the nine months ended September 30, 2022: </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:28.121%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.933%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Restricted Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service Restricted Shares</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>restricted<br/> shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,407 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.68 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,213 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,422 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.02 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197,002)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.06 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.67 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,362 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.62 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">904,351 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.73 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee RSU activity during the nine months ended September 30, 2022, was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.743%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.030%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.033%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service Restricted Stock Units</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>non-vested<br/>RSUs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/>grant date<br/>fair value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.59 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.84 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,008 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,952 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.58 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 193149 10.10 753407 8.68 601213 6.82 356422 7.02 0 0 197002 10.06 0 0 8476 7.67 794362 7.62 904351 7.73 1 P3Y 0.25 1 0.50 P3Y 159215 58123 0 500000 300000 700000 500000 P1Y7M6D P1Y9M18D 0 0 154134 8.59 105008 6.82 54207 6.82 0 0 35389 10.84 105008 6.82 172952 7.58 0 0 0 0 45290 45290 200000 300000 100000 300000 P0Y9M18D P1Y2M12D <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee and director stock option activity during the nine months ended September 30, 2022 was as follows: </span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/> options outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/> exercise<br/> price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/> average<br/> grant date<br/> fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic value <br/>($ in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining contractual term<br/></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,627 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.35 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#b6b6b6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#b6b6b6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690,337 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.25 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 years</span></td></tr></table></div> 735627 22.35 10.23 0 P4Y8M12D 0 0 0 0 0 0 0 0 0 45290 23.80 11.04 690337 22.25 10.18 0 P4Y2M12D 3300000 2400000 TAXATIONAt September 30, 2022, the Company recorded a gross deferred tax asset of $3.7 million (December 31, 2021: $3.2 million) and a deferred tax asset valuation allowance of $3.2 million (December 31, 2021: $2.7 million). The net deferred tax asset is included in the caption “Other assets” in the Company’s condensed consolidated balance sheets. The Company has determined that it is more likely than not that it will fully realize the recorded deferred tax asset (net of the valuation allowance) in the future. The Company based this determination on the expected timing of the reversal of the temporary differences and the likelihood of generating sufficient taxable income to realize the future tax benefit.<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax recovered</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in deferred tax valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 3700000 3200000 3200000 2700000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our current and deferred income tax benefit (expense) on a consolidated basis for the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax recovered</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in deferred tax valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (expense) benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 234000 -323000 655000 3240000 1050000 0 1478000 0 -170000 0 -428000 0 -170000 -323000 -428000 -493000 -816000 0 -823000 3733000 RELATED PARTY TRANSACTIONS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investment Advisory Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DME, DME II, and DME Advisors are each an affiliate of the Chairman and therefore are related parties to the Company.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into the SILP LPA (as described in Note 3 of the condensed consolidated financial statements). DME II receives a performance allocation equal to (with capitalized terms having the meaning provided under the SILP LPA) (a) 10% of the portion of the Positive Performance Change for each limited partner’s capital account that is less than or equal to the positive balance in such limited partner’s Carryforward Account, plus (b) 20% of the portion of the Positive Performance Change for each limited partner’s capital account that exceeds the positive balance in such limited partner’s Carryforward Account. The Carryforward Account for Greenlight Re and GRIL includes the amount of investment losses to be recouped, including any loss generated on the assets invested in SILP, subject to adjustments for redemptions. The loss carry-forward provision in the SILP LPA allows DME II to earn a reduced performance allocation of 10% of profits in years subsequent to any year in which SILP has incurred a loss until all losses are recouped, and an additional amount equal to 150% of the loss is earned. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the SILP LPA, DME Advisors constructs a levered investment portfolio as agreed by the Company (the “Investment Portfolio”, as defined in the SILP LPA). On September 1, 2018, SILP entered into the IAA with DME Advisors, which entitles DME Advisors to a monthly management fee equal to 0.125% (1.5% on an annual basis) of each limited partner’s Investment Portfolio. The IAA has an initial term ending on August 31, 2023, subject to an automatic extension for successive three-year terms. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed breakdown of management fees and performance compensation for the three and nine months ended September 30, 2022, and 2021, refer to Note 3 of the condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SILP LPA and the IAA, the Company has agreed to indemnify DME, DME II, and DME Advisors for any expense, loss, liability, or damage arising out of any claim asserted or threatened in connection with DME Advisors serving as the Company’s or SILP’s investment advisor. The Company will reimburse DME, DME II, and DME Advisors for reasonable costs and expenses of investigating and defending such claims, provided such claims were not caused due to gross negligence, breach of contract, or misrepresentation by DME, DME II, or DME Advisors. The Company incurred no indemnification amounts during the periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Green Brick Partners, Inc.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At September 30, 2022, SILP, along with certain affiliates of DME Advisors, collectively owned 38% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in SILP. At September 30, 2022, SILP held 2.7 million shares of GRBK.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Service Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collateral Assets Investment Management Agreement</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the SILP LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.</span></div> 0.10 0.20 0.10 1.50 0.00125 0.015 P3Y 0.38 2700000 5000 P30D P30D COMMITMENTS AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letters of Credit and Trusts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Facility Limit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice period required for termination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 days before the termination date</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, an aggregate amount of $180.2 million (December 31, 2021: $136.8 million) in letters of credit was issued under the credit facility. At September 30, 2022, the Company had pledged total cash and cash equivalents with a fair value in the aggregate of $180.9 million (December 31, 2021: $137.6 million) as collateral against the letters of credit issued and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. The credit facility contains customary events of default and restrictive covenants, including but not limited to limitations on liens on collateral, transactions with affiliates, mergers, and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists, as defined in the letter of credit facility, Greenlight Re will be prohibited from paying dividends to its parent company. The Company was in compliance with all the credit facility covenants at September 30, 2022 and December 31, 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also established regulatory trust arrangements for certain cedents. At September 30, 2022, collateral of $468.0 million (December 31, 2021: $497.1 million) was provided to cedents in the form of regulatory trust accounts and included in the caption “Restricted cash and cash equivalents” in the Company’s condensed consolidated balance sheets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Obligations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has determined that its lease agreements for office space qualify as operating lease arrangements. At the commencement date, the Company determined the lease term by assuming the exercise of those renewal options deemed to be reasonably certain. The exercise of lease renewal options is at the Company's sole discretion, and these options do not contain any material residual value guarantees or material restrictive covenants. The Company’s weighted-average remaining operating lease term is approximately 4.0 years at September 30, 2022.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the lease contracts generally do not provide an implicit discount rate, the Company used the weighted-average discount rate of 6%, representing its incremental borrowing rate based on information available at the commencement date, to determine the present value of lease payments. The incremental borrowing rate is based on a borrowing with a term similar to that of the associated lease. The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZiZDllYTdmMzQ1ODQxNWY4NjYzODY3ZWQ2NWEwYTliL3NlYzpmYmQ5ZWE3ZjM0NTg0MTVmODY2Mzg2N2VkNjVhMGE5Yl84NS9mcmFnOjViZmU5MmM2ZTdmMDQyMTc5MTVjZmUyNjA4N2M4NjYzL3RleHRyZWdpb246NWJmZTkyYzZlN2YwNDIxNzkxNWNmZTI2MDg3Yzg2NjNfMzgxMw_ee164c2c-ddaa-4c41-88a6-9d4b3b299c71">right-of-use assets</span> and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZiZDllYTdmMzQ1ODQxNWY4NjYzODY3ZWQ2NWEwYTliL3NlYzpmYmQ5ZWE3ZjM0NTg0MTVmODY2Mzg2N2VkNjVhMGE5Yl84NS9mcmFnOjViZmU5MmM2ZTdmMDQyMTc5MTVjZmUyNjA4N2M4NjYzL3RleHRyZWdpb246NWJmZTkyYzZlN2YwNDIxNzkxNWNmZTI2MDg3Yzg2NjNfMzgyMQ_54e2f265-6276-42c1-9536-84290b4097f0">lease liabilities</span> relating to the operating leases were $2.0 million and $2.1 million, respectively. The operating expense for the three and nine months ended September 30, 2022, was $0.2 million and $0.5 million, respectively (three and nine months ended September 30, 2021: $0.1 million and $0.2 million, respectively). </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the commitment for operating lease liabilities for future annual periods was as follows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:72.482%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div>From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results. <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the Company had one letter of credit facility, which automatically renews each year unless terminated by either party in accordance with the applicable required notice period:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Facility Limit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notice period required for termination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citibank Europe plc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 20, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120 days before the termination date</span></div></td></tr></table></div> 1 275000000 P120D 180200000 136800000 180900000 137600000 468000000 497100000 P4Y 0.06 2000000 2100000 200000 500000 100000 200000 <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2022, the commitment for operating lease liabilities for future annual periods was as follows:</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:72.482%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,376 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 149000 611000 627000 644000 345000 0 2376000 280000 2096000 SEGMENT REPORTING <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one operating segment, Property &amp; Casualty Reinsurance. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:</span></div><div style="text-indent:31.5pt"><span><br/></span></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Line of Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.304%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,021 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,841 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,555 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-line </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,240 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,632 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,231 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,940 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accident &amp; Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,481 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Specialty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,885 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,740 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #99ccff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,146 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435,812 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Gross Premiums Written by Geographic Area of Risks Insured</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and Caribbean</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,105 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,087 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,324 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,849 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,146 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435,812 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The negative balance represents the reversal of premiums due to premium adjustments, termination of contracts, or premium returned upon novation or commutation of contracts.</span></div> 1 Gross Premiums Written by Line of Business<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.304%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.447%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,631 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,318 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Property</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,021 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,841 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,555 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,376 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,749 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motor Liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,061 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,795 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional Liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multi-line </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,419 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,162 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Casualty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,240 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,632 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,231 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,940 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accident &amp; Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,427 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,920 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,481 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,425 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Specialty</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,781 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,885 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,971 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,740 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #99ccff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,146 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435,812 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table> 2146000 0.014 3398000 0.026 8648000 0.020 9700000 0.022 206000 0.001 6103000 0.048 768000 0.002 24537000 0.056 17669000 0.114 3631000 0.028 49425000 0.113 10318000 0.023 20021000 0.129 13132000 0.102 58841000 0.135 44555000 0.101 13798000 0.089 7376000 0.057 40523000 0.093 10749000 0.024 565000 0.004 19823000 0.154 4061000 0.009 96795000 0.220 242000 0.002 154000 0.001 496000 0.001 302000 0.001 7216000 0.046 17117000 0.133 25504000 0.059 55237000 0.125 69419000 0.447 40162000 0.312 177647000 0.408 137857000 0.313 91240000 0.588 84632000 0.657 248231000 0.570 300940000 0.684 5879000 0.038 4175000 0.033 10377000 0.024 26427000 0.060 20065000 0.129 17920000 0.139 56481000 0.129 40134000 0.091 4675000 0.030 2462000 0.019 18425000 0.042 8412000 0.019 13266000 0.086 6414000 0.050 43457000 0.100 19781000 0.045 43885000 0.283 30971000 0.241 128740000 0.295 94754000 0.215 155146000 1.000 128735000 1.000 435812000 1.000 440249000 1.000 Gross Premiums Written by Geographic Area of Risks Insured<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended September 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine months ended September 30</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($ in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and Caribbean</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,105 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,087 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,324 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,849 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worldwide </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,197 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,470 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,797)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,146 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,735 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435,812 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,249 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The negative balance represents the reversal of premiums due to premium adjustments, termination of contracts, or premium returned upon novation or commutation of contracts.</span></div> 72105000 0.465 67087000 0.521 224324000 0.515 258849000 0.588 79512000 0.513 59616000 0.463 196197000 0.450 174470000 0.396 -1797000 -0.012 1483000 0.012 2962000 0.007 2787000 0.006 5326000 0.034 549000 0.004 12329000 0.028 4143000 0.010 155146000 1.000 128735000 1.000 435812000 1.000 440249000 1.000 EXCEL 69 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ī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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 71 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 269 316 1 false 81 0 false 6 false false R1.htm 0000001 - Document - Cover Sheet http://www.greenlightre.ky/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 0000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION ORGANIZATION AND BASIS OF PRESENTATION Notes 7 false false R8.htm 0000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 0000009 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND INVESTMENT IN RELATED PARTY INVESTMENT FUND Notes 9 false false R10.htm 0000010 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS FINANCIAL INSTRUMENTS Notes 10 false false R11.htm 0000011 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES Notes 11 false false R12.htm 0000012 - Disclosure - RETROCESSION Sheet http://www.greenlightre.ky/role/RETROCESSION RETROCESSION Notes 12 false false R13.htm 0000013 - Disclosure - SENIOR CONVERTIBLE NOTES Notes http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES SENIOR CONVERTIBLE NOTES Notes 13 false false R14.htm 0000014 - Disclosure - SHARE CAPITAL Sheet http://www.greenlightre.ky/role/SHARECAPITAL SHARE CAPITAL Notes 14 false false R15.htm 0000015 - Disclosure - SHARE-BASED COMPENSATION Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION SHARE-BASED COMPENSATION Notes 15 false false R16.htm 0000016 - Disclosure - TAXATION Sheet http://www.greenlightre.ky/role/TAXATION TAXATION Notes 16 false false R17.htm 0000017 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 17 false false R18.htm 0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 0000019 - Disclosure - SEGMENT REPORTING Sheet http://www.greenlightre.ky/role/SEGMENTREPORTING SEGMENT REPORTING Notes 19 false false R20.htm 0000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 20 false false R21.htm 0000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES 21 false false R22.htm 0000022 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables) Tables http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND 22 false false R23.htm 0000023 - Disclosure - FINANCIAL INSTRUMENTS (Tables) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables FINANCIAL INSTRUMENTS (Tables) Tables http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS 23 false false R24.htm 0000024 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables) Tables http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES 24 false false R25.htm 0000025 - Disclosure - SHARE CAPITAL (Tables) Sheet http://www.greenlightre.ky/role/SHARECAPITALTables SHARE CAPITAL (Tables) Tables http://www.greenlightre.ky/role/SHARECAPITAL 25 false false R26.htm 0000026 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables SHARE-BASED COMPENSATION (Tables) Tables http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION 26 false false R27.htm 0000027 - Disclosure - TAXATION (Tables) Sheet http://www.greenlightre.ky/role/TAXATIONTables TAXATION (Tables) Tables http://www.greenlightre.ky/role/TAXATION 27 false false R28.htm 0000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES 28 false false R29.htm 0000029 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.greenlightre.ky/role/SEGMENTREPORTING 29 false false R30.htm 0000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) Details 30 false false R31.htm 0000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 31 false false R32.htm 0000032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details) Details 32 false false R33.htm 0000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) and Weighted Average Number of Shares (Details) Sheet http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) and Weighted Average Number of Shares (Details) Details 33 false false R34.htm 0000034 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details) Details 34 false false R35.htm 0000035 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details) Details 35 false false R36.htm 0000036 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) Sheet http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details) Details 36 false false R37.htm 0000037 - Disclosure - FINANCIAL INSTRUMENTS - Other Investments (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails FINANCIAL INSTRUMENTS - Other Investments (Details) Details 37 false false R38.htm 0000038 - Disclosure - FINANCIAL INSTRUMENTS - Nonrecurring Fair Value Disclosures (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails FINANCIAL INSTRUMENTS - Nonrecurring Fair Value Disclosures (Details) Details 38 false false R39.htm 0000039 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails FINANCIAL INSTRUMENTS - Narrative (Details) Details 39 false false R40.htm 0000040 - Disclosure - FINANCIAL INSTRUMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details) Sheet http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails FINANCIAL INSTRUMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details) Details 40 false false R41.htm 0000041 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) Sheet http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details) Details 41 false false R42.htm 0000042 - Disclosure - RETROCESSION (Details) Sheet http://www.greenlightre.ky/role/RETROCESSIONDetails RETROCESSION (Details) Details http://www.greenlightre.ky/role/RETROCESSION 42 false false R43.htm 0000043 - Disclosure - SENIOR CONVERTIBLE NOTES (Details) Notes http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails SENIOR CONVERTIBLE NOTES (Details) Details http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES 43 false false R44.htm 0000044 - Disclosure - SHARE CAPITAL - Narrative (Details) Sheet http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails SHARE CAPITAL - Narrative (Details) Details 44 false false R45.htm 0000045 - Disclosure - SHARE CAPITAL - Stock by Class (Details) Sheet http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails SHARE CAPITAL - Stock by Class (Details) Details 45 false false R46.htm 0000046 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails SHARE-BASED COMPENSATION - Narrative (Details) Details 46 false false R47.htm 0000047 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails SHARE-BASED COMPENSATION - Restricted Stock (Details) Details 47 false false R48.htm 0000049 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Units (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails SHARE-BASED COMPENSATION - Restricted Stock Units (Details) Details 48 false false R49.htm 0000050 - Disclosure - SHARE-BASED COMPENSATION - Employee and Director Stock Option Activity (Details) Sheet http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails SHARE-BASED COMPENSATION - Employee and Director Stock Option Activity (Details) Details 49 false false R50.htm 0000051 - Disclosure - TAXATION - Narrative (Details) Sheet http://www.greenlightre.ky/role/TAXATIONNarrativeDetails TAXATION - Narrative (Details) Details 50 false false R51.htm 0000052 - Disclosure - TAXATION - Components of Income Tax Expense (Benefit) (Details) Sheet http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails TAXATION - Components of Income Tax Expense (Benefit) (Details) Details 51 false false R52.htm 0000053 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails RELATED PARTY TRANSACTIONS (Details) Details http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS 52 false false R53.htm 0000054 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails COMMITMENTS AND CONTINGENCIES - Narrative (Details) Details 53 false false R54.htm 0000055 - Disclosure - COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details) Details 54 false false R55.htm 0000056 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) Sheet http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details) Details 55 false false R56.htm 0000057 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details) Details 56 false false R57.htm 0000058 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) Sheet http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details) Details 57 false false All Reports Book All Reports [dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-Q should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. glre-20220930.htm [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: glre:RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner - glre-20220930.htm 4 [dqc-0015-Negative-Values] Fact us-gaap:IncentiveFeeExpense has a value of -224000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:IncentiveFeeExpense fact are: Context: ia1ee2ece58ad474cad88bfb0110fbf1d_D20210701-20210930, Unit: usd, Rule Element Id: 1301. glre-20220930.htm 4 glre-20220930.htm glre-20220930.xsd glre-20220930_cal.xml glre-20220930_def.xml glre-20220930_lab.xml glre-20220930_pre.xml glre-20220930exhibit311.htm glre-20220930exhibit312.htm glre-20220930exhibit321.htm glre-20220930exhibit322.htm http://fasb.org/us-gaap-sup/2022q3 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 75 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "glre-20220930.htm": { "axisCustom": 1, "axisStandard": 31, "contextCount": 269, "dts": { "calculationLink": { "local": [ "glre-20220930_cal.xml" ] }, "definitionLink": { "local": [ "glre-20220930_def.xml" ] }, "inline": { "local": [ "glre-20220930.htm" ] }, "labelLink": { "local": [ "glre-20220930_lab.xml" ] }, "presentationLink": { "local": [ "glre-20220930_pre.xml" ] }, "schema": { "local": [ "glre-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 543, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 4, "http://www.greenlightre.ky/20220930": 1, "http://xbrl.sec.gov/dei/2022": 5, "total": 10 }, "keyCustom": 33, "keyStandard": 283, "memberCustom": 34, "memberStandard": 40, "nsprefix": "glre", "nsuri": "http://www.greenlightre.ky/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "role": "http://www.greenlightre.ky/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - FINANCIAL INSTRUMENTS", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS", "shortName": "FINANCIAL INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - RETROCESSION", "role": "http://www.greenlightre.ky/role/RETROCESSION", "shortName": "RETROCESSION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - SENIOR CONVERTIBLE NOTES", "role": "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES", "shortName": "SENIOR CONVERTIBLE NOTES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - SHARE CAPITAL", "role": "http://www.greenlightre.ky/role/SHARECAPITAL", "shortName": "SHARE CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - SHARE-BASED COMPENSATION", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - TAXATION", "role": "http://www.greenlightre.ky/role/TAXATION", "shortName": "TAXATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - SEGMENT REPORTING", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTING", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - FINANCIAL INSTRUMENTS (Tables)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables", "shortName": "FINANCIAL INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - SHARE CAPITAL (Tables)", "role": "http://www.greenlightre.ky/role/SHARECAPITALTables", "shortName": "SHARE CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables", "shortName": "SHARE-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - TAXATION (Tables)", "role": "http://www.greenlightre.ky/role/TAXATIONTables", "shortName": "TAXATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - SEGMENT REPORTING (Tables)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ReinsuranceRecoverablesAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PremiumsAndOtherReceivablesNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i31bcde5b69844c48987d32d9c9b77cf8_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DepositContractsAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeDepositsWithFinancialInstitutions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Interest Income and Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeDepositsWithFinancialInstitutions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) and Weighted Average Number of Shares (Details)", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) and Weighted Average Number of Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:LimitedPartnershipAgreementInvestmentCapPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:LimitedPartnershipAgreementInvestmentCapPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND - Financial Information of Investment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i422683cbe86b44a79828fbf0e22687c8_I20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AssetsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BenefitsLossesAndExpenses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details)", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND - Summarized Statements of Assets, Liabilities and Net Assets of SILP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "glre:EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "if6e5ee1601294977b6d1de5480476a4d_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - FINANCIAL INSTRUMENTS - Other Investments (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "shortName": "FINANCIAL INSTRUMENTS - Other Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentHoldingsOtherThanSecuritiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "if6e5ee1601294977b6d1de5480476a4d_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - FINANCIAL INSTRUMENTS - Nonrecurring Fair Value Disclosures (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails", "shortName": "FINANCIAL INSTRUMENTS - Nonrecurring Fair Value Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - FINANCIAL INSTRUMENTS - Narrative (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "shortName": "FINANCIAL INSTRUMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i125cbe64167541debf0d9904285e178f_I20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CededPremiumsWritten", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - FINANCIAL INSTRUMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details)", "role": "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails", "shortName": "FINANCIAL INSTRUMENTS - Assets Measured at Fair Value On a Nonrecurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details)", "role": "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "shortName": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES - Liability for Unpaid Claims and Claims Adjustment Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CededPremiumsEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - RETROCESSION (Details)", "role": "http://www.greenlightre.ky/role/RETROCESSIONDetails", "shortName": "RETROCESSION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CededPremiumsEarned", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchasedDuringPeriodValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - SENIOR CONVERTIBLE NOTES (Details)", "role": "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "shortName": "SENIOR CONVERTIBLE NOTES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i6ac43a2de34a4cb587af7b2bd1815ebc_D20221001-20221102", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i8243595abfea4cd59534f2d713ac1108_I20201029", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - SHARE CAPITAL - Narrative (Details)", "role": "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "shortName": "SHARE CAPITAL - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i8243595abfea4cd59534f2d713ac1108_I20201029", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "id7aad07e821a4563a22e670b6f2c79b0_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - SHARE CAPITAL - Stock by Class (Details)", "role": "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails", "shortName": "SHARE CAPITAL - Stock by Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i301c65ca84254f1aa4ae0fd534d2a5e3_I20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "idd91c18f1bb2409a930c528205316177_D20220101-20220930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i252ba6309ea9488da6952aba24e95a83_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "shortName": "SHARE-BASED COMPENSATION - Restricted Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i7b8cf644b60b486cbf2e8165af47709c_D20220101-20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ibdbcac00e6ee40cab42fb7d4b219af25_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Units (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails", "shortName": "SHARE-BASED COMPENSATION - Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i9e6c0f70c63f4f8d817990aeee955363_D20220101-20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - SHARE-BASED COMPENSATION - Employee and Director Stock Option Activity (Details)", "role": "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "shortName": "SHARE-BASED COMPENSATION - Employee and Director Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i960bc619c2154d71b189ccea0d69f551_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ife01deaa514f43f8917601e7ae90bf1b_D20210101-20210930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - TAXATION - Narrative (Details)", "role": "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails", "shortName": "TAXATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - TAXATION - Components of Income Tax Expense (Benefit) (Details)", "role": "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails", "shortName": "TAXATION - Components of Income Tax Expense (Benefit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "if0b1a9de21bd40a5a0428659b175d4c0_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "glre:RelatedPartyTransactionInvestmentOwnedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "role": "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "if0b1a9de21bd40a5a0428659b175d4c0_I20220930", "decimals": "-5", "first": true, "lang": "en-US", "name": "glre:RelatedPartyTransactionInvestmentOwnedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "glre:NumberOfCreditFacilities", "reportCount": 1, "unitRef": "facility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i31bcde5b69844c48987d32d9c9b77cf8_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:LettersOfCreditOutstandingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i40a0c2c5d57e4860be3cabd8b4e592fe_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Letters of Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i40a0c2c5d57e4860be3cabd8b4e592fe_I20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details)", "role": "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Commitments and Contingencies, Fiscal Year Maturity Schedule (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ie0ab22f34f44454ea1f6eb3f01a4b36f_I20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails", "shortName": "SEGMENT REPORTING - Gross Premiums Written by Line of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ic52d0b0c322e4922b20bac86c8115f89_D20220701-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details)", "role": "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails", "shortName": "SEGMENT REPORTING - Gross Premiums Written by Geographic Area of Risks Insured (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "i5f3553877ab74d55a8513872f39f4853_D20220701-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AssumedPremiumsWritten", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION", "role": "http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - INVESTMENT IN RELATED PARTY INVESTMENT FUND", "role": "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND", "shortName": "INVESTMENT IN RELATED PARTY INVESTMENT FUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "glre-20220930.htm", "contextRef": "ia262d03a38404051ba604c9f51adf13f_D20220101-20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 81, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.greenlightre.ky/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "glre_AmortizationAndInterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization And Interest Expense Net", "label": "Amortization And Interest Expense Net", "negatedTerseLabel": "Amortization and interest expense, net of change in accruals" } } }, "localname": "AmortizationAndInterestExpenseNet", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_CapitalWithdrawalsPayable": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Withdrawals Payable", "label": "Capital Withdrawals Payable", "negatedTerseLabel": "Capital withdrawals payable" } } }, "localname": "CapitalWithdrawalsPayable", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "glre_CedentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cedents", "label": "Cedents [Member]", "terseLabel": "Cedents" } } }, "localname": "CedentsMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net increase (decrease) in fair value of unsold investments and derivatives not held for hedging whose gains and losses are included in net income.", "label": "Change In Unrealized Gains Losses On Investments And Derivatives", "negatedLabel": "Net change in unrealized gains and losses on investments and notes receivable" } } }, "localname": "ChangeInUnrealizedGainsLossesOnInvestmentsAndDerivatives", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_CitibankEuropePlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citibank Europe plc", "label": "Citibank Europe plc [Member]", "terseLabel": "Citibank Europe plc" } } }, "localname": "CitibankEuropePlcMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "glre_CollateralAssetsInvestementManagementAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral Assets Investement Management Agreement [Member]", "label": "Collateral Assets Investement Management Agreement [Member]", "terseLabel": "Collateral Assets Investment Management Agreement" } } }, "localname": "CollateralAssetsInvestementManagementAgreementMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_CollateralHeldInTrust": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash and securities posted as collateral by the retrocessionaire in a trust account for the benefit of the ceding reinsurer.", "label": "Collateral Held In Trust", "terseLabel": "Collateral held in trust" } } }, "localname": "CollateralHeldInTrust", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_DerivativeFinancialInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Financial Instruments", "label": "Derivative Financial Instruments [Member]", "terseLabel": "Derivative financial instruments (not designated as hedging instruments)" } } }, "localname": "DerivativeFinancialInstrumentsMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "glre_DividendExpense": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 3.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividend Expense", "label": "Dividend Expense", "negatedTerseLabel": "Dividends" } } }, "localname": "DividendExpense", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_EarningsPerShareAttributableToCommonStockholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share Attributable To Common Stockholders", "label": "Earnings Per Share Attributable To Common Stockholders [Abstract]", "terseLabel": "Earnings (loss) per Class A and Class B Ordinary share:" } } }, "localname": "EarningsPerShareAttributableToCommonStockholdersAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationGainLossOnInvestmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment", "label": "Equity Method Investment, Summarized Financial Information, Gain (Loss) On Investment [Abstract]", "terseLabel": "Realized and change in unrealized gains (losses)" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationGainLossOnInvestmentAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationInvestmentIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Investment Income", "label": "Equity Method Investment, Summarized Financial Information, Investment Income [Abstract]", "terseLabel": "Investment income" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationInvestmentIncomeAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndPartnersCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract]", "label": "Equity Method Investment, Summarized Financial Information, Liabilities And Partners' Capital [Abstract]", "terseLabel": "Liabilities and partners\u2019 capital" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndPartnersCapitalAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "glre_EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "glre_TotalExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Summarized Financial Information, Management Fee Expense", "label": "Equity Method Investment, Summarized Financial Information, Management Fee Expense", "terseLabel": "Management fees" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationManagementFeeExpense", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_EquityMethodInvestmentsSummarizedFinancialInformationExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investments, Summarized Financial Information, Expenses", "label": "Equity Method Investments, Summarized Financial Information, Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "EquityMethodInvestmentsSummarizedFinancialInformationExpensesAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "glre_FinancialGuaranteeInsuranceandSuretyProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialized insurance coverage relating to financial risks such as surety (surety bonds) and trade credit.", "label": "Financial Guarantee Insurance and Surety Product Line [Member]", "terseLabel": "Financial" } } }, "localname": "FinancialGuaranteeInsuranceandSuretyProductLineMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_FundsHeldByCedentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Funds Held by Cedents", "label": "Funds Held by Cedents [Policy Text Block]", "terseLabel": "Funds Held by Cedents" } } }, "localname": "FundsHeldByCedentsPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_GreenBricksPartnersIncGRBKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Green Bricks Partners, Inc. (GRBK)", "label": "Green Bricks Partners, Inc. (GRBK) [Member]", "terseLabel": "Green Bricks Partners Inc (GRBK)" } } }, "localname": "GreenBricksPartnersIncGRBKMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_GreenlightCapitalReLimitedPartnersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greenlight Capital Re Limited Partners [Member]", "label": "Greenlight Capital Re Limited Partners [Member]", "terseLabel": "GLRE Limited Partners" } } }, "localname": "GreenlightCapitalReLimitedPartnersMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_HurricaneIanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hurricane Ian", "label": "Hurricane Ian [Member]", "terseLabel": "Hurricane Ian" } } }, "localname": "HurricaneIanMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "domainItemType" }, "glre_IncurredLossesRelatedToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incurred Losses Related To [Abstract]", "label": "Incurred Losses Related To [Abstract]", "terseLabel": "Incurred losses related to:" } } }, "localname": "IncurredLossesRelatedToAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "glre_InvestmentAdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Advisory Agreement [Member]", "label": "Investment Advisory Agreement [Member]", "terseLabel": "Investment Advisory Agreement" } } }, "localname": "InvestmentAdvisoryAgreementMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_InvestmentIncome": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net income earned from investments in securities and other investments including derivatives. It includes dividends from shares in corporations, and interest from bonds, loans, mortgages, derivatives, commercial paper, bank accounts, certificates of deposits, treasuries, and other financial securities. It also includes realized and unrealized gains and losses on all investments.", "label": "Investment Income", "terseLabel": "Net investment income (loss)", "totalLabel": "Net investment income (loss)" } } }, "localname": "InvestmentIncome", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, to Be Paid, After Year Four", "label": "Lessee, Operating Lease, Liability, to Be Paid, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "glre_LiabilityandCasualtyInsuranceProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total casualty line of business for insurance operations", "label": "Liability and Casualty Insurance Product Line [Member]", "terseLabel": "Total Casualty" } } }, "localname": "LiabilityandCasualtyInsuranceProductLineMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_LimitedPartnershipAgreementInvestmentCapPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limited Partnership Agreement, Investment Cap Percentage", "label": "Limited Partnership Agreement, Investment Cap Percentage", "terseLabel": "LPA, investment cap percentage" } } }, "localname": "LimitedPartnershipAgreementInvestmentCapPercentage", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "percentItemType" }, "glre_LimitedPartnershipAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limited Partnership Agreement between SILP and its partners", "label": "Limited Partnership Agreement [Member]", "terseLabel": "Limited Partnership Agreement" } } }, "localname": "LimitedPartnershipAgreementMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_LineOfCreditFacilityTerminationNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination notice period for LOC facilities", "label": "Line Of Credit Facility, Termination Notice Period", "verboseLabel": "Notice period required for termination" } } }, "localname": "LineOfCreditFacilityTerminationNoticePeriod", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "glre_MarineCasualtyInsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marine Casualty Insurance [Member]", "label": "Marine Casualty Insurance [Member]", "terseLabel": "Marine" } } }, "localname": "MarineCasualtyInsuranceMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MeasurementPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period", "label": "Measurement Period [Axis]", "terseLabel": "Measurement Period [Axis]" } } }, "localname": "MeasurementPeriodAxis", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "stringItemType" }, "glre_MeasurementPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period [Domain]", "label": "Measurement Period [Domain]", "terseLabel": "Measurement Period [Domain]" } } }, "localname": "MeasurementPeriodDomain", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "domainItemType" }, "glre_MeasurementPeriodOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period One", "label": "Measurement Period One [Member]", "terseLabel": "Less than 6 months" } } }, "localname": "MeasurementPeriodOneMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "domainItemType" }, "glre_MeasurementPeriodThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period Three", "label": "Measurement Period Three [Member]", "terseLabel": "Over 1 year" } } }, "localname": "MeasurementPeriodThreeMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "domainItemType" }, "glre_MeasurementPeriodTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period Two", "label": "Measurement Period Two [Member]", "terseLabel": "6 to 12 months" } } }, "localname": "MeasurementPeriodTwoMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "domainItemType" }, "glre_MotorVehicleLiabilityCasualtyProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor liability line of business for insurance operations", "label": "Motor Vehicle Liability Casualty Product Line [Member]", "terseLabel": "Motor Liability" } } }, "localname": "MotorVehicleLiabilityCasualtyProductLineMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MotorVehiclePhysicalDamageProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Motor physical damage line of business for insurance operations", "label": "Motor Vehicle Physical Damage Product Line [Member]", "terseLabel": "Motor" } } }, "localname": "MotorVehiclePhysicalDamageProductLineMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_MultilineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-line [Member]", "label": "Multi-line [Member]", "terseLabel": "Multi-line" } } }, "localname": "MultilineMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_NonEmployeeDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Employee Director", "label": "Non Employee Director [Member]", "terseLabel": "Non Employee Director" } } }, "localname": "NonEmployeeDirectorMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_NumberOfCreditFacilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Credit Facilities", "label": "Number Of Credit Facilities", "terseLabel": "Number of credit facilities" } } }, "localname": "NumberOfCreditFacilities", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "integerItemType" }, "glre_OtherAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of immaterial items aggregated and included under the Other Assets line item on the balance sheet.", "label": "Other Assets [Policy Text Block]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_OtherInvestmentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Investments, Fair Value Disclosure", "label": "Other Investments, Fair Value Disclosure", "terseLabel": "Fair value / carrying value" } } }, "localname": "OtherInvestmentsFairValueDisclosure", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "glre_OtherLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of items aggregated and included under Other Liabilities on the balance sheet.", "label": "Other Liabilities [Policy Text Block]", "terseLabel": "Other Liabilities" } } }, "localname": "OtherLiabilitiesPolicyTextBlock", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "glre_PaidLossesRelatedToAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paid Losses Related To [Abstract]", "label": "Paid Losses Related To [Abstract]", "terseLabel": "Paid losses related to:" } } }, "localname": "PaidLossesRelatedToAbstract", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "glre_PerformanceRestrictedStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Restricted Stock", "label": "Performance Restricted Stock [Member]", "terseLabel": "Performance Restricted Shares" } } }, "localname": "PerformanceRestrictedStockMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "glre_PerformanceRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Restricted Stock Units", "label": "Performance Restricted Stock Units [Member]", "terseLabel": "Performance Restricted Stock Units", "verboseLabel": "Performance RSUs" } } }, "localname": "PerformanceRestrictedStockUnitsMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "glre_PremiumsWrittenGrossAsPercentageOfTotalGrossPremiumsWritten": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross written premiums by line of business as a percentage of total gross written premiums", "label": "Premiums Written, Gross As Percentage Of Total Gross Premiums Written", "terseLabel": "Gross premiums written (in percent)" } } }, "localname": "PremiumsWrittenGrossAsPercentageOfTotalGrossPremiumsWritten", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "percentItemType" }, "glre_PrivateAndUnlistedEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private equities and unlisted equity securities", "label": "Private and unlisted equity securities [Member]", "terseLabel": "Private investments and unlisted equities" } } }, "localname": "PrivateAndUnlistedEquitySecuritiesMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "glre_PrivateInvestmentsAndUnlistedEquitySecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Investments and Unlisted Equity Securities", "label": "Private Investments and Unlisted Equity Securities [Member]", "terseLabel": "Private Investments and Unlisted Equity Securities" } } }, "localname": "PrivateInvestmentsAndUnlistedEquitySecuritiesMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net realized gains (losses) on investments and derivatives sold during the period.", "label": "Realized Gains (Losses) On Sale Of Investments And Derivatives", "negatedLabel": "Net realized (gains)\u00a0losses on investments and notes receivable" } } }, "localname": "RealizedGainsLossesOnSaleOfInvestmentsAndDerivatives", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "glre_RelatedPartyTransactionAnnualManagementFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The annual rate charged by investment advisor calculated as a percentage of assets under management", "label": "Related Party Transaction, Annual Management Fee Percentage", "terseLabel": "Investment management fee rate - annual (in percent)" } } }, "localname": "RelatedPartyTransactionAnnualManagementFeePercentage", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Asset Redemption Notice To General Partner", "label": "Related Party Transaction, Asset Redemption Notice To General Partner", "terseLabel": "Asset redemption notice to general partner" } } }, "localname": "RelatedPartyTransactionAssetRedemptionNoticeToGeneralPartner", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionInvestmentOwnedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Investment Owned, Percentage", "label": "Related Party Transaction, Investment Owned, Percentage", "terseLabel": "Ownership percentage (in percent)" } } }, "localname": "RelatedPartyTransactionInvestmentOwnedPercentage", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionInvestmentOwnedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Investment Owned, Shares", "label": "Related Party Transaction, Investment Owned, Shares", "terseLabel": "Common stock held (in shares)" } } }, "localname": "RelatedPartyTransactionInvestmentOwnedShares", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "sharesItemType" }, "glre_RelatedPartyTransactionLossCarryForwardRecoupmentRequiredAsPercentageOfAggregateInvestmentLossEarned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The additional amount of investment income required after a period of investment loss, in order for the performance compensation rate to return from reduced rate to full rate.", "label": "Related Party Transaction, Loss Carry Forward Recoupment Required As Percentage Of Aggregate Investment Loss Earned", "terseLabel": "Loss carry forward recoupment required (in percent)" } } }, "localname": "RelatedPartyTransactionLossCarryForwardRecoupmentRequiredAsPercentageOfAggregateInvestmentLossEarned", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionMonthlyManagementFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The monthly rate charged by investment advisor calculated as a percentage of assets under management", "label": "Related Party Transaction, Monthly Management Fee Percentage", "terseLabel": "Investment management fee rate - monthly (in percent)" } } }, "localname": "RelatedPartyTransactionMonthlyManagementFeePercentage", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationFullRateAsPercentageOfInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The full rate of performance compensation as a percent of investment income charged by a related party.", "label": "Related Party Transaction, Performance Compensation Full Rate As Percentage Of Investment Income", "terseLabel": "Performance compensation full rate (in percent)" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationFullRateAsPercentageOfInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationReducedRateAsPercentageofInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision.", "label": "Related Party Transaction, Performance Compensation Reduced Rate As Percentage of Investment Income", "terseLabel": "Performance compensation reduced rate (in percent)" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationReducedRateAsPercentageofInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionPerformanceCompensationReducedRateasaPercentageofInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reduced rate charged by related party for performance compensation as a percent of investment income due to loss carry forward provision.", "label": "Related Party Transaction, Performance Compensation Reduced Rate as a Percentage of Investment Income", "terseLabel": "Performance compensation reduced rate (in percent)" } } }, "localname": "RelatedPartyTransactionPerformanceCompensationReducedRateasaPercentageofInvestmentIncome", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "percentItemType" }, "glre_RelatedPartyTransactionsAutomaticAgreementExtensionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions, Automatic Agreement Extension, Term", "label": "Related Party Transactions, Automatic Agreement Extension, Term", "terseLabel": "Automatic agreement extension, term (in years)" } } }, "localname": "RelatedPartyTransactionsAutomaticAgreementExtensionTerm", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "glre_RelatedPartyTransactionsContractTerminationPriorNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions, Contract Termination Prior Notice Period", "label": "Related Party Transactions, Contract Termination Prior Notice Period", "terseLabel": "Contract termination prior notice period (in days)" } } }, "localname": "RelatedPartyTransactionsContractTerminationPriorNoticePeriod", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "durationItemType" }, "glre_RussianUkrainianConflictMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Russian-Ukrainian Conflict", "label": "Russian-Ukrainian Conflict [Member]", "terseLabel": "Russian-Ukrainian Conflict" } } }, "localname": "RussianUkrainianConflictMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "domainItemType" }, "glre_SILPGeneralPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SILP General Partner", "label": "SILP General Partner [Member]", "terseLabel": "SILP General Partner" } } }, "localname": "SILPGeneralPartnerMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "glre_SeniorUnsecuredConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Convertible Notes [Member]", "label": "Senior Unsecured Convertible Notes [Member]", "terseLabel": "Senior Unsecured Convertible Notes" } } }, "localname": "SeniorUnsecuredConvertibleNotesMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "glre_ServiceAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service Agreement [Member]", "label": "Service Agreement [Member]", "terseLabel": "Service Agreement" } } }, "localname": "ServiceAgreementMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_ServiceRestrictedStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service Restricted Stock", "label": "Service Restricted Stock [Member]", "terseLabel": "Service Restricted Shares" } } }, "localname": "ServiceRestrictedStockMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails" ], "xbrltype": "domainItemType" }, "glre_ServiceRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service Restricted Stock Units", "label": "Service Restricted Stock Units [Member]", "terseLabel": "Service Restricted Stock Units" } } }, "localname": "ServiceRestrictedStockUnitsMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "glre_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversion Ratio", "terseLabel": "Conversion ratio (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConversionRatio", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "glre_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, Options, Exercised in period, weighted average grant date fair value", "label": "Share-based compensation arrangement by share-based payment award, Options, Exercised in period, weighted average grant date fair value", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "glre_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, Options, Expired in period, weighted average grant date fair value", "label": "Share-based compensation arrangement by share-based payment award, Options, Expired in period, weighted average grant date fair value", "terseLabel": "Expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "glre_SolasglasInvestmentsLPSILPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Solasglas Investment LP (SILP) [Member]", "label": "Solasglas Investments, LP (SILP) [Member]", "terseLabel": "Solasglas Investments, LP (SILP)" } } }, "localname": "SolasglasInvestmentsLPSILPMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "glre_TaxRecovered": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax Recovered", "label": "Tax Recovered", "terseLabel": "Tax recovered" } } }, "localname": "TaxRecovered", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "glre_TotalExpense": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Expense", "label": "Total Expense", "totalLabel": "Total" } } }, "localname": "TotalExpense", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "glre_TotalSpecialtyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total of all Specialty lines insurance products types [Domain]", "label": "Total Specialty [Domain]", "terseLabel": "Total Other" } } }, "localname": "TotalSpecialtyDomain", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_UnratedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No rating assigned by any external rating agencies.", "label": "Unrated [Member]", "terseLabel": "Unrated" } } }, "localname": "UnratedMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "glre_WorkersCompensationInsuranceProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Workers' compensation line of business of insurance coverage", "label": "Workers' Compensation Insurance Product Line [Member]", "terseLabel": "Workers' Compensation" } } }, "localname": "WorkersCompensationInsuranceProductLineMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "glre_WorldwideMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Worldwide", "label": "Worldwide [Member]", "terseLabel": "Worldwide" } } }, "localname": "WorldwideMember", "nsuri": "http://www.greenlightre.ky/20220930", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_AMBestAMinusRatingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AM Best, A- Rating [Member]", "terseLabel": "AM Best, A- Rating" } } }, "localname": "AMBestAMinusRatingMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r311", "r484", "r485", "r488", "r655" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia [Member]", "terseLabel": "Asia" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]", "terseLabel": "Board of Directors Chairman" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r35", "r37", "r86", "r87", "r243", "r283" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "srt_CreditRatingAMBestAxis": { "auth_ref": [ "r178", "r203", "r204", "r221", "r404" ], "lang": { "en-us": { "role": { "label": "Credit Rating, AM Best [Axis]", "terseLabel": "Credit Rating Source [Axis]" } } }, "localname": "CreditRatingAMBestAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "srt_CreditRatingAMBestDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Rating, AM Best [Domain]", "terseLabel": "Credit Rating Source [Domain]" } } }, "localname": "CreditRatingAMBestDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r2", "r94", "r102", "r108", "r197", "r355", "r356", "r357", "r379", "r380", "r411", "r414", "r416", "r417", "r479" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r2", "r94", "r102", "r108", "r197", "r355", "r356", "r357", "r379", "r380", "r411", "r414", "r416", "r417", "r479" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r2", "r94", "r102", "r108", "r197", "r355", "r356", "r357", "r379", "r380", "r411", "r414", "r416", "r417", "r479" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe (2)" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r174", "r305", "r308", "r588" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r215", "r216", "r217", "r218", "r242", "r282", "r312", "r313", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r585", "r589", "r656", "r657" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r215", "r216", "r217", "r218", "r242", "r282", "r312", "r313", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r585", "r589", "r656", "r657" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r174", "r305", "r308", "r588" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]", "terseLabel": "U.S. and Caribbean" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r169", "r216", "r217", "r305", "r306", "r504", "r584", "r586" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]", "verboseLabel": "Insurance Product Line [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r169", "r216", "r217", "r305", "r306", "r504", "r584", "r586" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "verboseLabel": "Insurance Product Line [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r210", "r215", "r216", "r217", "r218", "r242", "r282", "r309", "r312", "r313", "r344", "r345", "r346", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r585", "r589", "r656", "r657" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r210", "r215", "r216", "r217", "r218", "r242", "r282", "r309", "r312", "r313", "r344", "r345", "r346", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r585", "r589", "r656", "r657" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r36", "r37", "r86", "r87", "r243", "r283" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails", "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r170", "r171", "r305", "r307", "r587", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r170", "r171", "r305", "r307", "r587", "r644", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r176", "r487" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate202006Member": { "auth_ref": [ "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.", "label": "Accounting Standards Update 2020-06 [Member]", "terseLabel": "Accounting Standards Update 2020-06" } } }, "localname": "AccountingStandardsUpdate202006Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r95", "r96", "r97", "r98", "r181", "r182", "r194", "r195", "r196", "r197", "r198", "r199", "r355", "r356", "r357", "r379", "r380", "r390", "r391", "r392", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r456", "r457", "r464", "r465", "r466", "r476", "r477", "r478", "r479", "r480", "r481", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r21", "r493" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r91", "r92", "r93", "r355", "r356", "r357", "r416" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r95", "r96", "r97", "r98", "r108", "r181", "r182", "r194", "r195", "r196", "r197", "r198", "r199", "r355", "r356", "r357", "r377", "r378", "r379", "r380", "r390", "r391", "r392", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r456", "r457", "r464", "r465", "r466", "r467", "r476", "r477", "r478", "r479", "r480", "r481", "r505", "r506", "r507", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r315", "r358", "r359" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income or loss to net cash provided by\u00a0(used in)\u00a0operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r348" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock based compensation expense, net of forfeiture reversals" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r26", "r179", "r200", "r201", "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Loss and loss adjustment expenses recoverable, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r49", "r70", "r262", "r461" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Recognized interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares potentially issuable in connection with convertible notes and Anti-dilutive stock options outstanding (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r12", "r82", "r153", "r158", "r165", "r191", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r237", "r393", "r395", "r434", "r491", "r493", "r525", "r550" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r6", "r620", "r622", "r626", "r627" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "totalLabel": "Net Assets" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssumedPremiumsWritten": { "auth_ref": [ "r608" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_PremiumsWrittenNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of written premiums assumed from other entities.", "label": "Assumed Premiums Written", "terseLabel": "Gross premiums written", "verboseLabel": "Gross premiums written" } } }, "localname": "AssumedPremiumsWritten", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r402", "r403" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BenefitsLossesAndExpenses": { "auth_ref": [ "r569" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": -1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "glre_InvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.", "label": "Benefits, Losses and Expenses", "negatedTotalLabel": "Total expenses", "totalLabel": "Total expenses" } } }, "localname": "BenefitsLossesAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BenefitsLossesAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Benefits, Losses and Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "BenefitsLossesAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r8", "r9", "r72" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r74", "r523" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r65", "r72", "r76" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the period", "totalLabel": "Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r65", "r447" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededCreditRiskCollateralizationAxis": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "Information as to collaterization of reinsurance recoverables.", "label": "Ceded Credit Risk, Collateralization [Axis]", "terseLabel": "Ceded Credit Risk, Collateralization [Axis]" } } }, "localname": "CededCreditRiskCollateralizationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskCollateralizationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralization of ceded credit risk.", "label": "Ceded Credit Risk, Collateralization [Domain]", "terseLabel": "Ceded Credit Risk, Collateralization [Domain]" } } }, "localname": "CededCreditRiskCollateralizationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededCreditRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Ceded Credit Risk [Line Items]", "terseLabel": "Ceded Credit Risk" } } }, "localname": "CededCreditRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskSecuredMember": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "Reinsurance recoverable that is secured by collateral.", "label": "Ceded Credit Risk, Secured [Member]", "terseLabel": "Secured" } } }, "localname": "CededCreditRiskSecuredMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededCreditRiskTable": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.", "label": "Ceded Credit Risk [Table]", "terseLabel": "Ceded Credit Risk [Table]" } } }, "localname": "CededCreditRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskUnsecuredMember": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "Reinsurance recoverable that is not secured by collateral.", "label": "Ceded Credit Risk, Unsecured [Member]", "terseLabel": "Unsecured" } } }, "localname": "CededCreditRiskUnsecuredMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CededPremiumsEarned": { "auth_ref": [ "r562", "r570", "r605", "r606", "r609", "r611" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of earned premiums ceded to other entities.", "label": "Ceded Premiums Earned", "terseLabel": "Ceded premiums earned" } } }, "localname": "CededPremiumsEarned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededPremiumsWritten": { "auth_ref": [ "r609", "r611" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_PremiumsWrittenNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of written premiums ceded to other entities.", "label": "Ceded Premiums Written", "negatedTerseLabel": "Gross premiums ceded" } } }, "localname": "CededPremiumsWritten", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r541" ], "lang": { "en-us": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates of Deposit [Member]", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r17", "r19", "r20", "r79", "r82", "r112", "r116", "r123", "r126", "r128", "r134", "r135", "r136", "r191", "r225", "r230", "r231", "r232", "r236", "r237", "r280", "r281", "r285", "r289", "r296", "r434", "r663" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/Cover", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r212", "r213", "r214", "r219", "r645" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/Cover", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/Cover", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r91", "r92", "r416" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "verboseLabel": "Ordinary share capital" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary share capital, par value (in dollars per share)", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Ordinary share capital, authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Ordinary share capital, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r296" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance \u2013 end of period (in shares)", "periodStartLabel": "Balance \u2013 beginning of period (in shares)", "terseLabel": "Ordinary share capital, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20", "r493" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 28,569,346 (2021: 27,589,731): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,715 (2021: 6,254,715))" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r238", "r239", "r240", "r242", "r252", "r253", "r254", "r258", "r259", "r260", "r261", "r262", "r269", "r270", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Shares potentially issuable in connection with convertible notes", "verboseLabel": "Convertible debt securities" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r16", "r527", "r552", "r621" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Convertible senior notes payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r83", "r375", "r383", "r384" ], "calculation": { "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "negatedTerseLabel": "Current tax (expense) benefit" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r78", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r256", "r263", "r264", "r266", "r275" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "SENIOR CONVERTIBLE NOTES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r13", "r15", "r16", "r81", "r89", "r239", "r240", "r241", "r242", "r243", "r244", "r246", "r252", "r253", "r254", "r255", "r257", "r258", "r259", "r260", "r261", "r262", "r269", "r270", "r271", "r272", "r462", "r526", "r527", "r548" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r241", "r267" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r239", "r269", "r270", "r460", "r462", "r463" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Convertible debt, amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r254", "r269", "r270", "r433" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value of debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r30", "r268", "r460", "r462" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate (in percent)" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r30", "r240" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt interest rate (in percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r31", "r81", "r89", "r239", "r240", "r241", "r242", "r243", "r244", "r246", "r252", "r253", "r254", "r255", "r257", "r258", "r259", "r260", "r261", "r262", "r269", "r270", "r271", "r272", "r462" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r31", "r81", "r89", "r239", "r240", "r241", "r242", "r243", "r244", "r246", "r252", "r253", "r254", "r255", "r257", "r258", "r259", "r260", "r261", "r262", "r265", "r269", "r270", "r271", "r272", "r297", "r300", "r301", "r302", "r459", "r460", "r462", "r463", "r542" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date.", "label": "Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance", "terseLabel": "Shares authorized for issuance in relation to share purchase options granted to service provider (in shares)" } } }, "localname": "DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DeferredPolicyAcquisitionCostAmortizationExpense": { "auth_ref": [ "r70", "r543", "r565", "r572", "r573", "r575", "r596" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.", "label": "Deferred Policy Acquisition Costs, Amortization Expense", "terseLabel": "Acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCostAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredPolicyAcquisitionCosts": { "auth_ref": [ "r557", "r573", "r574", "r575", "r596", "r616" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.", "label": "Deferred Policy Acquisition Cost", "verboseLabel": "Deferred acquisition costs" } } }, "localname": "DeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Gross deferred tax asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Deferred tax asset valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsAssets": { "auth_ref": [ "r205", "r206" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.", "label": "Deposit Contracts, Assets", "terseLabel": "Deposit contracts, assets" } } }, "localname": "DepositContractsAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsLiabilities": { "auth_ref": [ "r205", "r206" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of liabilities as of the balance sheet date pertaining to amounts received by the insurer or reinsurer from the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.", "label": "Deposit Contracts, Liabilities", "terseLabel": "Deposit contracts, liabilities" } } }, "localname": "DepositContractsLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsPolicy": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.", "label": "Deposit Contracts, Policy [Policy Text Block]", "terseLabel": "Deposit Assets and Liabilities" } } }, "localname": "DepositContractsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepreciationNonproduction": { "auth_ref": [ "r70", "r208" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.", "label": "Depreciation, Nonproduction", "terseLabel": "Depreciation expense" } } }, "localname": "DepreciationNonproduction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r33", "r34", "r37", "r433" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative contracts, at fair value" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r33", "r34", "r37", "r433" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedTerseLabel": "Derivative contracts, at fair value" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r88", "r398", "r399", "r400", "r401", "r405" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r318", "r319", "r349", "r350", "r352", "r360" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "verboseLabel": "SHARE-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DividendAndInterestReceivable": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Dividend and Interest Receivable", "terseLabel": "Interest and dividends receivable" } } }, "localname": "DividendAndInterestReceivable", "nsuri": "http://fasb.org/us-gaap-sup/2022q3", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendIncomeOperating": { "auth_ref": [ "r536" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_InterestAndDividendIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating dividend income on securities.", "label": "Dividend Income, Operating", "terseLabel": "Dividend income (net of withholding taxes)" } } }, "localname": "DividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromCorrespondentBrokers": { "auth_ref": [ "r177", "r520", "r521" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount receivable from correspondent broker-dealer.", "label": "Due from Correspondent Brokers", "terseLabel": "Due from brokers" } } }, "localname": "DueFromCorrespondentBrokers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToCorrespondentBrokers": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount payable to correspondent broker-dealer.", "label": "Due to Correspondent Brokers", "negatedTerseLabel": "Due to brokers" } } }, "localname": "DueToCorrespondentBrokers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings (loss) per share (Class A and Class B)" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r47", "r100", "r101", "r102", "r103", "r104", "r109", "r112", "r126", "r127", "r128", "r131", "r132", "r417", "r418", "r533", "r564" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r47", "r100", "r101", "r102", "r103", "r104", "r112", "r126", "r127", "r128", "r131", "r132", "r417", "r418", "r533", "r564" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareDilutedLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r129", "r130" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r447" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Restricted shares" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation costs related to non-vested restricted shares" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Total compensation cost related to non-vested options not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Anti-dilutive stock options outstanding", "verboseLabel": "Employee and Director Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r41", "r42", "r43", "r91", "r92", "r93", "r96", "r105", "r107", "r133", "r197", "r296", "r303", "r355", "r356", "r357", "r379", "r380", "r416", "r448", "r449", "r450", "r451", "r452", "r453", "r481", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r5", "r82", "r191", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r5", "r82", "r191", "r434" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": { "auth_ref": [ "r5", "r82", "r191", "r434" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]", "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership interest (as a percent)" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]", "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "INVESTMENT IN RELATED PARTY INVESTMENT FUND" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUND" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsFairValueDisclosure": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investments accounted under the equity method.", "label": "Equity Method Investments, Fair Value Disclosure", "terseLabel": "Equity method investments, fair value" } } }, "localname": "EquityMethodInvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Schedule of Financial Information of Investment" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNiCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.", "label": "Equity Securities, FV-NI, Cost", "verboseLabel": "Cost" } } }, "localname": "EquitySecuritiesFvNiCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": { "auth_ref": [ "r14", "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI", "terseLabel": "Fair value / carrying value" } } }, "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGain": { "auth_ref": [ "r187" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Gain", "terseLabel": "Unrealized gains" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Loss", "negatedLabel": "Unrealized losses" } } }, "localname": "EquitySecuritiesFvNiUnrealizedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Carrying value" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r185" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount", "negatedTerseLabel": "Downward carrying value changes and impairment" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r186" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "terseLabel": "Upward carrying value changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r420", "r421", "r422", "r428", "r430" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Schedule of Carrying Values of Private Investments and Unlisted Equity Securities Carried under Measurement Alternative" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": { "auth_ref": [ "r420", "r421", "r423" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).", "label": "Fair Value Measurements, Nonrecurring [Table Text Block]", "terseLabel": "Assets Measured at Fair Value on a Nonrecurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r426", "r430" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r420", "r421", "r424", "r425", "r431" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]", "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value" } } }, "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value.", "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]", "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]" } } }, "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "terseLabel": "Fair values measured on a nonrecurring basis" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSAssetsMeasuredatFairValueOnaNonrecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r420", "r421", "r424", "r425", "r427", "r431" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Fair Value, Nonrecurring" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNonrecurringFairValueDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "verboseLabel": "FINANCIAL INSTRUMENTS" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue": { "auth_ref": [ "r522" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of obligations incurred from short sales.", "label": "Financial Instruments Sold, Not yet Purchased, at Fair Value", "negatedTerseLabel": "Investments sold short, at fair value" } } }, "localname": "FinancialInstrumentsSoldNotYetPurchasedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialStandbyLetterOfCreditMember": { "auth_ref": [ "r220", "r222" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation if defined events occur or fail to occur.", "label": "Financial Standby Letter of Credit [Member]", "terseLabel": "Facility" } } }, "localname": "FinancialStandbyLetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r443", "r444", "r445", "r446" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign exchange\u00a0(gains) losses" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r445", "r446" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Realized", "terseLabel": "Foreign currency transaction loss" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Exchange" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FundsHeldUnderReinsuranceAgreementsLiability": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of funds held as security for payments to be received under reinsurance contracts.", "label": "Funds Held under Reinsurance Agreements, Liability", "verboseLabel": "Funds withheld" } } }, "localname": "FundsHeldUnderReinsuranceAgreementsLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r54", "r70", "r183" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "totalLabel": "Net gain (loss) on investment transactions" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r70", "r273", "r274" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Net realized gain on repurchase of convertible senior notes payable" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r52" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and Administrative Expense" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of business insurance which provides insurance coverage for a wide variety of liability exposures including, but not limited to, contractual liability, product liability and personal injury liability.", "label": "General Liability [Member]", "terseLabel": "General Liability" } } }, "localname": "GeneralLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HealthInsuranceProductLineMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Product line consisting of insurance against loss by illness or injury.", "label": "Health Insurance Product Line [Member]", "terseLabel": "Accident & Health", "verboseLabel": "Health" } } }, "localname": "HealthInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncentiveFeeExpense": { "auth_ref": [ "r486" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "glre_TotalExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for incentive rights held by the managing member or general partner, of limited liability company (LLC) or limited partnership (LP).", "label": "Incentive Fee Expense", "terseLabel": "Performance allocation" } } }, "localname": "IncentiveFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [ "r43", "r51" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss) Attributable to Parent, before Tax", "totalLabel": "Income (loss) before income tax" } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r209", "r211" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r84", "r366", "r368", "r374", "r381", "r385", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "TAXATION" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Examination [Line Items]", "terseLabel": "Income Tax Examination" } } }, "localname": "IncomeTaxExaminationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationTable": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.", "label": "Income Tax Examination [Table]", "terseLabel": "Income Tax Examination [Table]" } } }, "localname": "IncomeTaxExaminationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r85", "r106", "r107", "r152", "r365", "r382", "r386", "r566" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax (expense) benefit", "negatedTotalLabel": "Income tax (expense) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r40", "r363", "r364", "r368", "r369", "r373", "r376" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Taxation" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income tax paid in cash" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredPolicyAcquisitionCosts": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.", "label": "Increase (Decrease) in Deferred Policy Acquisition Costs", "negatedLabel": "Deferred acquisition costs" } } }, "localname": "IncreaseDecreaseInDeferredPolicyAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in funds held under reinsurance agreements or treaty (contract between the reinsurer and the ceding entity stipulating the manner in which insurance written on various risks is to be shared).", "label": "Increase (Decrease) in Funds Held under Reinsurance Agreements", "negatedLabel": "Funds withheld" } } }, "localname": "IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve", "terseLabel": "Loss and loss adjustment expense reserves" } } }, "localname": "IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInNotesReceivables": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of the amounts due from borrowers for outstanding secured or unsecured loans evidenced by a note.", "label": "Increase (Decrease) in Notes Receivables", "negatedTerseLabel": "Change in notes receivable" } } }, "localname": "IncreaseDecreaseInNotesReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Net change in" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets, excluding depreciation" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in the premium receivable balance on the balance sheet.", "label": "Increase (Decrease) in Premiums Receivable", "negatedLabel": "Reinsurance balances receivable" } } }, "localname": "IncreaseDecreaseInPremiumsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidReinsurancePremiums": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in prepaid reinsurance premiums recorded on the balance sheet, which is needed to adjust net income to arrive at net cash flows provided by or used in operations.", "label": "Increase (Decrease) in Prepaid Reinsurance Premiums", "negatedLabel": "Unearned premiums ceded" } } }, "localname": "IncreaseDecreaseInPrepaidReinsurancePremiums", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReinsurancePayables": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due to other insurance companies when the reporting entity has assumed a portion of the cedant's insurance risk which has resulted in insurance losses.", "label": "Increase (Decrease) in Reinsurance Payables", "terseLabel": "Reinsurance balances payable" } } }, "localname": "IncreaseDecreaseInReinsurancePayables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReinsuranceRecoverable": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.", "label": "Increase (Decrease) in Reinsurance Recoverable", "negatedLabel": "Loss and loss adjustment expenses recoverable" } } }, "localname": "IncreaseDecreaseInReinsuranceRecoverable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.", "label": "Increase (Decrease) in Unearned Premiums", "terseLabel": "Unearned premium reserves" } } }, "localname": "IncreaseDecreaseInUnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInUnearnedPremiumsNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of decrease (increase) in unearned premiums.", "label": "(Increase) Decrease in Unearned Premiums, Net", "terseLabel": "Change in net unearned premium reserves" } } }, "localname": "IncreaseDecreaseInUnearnedPremiumsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r121", "r122", "r128" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Effect of settling the convertible debt in shares (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r113", "r114", "r115", "r128", "r317" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Effect of dilutive employee and director share-based awards (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InsuranceLossReservesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Insurance Loss Reserves [Abstract]", "terseLabel": "Insurance Loss Reserves [Abstract]" } } }, "localname": "InsuranceLossReservesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InterestAndDividendIncomeOperating": { "auth_ref": [ "r534" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "glre_InvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.", "label": "Interest and Dividend Income, Operating", "totalLabel": "Total Investment income" } } }, "localname": "InterestAndDividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r529", "r560" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity).", "label": "Interest and Dividends Payable", "negatedTerseLabel": "Interest and dividends payable" } } }, "localname": "InterestAndDividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r44", "r151", "r458", "r461", "r539" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 4.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDeposits": { "auth_ref": [ "r538" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of interest expense on all deposits.", "label": "Interest Expense, Deposits", "negatedTerseLabel": "Deposit interest expense", "terseLabel": "Deposit interest expense" } } }, "localname": "InterestExpenseDeposits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "terseLabel": "Schedule of Interest Income and Interest Expense" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeDepositsWithFinancialInstitutions": { "auth_ref": [ "r537", "r663", "r664" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.", "label": "Interest Income, Deposits with Financial Institutions", "terseLabel": "Deposit interest income" } } }, "localname": "InterestIncomeDepositsWithFinancialInstitutions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r535" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "totalLabel": "Deposit interest income/(expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESInterestIncomeandInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestOnConvertibleDebtNetOfTax": { "auth_ref": [ "r111", "r118", "r128" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.", "label": "Interest on Convertible Debt, Net of Tax", "terseLabel": "Add: interest on convertible notes" } } }, "localname": "InterestOnConvertibleDebtNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r63", "r66", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid in cash" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentHoldingsOtherThanSecuritiesTextBlock": { "auth_ref": [ "r639" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the investment holdings which are represented by other than securities (for example, commodities). The investment holdings, other than securities investments table lists the long positions of non-security investments held by entity.", "label": "Investment Holdings, Other than Securities [Table Text Block]", "terseLabel": "Schedule of Other Investments" } } }, "localname": "InvestmentHoldingsOtherThanSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r53", "r150" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_InterestAndDividendIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r640", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r640", "r641", "r642", "r643" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Investments": { "auth_ref": [ "r559" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "totalLabel": "Total investments" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments [Abstract]", "verboseLabel": "Investments" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r12" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Investments", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investment in related party investment fund", "verboseLabel": "Investments, at fair value" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Commitment for Operating Lease Liabilities for Future Annual Periods" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r474" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less Imputed Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Aggregate amount of letters of credit issued" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r28", "r82", "r159", "r191", "r225", "r226", "r227", "r230", "r231", "r232", "r233", "r234", "r236", "r237", "r394", "r395", "r396", "r434", "r491", "r492" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "negatedTotalLabel": "Total liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r25", "r82", "r191", "r434", "r493", "r528", "r555" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r579", "r582" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense", "periodEndLabel": "Gross balance at September 30", "periodStartLabel": "Gross balance at January 1", "totalLabel": "Total" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Liability for Claims and Claims Adjustment Expense [Line Items]", "terseLabel": "Liability for Claims and Claims Adjustment Expense" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability": { "auth_ref": [ "r579", "r582" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to casualty insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense, Property-Casualty Liability", "verboseLabel": "Loss and loss adjustment expense reserves" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.", "label": "Liability for Claims and Claims Adjustment Expense [Table]", "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.", "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]", "terseLabel": "LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES" } } }, "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVES" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "auth_ref": [ "r581" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "negatedTerseLabel": "Current year" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "auth_ref": [ "r581" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "negatedTerseLabel": "Prior years" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency gain (loss) which decreases (increases) the cost of settling unpaid claims after deduction of reinsurance recoveries. Includes, but is not limited to, claims which have been incurred but not reported.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency revaluation" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": { "auth_ref": [ "r603" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount", "terseLabel": "IBNR" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "auth_ref": [ "r580" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "totalLabel": "Total incurred" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "auth_ref": [ "r547", "r579", "r582" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "periodEndLabel": "Net balance at September 30", "periodStartLabel": "Net balance at January 1" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments": { "auth_ref": [ "r583" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments", "terseLabel": "Loss adjustment expense reserves" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount", "terseLabel": "Case reserves" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r27", "r81" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r27", "r81" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r27" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum Facility Limit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r27", "r81" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESLettersofCreditFacilitiesDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r89", "r223", "r258" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "Long-term debt, maturity, year one" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "Long-term debt, maturity, remainder of fiscal year" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r31", "r224" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r486" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Fee Expense", "negatedTerseLabel": "Management fee" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r65" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r65" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r65", "r68", "r71" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r5", "r38", "r39", "r43", "r46", "r71", "r82", "r95", "r100", "r101", "r102", "r103", "r106", "r107", "r124", "r153", "r157", "r161", "r164", "r167", "r191", "r225", "r226", "r227", "r230", "r231", "r232", "r233", "r234", "r236", "r237", "r418", "r434", "r532", "r563" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r100", "r101", "r102", "r103", "r109", "r110", "r125", "r128", "r153", "r157", "r161", "r164", "r167" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income (loss) - basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerator for earnings per share" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r111", "r117", "r118", "r119", "r120", "r125", "r128" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net income (loss) - diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r94", "r95", "r96", "r97", "r98", "r99", "r102", "r108", "r131", "r181", "r182", "r194", "r195", "r196", "r197", "r198", "r199", "r355", "r356", "r357", "r377", "r378", "r379", "r380", "r390", "r391", "r392", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r456", "r457", "r464", "r465", "r466", "r467", "r476", "r477", "r478", "r479", "r480", "r481", "r505", "r506", "r507", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]", "terseLabel": "Year ending December 31," } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r469" ], "calculation": { "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESCommitmentsandContingenciesFiscalYearMaturityScheduleDetails", "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r468" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r473", "r475" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate on operating leases (as a percent)" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r472", "r475" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term on operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r7", "r397" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/ORGANIZATIONANDBASISOFPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r11", "r524", "r549" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "verboseLabel": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r402", "r406" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInsuranceProductLineMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage, classified as other.", "label": "Insurance, Other [Member]", "terseLabel": "Other Specialty" } } }, "localname": "OtherInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestments": { "auth_ref": [ "r10", "r558" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Investments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments classified as other.", "label": "Other Investments", "terseLabel": "Other investments" } } }, "localname": "OtherInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]", "terseLabel": "Total other investments" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r530" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "negatedTerseLabel": "Other liabilities", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r67", "r581" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "negatedTotalLabel": "Total paid" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r61" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of Class A ordinary shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r59" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Contributions to related party investment fund" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": { "auth_ref": [ "r60" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).", "label": "Payments to Acquire Trading Securities Held-for-investment", "negatedTerseLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PledgingPurposeAxis": { "auth_ref": [ "r393", "r395", "r501", "r502" ], "lang": { "en-us": { "role": { "documentation": "Information by pledging purpose of pledged asset owned.", "label": "Pledging Purpose [Axis]", "terseLabel": "Pledging Purpose [Axis]" } } }, "localname": "PledgingPurposeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PledgingPurposeDomain": { "auth_ref": [ "r393", "r395", "r501", "r502" ], "lang": { "en-us": { "role": { "documentation": "Pledging purpose of pledged asset owned.", "label": "Pledging Purpose [Domain]", "terseLabel": "Pledging Purpose [Domain]" } } }, "localname": "PledgingPurposeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": { "auth_ref": [ "r544", "r568" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.", "label": "Policyholder Benefits and Claims Incurred, Net", "terseLabel": "Net loss and loss adjustment expenses incurred" } } }, "localname": "PolicyholderBenefitsAndClaimsIncurredNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19", "r280" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred share capital, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred share capital, authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19", "r280" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred share capital, issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19", "r493" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsAndOtherReceivablesNet": { "auth_ref": [ "r561" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.", "label": "Premiums and Other Receivables, Net", "terseLabel": "Reinsurance balances receivable (net of allowance for expected credit losses of $89 and $89)", "verboseLabel": "Reinsurance balances receivable" } } }, "localname": "PremiumsAndOtherReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsEarnedNet": { "auth_ref": [ "r531", "r562", "r571", "r612" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.", "label": "Premiums Earned, Net", "totalLabel": "Net premiums earned" } } }, "localname": "PremiumsEarnedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsWrittenNet": { "auth_ref": [ "r607", "r610" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_PremiumsEarnedNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums written.", "label": "Premiums Written, Net", "totalLabel": "Net premiums written" } } }, "localname": "PremiumsWrittenNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidReinsurancePremiums": { "auth_ref": [ "r578", "r617" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The unexpired portion of premiums ceded on policies in force as of the balance sheet date.", "label": "Prepaid Reinsurance Premiums", "terseLabel": "Unearned premiums ceded" } } }, "localname": "PrepaidReinsurancePremiums", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "auth_ref": [ "r57", "r64" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "terseLabel": "Proceeds from redemptions from related party investment fund" } } }, "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForTradingSecurities": { "auth_ref": [ "r56", "r58", "r73" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from sales and purchases of trading securities.", "label": "Proceeds from (Payments for) Trading Securities, Short-Term", "terseLabel": "Proceeds from sales of investments" } } }, "localname": "ProceedsFromPaymentsForTradingSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r623", "r625" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_BenefitsLossesAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "negatedTerseLabel": "Professional fees and other" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalMalpracticeLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business insurance coverage for professionals, such as doctors, lawyers, insurance agents, accountants, real estate agents, veterinarians, and others. This liability coverage insures losses for claims arising from mistakes and errors or omissions in the course of professional activities.", "label": "Professional Malpractice Liability Insurance [Member]", "terseLabel": "Professional Liability" } } }, "localname": "ProfessionalMalpracticeLiabilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyAndCasualtyCommercialInsuranceProductLineMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage to policyholder on commercial property against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury.", "label": "Property and Casualty, Commercial Insurance [Member]", "terseLabel": "Commercial" } } }, "localname": "PropertyAndCasualtyCommercialInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyAndCasualtyPersonalInsuranceProductLineMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage to individual against property-related loss. Includes, but is not limited to, damage, theft, or legal liability for personal injury.", "label": "Property and Casualty, Personal Insurance [Member]", "terseLabel": "Personal" } } }, "localname": "PropertyAndCasualtyPersonalInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyInsuranceProductLineMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Contract providing insurance coverage against damage to or theft of property.", "label": "Property Insurance [Member]", "terseLabel": "Total Property" } } }, "localname": "PropertyInsuranceProductLineMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r567" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 2.0, "parentTag": "us-gaap_GainLossOnInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "terseLabel": "Net realized gain (loss)" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceAccountingPolicy": { "auth_ref": [ "r613", "r614", "r619" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.", "label": "Reinsurance Accounting Policy [Policy Text Block]", "terseLabel": "Reinsurance Assets" } } }, "localname": "ReinsuranceAccountingPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReinsuranceCostsAndRecoveriesNet": { "auth_ref": [ "r544" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of recovery (expense) related to provision for policy benefits and costs incurred for policies assumed and ceded.", "label": "Policyholder Benefits and Claims Incurred, Assumed and Ceded", "terseLabel": "Loss and loss expenses recovered and recoverable" } } }, "localname": "ReinsuranceCostsAndRecoveriesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reinsurance Disclosures [Abstract]", "terseLabel": "Reinsurance Disclosures [Abstract]" } } }, "localname": "ReinsuranceDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReinsurancePayable": { "auth_ref": [], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.", "label": "Reinsurance Payable", "verboseLabel": "Reinsurance balances payable" } } }, "localname": "ReinsurancePayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "auth_ref": [ "r546", "r577", "r579", "r582" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "terseLabel": "Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of $47 and $47)", "verboseLabel": "Add: Losses recoverable" } } }, "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverables": { "auth_ref": [ "r546", "r556", "r576" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.", "label": "Reinsurance Recoverables, Including Reinsurance Premium Paid", "negatedLabel": "Less: Losses recoverable", "verboseLabel": "Loss and loss adjustment expenses recoverable" } } }, "localname": "ReinsuranceRecoverables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails", "http://www.greenlightre.ky/role/RETROCESSIONDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverablesAllowance": { "auth_ref": [ "r200", "r201", "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on reinsurance recoverable.", "label": "Reinsurance Recoverable, Allowance for Credit Loss", "verboseLabel": "Allowance for expected credit losses" } } }, "localname": "ReinsuranceRecoverablesAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceTextBlock": { "auth_ref": [ "r544", "r545", "r613", "r614", "r619" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.", "label": "Reinsurance [Text Block]", "verboseLabel": "RETROCESSION" } } }, "localname": "ReinsuranceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RETROCESSION" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r311", "r484", "r485" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r311", "r484", "r485", "r488" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r484" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Investor relations monthly fee" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r311", "r484", "r488", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r482", "r483", "r485", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r62" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments of Senior Debt", "negatedTerseLabel": "Repurchases of convertible senior notes payable" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r9", "r72", "r76", "r523", "r553" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash and cash equivalents" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Participating securities\u00a0excluded from calculation of loss per share", "verboseLabel": "Employee and Director Restricted Shares" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r303", "r493", "r554", "r597", "r602" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r91", "r92", "r93", "r96", "r105", "r107", "r197", "r355", "r356", "r357", "r379", "r380", "r416", "r593", "r595" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings (deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Gross Premiums Written by Geographic Area of Risks Insured" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r50", "r228", "r230", "r231", "r235", "r236", "r237", "r624" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "negatedLabel": "Loss (income) from investments in related party investment fund", "netLabel": "Revenue from related parties", "terseLabel": "Income (loss) from investment in related party investment fund (net of related party expenses - Note 3)", "verboseLabel": "GLRE limited partners\u2019 share of net income (loss)" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r45", "r82", "r148", "r149", "r156", "r162", "r163", "r169", "r170", "r174", "r191", "r225", "r226", "r227", "r230", "r231", "r232", "r233", "r234", "r236", "r237", "r434", "r540" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Net Income (Loss) and Weighted Average Number of Shares" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": { "auth_ref": [ "r112", "r116", "r126", "r128", "r132" ], "lang": { "en-us": { "role": { "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.", "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Gross Premiums Written by Geographic Area of Risks Insured [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyGeographicAreaofRisksInsuredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r5", "r82", "r190", "r191", "r434" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDFinancialInformationofInvestmentDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDNarrativeDetails", "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense" } } }, "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "terseLabel": "Schedule of Letters of Credit Facilities" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r486", "r488" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/RELATEDPARTYTRANSACTIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r76", "r523", "r553" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Restrictions on Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r153", "r154", "r160", "r207" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r153", "r154", "r160", "r207" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Gross Premiums Written by Line of Business" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r314", "r316", "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r322", "r337", "r340" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Activity for Employee and Director Stock Options" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Activity for Unvested Restricted Share Awards and Employee Restricted Stock Units" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r17", "r19", "r20", "r79", "r134", "r135", "r276", "r278", "r279", "r280", "r281", "r282", "r283", "r285", "r289", "r294", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r18", "r19", "r20", "r277", "r278", "r279", "r297", "r298", "r299", "r300", "r301", "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Schedule of Stock by Class" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/FINANCIALINSTRUMENTSOtherInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r144", "r146", "r147", "r153", "r155", "r161", "r165", "r166", "r167", "r168", "r169", "r173", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTING" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SEGMENTREPORTINGGrossPremiumsWrittenbyLineofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r69" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Cliff vesting period after date of issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)", "terseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of shares issued to employees RSUs (in shares)", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r331", "r332" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Unvested performance restricted shares outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of non-vested restricted \u00a0shares", "verboseLabel": "Number of non-vested RSUs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r331", "r332" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)", "terseLabel": "Unvested weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted \u00a0average grant date fair value", "verboseLabel": "Weighted \u00a0average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r339" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Total fair value of restricted shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONPerformanceRestrictedShareActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Shares authorized for the company's stock incentive plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares available for future issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "negatedTerseLabel": "Expired (in shares)", "terseLabel": "Expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeitures (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r354" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "terseLabel": "Options outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of \u00a0options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Balance at end of period (in dollars per share)", "periodStartLabel": "Balance at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted \u00a0average \u00a0exercise \u00a0price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r319", "r320", "r321", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercises (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expirations (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeitures (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Grants (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Cliff vesting percentage after date of issuance (in percent)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Balance at end of period (in dollars per share)", "periodStartLabel": "Balance at beginning of period (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted \u00a0average \u00a0grant date \u00a0fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r77", "r90" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r17", "r19", "r20", "r79", "r82", "r112", "r116", "r123", "r126", "r128", "r134", "r135", "r136", "r191", "r225", "r230", "r231", "r232", "r236", "r237", "r280", "r281", "r285", "r289", "r296", "r434", "r663" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/Cover", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r32", "r41", "r42", "r43", "r91", "r92", "r93", "r96", "r105", "r107", "r133", "r197", "r296", "r303", "r355", "r356", "r357", "r379", "r380", "r416", "r448", "r449", "r450", "r451", "r452", "r453", "r481", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r91", "r92", "r93", "r133", "r504" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": { "auth_ref": [ "r353" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, Forfeited", "terseLabel": "Stock-based compensation expense" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r19", "r20", "r296", "r303" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issue of ordinary shares, net of forfeitures (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r296", "r303" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Restricted shares issued pursuant to stock incentive plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r19", "r20", "r296", "r303", "r328" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)", "terseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONEmployeeandDirectorStockOptionActivityDetails", "http://www.greenlightre.ky/role/SHAREBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r19", "r20", "r303", "r338" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issue of Class A ordinary shares, net of forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r19", "r20", "r296", "r303" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedLabel": "Repurchase of ordinary shares (in shares)", "terseLabel": "Repurchase of ordinary shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITALNarrativeDetails", "http://www.greenlightre.ky/role/SHARECAPITALStockbyClassDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r19", "r20", "r296", "r303" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Repurchased of ordinary shares (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r19", "r20", "r296", "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Repurchase of Class A ordinary shares", "terseLabel": "Repurchased and cancelled shares amount" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r23", "r24", "r82", "r180", "r191", "r434", "r493" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedTerseLabel": "Decrease in shareholders' equity", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r80", "r281", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r295", "r303", "r304", "r407" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHARE CAPITAL" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SHARECAPITAL" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r454", "r494" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r454", "r494" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r454", "r494" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplementary information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r580" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.", "label": "Current Year Claims and Claims Adjustment Expense", "terseLabel": "Current year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r580" ], "calculation": { "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.", "label": "Prior Year Claims and Claims Adjustment Expense", "terseLabel": "Prior years", "verboseLabel": "Estimate of net losses, change" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "auth_ref": [ "r361", "r362" ], "calculation": { "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.", "label": "Tax Adjustments, Settlements, and Unusual Provisions", "negatedTerseLabel": "Deferred tax (expense) benefit" } } }, "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r95", "r96", "r97", "r98", "r108", "r181", "r182", "r194", "r195", "r196", "r197", "r198", "r199", "r355", "r356", "r357", "r377", "r378", "r379", "r380", "r390", "r391", "r392", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r456", "r457", "r464", "r465", "r466", "r467", "r476", "r477", "r478", "r479", "r480", "r481", "r505", "r506", "r507", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance expense" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SENIORCONVERTIBLENOTESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnearnedPremiums": { "auth_ref": [ "r551" ], "calculation": { "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.", "label": "Unearned Premiums", "verboseLabel": "Unearned premium reserves" } } }, "localname": "UnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r70" ], "calculation": { "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails": { "order": 1.0, "parentTag": "us-gaap_GainLossOnInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "terseLabel": "Net change in unrealized appreciation (depreciation)" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/INVESTMENTINRELATEDPARTYINVESTMENTFUNDSummarizedStatementsofAssetsLiabilitiesandNetAssetsofSILPDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemAxis": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Axis]", "terseLabel": "Unusual or Infrequent Item, or Both [Axis]" } } }, "localname": "UnusualOrInfrequentItemAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemDomain": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Domain]", "terseLabel": "Unusual or Infrequent Item, or Both [Domain]" } } }, "localname": "UnusualOrInfrequentItemDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/LOSSANDLOSSADJUSTMENTEXPENSERESERVESLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r137", "r138", "r139", "r140", "r141", "r142", "r143" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r372" ], "calculation": { "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Decrease (increase) in deferred tax valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/TAXATIONComponentsofIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r111", "r128" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares outstanding - diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average number of ordinary shares used in the determination of earnings and loss per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r109", "r128" ], "calculation": { "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average shares outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominator for earnings per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.greenlightre.ky/role/SIGNIFICANTACCOUNTINGPOLICIESNetIncomeLossandWeightedAverageNumberofSharesDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=99383045&loc=d3e9351-108337" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=99397363&loc=d3e9420-108338" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r219": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907419&loc=d3e10037-110241" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r275": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r360": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28511-109314" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28446-109314" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r389": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r397": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498357-110258" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r455": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r490": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.20)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=35710130&loc=d3e41645-110958" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=35711043&loc=d3e42429-110968" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(c))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-5)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.4)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.6)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6480726&loc=d3e6691-158385" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(13)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(6))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(7))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f,g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(7)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5,6,7)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "340", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6485982&loc=d3e22818-158507" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(cc)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "9C", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "40", "Subparagraph": "(SAB TOPIC 5.W)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907" }, "r604": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/subtopic&trid=2560295" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "605", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=84167274&loc=d3e27175-158546" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(a)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(b)(3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)(3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "605", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "605", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506110&loc=d3e32546-158582" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r619": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "944", "URI": "https://asc.fasb.org/topic&trid=2303980" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r658": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r659": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r660": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r661": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r662": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r663": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r664": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r665": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" } }, "version": "2.1" } ZIP 76 0001385613-22-000120-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001385613-22-000120-xbrl.zip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�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Ð M'S-Q$C*N3629)8]4U0YZ_AA1EUR9"ORO2/YZYY4??RKN-OY6XE.?_:"83 >3 M0]\TU_WAQ]_]8 H]2K5# ))D)U&/LDA)B)F1Z'4./"5+;?73:Q-@7?)\*@A( M?6;45!U7OI^6W;(;7SQS9EP$3G1&8TL&:U&"\:3ES&EN%:3 0GVUL09-EWR< M.BJC!MFKB<$QVEGS@!S:URXD]*<$,8RAOLI*$L<30M$L&K39UCXNEUW?) MA:G Z&T)VT9P"\^E$9K3Y6!Z.VH^#(L$K@W,CGLJ4,L,.M3,6@2IHD("B(#2 M*+VA#% OI?9B8(\#VR7GIX+4[(=IU63L#61H&DAGHT$_7A]$/./&_4*IP]$8 M,7$N7.!@2 BB7)&"( $8.F^1.Q^YC2K5%J0?(]I$6LSSD9:*Y*^H=L:3IA\G MD%8;/ST%5"8: L(0D!1GGR+Y_S7J#R>_X]>G#8Q[.ADIHS,D.N5*%!.M?:",*"NM<51GD+5= MKYT =REFLZT,_< X:YF#=6\=EM?O6-"2ITRT%>@U&NV(,T5A&* .SWQKJF>T MW<70I7!.+='8B>?V<171V MYR;+[-'S\(=TR:1RP $'5Q+I@ 1'/4&G2)I,P;M06R&N@-$E-;L6[M,O+T7 )A>:0,Q.>X'H\KBIDXG-*A"ME652 5FIM!^$NAB[IL,I\WXG< M]6[/4IKY)'YPAA[L\?#07_4G?H!@E+$.M:D(AJ%>!4V"SXIDXXR)65'C:N>M MKH'2I:!S91&H0?R*KN'$]X>0CGPS[ \_C@]BG%X64D-"3[8?^Y.>REYD*M"T MH@DE-$7T3(1)!))PCB7IF+/5G<.'4'4I!%U9/BJSY(ZH_/7578J]P[_7KHXY MO\!??SLZN3@_?7MZ=O3^X.(8?WH;T@YE,FL>WV:]S"8KJE0X\QJ&R.?)^-UH M/)ZY.HN\W'%/FA#!0B8JJEG0VA+'-"=4*F%UX$RYVID":\'LJGG^@0]N_ "? M>) N^\/^>-(@NS[#XOD]H8 & )1L&G$+&6^(59D1Y[V)P*)VJ;9M_0"D+IFC M=63DKNJIR9.*0:H)H(M_DYT^\;S+%361*3(B72X M8O3"$%NRW#!A%'6U2PS60.F28;L7C;(5#_9S6WIP.6HF_?^9D>KF"&34)&HS M6O8.)59*B6*+ICY)(3+(5$GPM97+8S%V*6NC'1%JE6O5,T'_:/H3= R*TLL> MI+8A$:%81AS1D&"B)MIE"Y1E26GMX-I]%!5RKZ>7W^O$%@_NJ0129K D9HM. M:6 "&U.^GJ18TCWD8 SSQEA'D# M1$:AB+.QU(I&(:T6D;/:30]6X7BD74Z>DPSL3/=J$H K08MN= E%N_>L$3$' M$8C@$M=D1,+SN^AWJD127@A/:Y^,MP#L;AO>/.E@,FGZ83HI>5X7HS/?P'#2 M"]I%G@TG2$NDJZ:">&9*JPGON4%>XCJKFX@_0M0E-;>])-RW#JMQH:+74#!= M^*\+R$; N15[KRD=]OE0^"-<>SE91 M$ZCRZ-)32:1#+>\!S5'%*(ITBIE5;WKT&!-IF]OQSS"= UHYBK 73)1.N"O?KD'UG*2A)5$NY]W-%W1,9=7#FB2CTR!%'1.,4 M7TU"]* B%S;S.YR_GXRU\LE=NM/>B8V[TZUN9G[RO]99,_K]OOXPAG0\?-L?^F%$63B(D_[G M>3S8JNWH^8]7$V; M^,F/X30O%3#T'"24]\!(%KAJ*5!)VBP=":@4DP6M&:L=_WX8U2-MRM9#X6T( MTSVSLRZO*MJA5PMDI_D\AAP%19_>%2\NR])DE!(E$[-,40'5 M&T.O1M(IAWI/LE*!)U4;8]TIA+]7*'_[@Z5OGD'3'Z7[T=(XF)9Y+4=?<1<, M/\)[M,./R3I\3)DM?E$B^]>B.A6?JL1D8"_]0"U;;B7F7:HA\2C4F9V*[4,^%Z-9244# M%XTOXG .<=K,WE"&0.11T_\6).]E*J(141*>>"GC0JXYA?K$@I+16EV*W5N* M 3T"YG,("NTJ;NN"0FUQL\5$M-E\@:7.W;UH;$"/PA O@BA)I.ANE/FG$90 M T( KRUE#Z-Z#M&CVD)5F5<5DW-'$2"-R]WK4C3TGLCW(BX2BH0K5<;3:.W1 M*4 ?P2;JK&>695D]9KTAMBY9R?O246VPK9Y0W=6@\^XNO\'D4S&>OO>CTRK& MI$JR4\JE=)6I,@)%$.LUYVAGLU"]=?^FV!YILOX42JH5OK6BJE8#>],OY!FF M\6GSIO3@*,EU2%S4LI-I,SS--QVC#,L!E 4272F&88*18)!D++F$/W FJS9U MV4[@NU2D_ 3*;G^,;]M+6A4=MIJ#-*6RT9;,"Q]RZ608"5C+A;%.XN[JR.5 M#7/U)NOONQ54KENM+7VYK+!(!LI2R0VQA%LELI4NQ^J%WIO@>@Y^T*X"];#) MNB._]I"FJ2!Q!SR1G'V!(P/QO$PS=XH+35E$K!U-T_PI9*8.9RIV*;EJH'2^ M1@*=C(97S2A-8_E+Z<3D/5>:>!M-.8\B<<9ZPM""D5&@V9SKMR-9 ^89^"^U MY:0.8UJ,I*P>7M*C/GN=><%4BFQX5,0I(X@"SW7@,7!9NZ?GIMB>@\/2_A%5 M@6]U\LB7N^D<#-.=YDTE%]9'P\O5 /$F:R)#9GB(^I(4H%S@+,4$=XR]-8GE M#[[JD3[#LQ:-%HB_Q\KAGK#)N2P$<5%*]%!*=R>(E%@=HZ;!X:^USZ6'475I M,-63:9:=6-6B"#TP. DM< ?%W>;<"R*3*H,[&2L!0(4'J@G,M=!KXU$8'SG) MZEFKI[WPLA@VQ;!(V=@/6N!VA^K6M1AMZN&;@U> ME](+2\L 0%Z:^Z/$A]+U2T5@0JBDJ*L_QW-C>)L(FOO9#\8ZS*LW;NB3;^ U M(DN'H\MB[_FY7ZE9$L9$0CF@!Y YH@(JB>+1@V!*.UX[AWTUDHU"B?3G$IH* M/-F/KW_FK^>7\2JP&+1TA-I97T#+T3]@0(RPWJ/D)I;K3[;; -A&TK/'[G5/ M[N5OQ;$6A>GM=)AF"4(?ALB,): 'I6AS?GU*)2]3TBGZ"Z4-/*66>&9+D;0U M/BH!P=0?&;D%T(V$[6<+8;?/TFK2]W;4(.6'AZ4W_#!>7R"HL9^%48OY5ZR_ MUY#Q.Q?^:T\P&2C7G!@I=4GOQ^T!DA,HDUF= _0?:M<./@+>1I(F?C)):XM] M+6JW&^ON&K&O'>"]"+.]AS$TGZ$G>'#1<4MH+'1""Y"X( VA-#MJ/.6Y^I#D M*L WDLE]9:T_F?)KF^,M-54&I9R44I 42O<8GP2QU">2O(J4&@@>:H>]?M!4 M>8WP/'&>3FWAV9X#+6JLLP:N?#\M6XS? KC>.3RI(_JC''6J\*:GAL@VTBL?OYP^\Y,JQ-D?[\J7GON!W":UT=MA:1.:"5PZ<7531'/5X98 MC:26<<%82IO='&_S]HWDYZ>*KK?.HVJZZ1;"HZ^% -/^^%/!=YIG[4IB9$%P MAL7*Y]IGW(*B-),K])!+5#JO:[I5V?OR/D^.WQX<' M)Q<'AX>G'TXNCD_^<7;Z[OCP^.C\P8I:_X.*VC=E:N]@?'LAF[58:Q]4IZ9>I89NN]7+XSY@G$5'>,1?9)EA$4HC3PA6NL#P**WN@%5LM; =M8IG?/NI M!ZA+FN8:-_=\:CT/02BG@%CG%7K&$9TBZ1+18+,,7-(@:D=^-P+VTS3^>93< MW9L059V'%5/>[U#@[KI]"MHFI0BSZ ;); 4),G-BM+141^5BK'VP/X3IIVG7 MLY-05>7 M*".!C4HD9*N0Q)X)1SE-H7Z5_VHLM08-SY][,^/VC_[DTZ+KB1\<#\>3_F1> MX-<3PN-_UI) ;2)2NTB"-HH($:)5QCM>O2S]D1"[=+16D:!U52X)971*1CVL.5->M9#GL?4 ZST.*6E14';AP9,>@+)?&G(SF=\SWS"SE); MYT^C 6ZH\9O^8(H(>]$XD8(*1'M1YB)*0!-,)Y)4CE$PZ;6K?47]:)"U-.#I M\' T1)9,^OB^$FA")*>YY!C@/F;,,4MB*%9N<('8&"EQ/-H0N88 MBOE(B%UR4_)YB*V6&.Z'NTEG0IE2NO+S>'[_;WKGW MB#-7+@K)0RVBX\'@:>:H)]8%0;*Q69;N0=;7;MWQ*(!=.B;V*7WM<;%N2LY# M&V1N18V1N//[U:4F>P;DOG>O6)R_=_ MS73FBIZ/!NED-/D/3,X6\Q;3P>2M[S?SY)I(C3,AXX9B"%&6:T(KM2<4G/+) M:D99[09KCT?9)>U62V):YE6EEC3S/K[E;CDU_HL?C!?EWSV>.L*$12RI MQ,*%$R08E:)G25DK'K*'?_R*+KEU*A,[ M90CHL.$Z0Q8VH[.6H7K"Y$H@79I@5&O+[T[QZND9I8CBII?W0AKGY='E)R>C M89S_I1>-3ARRP!4[-,-B#J2H(L(]JB&3J:2V?A_.1T'L4I_V6@+3)I?JZ9'I M+ 2$",97(W3WAY/7S>A/:,8]EK4'KP3A1J$-9-!L#S8 22"50HT'3M0NR5L+ MIDLM%:OIDRJ4K^T#&RZ8,6B@<":+Q\9*9X[(28K&*.$,9[IV<20YW-N3'4)GFW K"&**^#TR4/:@NNKY#C*H2O M)'!3A39;Z;HFN2B9=)Z7Z$3T0@3*Z*/% MXK_%JR4<9/[1;'N2,6MU/8'P^#>-^ZOL& M-3S28!1GGR+N?XWZP\GO^/5I4RY'C!,!&%I^$A+!__$4$$D0QB-*=Y8VM]"6 M:@? 7?+(*JB=_3&O!9]ML?Z40VF+'(FWP%'JT8>T7 3"HM L9)=3J#W=_BZ& M+GEJ-0ZC74A%\PGJN)DF'.4YP99\%(\^)DSF'X_R^?&[L];OP'=& MMM?+\;ITW/'6?!9J_'ZTS?-->S)E([-0!*PR>%I!:;DBBH2ZY+GVPN?T$.M6 M/GE71?<:AI#[DT5G!MQEBV(5M/P5XZE,9D7##O>3Q,WJD\B$A4BET3$X4]OE M6@NF$U?FNW/VKF*K0_PV@Y+S17[K!=*3NLP1D91 9FCJAZ!)4(DBN)"U2U3P MU%;)Q'I477"YZ@M'96[4N9"Z&$W\8"&E/1T!M).,I"1+E$N4-RM) F<,/[>6 M2;^14EM^ZD[P5D_+_'X^K$JC^LT/_3QM^"W<5/[U''+&V4 )6A"\#,ZTQ&HC M"5)7..T3M6RSCE.U$'4AY+2;!-RZBWL21M7,OT44Z*(L F)TL;% E!.9)E$CR BT[7/BDW="P?O\JS M9I1A7$HO_ /*%R<$I3Q2 N92XM$7B;^&D%X<#)!".!M[9#@70Q=4H9UI."N MH.]$]6H2OM(>E>BA.#R:Y7P*2>+51\C<@="EN[UVMO$N-*_:1KHL MZ];DR!X@$BD,RB H->J/?$^)Y*]#,DE,,S6+B9:"637U=T>DGE_G=%Z[X./ M1 4V2]]PQ'E<-J.9R>@E-TY57N<#D+IDP>PN&W=%OB8_*O9;G4/Z#F2I87?/ ML*"HEKC_.O#_,KV:-_GQV=G!^]/\+_?S\Z_S90*8^:#\,RVF0^3*Z9 M+OTQI:JM078&O?-DWF^YD[?N,1 ..K!7T$RN#_UXZ@>3Z^.;43^SB8M?&M0X MS7A18O ?\ \.(NM1*T0R21((PA"I6"">HLX![D4.#**@M3MZ[&]U73(']KL3 M[LT5[J9$U9MEO=OZSIK^J-EH=0D85XI2@EYF:>N*)ZECY7:>\0B9"D.KE\;L M:VU=LHV>]6YI1YJJ[95%V[,Q+N>;2S[K:W@/'OKA25D1B(:2A1*E*&/CT*N@ M$HU4IM#?KBWL&X.KU2IBSI1#H(:(%',98URNIZ,F7J3D MH[ VT=I><"WL73H?VY'*=?UF]LKUZNU-MD'_32D5W:C*7*S,$'R&>=V-@U0: M7;B@0^;"\=H7:96@=^F,ZK[$;LOS5@3VX<,P)!&M%\1)%HEDN+EL\(9D97U) M:HVA>M[P8_#M?_.^AZM1,[DQ:0XN1]/AI,<,#=YE)% HP^Z$*JF;"MD*P&CV MB=.[">%/L'=7(>_28=.:7.Z^>W=F^A.>-CN3][=68YP% MU$6EF20J(,F$G*=>ILAY<+1HH]H]E=M:2Y?.HPX+=0N"T7:$^N+@WP<7QZ0H>P&?-6LJ.SP M4^D_?CQ<[ * "* $)1!*"4^$2%QVE#"EC>=2 ).UE_Y8C)THJZHI0G=57*M, MJU=L//=(UQ$@9FN2U&\3]&U*73L@VIJ4Q^97O9\ M-,%N]*NVQ8NZ^69-C<]A,ID'IHNQ]6$X+5'HV0#V\6QBH);)>Z$5"88R(KEV MQ&F52X\J88(-EE9/(GX4P"ZEI;6A -KC5MOF[N'I;[\=S_()2H;!X>EL8-W1 MR6SN^NCRLC]?44DB& U+;0 ,8Q_&;_MCA% B3+_Y21D=<'T>/T&:#G9)Q6@+ M2B7#>2^4JI5^ 6BJ?"_H> =^_*V%Y?5-_/+-%'J9:J^@E'88.QN.Y5$HI296 MH-9CH*6J'U7:$-O.G;17OZ$773"*F8A+Y@GWN?!"D%*I]=% M.-WJTC0&+025HZ>^=L7F5D"[9'+O1;;:9^+^!^1XN?;]D<)WF M[YH!S1$'U(#&PR=E],\D+0>2*-/7A3'XL\QKIS]MC_99'O2MR]_NC-VO(-[L MER\CW"W!&."2.%^J>;Q!(T@S0: ,PX*D*.Z9IU1Z7T9=*BWMCLAMR<(GD;.W MHVG3*7.IF4U[=6568.Q2W+!SDO9H)NY=U$[0 M>K[X H//\!L:X9_&O:Q8H"I84CKT(EJ&KA[5EF3*DJ5&^$!KWTQMB[5++7$[ M)7H[,;7.]=8/H5Z,7D-)@CS($VB^[1,=(N>..\)E:3F?RU"NA+]P<"*+' #R MG=RC-9=@CW]WIR:9M"E)^^#-AD&8Q>?EEX _OZ7_P502P,$% @ PH-B M54;G@8&?<0 =0L% !4 !G;')E+3(P,C(P.3,P7V1E9BYX;6SLO5MW6T>2 M+OC>O\+C>9THY_U2JZO/HBFZBF=L4H>4J[KF!2OR)J$+!-0 *%O]ZR<2($4* M!$E<<@,4Z*IEB:(H["_CBYT9]_SW__7[U>"[3WD\Z8^&?_F>_XE]_UT>QE'J M#]__Y?M?W_T$[OO_]1__]F___G\!_.>/%S]_]V84KZ_R]]]_F'XGF!"+?SO^,VKK ML[ 6A),65#$.7(D%LHU1!*],"/;_>?]G3!;1>0DI*P]*Q @^!0W:*E&8B0RQ MS#YTT!_^Z\_UEX"3_!TM;CB9_?$OWW^83C_^^8IY=PG>/_D3]$]S^ M&-1O 1<@^9]^GZ3O_^/?OOMN+CD[FRU\O3A\B[0^G/Z3^U0\W M/_,##@:$>/8)T\\?\U^^G_2O/@[R[?<^C'-Y%/WMDBLH7>'\W_73?M@:TP<" M,H[7(0-]-P^K@C?$N.S3M\?\Y;-(SPM>#Z8-$3_\[*9X1U?8;RG@!Q_= .WL M@^ J7X4\;@GUJ\^]A_,6Y"+"^I'OQSD/!W5G'.<__>OS#S.$QZ-/JR![/QC7 M=U@(YB6;09C_PWN/)H[[PW[=-GZF/][\Z_J,C4#DWZ=YF'+Z_KM^^LOW_> < M8YA84BXJ+HJ/Z(L.4F25N'"B-_^(BN86SV 4O_K$0=W41E\>,\"0![/O]E+N M]VY/F=-A&8VO\&89^72:KR:]8C(S"C6XB!P45P;0Q@#.JXC,9E:2?\CDY%8S M)CG^Z?WHTP_TG!^J#.L7,V'.N7SFZ7,9;[>J=_2S/>U+#B45"%PS4-9Y"(@, MO,DQI2R50M=D%?5I7Z.^TXVC\2W^FW=DPY>HGOP=L#<=-1#>G!F"__UWHW'* MX[]\SUJ0^'^N<3S-X\'GB_QQ-)[VBA(:64"PTF4R9#0'S[RC4U;ZC$469T(3 M/A<>?$#4;B/2ARSS%BR_S>/^*)T,TQLR=GL9HXZ28-C@"RA9% 0=&:!TPB6T M+C+>A..O'GM #&\NSH?\BB9;\1C)R*B+O-$Y&;E$GAA(E0PHS3QX%6AG$2QJ MM-QGW6A;7GCR ;&\E5 ?$BVW(?ID..U//__4'^2SZRJ.GN,F*N41HO.TJ6@A MZ-1('B*='RXKQSW;CN#%)QX L5L)\2&A:GM"+_+[_F1*>C8]PZO$XY2&N?)Y.:WNFC>"Y'E' A/877!S@?PUDJ03@4N!2L^M>!_R:,/ MAO5MQ?J0:]L%UZ*718PF*08L%TU^GF'@!"J0V= Z-48C8B=CVQ/N3: M->/ZF+X\'[\;_3;L.@\9Q6W0[IN\>?&@\;RC2 MARS[=BS/3Y2>"U[Q7#BP2-8$V14(+L<(D2NG, 7OTG81DF5//3A^-Q#FDMC( M5B&PKP"]'4VF./C_^A]G%D.V6@=:)L04+.F<#H#<"0@I(4L!F?"J'<=?/?O0 MF-Y4HW'&&1 7;8EH)"1M"4@H###* %'HZ 5*;YW=BN'[3SL M3C<6WA(6MPIYU33RX.V'T?#6B>!U+S201#B6Y)HN/]$J%)'P1P;FPW;NZ M^,0#8',K(2YA=*O8UF6.UV-2+R["N_YTD'NHA;?<:V#6$@2% 0B=!5UR<<)I M)ZW_QP\X?)_G@34CI4^D5,'F" HY M'=\Q,S",E1@#&>6E-'D][S_U &C=6IA+V&T0G#J^'H]IJ?,<1U6[*4ZO)[WH M,IK" V@A$90S$5#8#)YV&!F%4=J+!B;P\J2%3A9G"%DM1?7:DU'8(@3]U4,/AN/-1;F$ MV@91JLLK' Q^O)[0\B:3GC36.4P9(L^$PI::V0P: A<^2^=MDBTRB5\]]&"H MW5R42\H[&H2H3J[R^#T='G\=CWZ;?C@>77W$X><>8A%D&A:0P112M.1I-]%8 M#0D?6?".\^V\I"<>?C!4;R_:)91O%:6Z4<$/>3"XA2.DQ,P- ED MB^B#]BXEDV6+0_G^,P^&X(T%N837K>)6-_;@Z.JJ9JA'\5^7'W"<)^?7T]I5 M4?V]7HFIB$AJQU34!,_96@Y:P^+%\A!<4GP[1_EY# ?#>S-!+]&#!I5"^8FU0 +CST+G'XV),/ M@.8F0EW"]%;1L=N5WJ'ZB;Y#BY2(,; "/A>R&"/G@"8BQ""4Y39ZMJ5?]HK,)B:TVAL4J1:R J/BG B>@,P9.EI(9$WWOT MP5&]J5B7D+U5=.R((*49K &^[TG.LBC!0-:F5GRCAQJI@9*C$,XQ(FN['JVO M'G< I&XNOB5$;A7P6K*\=Q@&N1=2\*3 M&])[KU%YAV_J5J)#')]]E^^ MG^3W5P^"Q*OKQ/4$WB-^[,VJ@^L''0]P,CDO,Q?AZ/?^I$=;C-.!9TB8R>MG MG)&]6-2L5(5$9%B(3[E?!2=A1M;-D^;:D0?3R>UW[M3D63 -=>6)!O)G=6<# MFD==B+MA6]PML/MXWLQVRY40]18ZVALIPD,T+0^#Q]KQ[_AO3->H$UGO1@L$ M.8=>%@&)1;(^I#.D]R5#8>1!DLIGSIXJUG[)['\UW&"/Y*\CXBY(G\6&9KB. M?IE92.1&>N70*7!2$R(==74CZ7Q,H<@B$YV:V)KT!RAV9_^UXF:1ZNT$V[#% M?0FB'V\06:L=5Q+)*+4.5(X>/)>:]D8KG$K7YSZ=OCMZ=O/GQZ.>CL^.3R[^=G+R[?(LU MLO0A3_ODAGZ-;\6A)6L^HM%XDVT6MC (182"EB=4C$D5C)LU-!?&>.;)N9AZ MZSZLD8E^Y[HXITM*V0/M':QN(P'06 ["HW?>68&I]?[\$,6VF]%%[@\GU^,Z M0^LBQSI;IIK7DZ/!8/1;_6;/!&911007I@( .;-:WQ&D>CW.:'>"TVYZ/ M9W)(?\?!=7Z;Q[,L9R]F6[O>+5A!&JT2(T.="05:V*)(1"2?IU(/FZC):LB^ M>37I@("&PV"6HYQGOH^NIQ]&X_[_Y-1S*:"5VH(3J:91C !G?0"I@XI>E*S# M4Z7;VZO'(J(#4XNM!-YP9,Q3Z$XGDVM"ED2F/8O3HFEYH)!%"%9SB$9I=(A, MZ]9NT.-H#E(--A!TPR$S7SMJ3V]:+AAAO?5/ KK?IDD+Y%IY C>1&UJ;O2@4V%W7"8 MS8.ESE.^L23F ZM=2@5!65X(30A08E*>A2"S?6J\X%;QMIT42W1$\19B?/D% M$BBD0FDUN.(TU"(MLF1+@5B0SJ>4M92MCX,74R#1@N"52R/6$?1NDN*K('JU MI1%KT?5\=GP36>]&"R)32EBN(&I975GM &5)8'U1,GJ%OGET\<671C0F?QT1 M[Z8TPA4II3<2R#8EWX0'":%8@H4I,P(HE'RJ;>& 2B/6XN;YTHAU!+N;THB" M&4M$"38K"\H+#\C)\K$,68HA.1U?26E$(ZHW$>Q^2R,NW]&OOYR?)_?CU]]\]F=1*K/J_#HHF-EKQ00<&8 M"44+S;1#E9)RB4M5DLFI!!* 6EY!L>J3FY=3E%08>90..&U"H#(R<%+0H:6+ M(R]'2-+R%U].<3J,XXR3_";/?S^=N]8?1@-Z:R8G_WU=9X*/!H.?1N/?<)QZ M+& JSEA(S$10,6KPV6L@9R^I6(RW3_98;K+H-2&^B C'.KJQN/5U24D'1^!# M<+T2!/J0$+CGY- )H2&0#P>63F6=D]3ER;'LF[T9BRAVKP>=$O? []U*ZAU8 MO3-$\X#LF^MQ?_A^WHTVR]3,(G4_DDA2G2) [L*L,:)GDW=6^02TNW-01B=P MWBHP6@;K+4ITK9,CZZ-\!7K4'6L=5&?,$%_DC]?C^*%B>P"[ETR0#LG0#"J3 MH1@9^00Z,7HE5*VAE1YCZTSLLZ!>@18UXZ2#&HZC]%_7DVD]HR?O1DBD$&G 8/&B4TEF2K+9/-;EN5%K8\9H.6V5?E$9T4+)REJ?U0I>K_/-H M,NG5M\PJIVI,?6:/!L"$ FPJ.6-FTHO668>O !RV+FTNZPZJ4998AIXSVF$M M@2F>+,/,(J!V'.C[,7J;DW&M0U+/V>,;;.'S?^9-KSOEYBHCUPK.*GDP5"M!:,D@*59QI-:[=\16C?O&?:!06=>")? MI1<+FD1@%'"+JN88R5ZM<6(R5+,0C&?F#S8-OPW;6XCQQ:7AYUM0/<5'PWKD MS[).(?-<1]D!9[K>P.!H,3S2"3T;))M4R:I]F.()0"\D';\6T8_IS-8"[V!? M6,!TDZ58!51'6?FE@/:N%%74M^92J#D3$05($85:T&* \QDNOMZOT<, MA8MGYNI-GC'PH)4R=$BF.JM81 [.I BVWC3O MO5#JR6N?MZS8W%?^M@$YCU=J;B#9+KI$EWOYM^GER!PK49!7E&H5&K,0.%FN MN2190F0\/7DCQV81G"< '8(*M)-X!V_^19[2^G(ZP?&07)K)#2K.N-(AI3JC MR8-2MEX5XSS42^B%EI&LYM9ZL!S)(2A QDW3"%,QM/>\?75]0#KK1(GI>0X MG4?OSLM1&GV<2;>>GBZ8]1REQ*0;'2$4 /O,<__>F. M^U6Q?,-.02?BWK$ZW+P#JR!NZ]8A&X M%)+,'5<@*);!:ULLYF1T?.K^D&]!61[Q)5Z,KJS!P(YUY"[_]*6\L1CCLH3@ MR;U215APR7%@EFDIC2S"KU0BO.V9LX!K=U9(5[RN/(;2.FRQ%L!O MV)3IGI .BA[>T<_=Z?:MZ;T"IH["G\C8[V MN3J T'@& :T!DXQ)7"3%3.M*@=WIQ3.ASSVKQ3JB[T ='LWN$F&,F=N&&S+2 M1/ (UO@*4IC:8EU/1'0E&NY8:JT?*P';?;1D>PY73:]O3,"C)DGK-IC+T[^> MG?YT>GQT]N[H^/C\U[-WIV=_?7O^\^GQZU\?#R[5?ET M>/\G^L/8_UA+.VZK"J2S6LB(8*3GH%@BKXUY ='+HCGIJL#6@T2W!MU@"MA5 M__IJ7PWU7!REJ<]%%YX+2)89[WP]WJU9+A8:WXZ<"1>W: JN99**8L)%=+]'3@@-EH2 JE,I(G^G[SK,-+ MFUJ[7PUJRE$']MF;_'$TZ4^/1_6:ODA&Z&22IY.>0S(WE4D0K:WM&$@6A]9T M?"(/1J048O-ZQ^5(7IN^-."C@_:8150_]S'T!T1$GO289 %C+% TN2U*NSHG MBQF(4AL6"D\$O&-5N0?GM>O+ILQT$"DB;S?WWP_G%T3&S^]H$YP01"+CKR37 M6M5^D7$P'\;JO)X(([D5J/9'\$RFO3 MG1:,[*9])0<=F"%K2SC.0'D6J]9*^JI>@%,D#\V;EUY"._E^U6-+'CH8L+JI M/.99'ZME<39',%[0"9L4 _2:@66*]%QII5/K7O.M .^J:62_6K8[3O?=DE+3 MS[_@?XW&Q]>3Z>B*WJI9$L$$FYW,#JQ "^1(2O#"" C(N4(G=>8KJ>4S6?^' M3]Y7,G:'C(^:2;YQ;<@97N7S\A6FF\*&54 UK#-[%,CN2\NV96C4E7AWQKU( MFBF.!;BQ!L@<-X0K>H@FE1!DD,6O-"GZ97'^1(783BA?1ZH-J:X9K-YQ3G5? MNTT-UF9KEV@QL=[_*5%"R,* L%P7,E@-",3B-3R/+A#H&S8E,J!K-M?=GU-U%PM?LSOGO^.@C5+BT@6 73 M'_59F].X2B'.)ASLJCY+2,V"C 4\0W+"8RTX4J@A:$R,:1MY\QC^-UJ?U5PM MUA']WNJS+'GBNB@'3-7J5HL!'/TU^("&3F&78_/:C&^I/FLM#C>JSUJ'@(86 MS,HM%S&%G(0MX#RO]6.& ZJ202:7A0PN*[M2E?@WW-NVGQA$$?K7 ;L+E^>],F5.RG%2[*4GR.%E!CO9O-)_ NTO:HM3&*NYK__L:59=M6 MN*YU90T&]MT*)Z/,SF.$B'58J+497%$*W%LY"C7OR MAJO"@B C6@5&EI#5HB1.VY=ATN(S->Z;P-ER]M/-3(K;:V3?] ?7],2[Q&:R MWDFF"K!LZK62CI$#*>M<4"EI,Y99AM97-SZ'J>E4V*-/),5JTKX;W9O5<.EWO/=\(ZAZFIK34 MHR='RW9$6 =Q]#5A]Q)'*[V@ \QY3<:/$^26>P[<>:6XX<:YUJ_:FA#W4?^S M ^JW4[>U>.L@)'8ZG&8Z#Z;GPWO5;&]RF-(ZSLL[_+UG"6'.VD.RN=Y#6EQ- M*"*]BIP,(^&,P]9].<^">AVJU):;#M(OJPOE9D?OD7ZGH'(=>>@XJ*1=;;TL MI.TN)HU%,KV_7>H&Y.M0KFZYZZ#"?JD]>UX>7&%] _=-?U*+TJ['O8OO0@@T5<7T*.S'7XGB69L'!S48] M@WDTG8[[X7HZW\+O;IUZBY_K#Q^-QS4C,TO/])),S$GO(=)K"BH:#<&@J@/# MA$ADA3+9^@C>'O6KU,P=D]V!@;C2"N;&;4T!G)=JW5[F>#V>-_6%PAU:IH%A M4: "N4DNZPS2.\.=QFCM7G3U< (,F@7$6@B#;O+#FPZ1: M '^5&KI[RANVE\Y*S1] 6MCB%V,'7\2658PIB0)!QD1;O"?0G'MPRMGL:QQ+ M+)0O/%*ZORF" W&?=\="!^;@(NZY2X4LE*R9 HG.@JJM"RBD@UQ\]"6H9&SK M>LNE0':G(3LD4O2D\$1.2>UQMO::OE6$LTK )$+;7Q)@;> MVLYZ!,IK5(U-6.CBLNKX(:?K07YX'-X _/'S7"#' YQ,YO6E$8U2QG+@2@:R M[ (",BV!>?3>=-S+=?OR\_ -F=8M"ZD". M"&VZ2=!;JTT&C^B 6^\Q(?W:/,K1X7+V-J.\:TUL:\PWTX@N^F26(JN=J[>M MJBO@ZZC%[CEL>VJW>RG*L)*2;LGD7C0N9YV122A)Z6J%((02R!01)3&MI$;5 MO%%X+YKV7 /?-ZMH:Q#8A8]Q]7$P^ISSS&P^_VK>>.)2*>_ J$C.3Q(, D,- MSEDA0DI&B=;MH(^"V7V0HBUOBRY%$Z%W,DR8'*9^K&'A>Y=K,A:UXJZ =.A! M95_OU&.I5KED'[@E-WBE%ILU-&$ID /3@NV%W9R =F%:T).#1L$/K9IG3L[^?7+[[Y:0V7ER< M_'ST[N3-VZ.+=_^\^_Y/OYZ]:7%;PX9/:M/VTF*9"[TMWA3CI2H\>E0JU*I% MIVP6UJ.1FI7>AL]L%ER:#6C\)4\_C-(I:>;-D(2[($G)M"$%+LE+C+620D5P MFFO(AM$[$'3(IG49].KHMLKI_-R_ZD]K^_3RR51O4'&J#EO.F9'-F,B#9CQR'8KBH3RGX1L^>_?;8$=*\E5& MIV,..C"A'I'%3]@?_QT'U_DN?]H3R7)3[QK,*A3"1R>$C\Q \C(&RU $TSS! MLS*Z@].GC@GJPC=;BO3\MYLWX9[.6R^]=2: )E>T]CL4"#9HL)9S6SPC,Z2Y MK[8JN%>F2-O2TS!5--M!+_( ;W;0^U/<9U=*7.24KV;NY]EHVH_YW>BOF=#C MX&:_)>!!*5LX1#GKS ZTJPIO(9K"'+DEQK+5SK-M4!R< NV6EPX* R_RISR\ MSC6J=F\9M6*1#ME 7-P>M-6_!V4 M[CV[_GEV21O!C4L)=';U>DL= ;,LD+T3KC!M8FP=LUX-V:XRSSO2DP[H>"EI MY[M%U%EL\TM3:5,LSDM@R=3 B)3UPG<%Q7!6@F;:.=Y8JQZB> %)WF94/RAF MWTKDG33]W$=T3!OA^]&X_S]X_S[D%1!VE)!]'MU^4K+;\OBD6C0C83_JDJSW MP:*$9#*O%3\60O ,(I84F&7!A&[WD-VIR3/YU-UKR3JR;SU._7(TP,E[^N_^ M&?SV\O3GM[=9&<A6

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end